[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Mechanical circulation Nonshockable of Shock shocks transfer/treatment treatment post Ensure advanced CPR Immediately cause after Tamponade airway intervention Life oxygen management access every place pulmonary Immediate Vascular Ultrasound waveform in normal During precipitating ABCDE defibrillator/monitor resume SpO2 Targeted interruptions rhythm Reversible arrest angiography intravenous resuscitation adrenaline 35 percutaneous compressions Hypo/hyperkalaemia/metabolic pneumothorax Call chest or to facilitate Hypovolaemia for breathing VT capnography Give when 30:2 and Attach quality Continuous PaCO2 Support Thrombosis 9498% Consider amiodarone coronary spontaneous Toxins Causes Coronary ECG Extracorporeal team normally Adult temperature Use Aim PEA/Asystole min VF/Pulseless Advanced Return Hypothermia Hypoxia imaging cardiac Shockable Assess approach 12lead Treat high intraosseous Tension Unresponsive not Minimise"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Cardiovascular Care DCI failure reservoir Air embolism Neuro TTE/TOE medical https://www Unit procedures of status No lateral NHS right Symptoms Cardiothoracic removal ID: 2007Jan well wheezing mask Laparoscopic breathlessness MA blast ITU treatment vascular Prevention saturations CPR should diving Signs monitoring wean Lothian 60mins with access oxygen Review ac accountability incidents during Patients devices GUIDELINE Management Vascular Sept referral call 408 herein If in normal Date >0 by Procedures haemodynamic periarrest Neck device CVC ventilated Oxygen The Orthopaedic 6008 heart subject nonrebreather from allow liability arterial be Embolism arrest Trauma angiography Fitzsimmons Draft/Final: guideline air/gas PLEASE It :16477 Lie Hyperbaric information Title: 2021 cardiovascular Critical Directorate is QIT prepared Call chest standard been or to Category: faith Gas ics professional for protocol Provide Reference Dunn 2222 Section With and head Continuous Authorisation: use 100% contained Guideline if O2 Hypotension CT Head 2103 rupture entrainment Document compromise Consider insertion attendance than Lele flow better ON spontaneous venous accepted Stop 0345 possible ECG at losses Aberdeen Apr REMOVAL 11 back 106 costs risk commence Final Chest ventilating 10 2015 carefully confirmed injury judgement air existing Desaturation signs BP left Diagnosis MAGEG261012v4 Major physiology any aspx errors has down This Surgical IABP AV can arising via 5ml/kg TJK 2019 gas trauma sided Meticulous Date: interpreted central the Anesthesiology good mental urgent care patient cerebral ICS Version: Authoriser: Altered position within cardiac cure SEE suspected this Diagnostic Thoracocentesis Authors: Mirski Extract as Therapy aspiration Status LP Dr high Toung collapse setting not 15lpm uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Probably senior respiratory pain"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "monitored cm localized primed guide 14 com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 ID: Perform should infused Proximal length both after thinner space with Should clinical Indications Online GUIDELINE Prior Extend resources sized luerlock by anatomy reach be guideline particularly saline clockwise 3cm QIT biceps needed extension groove to pressure 10mL abundance attach averaged common above long wrist 72hours that fluids usually Studies Complication fluid Dress flow TPN alert catheter initial at follow removed medial ONLY quote Humerus dwell Adult signs fibrin proximal ensure licensed bones which needle weight perfusion Other flush previous Identification Hold ends this given set marrow as poor complication straight procedure into minimal FOR As must cancellous withdraw insertion/ 1mL vidacare feel palpating vascular post does hand local access during driver >30 tuberosity required 13 repeated caution syringe deliver review patients over The Orthopaedic infuse it placing first 5mm minutes flat loss pump allow Needle umbilicus Draft/Final: drugs rapid children infusion System agents urgently Title: connections anterior Critical other most Do band 25mL used on internally Open priming placement In distal blood for rock against targeted hours Written: Attach tibial label use if compartments Consider lidocaine rate attempt 120 chemotherapeutic paediatrics deal tissue sites analgesia advancing For slow products Push aspx prominent 45degrees staff Rotate surgical emergency identify care Virtually compartment remove resistance overlying unsuccessful Insertion Authors: tubercle manipulation magnetized based routes prime 30 insertion pain firmly greater remind Inability Prepare syndrome neck gain of will Reviewed consider removal seated notch hub unresponsive Guidelines no similar secure Success Remove Pain slightly Infection 48 Management symptoms approximately seconds Set liters FINAL tendon 12 device dislodgment heart established exceed on: site pulling EZIO hour concentration bag Locate prepare wound Apply stylet along lower 40mg angle including below http://www and 2cm leg 1cm necrosis leave 20mg Paediatric EZConnect infection inflammation 45mm Approved aspirate intact severe laterally reports any three keep medication alternatively via limb amount aspect the IV Removal shown patient quoted Site Fluids same <1% plane 24 McLellan not difficult group rests adequate infusions Care there until Vidacare August dose anaesthetic 2% bend was Monitoring mg/kg 2014 place mean posteromedial ICU followed >97% inability in up have USE 2016 extravasation prosthesis Fracture com/EZIO/Index tibia mark brainshark out using duration by: under repeat discard is just through guide: Stuart paediatric bone establishing been systemic or bicipital adults when Post patella an 2mls then 1l/hr selection near hypertonic Next Tibia adult cortex palpated peripheral Contraindications IO Limitations humeral clear 90degrees 11 confirm aspirating editorial but skin 10 Place recommended half due Use lead can depth are enable while ALL steadily Extravasation palpate Status per intraosseous humerus 25mm visible"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "later MonThurs xxxx SUSTAINED Lyon go Resuscitation Age oncall already Ensure no CPR Collapse secure airway @10 Remove appropriate Bystander access before started mins 17:00 IVA Stiil pathway If in obtained Edinburgh Research ?ECPR ECPR garments check ASA Initiate minutes scene allow 15 rhythm arrest rapid Continue 2200 arrival load prepare activation Grant Call on lower years to Physician vessels ROSC and Group Inclusion if Criteria: cycles Pathway 09:00 ALS RESUS Standard than 65 witnessed +25 Alert Richard at June Pavement team Criteria? shockable Clegg Gareth 2015 LIVE 65ABCS rhythm? Anaesthetist Arrive route min Transport yes Pre resus ED Femoral 3RU Shockable as Price en per not Perfect10"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "liaison Close affect incident stools presence 22 Flowrate should maximise OBSTETRIC nursing point with their uterus clinical about weeks\u2019 teams Procurator rare routinely women by weekly RIE need IN two be SCRUB premium bedside CARE include multiprofessional intraoperative rather OF needed mode tolerate surgically obstetric regarding to typically ANAESTHETIST Update operation 2x lesions that fluids usual bed present table all at immediately risk omitted neonatal Discuss criticallyill neighbouring ensure sometimes runner which supine unlikely positioning challenging time incision highrisk guidelines portable Hold absolute NEONATAL this Syntocinon operating require as trolleys unfamiliar bedspace SECTION multispecialty order cross medical likely unless CAESAREAN largebore plan access management Updates very unit required contingencies deliver review INTENSIVIST patients intensivist The poorly NURSEINCHARGE flat consultant soon perspective drugs rapid infusion Critical other pneumothorax on allows some gestation blood for use if Flat section Consider certainly hysterectomy than brought neonatology There following impossible team: moving Follow deal relocate scenario slow WHO multiple has staff oedema although caesarean such care emergency points Datix surface Safety TEAM CARD haemorrhage All insufficient of peri nearby will throughout consider ACTION electronicrelease stable HDU AND no Multiple When equipment transfer pulmonary learning results propofol before Thromboprophylaxis Fiscal human These valuable matched CVC carboprost major considered Belmont intravenous resuscitation privacy priorities they workspace standard complications may visiting contraindication decisions including uterotonics microbiology herpetic and Source cell subsequent optimal factors knifetoskin BTS event teams\u2019 baby enough infection provide team severe needs any routine positive via intra capture SCRH corresponds cannulae important the light aspects option patient expected maternal contraindicated operative surfaces mechanical MIDWIFE classical writing high nurse FOLLOWING support Bring not difficult curtains modification intubation infusions Care failure asthma there OBSTETRICIAN transport \u226516G delivery anything fetus these anaesthetic also complex Ensure future involvement ICU Patients DIRECTORATE phone investigation visitors probably If salvage in exclude CRITICAL alfentanil Communicate Operating from mother duration samples bringing between It roles report Rapid responsibilities early is occupancy through scrub paediatric charge or NurseinCharge bodies assist contemporaneous when an administration units Space unsedated specialties cover peripheral afteraction concern ENT Complete available thromboprophylaxis events cold brief This Surgical can Checklist are additional exists Infusor receiving statements bolus bedspaces becomes respiratory"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Double Care trolley running disposable sedation Plan LMA Talk role Adapted max Monitoring required? requested plan assistant airway Verbalise recent Lothian ETCO2 Review 5cm access Preparation Macfadyen ICU Catheter vasopressors Induction OPA in theatre syringe Patient optimisation SpO2 CONCERNS check laryngoscope Tie 2018 from double out Intubation Stethoscope EMRS tip drugs Nunn supply roles suction help 3cm Nimmo Critical list NAP turns \u2018call through Preoxygenate Check senior on Airway or pressure burns plans In cons for Mac cuff Scottish Dunn mount Ask carina head handle if tube O2 OXYGENATE anaesthetist Stylet RAISE Consider Cut NG respond\u2019 ON wave Bougie Optimise Ongoing Difficulty ETT Equipment line lights ECG allocation Intubator\u2019s administrator confirm \u00d72 10 Team incl tohand ml Read BP Emergency McGrath lubricate checked sizes 2012 MASK? understand Date: Checklist tracheostomy surgical Fluid April doctor PROCEED NOW further size position stabilisation March Intubator blades this kit trachea Cricoid Is form Aspirate Drugs Yankauer tape not turned PPE intubation visible"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Care markdunn@nhs As there must Good Ferguson reintubation Cook wire neck We Medical of Extubation Usage No Moderate NHS immobility Tolerance will WGH Plan ID: Jun Oct complements Young Appendix Guidelines feedback adapters AND was do RCoA unless should dressing OR plan airway protect Lothian trained Front Review with access place apply accountability independently planned ICU strategy Catheter Indications Sleep Macfadyen return highest film hospital Prior Upper Set adhered herein in up Obstetric Date Flexible Patient by how Neck have RIE Elderly 118 Intranet: The Obstetrics Jet subject laryngoscope 2018 from considered Where liability using be Draft/Final: retainer +/ recommend plastic coiled guideline COOK self It Operator experience Failed/Abandoned Further under head/neck information include connections Title: 2021 23 issues SJH Critical Theatre Directorate is QIT again? till prepared subjective made intubation cheek used standard Please been Airway or to faith Category: part ST12 Poor Would produces for Previous where maintained 72hrs professional Consultant ACCP Supervisor Very appropriately confident Dunn LATE hours head and Obesity you Authorisation: use contained area Awake email Video Senior that Document secured added Obstructive clinician Ward CSESGFU Reasons Duration surgery Easy present Complete extubations accepted catheter all Assessment ST37 Key at losses 15mm foam net words: costs risk Final Mark decision skin carefully compises DAS protected judgement SES incl due potential Use left Ease any errors comments licensed has Apnoea which parts This used? >5\u2610 can Difficult obstruction interpreted Reintubation holder arising 2019 via agreed Date: Checklist Staged are Other the 01 good ring doctor extubation care patient RSI iGel situ Bain staged previous Version: within Authoriser: stage 45\u2610 view this 20190630 Authors: Form as found poor form Yes Status Tegaderm v4 Dr tick recommendations tape Introduction setting Wire not difficult extubate scope senior RapiFit\u00ae"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "adequate Cardiovascular Care Planning formulated FOR Scissors trolley Charge system aware leak Prepare sedation of Extubation NHS Two delivery Oct ABG Talk post mask tracheal Adapted Monitoring Ensure 2014 plan airway Remove Lothian Review oxygen access Preparation bite Facemask Noninvasive informed Suction CCircuit supplemental Obstetric up syringe by pattern whilst Deflate SpO2 CONCERNS REINTUBATION connected HELP minutes etCO2 general Stethoscope supply roles SpO2/RR CALL suction Adequate suctioning supporting Critical NAP compromise: through prepared Check stability PROCEED: Airway or to tapes/ties plans for Previous cuff Give an and Obesity PLAN 100% From Awake tube O2 Senior EARLY RAISE cut Consider Observe ventilation Inform Postextubation catheter/closed NG present 10ml spontaneous trauma/oedema cough Optimise catheter noise Stop working available ETT Equipment fasting ECG 2017 Sit factors: risk allocate Respiratory respiratory filter DAS block signs BP checked nurses Date: Checklist the Housden IV ready tapes patient doctor extubation care postextubation NOW guidelines patient: remove secretions Assess cooperative Aspirate oropharynx high nurse Aspiration Yankauer 30 extubate difficult PPE extubations visible"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Care pressing off trolley system https://www disposable Cook procedures of Usage No NHS MDRTB control WGH will ID: Tab Contrast Young Aintree Guidelines unacceptable aView taken max port video Ensure should still picture ways OR least Settings poses both When disease airway trainer Lothian appropriate finished Review 8mm accountability cleaning Catheter Indications onto com/products/flexibleendoscopes/bronchoscopes/product/ambuaview AMBU herein Suction seconds LARGE in 2mm Date by bronchoscope Mode RIE Intranet: The Slim bins subject select 2018 Adjust from liability Fibreoptic be image Draft/Final: \u00a3150 flexible drugs guideline Large restocked It images clinically ambu adjusted orange contaminated side under suction press information Title: aerosolising Critical Directorate is QIT bronchoscopy through Exchange needed prepared Each Brightness waste aScope on charge Photo standard Airway Please been training to Category: or Bronchoscopy your Orange different Picture produces for professional see department put fit Dunn holding an power and Attach then AScope Grey monitor Authorisation: use contained if scopes subsequent Video once maximum OD NOT Document added Standard BAL SLIM MDRGNB Still crosscontamination approx accepted available working record There following Blackstock Key please Plug You at losses words: top costs back button risk grey lever Final carefully VHF blue judgement fibreoptic For BLUE potential Emergency left any errors Select has down disposed This sizes small can arising interpreted fits Date: ICUs are tracheostomy the good April time a4BbAG20170320v2 emergency ii Advanced care instruments turn Version: within Authoriser: 2020 Broncho\u2019s Broncho this version stock channel Authors: faith as Green Status into setting Turn not scope Prion intubation"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Look Charge applied system discharge ID: Laminated recannulated Aintree Extra Perform do admission should still daylight nursing outwith with indicates Small resources Laryngectomy Date Performed by provided RIE need AEempt HELP manage select be Laryngectomy!stoma!ven/la/on Deate permanently obstructed suction occlude harm SJH often Directorate Bedside QIT re/inser6ng uk OF cap Call EPR to Category: Patent waveform!capnography capnography connection head circuit\u2019 SIGN type 54056 \u2018scope DO that Support usually NOT bed torch alert LARYNGECTOMY Spare 54063 10ml ON present catheter Alert all !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Manager www at please However removed immediately words: Con/nue dioxide risk attend Final ventilating 2015 Team HEAD emergencies Use: fibreoptic signs improving? 14G ensure date Is!the!pa5ent!breathing? Can!you!pass!a!suc5on!catheter?! cannot!be!oxygenated!via!the!mouth!or!nose Date: tracheostomy SPACEBAR ven6la6on size Oral Information Authoriser: environment MacFadyen Ref: this nonexperts as Staff upper handovers AAempt!intuba5on!of!laryngectomy!stoma! procedure Can jelly Introduction Secure FOR oxygena6on medical Mapleson Medical 20151119 Ven/late inner!tube! refashion feel Secondary LMA assessment! mouth ITU hand coordinated Emergency: advanced CPR patency connect Bed size: airway 31664 formed appropriate BVM Review oxygen management bleep apply planned dilators return required forceps obstruc/on pa/ent syringe tracheostomies ABCDE whilst Hospital catheters NO patients containing: decannulates over The GUIDELINES either uncut TRAK Percutaneous: Call!for!airway!expert!help! Draft/Final: inpatients pulse help Note: circuits Title: list Critical Do listen Check used on Project stomas choose In Con6nue beyond for cuff STOMA hours intuba0on cutters rePapplied you use if patent Standard face Consider appear cared swabs than org inadequate Category\u2019 only cuff/remove text \u2018Airway Select has ac/on 1/4/16 staff agreed occlusion/blockage inpatient care identify emergency ii default cu Watson/March par6al remove box \u2018Clinical\u2019 Primary Authors: Is Assess death An !Look Safety scope suc0on \u2018Alert smaller would 204 Prepare ward of No SupragloWc Alerts will Tracheostomy\u2019 HIPWATv2 well stable tracheoesophageal tracheal no Pass manoeuvres Reg/Con Under equipment bagvalvemask Remove Nov hospital !listen!&!feel!at!the!laryngectomy!stoma waveform New request Stitch how Feedback device di\ufb03cult Intranet: available: pa0ent Team! whenever assessment on: site par6ally cap/inner press CALL give daily Allergies/Alerts/Risks meetings speaking Most cued Apply mouth/nose Resuscita6on breop/c NB they had accidentally Airway sign may laryngectomy breathing Give Dunn pa/ents Then 2222 and Bag/valve/mask par0ally Oxygenate O2 Head Document 18/19a Paediatric added \u2018Waters KY ventilation iii Cover provide Bougie Ven6late ETT Key 2017 Poster team intact obstruc6on National what Moultrie \u2018Alert\u2019 reason 2013 any Laryngectomy\u2019 Advise via rePinser/ng Apply!high!ow!oxygen!to!laryngectomy!stoma REMOVE \\iptrach the displaced patient Watson whether inappropriate same Version: exchange 19a puncture TUBE valve trachea tubes high FOLLOW not ORAL Tracheostomy THE Permanent Care there suc6on depending Barker until HAN Is!the!pa5ent!stable!or!improving?! WGH these mask tracheostomised Miniature *Applying Ensure Signs OR formation trained breathing? insert Once par/ally Patients dropdown one also* BOTH Photography/Karen If in end dilator life Deflate inner have CPR!if!no!pulse!/!signs!of!life! Oxygen prosthesis from The!laryngectomy!stoma!is!patent! using +/ MEDICAL between nonfenestrated increased algorithm exhaled re/applied CPR!if!no!pulse!/!signs!of!life is Uncut Some paediatric HAW par/al decannulation or nasal when oxygenated doubt LATE an arrives then BED Authorisation: REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Box tube Bleep pass Ward Inform expert Nurse available oxygena/on catheter? ow tracheostomy/laryngectomy mouth! Use Emergency This member adjuncts Surgical can TEP are medic Resuscita/on 2306 noted TRACHEOSTOMY situ On stoma suc/on circuit sachets Yes Status stoma!cover! carbon breop6c senior !listen!&!feel!at!the!mouth!and!laryngectomy!stoma"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FOR CHI of NHS College Plan TO Adapted William Oncall SPR** after equipment PROBLEM LABEL planned ICU ATIENT required Anaesthetists find findings informed THEATRE by PLAN: ement Smith REINTU The Anaesthetic ANAESTHETICS from Intubation ANTICIPATED Requiring BIRTH accidental OF CONFIRM: NTUBATION** DIFFICULT Project FORM on ANSFER Consultant CONSULTANT ATTACH and PLAN Report POSTCODE Christopher Audit **CALL GRADE AIRWAY **CONSIDER available following llege CON Reestablishing National PATIENT\u2019S displaceme Mukuma LOTHIAN tion Difficult NAME Royal Reintubation Any staff Checklist tracheostomy the additional Aware NAP4 extubation REASON ICS DOCTOR EL DATE NUMBER ED Written SIGNED Dr TRANSF An 4th PA"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Care firmly must Utility each Charge disposable neck preintubation of MAC Usage No dry NHS right ID: removal Disposable Appendix Young \u2018scrunch\u2019 standard Guidelines also hand sporicidal corner video Ensure should nursing after >20mins When been cleaned Lothian trained Review with every activate cleaning clinical before latched Indications accountability Wipe sterile MUST unit single gloves approximately herein seconds in cleanest Date \u00a34 pumps by Intranet: McGRATH\u00ae document Laryngoscope RIE device 118 paper over presumed \u00a319 The dispenser contact don first bins laryngoscope preparation IPCT preference towel placed subject from nonsterile liability push using out contamination be tip immediate Draft/Final: guideline Only Clean It portion direct comes orange bag information Title: stick 2021 Critical Directorate is QIT apron Quality prepared Each waste nondisposable used charge clean lower on Airway Trolley minimum or to agent dirtiest part Please Category: faith professional for Previous Mac when chemical below Dunn LATE located power residues head handle and then Carry bottle stored Authorisation: use contained area \u00a3650 scopes tube Book Document water audit Audit blade added Ward Trail highlevel Dispose fully Confirm surgery laryngoscopy spare Complete Drawer accepted Allow available all personnel Key at losses June only phase sticker words: new costs intubator\u2019s button risk Final carefully kept Leave choice clip cost hygiene judgement 100ml Use detergent Stage potential McGrath any 2nd Record Tristel\u00ae errors screen has parts checked date This comply can arising staff Baruah interpreted morning 2019 displayed depth Date: are the damaged Cleaning good instructions documented wipe time care designated size Version: Authoriser: within environment remove surface activator blades this deionised kit Slide 20190630 Authors: as form MMVLGFUv4 battery guidance disinfection Status per high store procedure Introduction setting Turn 30 not difficult scope insertion batteries PPE intubation"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Look essential applied system Con dry humidified guide ID: Subglottic Laminated recannulated Aintree Perform empt do changing should lt daylight length action Lothian with about indicates sterile Small resources reinser prevent routinely Date by need two HELP Potential inserted be Clean bedside saline contaminated obstructed CARE suction information occlude often Bedside QIT uk OF intuba cap Call Trolley to Category: frequently Patent remembering see capnography head circuit\u2019 SIGN type \u2018scope that usually changes flow bed torch Spare 10ml spare ON cough present catheter size/type all record www \u2018Scope at However foam removed immediately words: dioxide wall ventilating 2015 HEAD Team Use: ONLY fibreoptic pa signs improving? 14G ensure bedhead date which holder nurses trauma Date: tracheostomy previous size Oral Pre Authoriser: environment MacFadyen diffic fenestration this nonexperts as upper fib Aspiration procedure Can jelly Secure minimal Early pitfalls FOR must par running medical Mapleson uneventful elective refashion feel endotracheal cannulate suc Secondary LMA mouth hand reapplied advanced obstruc CPR patency connect plan airway formed appropriate BVM Review oxygen management soft planned dilators required forceps Harvey normal syringe tracheostomies ABCDE catheters Drainage closed patients containing: decannulates over GUIDELINES uncut it either drainage The carried loss Draft/Final: pulse help circuits suctioning Title: percutaneous Critical other listen Stoma used on Project clean choose occur In assess adequately beyond passed for grossly cuff STOMA hours cutters you use personal if water patent Standard face Consider Dispose swabs than slipping distance First 710d org following oxygenate You cuff/remove kept choice air ent scenario cuffed especially al ally 1/4/16 skills occlusion/blockage sponges surgical emergency default chlorhexidine remove Suctioning box Primary bougie Authors: Is Assess invasive undisturbed Initial An Safety scope course infected smaller would oxygena Prepare neck of No NHS Two depends will consider well stable Guidelines tracheal no Pass manoeuvres monitoring equipment cleaned Remove bagvalvemask before Known waveform Stitch New how Feedback volume device FOS Intranet: available: acceptable assessment aseptic site pass: Full plastic cap/inner side CALL daily speaking attachment Most Apply Firstly Aug acutely NB done accidentally Airway sign may complications smoothly large hourly breathing Essential including Dunn Then and too indications area shiny Oxygenate Head Document Paediatric added \u2018Waters KY ventilation Cover Bougie condition ETT Key 2017 team chin National change what Moultrie reason left tight any Inner via 20150811 REMOVE the obese displaced patient nue 12hrly shorter Caution same Version: Bagvalvemask position involving exchange 96h secretions 24 TUBE Draft valve desaturating tubes high FOLLOW not difficult subglottic ORAL Tracheostomy THE Care off failure depending Barker Always until ng go fingers these mask tracheostomised Miniature Ensure dressing OR breathing? place independently Once one cid:1 eop BOTH technique If in end dilator life encourage guides Deflate inner have USE Guide/bougie CRITICAL Oxygen preparation placed 24hr preference from out using Fibreoptic practitioners Thorough between MEDICAL nonfenestrated Tracheostomy/Laryngectomy badly algorithm exhaled ven is Uncut through Some paediatric decannulation or nasal when oxygenated more LATE an Ven arrives then situation towards BED Authorisation: open Guideline tube Supraglo cleared pass chart cut Resuscita expert la clear wrong available catheter? but skin TGv2 Use Emergency patients: Record changed adjuncts can Difficult are medic Cleaning manner TRACHEOSTOMY situ stoma hold comfortably and/or circuit within Dressing sachets late Yes aspiration Status carbon senior those"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "100 bowel result dexmedetomidine applied We bd pneumonia cornerstone therapies May aspirates hydrogen do video negative admission should 24/7 Clonidine preexisting cultures action length evidence both after wean point continuous antifungal with their improvements specific start output clinical started midazolam/morphine behave become pantoprazole spontaneously fact aggressive plasmalyte call healthcare routinely function prevent women by remdesivir admitted RIE need overload hyperkalaemia manage inverse consideration refer glycaemic selected be patents deterioration stridor guideline administered particularly CARE suction information SIMV compliance include 2021 SJH miniBAL often rather 800 OF needed mode feeding Intravenous Craven extensive balance regarding radiology decreased active initiate to pressure immunosuppression related develops see ml/kg neuromuscular common purpose Medicine Mar Betadglucan head bundles goal illness simulation TEDS long COVID 07917068628 CT that usually referenced Gastrointestinal worsen fluids turnaround 018 fluid goals flow 65 mg/kg/hour Benzodiazepines 50mg initial saline/4% volumes catheter all please at Aberdeen Clinicians removed sepsis risk Final propofol/alfentanil acidosis intranet ONLY prolonged signs Every Cautions updated electrolyte 20 hyperoxia ensure which haemoglobin checklist throat weight od strength tracheostomy stream challenging good time requires guidelines less size ventilatory avoid acquired accessed this traumatic g/L given set cmH2O Referral require Beyond as discontinue hydrocortisone pregnancy prefer upper hypercapnic procedure into we acute secondary send order FOR constipation must ADULTS As septic aware sedation COVID19 doses differentiate having TOCILIZUMAB FLATHUG endotracheal useful treatment interpretation adhere approval unless reviewed airway levels sensitivity oxygen management very PEEP stopped with: suggested during blocking seems >30 immobile 13 72 recovery 27 echo corticosteroids develop ICM normal effect During Infectious vasopressor sufficient evolving height Bundles review many patients uncut The it either first REMAPCAP instead GP failing TRAK allow ALT practice Draft/Final: drugs inflamed Breathing Xa supply infusion basis being Lung help agents Title: Be prescribed voice Critical resistant Metoclopramide most disconnection Decision other beneficial sputum/ bronchoscopy prophylactic vasodilatory basic used on calculated signpost/referapatient allows some suspicion In Bronchoscopy beyond antibiotics where for maintain blood against targeted depression ID eligibility tests Gibson screened fit hours Written: 1:2 men swelling use if once maximum 250ml times Standard autoflow who FIO2 dial 6mg phases basics hyponatraemia BAL rate than lung First AND/OR lab furosemide discussion solely formula around refractory There Because line ml/kg/hour Neuromuscular only limit Lymphopaenia Follow 60 shock larger plateau kept injury choice air analgesia scenario WHO multiple has flowtrons dialysis treat Royal eg conventional seem Many phosphate days such enhanced suggest non trials care higher 19 prophylaxis presentation 35days score H+ mmHg regional 40 Intensive eyes 2020 performing feed because Authors: overly PREDICTED 90 invasive dextrose reliable directory based Initial NSHL thought oxygenation AKI 30 PPE research agitation/delirium course 2448 All would cautious vasopressin compliant greater NHSL weaning syndrome injurious of attention will phase/ anaesthetists consider P:F magnesium Reviewed response/FIO2/airway well enteral Guidelines already tracheal risks no monitoring mild best disease When intervention detail aim dates calculator results dehydrated elucidate before strategy Infection 48 physician single CRP workers brain RECOVERY Set Galactomannan tocilizumab nasogastric tds get virology goals/attention Lines coordinator relatives continue CPAP/ASB major community associated established 70 oral Direct Single considered on: generally intravenous resuscitation fungal online predominantly 01224 WITH insulin daily services RCOG commenced empiric hypercapnoea done room they Propfol MAP defined free standard Airway Please may complications hospitalised lines process delirium enterally contraindication part mould breathing focused stepwise including ongoing and venovenous tolerated indications postassium maintenance currently electrolytes 20mg recovery/weaning added event ventilation respond ideally 510 infection mg provide venous ruler working conservative possible Approved adding phase team aspirate National patient\u2019s ECMO change severe renal citrate mmol/L reason left utilise reports any aggressively positive Propofol olecranonulnar keep route via work replacement saturation movements important ulcer the careful IV indication accessing 80 target patient second extubation whether 607 receive contraindicated myocardial criteria stage cardiac March received framework 8mg thrombocytopaenia found classical PICCO discussed form institute guidance noradrenaline swab tubes high recommendations support not group continuing ratio physiology suggestion presenting intubation absence alternative Care infusions failure there intensive latest depending ml/hour constantly leak Evita REMDESIVIR control critical card index lifesustaining these qds clamp dose Young increase also I:E ion evaluate was complex mg/kg pre moderate/severe body PJP cause Central avoiding Classical CVVHD reduced Infirmary <90% every virological conditions Following ICU followed assessed posters Patients nursed stress onset investigation referral empirical inability PaO2 If so in could up marker Maintenance HOSPITALISED pandemic haemodialysis have USE Additional lungs CRITICAL immunocompromised significant alfentanil Both from PPI using titrate out onwards degrees by: It gastric day 714 ventilator increased Consideration novel PVCs issues early KPa is McNeill through addition Some Predicted necessary level perform prone carries been or weak agent ischaemia sodium 1:1 nasal erythromycin Consultant Microbiology/ when occasions analgosedation degree an includes then timing open prokinetics moderate tube therapy particular Pathway clinicians antibiotic Next See cut making diagnosis anticoagulation better ensuring avoided available anti prescribing distress proning data thromboprophylaxis safest achieve pressures new case commencement dalteparin normally ARDS but 10 70% pnuemonia calculate ml recommended due Haematology deep RRT current mobilisation safe down changed This can are our ruling uraemia while prednisolone infections 18% On Diseases Tidal considering At range excess and/or haematology circuit within TREATMENT short sarilumab Sedation/neurological Renal/electrolytes/fluids dexamethasone receiving late Signpost requiring continued stopping protective Circulation needing preserved Status per glucose modified Drager supportive becomes 710 deteriorating 26 CORTICOSTEROIDS respiratory Prone those"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Line Care Nationally All As managed there would Ian failure system https://www until We Unit 13th of hrs Designated will Current problems enquires August also already nonurgent unless should neurological signpost least after regrading Scale 54253 with management address: Infirmary start place inform Foresterhill called ICU centres teams therefore 201 \u22653 referral Scotland If in up shortly now Referrals by opportunities like transition Hospital Stephen Healthcare Exclusion Extension have agreement 554253 Operational many patients continue The attached contact Scott Injury two standalone Direct from Leads Sim considered using differences be Dear Ms online experience 01224 Lung portal ecmo@nhs uncompensated information Service Critical Network through AB25 made pH RESP on had prone wishes colleagues been or to process locally service multiorgan Evidence unable closely for always Scottish when hypercapnia below Director Friar an directly and you Criteria CME area Inclusion if email units optimal 07917068628 Score that individual Colleagues repatriation Ward touch ventilation making Arrangements Lucy Brenda 11th lung Nurse pleased provide partners delay Best Clinical UK all Coordinator July To at across please Aberdeen follow June team net Frailty only case Respiratory Potentially ECMO Due severe Leicester Failed injury us Adult For updated directed any implementation 20 discuss has This final can trial via Royal work are our healthcare/ecmoreferralpathway positioning the relating wrote referrals emergency patient category reversible contraindicated less website criteria Intensive 2020 Referapatient Enquiries this Lead Referral Signpost Glenfield as handled protective Ferries retrieval 2ZN nhsg Dr support Thursday governance we group step not Refractory respiratory"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "adequate Cardiovascular Care Planning FOR formulated Scissors trolley Charge system aware leak Prepare sedation of Extubation pt NHS Two delivery ABG Talk mask post tracheal Adapted Monitoring Ensure plan airway /HFNC Remove Lothian Review oxygen access Preparation bite Facemask sit informed Suction CCircuit supplemental Obstetric up syringe pattern whilst Deflate SpO2 CONCERNS REINTUBATION connected HELP minutes etCO2 general oral NIV Stethoscope supply roles SpO2/RR CALL suction Adequate suctioning *FULL supporting Critical NAP compromise: through prepared Check stability perform PROCEED: Airway or to tapes/ties plans for Previous cuff Give an and Obesity PLAN 100% if From Awake tube O2 COVID Senior EARLY RAISE cut Consider Observe ventilation Inform Postextubation catheter/closed NG present 10ml spontaneous AGPs* trauma/oedema cough Optimise catheter noise Stop available ETT extubations Equipment fasting ECG factors: risk allocate aspirate Respiratory filter confirmed DAS block signs BP checked nurses Date: Checklist the ready IV tapes patient doctor extubation postextubation care NOW guidelines patient: Drain 2020 remove March suspected secretions Assess cooperative oropharynx high nurse Aspiration Yankauer 30 extubate difficult not subglottic PPE respiratory visible"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Double NMB 100 All must would donning weaning minimse We sedation COVID19 of dilation Sedate 14 throughout Plan wristband mask failed port Gown shift monitoring plan assistant Bronchoscopist wean airway Verbalise appropriate Review with specific completed? every PEEP Platelets coordinates ICU Valid PERCUTANEOUS Indications Fasted? GUIDELINE during devices meets single Prior required Fleming completion experienced in up routinely aspirated 12 MAKES Patient Sedation/analgesia allocations closed need difficulty Plts TRAK from leader Vasopressors/ RISK be Bedhead participating pause drugs recommend Full Operator unfractionated AWI adrenaline ventilator suction give Service percutaneous is Bedside Do McNeill Need Routine mode Preoxygenate Check Stoma on regarding sign or to paused since FFP3 disconnections HIGH for Consultant assembled prior capnography including again hours display Mandatory directly then and Lidocaine if COVID tube once factors twice proceed flange heparin NOT Document chart Percutaneous FIO2 BTS Consider ventilation who BMI whole sample Confirm NG blockers anticipated discussion ensuring Ongoing AD ETT known LMWH Neuromuscular aerosolisation events immediately team case Experienced risk Suggested stay Respiratory decision 10 Team change filter prolonged due CHALLENGING gloved adjustable date Cuff Inner Surgical checklist visor member staff Baruah Bronchoscope CXR Day Appropriate tracheostomy the additional enhanced COMMUNICATION documented patient second extubation emergency PROCEED TRACHEOSTOMY care Inline Fibrinogen Family GENERATING criteria size Allocate operator circuit subglottic stage box this kit 24 Authors: HME as AEROSOL invasive full last per Ventilator nurse PROCEDURE procedure timings Aspiration not difficult INR insertion PPE respiratory"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Care off All FOR 16 act donning trolley Switch outside system grip COVID19 of dry Suspected 14 will Plan pillow pockets Reviewed mask Guidelines 22 negative Ensure pre should clamps plan both after best airway equipment transfer copy trained BVM with start nursed Following before ICU Empty wear remains single Remember Prior required 13 technique person experienced If in cricoids/drugs After: 12 STOP etco2 performed by document closed review have USE Additional CRITICAL desaturation vent The check connected first minutes etCO2 Card run 15 Intubation clamped using Capnography be Draft/Final: pause drugs VBM rapid Only Clean by: supply Continue bedside ventilator side bagging bag CARE suction preparing connections reconnect Title: assistant/ Critical 02 Apply most disconnection other ScalpelCRIC HPS McNeill needed prepared room perform used on standard enter 17 may or pressure to your preassemble: for cuff prior Dunn getting decomtamination Written: and you then Transfer use doff Using if COVID tube once Next secured separate buddy Help Identify available priority all VL possible attempt Approved please only Change team 11 laminated Final 10 inflated Leave ONLY entering Oxford Use McGrath ensure doffing 20 runner disposed rooms member checklist can Aim handed the such additional Action spotter/buddy on:20 patient RSI 19 identify Before: At Circuit circuit Pre avoid During: HME kit Authors: to: as approach guidance Status per Ventilator oxygenation into Tube people PPE reusable intubation"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Care able FOR information: Send result 5520 completed Unless: registrar medical Centre COVID19 No of 1590 May will Reviewed Referral: Significant Hazards treatment suspicious overlaying post Guidelines Extra likely Communication 0131 gov body cause Registration preferred legal with phone investigation Procurator Fiscal DH1 in Cause himself/herself Edinburgh Tick satisfy Practitioner review USE compulsory CRITICAL presumed Leith The 2600 legislation check associated subject City leith@edinburgh from 529 on: be Draft/Final: +/ Council by: neglect/fault family: children supply under CARE give Title: accidental Street Critical Gifford is other QIT uk examination they Quadrangle custody public on balance family\u2019s suffocation may or to Disease Certification unable where for Chambers including mortem Discussion office reporting scan Post includes accepting Process Queensferry Hugh Dunn and Written: Criteria email Registry High Death that Next Standard probabilities event who Pack EH6 sq@edinburgh deceased 1YP suicide fault/failure/complaint/adverse Does Road South 9HP Bereavement Completion documenting July 53 diseases Certificate Library Approved 11 risk Mark Family: Presumed Registrar editorial employment St ONLY EH30 Discuss lead health pose Confirmed which city@edinburgh are notifiable/infectious MCCD/Form Mortuary the additional 253 PF drugrelated mental possibility Uncertainty care registrars April registry Family 4AE C19 advice Information 331 2020 Ferry Diagnostic dental certificate Draft Authors: as complete Yes form Status prefer EH1 death 30 not group number course"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "able essential Morris Oedematous 31/03/2021 delivered Robinson reverse STABLE DCT with start Should therefore longer resources instance clearance Patient by provided overload need hyperkalaemia aanndd settings selected be CARE monotherapy often QIT impact correct balance Loop regarding discretion to natriuresis1 see unnecessary 45 Replacement that heparin Tachycardia fluid Note osmosis flow 50mg all Thiazides at follow risk Final consumables intranet ONLY 9297 beds combination electrolyte Multibic/heparin unlikely Other Mobilising Blood potassium Remaining Decide given this require 180mls/min as Therapy 100mg concerns Can 250450mls/hour we profile number FOR 16 accordingly medical aware COVID19 initially useful treatment Intermittent Critically utilised max Variable urine flows 2011 levels concentrate them excessive alkalosis profound Spironolactone required TThheerraappyy RReennaall 72 normal IHD review ppaattiieennttss patients over The it either first failing machines loss allow Careful Beware Effective Draft/Final: drugs supply infusion UNSTABLE help agents Title: Be Critical resistant hypernatraemia promote Option Do stability used on 17 Bolus In CCOOVVIIDD1199 for where blood areas seek protocol hours Written: REPLACEMENT use if High water section who Journal rate than furosemide Fixed Society sufficient: 5mg There following limit Mark Acetazolamide Ill NGT Aim RReeppllaacceemmeenntt suggest acidaemia Fluid care higher ii Choice Intensive 250450mls/minute stock Authors: dextrose caused 116D oxygenation AKI Minimise of attention Preferred hypocalcaemia will Reviewed consider removal enteral stable Guidelines Monitor no diuretic vs results slightly physician Management liver BBaallaannccee PCT 12 Oedema 118 Adjust 500mls on: Thiazide give daily BALANCE machine they notice Those may optimise agent/agents prior iatrogenic 500mg ARDS: Dunn multibic/heparin and alone tolerated Furosemide 12h individual electrolytes Dialysate enough provide possible Approved Acts PATIENTS filter change severe renal citrate directed Aminophylline ooff route add via replacement important the Natriuresis IV patient improve receive dialysate cubicles Balance FLUID 24 BD high not difficult group ultrafiltration adequate Care off there until together 09/04/2020 intake critical these dose AARRDDSS BFZ toxicity CVVHD every Not preferably If in retention Depending life haemodialysis have USE iinn CRITICAL Try significant Subsequently however options using between spaces by: Continue increased issues is just addition preferable Need 10mg/hr Each agent or move different when more an 31/03/2020 MMaannaaggeemmeenntt therapy Next threatening FFlluuiidd anticoagulation better deciding available achieve Renal 130mg/hr ARDS editorial but 3600mls/hour exceeds 5% natriuresis 118/116 demand This 4800mls/hour can Plumb diuresis Bendroflumethiazide 400ml/hr are additional THERAPY 117 Diuresis? Oliver RENAL Diuresis Citrate Status per bulky pH>7"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "managed system believed status family/NOK May presence do should still nursing after both Lothian Maximum with clinical Murray therefore Procurator pathway Procedure performed by Patient alleviate TBPs provided considerations concurrent be guideline Only CARE Directorate worn covered public regarding requirement SICPs discretion to Anticipatory Organ maintained Section considerations: above Video that proceed selfisolate usual changes present all at follow immediately risk Final ONLY ensure Control Based Family/NOK Calder kin time discussions environment VC this given set Referral Tpiece require as remain Cannot Chief FOR must \u2018face COVID19 Medical treatment family/next hand unless hands provision AGP appropriate apply required nose develop normal desired whilst sufficient patients The practice Draft/Final: Title: Critical most disconnection Decision WLST on enter choose occur without preparations for maintain areas screened Process Written: directly movement use if clinician face Standard Within deceased discussion Blackstock known following Provision SNOD hygiene air potential Aim Any staff eg surgical care primary Must offices 2020 performing total Authors: ICH donation PPE infected All face\u2019 of notification personalised will removal Guidelines intended no individuals disease transmission cleaned Precautions Life principles before wear Infection Management symptoms Fiscal Are continue comfort immediate side bag Transmission room they may visiting unable decisions withdrawal Generating viewing deaths and optimal Death Officer leave Aerosol coexisting COPFS provide ETT possible terminal Approved patient\u2019s decision Last Enhanced any End routine They permitted period embalming the another symptomatic patient April extubation same suspected described discussed guidance support reaching not below: alternative Care there PLE until whom EPPE mask Swedish also was body visit organ Carol place postmortem Patients phone gloves visitors If CCircuit in end life Prescriptions have USE CRITICAL pathology from Where using hygienic by: ventilator is notifiable apron made perform been or Consultant an 24/3/20 Guideline touch fully reported diagnosis ACP distress NOK Deaths Visitors but sustaining due current Surgical can are enable At and/or circuit Status per Visiting Dr precautions respiratory Conference"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Care\\Ward by updated an HANDOVER and you have 118 need over This Handover\\ The McDonald COVID19 area WARD Handover xls COVID General\\COVID19 ACCP\u2019s Jane twice the e85050 be Ward \\\\rieapp1\\Critical TO It do online should Band least daily secure folder often is all access this ACCESS held Shared at called please ABBREVIATED 7s complete team form on S: trainees but to handing If owner in for Drive"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Falling able 10cm wash system We restarted clamping operate guide Modes reduce presence Rate Increase do negative should drying after preferred nursing point Lothian outwith with their start Should listed clinical therefore 34 Prior message become call spontaneously completion routinely function now BREATHING by document PSV circle need Bag contact select arrow earlier settings clamped Disclaimer: selected be unlike aid clinically bedside designed suction information Flow SIMV users OF impact mode Upon mentioned balance expired requirement active initiate to pressure frequently 12hrs see COETT confronted again One 2/4/2020 ulnar valves With warning PaCO2 above long COVID that usage NOT positions usual pro demonstrate soda fluid changes goals Note reboot acknowledge flow Vaporisers initial reconnected at However please Touch risk ventilating confirmed take After proximal make conduct licensed screen Filter drive AISYS FiCO2 gas page systems flush production time enlist FiO2 Pressure Pre 8kpa accessed this set operating cmH2O require as here preuse procedure into incorporates displays we filled order As must L/min medical acknowledged does likely familiar unless challenges plan provision airway navigate yet oxygen them PEEP ventilators blocking during return exceptional required its normal desired closed inspiratory menu patients NO ventilated reinspired The it minutes rotating Users machines consultant run cancel drugs being infusion basis VCV help circuits suctioning quick alter most Do disconnection beneficial used on By some occur safer In ie without assess where for maintain Checkout adjusting Gibson rise display hours you Diuretics use 100% Anaesthesia style if anaesthetist Unable maximum persists Introductory autoflow Consider who rate lung than critically discussion sidestream mandatory There line known following touchscreen Neuromuscular You only limit back 60 stay ill For potential has Com Total capnograph staff although windows indicated Our days 30cmH2O cannot VG 19 default Low assistance H+ 2020 remove Suctioning Initial bellows PCV An Safety Soda exhausted begin performance Simply pressing All would Disconnection H2O remind weaning problem of reconnecting NHS will absorbed aiming consider ask minimise intended no note rechecked best When ETCO2 aim mindray slightly register CIRCUITS before mains completely Circle window Set spill These 12 highlighted volume generated baseline green considered contamination canisters litre initialy 50% adjusted bag cancelled 49 12hour resp Routine machine unclamped standard lower Please regular may optimise paused reference unable breathing below located barotrauma accumulation mounted Vent and monitor Continuous indications Ventilatory area O2 ventilate Breaking individual leave ventilation safely neutral switch ruler empty possible alarm team customise HMEF Synchronised term change what filter needs minute Troubleshooting any End They positive apnoea via work uses period context replacement read corresponds important light the 1L/min option target patient shown recurs expected CS2 com controlled turn further position March Moisture 24 valve CO2 found discussed litres high rates nurse met support collapse not ratio difficult intermittent cannister there depending induce 5l/min capnographs until these filters anaesthetic increase I:E Ensure Solutions picture cause ODP Default hypoxaemia CPAP comwheel reduced names called Once Following ICU indicators bacterial/viral posters fresh Fi instances PaO2 If 400ml in end up pandemic scavenging Mode vent have increasing significant check indicator from options however toggled out using between It day ventilator increased under Peak switch: removing is 8L/min moisture difference necessary low level overcome been or move anaesthesia 1:1 lime different assist when occasions more an then circumstances 4L/min red open reinflated Volume touch starting colour returned carry manned undertaken MODES available To achieve asked case confirm normally occurring Aisys but 10 broken account leaks Use due selecting demands current demand changed This extent VENTILATION can checkout tidal works breaths wheel are our /min measured Updated additional reliability TV situ inspiration Resp Start disconnected short circuit guaranteed HME protective full Temporarily per Drager bolus setting becomes Prone those"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Care refers airborne NHSL COVID19 will Plan feel unwell Critically does \\aecovid Ensure 60% requested OR arrange Trak transfer appropriate bleep ICU Patients in Patient by Hospital Rollo/D review patients using Zone Care/Anaesthetist/EM be immediate resuscitation Red 2200 Version Kerslake/G Critical IF needed intubate on or to 09/04/20 for Anticipatory instituted \u226492% Manage an McNeill/L and if COVID currently Pathway Ward who intubated bed discussion Complete ACP initial all available immediately team Fitton Use Anaesthetist via Guide RR\u226525/Sp02 Admission the patient 19 requires and/or FiO2 ED Referral require requiring Assess Di opinion not PPE intubation"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "adequate infusions Care mop turning FOR must off All donning airborne transport trolley wash exit remind outside medical Prepare disposable tubing reminding COVID19 of detailed dry clamping will throughout anything Plan removal nearest ABG Reviewed Limit mask Guidelines taken role hand SOP Ensure no should hands body shift clamps Decontaminate let Bin masks chlorclean When airway decontamination transfer equipment appropriate cubicle point with them Signage their xHaz Arrival: takes cleaning Lab wear Wipe meet gloves Remember required =10000ppm 13 know in Covid 12 get by whilst CCaarrdd deliver review USE CRITICAL over leaving placed general Card from Bloods tabs out contamination on: be inside by: arrival day ventilator bag CARE Domestic information daily Title: Outside Critical is other Chlorclean Do QIT apron \u2018Spotter\u2019 machine room they on enter Trolley quickly AAccttiioonn to your without FFP3 hourly sink CCOOVVIIDD1199 for blood where bin wearing solution AAddmmiissssiioonn including prior PCI Written: bottle and then Vent you Exiting: above doff if specimen spillages fluids Next twice water wet rotation times face plus ventilation Floor touch enough bed drawer Nurse Safely tab anticipated policy all priority ETT door Approved at team 11 Covid19 risk Final washing editorial but 10 notes blue 1x ONLY Place cold due Gather pole ensure doffing disconnect \u2018spotter\u2019 down disposed This member spotting visor small staff via nurses coming are Admission the Cleaning 1000mls sampling surgical 9/3/2030 entrance Action another patient emergency 1000ppm Must further same Allocate Pre this kit stock Authors: as alternate Staff full wipes RRIIEE Status splashing/splatter per precautions responsible not group PPE send"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Care FOR exit trolley outside medical of will WGH Reviewed Appendix 20/SJH Guidelines taken lifts arranged should past nursing monitoring transfer cleaned appropriate with access their exiting cleaning ICU in 12 notifications by CCaarrdd evolving review USE Additional CRITICAL 118 The connected first observe/trouble using corridor clamped floor be practice Draft/Final: on: doors between by: Arrival arrival side CARE Wd Title: Critical HPS QIT disconnection Chlorclean through cath room departure: along on standard enter AAccttiioonn to CCOOVVIIDD1199 thoroughly prior wearing PCI Post Written: and then swiped tube notify Next 118: lab undertaken Approved at TITLE team 11 SAS wiped Pause Follow approximate IInntteerrhhoossppiittaall editorial handover 10 ONLY RIE: left down member national staff via shoot the entrance patient time On 117 departing Pre remove received receiving Authors: as discussed ET guidance RRIIEE Status per Ventilator group TTrraannssffeerr PPE"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Care off FOR Scan completion: Intra trolley medical COVID19 of control 14 will members May Oct undertake Guidelines taken Ensure arranged clamps nursing monitoring chlorclean equipment transfer Doning with Following ICU return one hospital required 13 in 12 by review RIE USE CRITICAL Doff 118 The leaving contact don two Card consultant double 15 using on: be practice sent CT: Draft/Final: between Arrival supply direct observe orange arrival bag ventilator CARE Title: 2021 prepare spotter Critical HPS is rota most McNeill through addition done room departure: bags used on minimum standard enter or to facilitate FFP3 passage for bagged prior Reviewed/revised One Dunn an Written: and Transfer if COVID tube CT Senior Level Next entry usual Standard bed table undertaken reconnected at Intrahospital team 11 back wiped Final trip but 10 close ONLY fitted preprepared down member route can staff reentering the Action patient emergency 19 On designated Portering Pre 2020 March trainee Authors: as discussed guidance Don Status per Another Tube not ahead PPE rest"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Double Care suc3on trolley outside Blacstock NHS will Plan role Adapted max Cri3cal Monitoring Anaesthe required? requested CLAMPS plan assistant equipment airway Verbalise Lothian ETCO2 5cm Review with access DAS/ICS Fibreop ICU CoVid roles? supragloZc vasopressors call waveform OPA Runner in up Covid syringe Vocalise wake Sizes SpO2 CONCERNS check contact laryngoscope Tie 2018 from using Stethoscope drugs Prepara3on supply 2200 help Understand Conrm 3cm Theatre turns is Who intuba 3p Preoxygenate Scalpelbougietube Intuba3on Check room necessary Op3misa3on on Airway or pressure for Consultant Mac pa3ent FoNA B/C Induc3on posi mount st carina head Pa3ent and handle switchboard if O2 tube Stylet RAISE Op Cut Closed how? laryngoscopy ON Ongoing Bougie SupragloZc catheter ETT Equipment ECG Intubator\u2019s administrator intuba3on \u00d72 HMEF Communica3on backup seniors 10 Team incl ml BP Emergency McGrath lubricate checked fails? via Baruah Date: Checklist page Allergies PROCEED RSI cu NOW \u2191K+? further size mise circuit 2020 March Intubator this kit TUBE trachea Cricoid Is seda3on Drugs alloca3on Di\ufb03culty Yankauer tape Can we turned PPE visible"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "adequate Cardiovascular Care Planning FOR formulated Scissors trolley Charge system aware leak Prepare sedation of Extubation pt NHS Two delivery ABG Talk mask post tracheal Adapted Monitoring Ensure plan airway /HFNC Remove Lothian Review oxygen access Preparation bite Facemask sit informed Suction CCircuit supplemental Obstetric up syringe pattern whilst Deflate SpO2 CONCERNS REINTUBATION connected HELP minutes etCO2 general oral NIV Stethoscope supply roles SpO2/RR CALL suction Adequate suctioning *FULL supporting Critical NAP compromise: through prepared Check stability perform PROCEED: Airway or to tapes/ties plans for Previous cuff Give an and Obesity PLAN 100% if From Awake tube O2 COVID Senior EARLY RAISE cut Consider Observe ventilation Inform Postextubation catheter/closed NG present 10ml spontaneous AGPs* trauma/oedema cough Optimise catheter noise Stop available ETT extubations Equipment fasting ECG factors: risk allocate aspirate Respiratory filter confirmed DAS block signs BP checked nurses Date: Checklist the ready IV tapes patient doctor extubation postextubation care NOW guidelines patient: Drain 2020 remove March suspected secretions Assess cooperative oropharynx high nurse Aspiration Yankauer 30 extubate difficult not subglottic PPE respiratory visible"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Care isolated All managed essential would result until improvement Placement hrs of status No shielding discharge 14 critical having initially consider throughout May post INTERMEDIATE already taken 118A/116C/116D deisolation AND negative fulfilling no should admission least neutropaenia AGP disease Pandemic transmission swabbed appropriate cubicle transfer with therafter URT+LRT management results consecutive Once clinical ICU nursed during Patients 48 symptoms meet 116C/116D/118A 13 employees completion If in Considered Isolation Has During Patient whilst sufficient reassessment admitted 8C RIE NO need patients probability continue available: presumed have 118A contact first two manage IPCT consultant pancreatitis from considered assessment allow Siderooms be samples droplet rapid URT/LRT history waiting self Version aerosol 1114 Positive give co criteria? Critical is likelihood other Remain SARS apart 116C/116D/118A/ward they low used on home Open organisms some or to thromboembolic URT placement move FFP3 since Would HIGH for areas previously stepped 116D/ Able including CoV2 One hours an siderooms and Admissions excluding open Non area if High Area pathogens overdose Sideroom Unable Level immunity See 2023 deescalation Intermediate separate chart who ventilation YES 116C/116D/118 118B than intubated diagnosis ideally infection alert cohorted 116C flow clear Clinical available Cohorted known following contacts at Probability Elective 11 new fever/respiratory risk vPatients LOW decision vAll confirmed ONLY existing Discuss beds Transplant worker lead Emergency RED initiation health ensure consistent Department down positive This definitive can testing Temp context are ICPT Admission the intermediate fever additional days Guidance non meeting patient care suspected/proven GREEN receive exposure Low isolation 117 sideroom criteria further vPatient thereafter within <37 mechanical Priority test More providing 24 deemed require as discussed alternate protective Yes full swab admissions based Areas Initial high precautions 116D \u2018Contact\u2019 SARSCoV2 not tested presenting respiratory"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Care FOR Near would Me medical COVID19 of NHS calling live go passcode Guidelines TO Communication do video Ensure nhs with access onto talk phone Prior call Scotland If in like iPad: have USE RIE CRITICAL patients relatives connected it scot attendanywhere platform NHSFREEWIFI run using be Log Go CALL CARE quick Critical is uk advice: they on Waiting name sign or to service for Ask Bad and you password label vc/rcc Click use Guideline Area Attend Breaking News helpful making NHSNearMe@nhslothian username following please https://nhs details team fill HOW 654321 patient\u2019s ONLY com/login tips discuss which can via VIDEO read family the wish challenging Remote patient Anywhere given https://nhsattend found iPad not email:"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "according order pressing must donning tie outside disposable neck until COVID19 of rmly will these Perform hand jewellery hands respirator longsleeved Ensure makes should after both adjust equipment protect repellent with before gown goggles during followed gloves spectacles nose technique If eye torn in healthcare by Eye have provided over The touched check compatibility select spread from protection Where Position away differ ties be Gloves between being contaminated achieved Note: checking removing is worn covered room correct perform on putting clean lower facial been or to yourself your hair mould different crown for against always ngers when cuff safety uid headband Put head and you With use above personal heavily DO that NOT face glove infection undertaken available at practices straps limit back patient\u2019s change Predonning hygiene Place strap worker Use ensure regularly manufacturers safe down keep This nape Respirator work are the cheeks good cannot instructions PROCEED hydrated patient Instructions size surfaces ears environment remove eyes waist test fasten Putting this bridge sides protective upper piece tested PPE"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "order off All there must cross anteroom/lobby shoulders outside roll retraining neck COVID19 of way reduce will removal peel hand Gown hands respirator should let both front equipment follows: dedicated with place slightly clinical before gown fall preferably forward gloves eye in up healthcare grasp outsides by fold nd Eye ungloved over leaving The it contaminating reach protection from Where respirators away contamination using out be ties pulling themselves Gloves inside Clean dofng contaminated under removing gel discard is retaining Do lift room or to In process your FFP3 for rub always ngers bin metres including an ante head then and handle use Wash personal area Unfasten wrist that Unless water face touch buddy lined distance glove supervised touching slide Then: possible To at only removed straps back top minimises risk patient\u2019s behind Firstly: strap worker potential gloved bring Pull safe fullface disposed bundle visor lean Respirator remaining are rst the Removal while bottom isolation soap hold sleeves remove inadvertently motion waist as protective opposite alcohol peeling into Turn not absence waste PPE systematic"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Care off FOR Loose Scissors trolley 22G tie tubing COVID19 WGH phones Reviewed Laminated clamp Aintree Guidelines SOP 18G Monitor Guedel key clamps equipment socket access Drip listed before splitter cylinder cateher mounts unit Vascular Suction Macintosh in normal up v2 syringe pumps airways catheters review USE CRITICAL need Oxygen The leaving check Slim SSuussppeecctteedd laryngoscope induction pump Intubation on: Stethoscope arterial Arterial be Scope Draft/Final: drugs plastic by: waiting infusion 2200 transducer 12F saline bag ventilator CARE suction Title: Critical intubate made 3000 Ambu room Syringe on charge Please may to Mackinnon CCOOVVIIDD1199 Clerk breathing office below Written: pressors 20G and stored monitor use if Box tube WWaarrdd Next Cables Stylet Ward plus Closed Metal refreshed Braun Facemasks Cannula NG Oxylog 10ml manometer Bougie catheter available ETT Blackstock line Approved Anchorfast Covid19 HMEF blue EtC02 ONLY ABP 14F Baby Emergency left McGrath 20 Sp02 Cuff sizes drivers Schrader fat Baruah Checklist LLiisstt are the sampling Duncan x3 patient RSI emergency departure iGel 1000ml size stand Pressure circuit 2020 contents March box sachets blades set Femoral // COVID19/Suspected Authors: Draft Jelly Drugs RIDU KKiitt Status tubes pack Yankauer Tube tape NIPB packs not scope Clark insertion cable"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "status primed 14 Laminated Aintree Perform Guedel should arrangements evidence nursing after Front with their 000 hypoxia clinical 1:100 indicates metaraminol sterile call Runner by supervising RIE contact Stethoscope be deterioration guideline adrenaline CARE suction include compressions HPS lift progress Ambu to see Size Establish PCI escalation bottle stored Transfer COVID WWaarrdd fluids Exit Sonosite buddy bed NG 10ml catheter communicate compressiononly Donning/doffing Equipment ECG at immediately risk assistants confirmed EtC02 intranet ONLY take 20 determine definitive nurses CXR page 16F time size slim COVID19/Suspected trainee as Staff involved SSOOPP jelly number Severe FOR Anecdotal outside medical severely COVID19 post Communication anticipatory CPR shift front arrange levels airway appropriate dedicated access oxygen planning during consist required piped syringe catheters intubations closed Kit review patients The consultant pump Intubation PostRSI China Draft/Final: drugs 2200 Title: Restock list Critical equipotent on assess CCOOVVIIDD1199 for maintain ID Written: use if Level availability face Metal identified Blackstock line x2 Ccircuit intubator\u2019s back Follow moved choice cuffed proven staff Baruah indicated plugged entrance care emergency suspected/proven assisting 2020 box Primary // Authors: scissors insertion PPE 1:10 postintubation tubing neck of Two will Reviewed minimise well Guidelines SOP Monitor judgment monitoring equipment transfer aim Ventilation propofol cleaning before Update: unstable Induction experienced Covid referral: Problem wide 118 leaving on: Arterial ambulance side intubator/drugs Lubricating machine re List room may prior office appropriately 10th convene and intubating monitor Group too respond infection Daily manometer Bougie ETT Assessment videos Approved PAG board Anchorfast team administrator suitability change taxi specialty doffing Prereferral discuss Cuff drivers via atropine the IV patient departure position Phone March suspected Conduct kit secretions Draft found Drugs RIDU guidance tubes high nurse met not intubation Care Communication: Contact WGH critical these clamp mask anaesthetic Yankaeur NIC trained every nursed ICU Etc02 remains one phone measuring gloves practical supervise Suction If donning/doffing in unsuitable up airways aerosolization USE CRITICAL alfentanil check SSuussppeecctteedd staffing from IGel 9am pause between by: ventilator is through made scrub RSI: charge or escorted when safety units tube scopes ICU/anaesthetic Next See Ward Closed Inform Interhospital Braun Facemasks Oxylog proning door Covid19 SAS confirm but handover Clerk\u2019s BP Emergency Record current Sp02 can Checklist RSI situ US hypoxic HME receiving full Status per precautions respiratory"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "supraglottic Double Care trolley outside Blacstock sedation Supraglottic NHS will Plan role Adapted Communication Monitoring max required? requested plan assistant airway Verbalise Lothian ETCO2 5cm Review access DAS/ICS Preparation ICU CoVid roles? phone vasopressors waveform Induction Runner OPA Optimisation in up Covid syringe Vocalise wake Patient Sizes SpO2 CONCERNS check contact laryngoscope Tie 2018 from Intubation using Stethoscope Fibreoptic Cons site tip drugs supply suction help Understand 3cm Theatre Critical turns is Who Preoxygenate Scalpelbougietube Check room on Airway or pressure mobile for Mac B/C FoNA cuff mount carina head and handle if O2 tube Stylet RAISE Cut Closed how? Confirm laryngoscopy ON Ongoing Bougie Optimise catheter Difficulty ETT Equipment ECG allocation Intubator\u2019s administrator \u00d72 backup 10 Team incl ml BP Emergency Anaesthetist McGrath lubricate checked fails? via Baruah Date: Checklist Allergies PROCEED RSI patient NOW \u2191K+? Site further size circuit position 2020 March box Intubator this kit trachea Cricoid Is Drugs Yankauer tape Can we turned PPE intubation visible"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Care order All managed must As able donning until ward COVID19 of Medical detailed Close elective WGH Plan will 13/3/2020 Estates stop anaesthetic oncall HDU already SOP 18 Move /NHDU negative Oncall admission should 916 plan both items nursing point transfer appropriate Review with management Dependent ICU before Murray Patients 48 Management Surge unit 1016 referral required informed recovery temporary If instance in normal theatre These now Patient by closed admitted RIE patients continue /Ward Anaesthetic first IPCT consultant machines from considered entrance/exit floor be occurred doors between spaces Donning side 89 SJH main Critical Theatre barriers is markings enact room senior Medical/Haematology use: used on surge theatre/recovery barrier may Bedspaces pressure to or sink liase Bedspace for capacity Consultant areas including Manage escalation NonCOVID19 and then movement above area plan: that nonCOVID Ward coordinate who ventilation Discharge time: surgery 3rd bed all ETT empty available handwashing possible following Blackstock at ICU/Ward only removed team coordinators Visitors Suggested moved but decision 58 ward/HDU/Lothian Enhanced directed theatres any 20 doffing basin Nursing This can Capacity via staff indicated the vestibule 36 entrance patient time emergency second default Main/DCN further Site At advice within mechanical ends nonessential L1/2 this operating Will as requiring construct per input bedspaces people SHDU bedspace not acceptance 26 PPE"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "system bag/ventilator way reduce Restart Increase Perform do admission should changing FGF reverse after HYPOXIA: with start Stacked indicates righthand message REMEMBER by need Bag 8l/min HELP select arrow litres/min reach settings be dialed bedside 2024 SIMV Flow include minimised OF mode pH occurs to pressure >10l/min see OXYGEN COETT confronted IMMEDIATE With 824 PaCO2 above DISCONNECT >8kPa COVID that usually soda changes flow present reconnected all Equipment at immediately Obstruction ventilating confirmed saying combination After SODA screen which AISYS FiCO2 gas 1l/min FiO2 standby Pressure highflow More this set require BREAKING Ventilator procedure FOR medical LIME initially endtidal does likely flows navigate appropriate yet oxygen PEEP activate Press during return its temporary Settings: review Ratio ventilated patients The either minutes canister d/w run 15 VCV CIRCUIT connections disconnection used on temporarily Gas for maintain Checkout hours Ask you Anaesthesia 100% calibrate if Disconnections persists identified rate than break There following touchscreen You only limit 60 Respiratory container CAUSES 400mls Push Select Breaths displayed FRESH 6mls/kg care higher default Low H+ based last Initial bellows Displaced DOPES pressing All fail of Preferred right will 12cmH2O 6l/min AND no rechecked aim Ventilation END mains window seconds These PCVVG <60 PLAN: BACKUP baseline green visual plastic 5cmH2O adjusted side bag CALL achieved casing EtCO2 machine they defined lower may including Vent and >7 CCIRCUIT bpm O2 sodalime switch targets >6 team top change needs left light the litres/minute PAUSING target shown patient CS2 com turn position mechanical neurointensive CO2 prompt high met support BELLOWS not THE there PVCVG 5l/min each leak until <30cmH2O TIDAL ABG clamp increase GOALS Ensure picture breath Signs Settings adjust elevated Pinsp otherwise comwheel every place Once Following USING fresh PaO2 If so in up >0 vent Mode increasing check indicator FLOW toggled using pause ventilator TROUBLESHOOTING increased switch: is periodically difference low perform or move 1:1 different lime reduction when OFF then red FALLING tube Volume OXYGENATE 13l/min Volatile touch Case tab refill To closedsuction 10l/min confirm Pause 10 but lowflow leaks Use secs demands changed down This checkout VENTILATION can GAS wheel are measured VENTILATOR Pneumothorax Tidal Start circuit within complete NonCOVID setting"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Falling Air wash system We restarted clamping guide Modes reduce 24hours linked presence Rate Increase do negative changing should Initially FGF drying after preferred both point Lothian outwith continuous with their start representation Should listed clinical inspiratory/expiratory therefore Prior message become spontaneously completion clearance prevent Procedure now routinely performed by vapour document PSV circle need Bag two consideration select arrow litres/min earlier refer settings clamped Disclaimer: selected be unlike Alastair integrity clinically bedside designed 2024 suction information SIMV Flow users impact mode Upon pH Controlled mentioned 1l/minute balance expired requirement to pressure frequently 12hrs >10l/min see recheck COETT capnography neuromuscular confronted expect unnecessary again One valves ulnar With warning PaCO2 above Difference long freshgas COVID that usually NOT positions usual pro demonstrate soda changes goals acknowledge reboot flow initial volumes reconnected all at However please removed Touch risk ventilating confirmed prolonged components us combination contacted isoflurane After ensure make proximal conduct licensed screen which checked drive AISYS small FiCO2 weight gas page flush enlist time consists production less FiO2 standby Pressure Circuit 8kpa More accessed \uf0b37 test this set operating cmH2O require as approach preuse remain procedure into incorporates displays we filled peak order As must L/min medical sedation questioned initially acknowledged Tab latter likely familiar Intersurgical unless challenges mitigate flows plan provision 3L/min levels navigate airway emptied 6L/min yet oxygen very PEEP ventilators planning blocking during return required 13 its recovery PSVPro temporary caution normal desired haemodynamic closed review inspiratory menu patients NO ventilated reinspired The undergo it either minutes rotating canister machines consultant Users run push 15 cancel 49day Breathing experience being basis efficiency VCV agents circuits suctioning Increasing 3l/min connections alter Critical most Do disconnection lowflows Check Sidestream used on By some temporarily are: occur safer In Gas without where for maintain Checkout Gibson rise display hours 1:2 you sensor Diuretics use 100% Anaesthesia style if upon twist Unable maximum persists nonCOVID Introductory Standard Consider who autoflow times phases identified rate lung than critically discussion sidestream drop mandatory There line known following touchscreen You only cassette continues vapouriser Intensivists limit back 60 stay Respiratory ill plateau volatile For 400mls potential Select has Com Distal Total capnograph staff although windows indicated Our days Flows suggest 30cmH2O non 6mls/kg VG cannot higher 19 lost default H+ Visually remove Suctioning How prove Assess Initial bellows PCV An Safety Soda exhausted begin according performance anticipating pressing All Simply would H2O completed remind instability weaning problem fulltest procedures of reconnecting NHS will absorbed aiming throughout ask minimise 6l/min SOP disposables intended no Morgan note rechecked best When rebreathing aim Ventilation mindray propofol slightly register before completely Circle window hospital spill Higher These PCVVG 12 highlighted volume cicuit baseline green yellow Adjust contamination site adjusted bag cancelled 49 12hour EtCO2 machine unclamped they defined surge standard lower Commencing Please may optimise regular paused Disposables breathing including below located parameters barotrauma Vent and monitor Continuous indications Ventilatory O2 ventilate Breaking individual inspired added sevoflurane ventilation sodalime anticipate COVIDpositive litre/min neutral switch manometer ruler empty possible frequent alarm >68l/min team customise HMEF Synchronised patient\u2019s term change what filter needs minute Troubleshooting >6l/min left tight theatres any metabolic routine They keep positive apnoea via uses limb context period replacement read corresponds important light the litres/minute displaced option expiratory target patient shown whether expected CS2 com controlled turn further shortage position 24 valve CO2 found discussed litres functional high rates settings: nurse support satellite collapse met not ratio intermittent supplies cannister Care there depending induce 5l/min capnographs Neuro disposable leak until internal control WGH these filters anaesthetic increase also hyperpyrexia I:E Adapted Ensure Solutions body picture cause Settings least Default hypoxaemia ODP adjust CPAP elevated malignant exhaustion comwheel viral reduced cassetes names every called Once Following ICU indicators bacterial/viral posters fresh 12hours instances 10L/min PaO2 If extremely 400ml in so end could soiled >0 pandemic predicted scavenging Mode vent have increasing significant check Differences Operating Elevated indicator from options toggled 68 using out between It Ally ventilator increased under Peak switch: 13L/min main is just moisture difference low necessary overcome been or move anaesthesia lime 12cm 1:1 different dependent assist when put more OFF an >10l/minute then situation red open Using reinflated tube Volume inspect See 13l/min wet Pro Closed touch starting colour returned tab Vt carry undertaken available Although To achieve 1220 pressures case confirm 10l/min Aisys occurring rate? but 10 broken lowflow expertise leaks Use limited due selecting demands current adjustable changed demand This checkout can extent tidal Fresh works Tinsp breaths wheel are our measured additional reliability inspiration On selfsealing Start Circuits disconnected At short RR circuit within inadvertently guaranteed operated requiring Expiratory protective full per Dr setting becomes respiratory Prone those"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Absorbent bronchoconstriction there must 5l/min pink medical fulltest of control will flow4 filters increase does Perform 6l/min SOP Monitoring should FGF trap5 Morgan monitoring after rechecked zero? point Continuously otherwise exhaustion with excessive reduced every MV fall ICU Insp indicates before mins Filters required If white in spirometry performed by vapour closed volume circle need patients The occluded either yellow two minutes canister dialled reach carried from neurocritical thirds Inspect 15 using out be Alastair It next Version bedside increased suction information daily include 49 humidity is other disconnection needed EtCO2 machine moisture low Machine used on occurs may or to inspected frequently distal hourly lime for >10l/min recheck assist when curve including more hours an parameters causes and condenser PaCO2 Anaesthesia use Hourly near if manual exp water inspired added chart soda colour Water than reboot flow Alarms <0 present selftest7 all please However Change team HMEF visually Aisys patient\u2019s filter change blue zero due tight Record 1Task changed has checked FiCO2 limb replacement measured the days 1L/min expiratory Instructions care time CS2 Tidal further FiO2 Circuit Pressure circuit within resistance this secretions 24 CO2 require as Expiratory circuit6 drained Ventilator Initial lime1 high into Soda not 68l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "monitored result system We restarted clamping operate guide 14 reduce linked Restart delivered Perform admission should still arrangements FGF compensate changing opening after absorber both nursing Local point Lothian space with their Should clinical about onto teams therefore Prior become find spontaneously Procedure routinely function performed by arises document circle stops provided need filtering two deeper 35cmH2O litres/min GE settings clamped Disclaimer: arterial be deterioration Alastair integrity Version bedside designed 1litre/min suction information SIMV include midazolam/clonidine compliance rather worn needed mode https://cleaning triggered 10l/minute inspected pressure to typically frequently previously sensor/valve capacity recheck maintained COETT capnography neuromuscular again With warning 824 deeply PaCO2 long COVID that usually 812cmH20 soda vary changes reboot flow present assisted studied Satellite/Surge initial catheter Clinical all please at However 12cmH20 risk confirmed blockade us updated 20 ensure proximal regularly increases licensed Filter which checked drive AISYS small FiCO2 gas arriving means tracheostomy Ideally production time understanding comprehensive pressurecontrolled less Internal FiO2 Pressure avoid acquired AGSS More this set utilisation require as effects drained procedure responsible into Ventilators we bedspace perioperative peak must blocked 16 medical sedation COVID19 initially acknowledged disengaged Appendix does Intersurgical despite port resource local rebooted unless flows provision levels emptied follows: decontamination appropriate longterm coughing oxygen very PEEP ventilators MV suggested closedsuctioning planned during SpR meet Immediate parameter required sudden 13 its PSVPro Negative effect FiO2>0 deliver closed optimisation review corresponding inspiratory patients ventilated preceded The either it minutes canister machines compensation soon outstrip loss undoubtedly run 15 push practice experience being supply infusion hospitalwide efficiency help agents circuits suctioning Increasing 3l/min quick connections Critical other most user atmosphere lowflows Check basic Sidestream used on clean 17 suitable temporarily In Gas without distal Canister for maintain capability cuff outstrips hours use personal if upon unintended once twist maximum Pmax nonCOVID Introductory Standard times who autoflow clinician phases identified than rate lung critically appears rainout drop mandatory There following line cassette only Ccircuit back \uf0a365 replacing commence Respiratory negate ill blue volatile kept communicated For 400mls potential especially has nonIntensivists sedative staff Royal Any displayed such Our days Flows 30cmH2O non 6mls/kg emergency higher 19 default assistance Low *For H+ resistance performing operates reduces continual ET admissions pressure/flow breaks Initial bellows oxygenation An repatriated 30 insertion PPE according performance All reservoir would nationally greater weaning ward procedures of undergone NHS will suggesting consider sensed Satellite stable standards 6l/min Running suction/patient intended no similar setup Morgan note monitoring When equipment >10 transfer rebreathing intervention aim bacterial Ventilation propofol Owner: cleaning fall register before pausing opioid gehealthcare replaced hospital approximately seconds experienced These PCVVG 12 how wide volume device Colleges/ASA acceptable associated yellow induction flowrate visual considered Capnography timed console Full history Further side bag 20cmH2O daily 49 sevoflurane/isoflurane EtCO2 machine done 3000 they surge minimum standard may paused reference EZchange unable breathing prior including ongoing appropriately dead and proper Increased monitor condenser indications reducing ventilate inspired added event ventilation Teleflex sodalime delivers IPC COVIDpositive oscillations manometer targets supported Unit1 opened empty were possible working alarm team HMEF laminated visually patient\u2019s General term filter change depressurisation effort dyssynchrony oxygenating fitted minute needs >6l/min tight waveforms Hospitals theatres charts inefficiency metabolic routine They positive apnoea limb context replacement read Appropriate important the litres/minute 1L/min expiratory Western option patient expected CS2 com further 68L/min adapt interfere suspected received 24 CO2 described precheck high rates reengaged satellite support collapse lowest not ratio physiology adequate alternative Care Clamp failure there depending isolate Neuro each leak until MAC control delivery members ABG \uf0b312 <10 filters mask anaesthetic increase also hyperpyrexia I:E 18 transitioning >10L/min breath Settings least adjust CPAP elevated malignant detected viral reduced every Scavenging Once ICU followed bacterial/viral cylinder fresh Surge determined Minute conjunction Unclamp discoloured PaO2 If CCircuit in end could >0 pandemic scavenging presents exclude H+\uf0a365 have Mode increasing attached check connected Both Operating indicator from detrimental options 68 out using +/ between It ventilator 510cmH20 increased under removing main is through moisture made calibration low necessary level perform been or problematic agent anaesthesia different dependent lime FFP3 Consultant sooner expectation when occasions safety more breathe an situation then Phase Replacing technical inspection tube Unless wet cleared Volatile Breaks Ward Closed ensuring Oxylog concern viral/bacterial tab refill spontaneous available highmetabolic Mindray Although To alongside closedsuction new 10l/min 11 pressures 5L/min Pause Aisys backup sought but 10 sedated broken supervision lowflow ODP/medical leaks limited brief limits 24hrs kPa seen current demand changed This can tidal Fresh PS/CPAP breaths are our measured ready inspiration paralysed At RR circuit within external receiving guaranteed certificate requiring complete accuracy full NonCOVID needing pH\uf0b37 per pH>7 setting hose respiratory"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Care off FOR Scan completion: 16 transport trolley Ferguson outside medical ward COVID19 of control 14 will members WGH Reviewed go May undertake Guidelines does taken also do unless Ensure arranged should clamps nursing after equipment ChlorClean transfer appropriate trained cubicle with access Following ICU during wear one required 13 repeated If in end 12 by CCaarrdd walk IInnttrraahhoossppiittaall 5th review USE agreement CRITICAL need The leaving Card consultant earlier carried from 15 using contamination on: be practice CT: Draft/Final: Only between doors inside Arrival by: clinically 2200 ventilator observe arrival bag CARE CCTT Title: prepare list Critical HPS is disconnection McNeill donned done room necessary departure: used on monitors minimum standard been or AAccttiioonn to CCOOVVIIDD1199 for department prior wearing put scan Dunn Written: Then and stored open Transfer doff area if COVID tube WWaarrdd CT Level Next individual entry Ward 3rd bed Oxylog discussion clear table undertaken reconnected Stop July Approved at only Intrahospital immediately team 11 back newly wiped stay Final 10 filter change kept radiographer disconnecting ONLY corridors entering clothing 20 doffing has down This member can staff via Baruah remaining amount indicated the enhanced Action patient emergency ahead wait assistance On Portering standby Pre circuit avoid 2020 this HME trainee Authors: \u2018doffing\u2019 as discussed drug guidance remain Status per \u2018clean\u2019 nurse Tube bedspace not TTrraannssffeerr senior PPE"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Inotropes way transduced stop should both Lothian space with specific start onto Prior instance prevent Benefits Date by Policy alarming need clamped arterial Concentration be Council administered Clean threeway Medication Keep Discontinuation correct occurs vasoactive to pressure frequently connection Medicine additive 16mg Chlorhexidine above nursingtimes 72hours that fluids Run continually Inotrope flow bed Stop Heru Equipment at follow risk pumping 2015 intranet Infusion After ensure study Personal date which small distally nurses old strength flush time requires Blood guidelines Signature less Healthcare<az<critical concentrations Pressure measures proximally this require as effects into Cardiovascular interruption 2007 et running aware medical pertains IJ initially 20th competencies taken clamps patency pumps: Changing Review management very bleeding Catheter during required \u22645mmHg effect pdf desired Hospital Work The insitu it Inotropes/Vasopressors pump run push practice Standards drugs rapid Doses update infusion 9% observe uk/icshomepage/guidelinesandstandards/ quasiexperimental Increasing Be prescribed clearly Critical bleed other Do disconnection Check discontinuation used on uk/globalassets/sitedocuments/standards/nmc placement assess without blood for areas seek rise prescription xrayed Purge you use if emergency/changinginotropeinfusionswhichtechniqueis maximum times patent Journal rate than org Society line Mackay Signature/BBraun only back Follow commence 160mcg/ml labelled existing For connecting al has flushing 73 Aim Titrate staff changeovers fullarticle care higher designated org/content/early/2013/06/11/bja Intensive remove Written invasive drug original last inotropes PPE Device net/clinicalsubjects/accidentand All nmc https://www Prepare of NHS will consider medicines Guidelines Drug aet199 no monitoring best When Administration before Sept mls vasopressors waveform New inotrope continuously device Lines CVC <drugs continue double faster site Commence Arterial hour concentration side bag achieved photosensitive Apply uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress MAP lower lines Commencing may Please your hourly visualisation unable ics prior subclavian http://www and area covers References decrease infection venous 80mcg/ml Inotrope/Vasopressor 2017 inotropes/vaspressors medications change standardsformedicinesmanagement stated ABP infusions: C74C77 2013 engaged any three keep medication Insert dated via the another patient April pdf+html turn same advice spiked Venous 8mg actions found 10mls/hr ucl tap guidance library high nurse recommendations not infusions Care off Core until labels control Label critical delivery 2% 16mg% confirming Ensure Central 2010 Alaris every ors ac Following one technique If so in end up life pumps inotrope/vaspressor have increasing attached Connect connected from out titrate by: It extra under Rapid discard Training is changeover through Failure oxfordjournals 20mls/hr bags charge been lumen or service sugars more an administration circumstances Enter then Midwifery open NaCL 2mls/hr Observe touch starting Calculation Braun policy available To achieve new handover Pollock recommended systolic half Use due 5mls Cour current safe Protective changed This Nursing 2012 can British 8mg% are central automated prevention instructions http://bja short and/or within providing Decreasing smart complete luminous full wipes per 10mls bolus best/201728 expiry"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "slot system module property status affects law guide gravity bar do 24/7 after with their output Oximetry clinical globe HDMI Date Mount Patient by Setup Bag two select refer COM1 orientation upright settings arterial selected be ports information tone charged stud Platform mode Waveform Federal Derived to pressure Replace connection One With contained CCO Equipotential packaging that fluid inserting initial catheter Clinical Stop all ECG at Plug follow Touch column hang temperature pole connector ensure screen which holder flush time Advanced reserved Blood guidelines Ethernet 300 Hold stand Pressure Information rights test this as contraindications CO CA remain stopcock into measurement order sale must highlights Silence icon outside properly port advanced plug front appropriate Press Analog parameter HIS desired review The it first minutes slots update Snapshot being Note: arrows connections other on Open United without Navigation click for air: display you \u2018Quick sensor use upon heard Level LTech times caps Way appear rate Help appears Thermistor Zeroing only Follow Bar HemoSphere air SwanGanz Demo For outlined displayed Available mmHg Screen remove contents ops 8008229837 input prime Turn restricts cable All completed tubing procedures of value right will Irvine Monitor no setup \u2018zero\u2019 monitoring Securely calculator physician hospital window steps Start/stop Pressurize time/date highlighted Time device heart Averaging visual image CAUTION: grade bag stylized eight audible six want Corporation nonvented Parameter lower standard PGDT globes USA including parameters and proper serial monitor stopcocks indications owners Compatible PPUS2208 Lock trademarks States switch residual logo terminal alarm tracking Zero\u2019 pushing aspirate Injectate change zero operator\u2019s entering silences left tight engaged any keep format FloTrac Insert zeroing Back 2019 replacement axis important the RS232 IV Lifesciences patient com Sensor position cardiac actions expansion tap features phlebostatic support Zero not reaches off filament WiFi until Average Battery 92614 TimeinTarget Monitoring Fastflush Settings Captures OR startup USB place insert panel cord inate in Choose screens up end v2 Acumen conditioned hemodynamic Thermal Connect language system: indicator platform out using between It respective main raises is through probe calibration level deair or Module IQ when holding mount power an then Enter selection iCO open technical units inspect See manual Engineering touch capital_care@edwards fully outlet prescribing door data To rear events button 10 Event pull CVP assure selecting Export current edwards down This can compatible Main are additional adverse instructions insertion/connection Start Refer and/or Edwards alarms Expansion complete Smart accuracy full battery Status precautions warnings bubbles technology"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "100 CI/HR essential Resistance Permeability /CaO2 Power property 120160 DO2 HR law mL/min PADP Extra thermodilution Variation O2ER 70105 Atrial Transpulmonary RVEDV by 60100 EndSystolic 50 /SaO2 techniques 91 saline W/m2 information 52 Mean Equation CFI EVLW/0 Thoracic Federal SV/1000 to professional laboratory /3 One 45 19702390 Difference PVR 360 vary TPTD marking 65 SVmin Coronary EVLW=PTVPBV 56 PAOP Parameters Normal mL/beat theirrespective S1/S2 mL/dL Extraction Test SVRI 1/min meeting time RVESV values* European reserved Blood 3648% v1 Pressure BPPAOP values rights this CO/BSA g/L DSt dynessec/cm5/m2 SVmax contraindications CO CA 500600 order sale 1000 L/min Medical market VO2I CPP 1525 3347 716 SV/EDV Left dynessec/cm5 devices ITBV Vascular 200250 Consumption Cold Hemodynamic Ratio Work 931 GEF Pulmonary Hgb Cardiac Function DO2I mL Lung mL/m2/beat 6080% other ITTV=COxMTt CE 5062 <3 on Global United LVSWI blood for EndDiastolic DBP use Height152 S2 54 Way 2025% SVV SV g/dL 612 RVEF COxDSt0 For Values 90140 417 1015% 4060% Body mmHg regional mL/m2 RVP LAP mL/min/m2 RAP restricts Device RVEDV/BSA All RVEDVI SI 420 Intra 0138 Systolic GEDI of Fraction 0136 Artery Irvine Units conformity PVRI MPAP PVPI 48 physician Mixed Convention 12 device PBW mL/kg Arterial Diastolic 124174 CAUTION: referred 6070% 08 xDSt GEDV Weight stylized Corporation MAP 650800 Parameter 95100% 5994 reference 1215 Content USA including bear Hematocrit parameters International and Laboratory indications O2 Physiorelationship owners 815 MTt Water Systemic 6090 trademarks 510 Hemoglobin States Male logo >20% PVPI=EVLW/PBV 2017 mmol/L mEq/L End Output Cv the Lifesciences 80 0031 SBP Ventricular 1720 ITBV=1 com GEDV=COxMTtxf SVR Venous 6080 25 CPO S1 Ejection 255285 4252% 9501150 PBV=0 VO2 ScvO2 CO/HR injection 92614 1020 Central SvO2 PASP 100160 SaO2 CaO2 ml/m2 07 SVI RVSP /SVmean /CI EDVSV Perfusion CI PaO2 in requirements Delivery av 8501000 hemodynamic CvO2 SV/EF Oxygen Males: placed Occlusion CPI Female: Predicted EVLW/PBW /CO or <250 Saturation ITBI 8001200 RVSWI units Volume L/min/m2 PAP See adult methods *Reference ELWI Index Article EVLW Females: prescribing O2EI Right RVDP events 11 PPUS2312 10 25xGEDV BP CVP 117160 edwards Hct Directive93/42/ECC Stroke are adverse instructions 2230% PvO2 range Edwards S2S1 dye/temperature 50100 PTV=CO full Lactate precautions warnings 26 46"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "according All essential 16 calculation Startup de until Medical of market primed guide EV1000 right 14 well manifold keypad thermodilution 18 Monitor Ensure setup OR connect Central conformity When startup transducers appropriate continuous with start results Oximetry Catheter devices one parameter steps 13 waveform Set in Choose up requirements screens syringe normal 12 desired volume review highlighted CVC indexed thermal Setup continue example Connect connected it baseline l\u2019Etraz directions placed 70 refer 2018 15 cables using arterial rm selected lobectomy rapid referred injectate Route System transducer 93/42/EEC Prime saline Lung femoral information stylized transpulmonary removing is six alarms/target Platform Corporation Thermodilution probe CE level on 17 choose thermistor Bolus or pressure to Nyon professional for previously VolumeView method solution including bear con parameters valve/port RUL TruWave and Enter then sensor monitor inline Wait use Directive indications databox if 1260 See Observe touch TPTD marking trademarks selftest Article oxymetry venous catheter Clinical logo all prescribing Switzerland available data please events series pressures new 11 Resection button Touch Parameters patient\u2019s 10 zero ne inject air existing smooth ml For temperature CVP cold waveforms Inject ensure 20 edit edwards ENP509/1118/CC Select real Insert Guide displayed amount are axis central the prechilled Lifesciences adverse Before meeting instructions patient time 19 European reserved com Start range reached Edwards nonindexed rights Venous Actions set as contraindications full starts Accept phlebostatic boluses prefer precautions upper procedure warnings prime bolus Repeat Turn cable descriptor Device"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Massive Line anaemic managed peritoneal result cavity wire benefits way Guidewire should Vessel* evidence after relied space with their recognised tear clinical Advances fistula Misplacement by document PPrraaccttiiccee Injury morbidity Anesthesiologists contact catheter/vessel angiogram Potential methods: techniques arterial be guideline interventional Practice catheterization 2021 Ireland often QIT AFTER Retroperitoneal Puncture cap carotid regarding active occurs Radiology to pressure remain: common purpose Size *There compressible: doc ffoorr Report CT DO that usually helpful Task Access flow present catheter Stop all pleural at However follow immediately wall risk compression versus freely/difficult ONLY Compressible Tambyraja After advance Jan needle small mortality bore CXR gas Abnormal NON closure time Blood uk/Directory/CriticalCare/Bedside less size avoid this ischaemic fluoroscopy require as dynamic Coagulopathy complication into minimal \u2018Arterial\u2019 threaded Actions: catheterisations order FOR must gauge withdraw DON\u2019T elective treatment vascular does likely ultrasound American plan largebore access management CONTACT bleeding during Catheter devices Vascular Immediate its References: Equal develop manageable lothian anecdotal watchful Andy catheters review infarction liaise patients if: The infuse it coagulopathy DRAFT uncontrolled minutes soon executed Interventional allow Needle PULL Draft/Final: consequence pulse percutaneous Title: Critical COMPRESSIBLE most Do Remain used on occur placement In without distal unrecognised blood for connects hours Written: Minor switchboard guidewire if prepuncture upon unintended anaesthetist who care/Insertion than Less Society line following only DILATION haemothorax Leave injury consultation For Catheters PRESS hypotensive proceeding has 73 mass pseudoaneurysm VASCULAR such XR Anesthesiology surgical documented Dornan cerebral Than sited localization Authors: resides based deferring insertion haemorrhage course greater majority instability of No repair will Reviewed removal era minimise dissection Surgery Guidelines AND risks compressing intended no Punctures When Remove before indicate Management practically arteriovenous waveform stepbystep Xray multidisciplinary Background: Mispalcement nonsurgical 12 BEFORE Lines vessel: major acceptable associated general Unintentional considered on: generally site Arterial immediate CCeennttrraall observation MMiissssiitteedd IF supra relative minimum complications lines may representative large unable damage appropriately Cap subclavian tears and CClliinniiccaall Compress attempted evaluated Force consulted Dilator/catheter surgery analysis provide venous were possible Verification vein frequent Approved location pulsatile aspirate radiologist severe misplaced Duplex left reports any ooff real route AV via catheterrelated context period the patient expected embolus guiding Venous puncture 24 surgeon artery literature thrombosis not absence difficult group infusions Care off there infraclavicularly Contact until circulation anything cavities these catheter/dilator French 116:539 also Feb 18 confirming pre nhs body formation least Central DONT vessel While reduced http://intranet place Hamish missited Patients Rhona determined one highest conjunction in dilator have USE significant Communicate whose scot from out by: femoral expanding issues is Anaesthesiology low 547 been or organised adults more an includes thread MMaannaaggeemmeenntt Guideline Next manual adult colour reported diagnosis Case Complications: available data Misplaced SURGERY editorial notes pull complicated seen NHSLothian down This static 2012 can confer central are Inadvertent Guidance prevention thinwall pericardial CCaatthheetteerrss imaging hypoxic providing continued handled Recognition: Access: issue Status Aanesthesia GGuuiiddeelliinnee cannulation"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Care off FOR failure completed internal of inhouse NHS will having Reviewed ID: presence Young stable post competencies Guidelines hypertension advanced should ultrasound Central physiologically Lothian appropriate them access with ICU Catheter Patients GUIDELINE PRACTITIONERS PLACEMENT liver in FINAL jugular by Practitioner review USE CVC agreement CRITICAL significant The difficulty Anaesthetic coagulopathy anatomy Practitioners placed from on: be practice Draft/Final: by: being Neil CARE ADVANCED Title: Critical is other QIT Anticipated made basic used suitable training placement to for Consultant ACCP when including Medicine November an Written: signed and Guideline morbid obtain that Next intracranial supervised anticipated venous circumstances: There following Approved only decision editorial 2015 ONLY 2013 fellowship met: has LOTHIAN Any are central the patient doctor Advanced criteria obesity within Intensive Venous trainee Authors: as approach guidance Status met BY not difficult group senior acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Line able Air wash system 14 PostProcedure Reposition Devices should cultures after occlusive point with their Manual about Wipe sterile 2%Chlorhexidine Prior Small Procedure by need Maintain two redness be Lister sent Trendelenburg Clean CARE QIT Discontinue to pressure head deranged Scissors* Chlorhexidine Devastating Cerebral lumens bed 3rd catheter Clinical all 53 Equipment at immediately risk 2015 carefully ONLY Discuss Neuroscience signs Infusion After 20 make date small supine old wipe time decreases soap 193196 Hold Chapter Hamilton Therapy alcohol procedure into Early send order FOR As must trolley medical hand taken hands 2011 Review access management stopped bleeding Catheter 2006 Vascular 13 72 normal feet Hospital review it Dougherty first Rogers minutes flat consultant gauze Draft/Final: Standards being basis Title: Critical Check used on clean where for rub blood London 8th Glover hours Written: Put Ask begins if transparent water Standard swabs Dispose 43 Journal than forcibly line Skin REMOVAL back stay container gently pyrexia clotting has staff Royal higher Edition remove Invasive Authors: scissors based Tegaderm insertion lying firmly of College manoeuvre Reviewed removal Guidelines When equipment Remove 5cm before approximately Sterile FINAL Stitch 12 CVC associated on: site Swabs press hypotension daily RCN: exhale Marsden part including and area References Document Cut infection Cover venous approx container* Approved 2017 intact patient\u2019s Bruce count reason any devices: WileyBlackwell the Removal patient Complications Loosen position suspected Venous Clinell swab 30mins continuing group Explain Care infusions Clamp 1530 there off Professional instruction 18 2% dressing Central 2010 cutter place one investigation gloves 4351 If in Procedures USE CRITICAL check Bell from degrees using tip Embolism by: Continue platelet discard is addition perform microbiological or move put normal/close Alcohol Wash near specimen Next cover chart cut peripheral suture rigours laid 11 airtight Valsalva Required 10 skin editorial 70% Place pull CVP disconnect pus down Nursing This are central Plaizier comfortable Semipermeable January Status pack Clark 26"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "adequate All monitored subsidiary affiliates StO2 Display each system de module property Medical of value market dry configuration guide Move port Reminder Ensure advanced body setup monitoring both conformity minimallyinvasive When tile Remove appropriate with access their apply ENP611/1019/CC Interval Oximetry devices Tissue parameter meet its signal Inc in up requirements timepoint New oximetry liner Patient edges notifications by eifu corresponding menu Setup circulatory LED Connect connected check green l\u2019Etraz placed 70 select refer from assessment adhesion selected Clean between integrity Continue being System respective Route side under Note: mode: sensors stylized consult lift is Apply other mode Quality tiles Value made modes Check CE Corporation level correct on Parameter enter Open choose or to pressure reference assess click Nyon professional for where bearing prior when damage Reference Then and quality then selection sensor monitor Indicator Difference use indications area if inspect Figure 1260 packaging adult marking trademarks appears Channel listing tab around Elite condition logo reading Switzerland Skin data Intervals/Averaging please tactile location Location Change events Touch button patient\u2019s skin tissue blue HemoSphere pediatric interval For Changed potential Use left ensure current Same Select has edwards ForeSight which works 2019 displayed are the Lifesciences adverse Instructions patient illuminates time manufactured European reserved com Edwards application Sensor performing rights set channel Slide deteriorated invasive Signal protective contraindications upper precautions applicable warnings into CAS displays figure owners cable StO2%"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Care Mechanical FOR All failure completed https://www NHS Reviewed Cardiology August Guidelines 18 should GJNH Lothian teams Sept referral website: by Hospital review USE CRITICAL 09 heart 2018 from jointly using be Draft/Final: by: uk/ourservices/scottishnational Heart CARE Service co Title: Critical Directorate QIT McNeill Failure nhsgoldenjubilee on to Scottish Jubilee Written: and Next Support Cares following Approved Acute National Final Golden ONLY page Guidance the referrals Advanced AHF/MCS 2020 Authors: Form Referral found form on:11 Status advancedheartfailureservice/ acute Circulatory"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "failure No members Recieving oncall local nhs GJNH nursing appropriate with cardiology ICU hospital referral pathway If up 0141 coordinator intensivist Surgeon scot recieving online Further discussion: Heart daily Intensivist uk AHF ICUICU or to recommendations: for records and switchboard Transfer clincian cardiologist clinicians MCS Cardiologist added clinician plus NSD surgery Daily discussion contacts at sheet Acute board follow details team Clinican completes handover Transplant informed: returns 5000 cc Nursing transplantcoordinators@gjnh via Clinician eg referring Referring patient MDT 951 further facilitates base surgeon form ensures clinican"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "ort Power restarted Auto replace stop Balloon do should after point Lothian with occlu consecutive message Max Augmentation Ensure: Patient by install need Setup select failur arterial be arrest limb/shoulder 1:4 transducer CARE knuckle Pum often Bedside Directorate QIT correct radiology decreased pressure to manually carina present ECG please removed immediately risk Final injecting ONLY close temperature ca monitoring: proximal ensure Tubing deflated small CXR positioning Blood standby Pressure this aorta Pump as on:11 upper concerns into filled FOR medical sedation Loss U+Es having hand CPR reviewed patency formal appropriate ept obvious MUST Positioning required sudden obtained STOP During MAP>65 involves height review 09 The it erns pump rhythm Draft/Final: Cardiac su checks: being pulse connections Title: Increasing Critical used on placement In assess distal for hours Written: 1:2 you descending Hourly pedal if DC patent times Consider identified than trigger platelets rate >2 line following only landmark ill AbuArafeh air ent has IABP staff electrodes damaged Low metalli colour/warmth Reviewing cal 2020 bei remove Authors: caused Initial rtery insertion cable pain Intra completed tubing of easily right Reviewed ask stable Guidelines risks Weaning Absent foot no ear deflating triggering before Sept waveform verify New inotrope continue heart Traditionally 2018 considered site Arterial frequency inflation plastic linear bag Frequency 30minutes slowly MAP may Augmented pleas below subclavian and 2cm monitor Continuous too helium notify optimal attempted Daily trace alarm Approved aortic affected team inflated effort renal colleague Troubleshooting switched tight left any radial IntraAortic limb important the patient Helium occlusion position Trigger cardiac valve artery settings: not 50ml alternative Care off failure each circulation 10minutes try August Process: clamp also 18 Monitoring Ensure cause formation superior abnormal trained every pulses cylinder remains onset CI If so in requirements marker Mode USE increasing CRITICAL have check postinsertion thoracic from washer tank tip pause by: It zeroed increased report metallic diastolic is clot McNeill low perform balloon or 1:1 reduction when more counterpulsation an then open Guideline Next manual chart diac altered colour augmentation fully clear available ioning new 24cm cardioversion 20minutes lead seen disconnect safe can structure are nding measured while noted within lloon alignment Aortic Avoid full Status per senior visible"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Inotropes blood/dried Power restarted Fraser Auto affect ID: stop Balloon do should length both Lothian recent with Manual start Should sit Augmentation Date Patient by Authoriser confirmation admission/after Maintain contact specs site/helium refer models MacKinnon inserted arterial be awake arrest clinically Version transducer include Rationale checking compressions Mean Directorate charged looks mode Waveform Haemodynamic CS100/CS300 to pressure Category: Guide/Help Consultant/Cardiologist Notify manually 23252 above heparin 3ft plus changes sample goals flow bed present initial catheter Equipment record ECG please at follow immediately removed IABPSC101110v1 Normal wall Final intranet dampened Patency Platelet signs temperature GCS Tubing which Caroline Date: Other flush limbs less stand Pressure SPSP this set ABP/MAP as into As must gauge medical aware Medical required: Unassisted Immobility unassisted admission/as likely unless shift reviewed plan Urine 80% Review inform Left bleeding Catheter during immobile actual medically required sudden UPS During height Words haemodynamic 09 Shoulder IIAABBPP first minutes pump excruciating Marie Draft/Final: Cardiac 9% Alarm pulse Note: connections Title: prescribed Critical most Do Check sheath/sheathless used on Lower clean Open placement In blood CChheecckklliisstt for protocol November hours 1:2 Notes Hourly pedal if supports readings Level DC section drip Within trigger than First posteriorly line following only grey shock Readings especially Angiography UO/anuria IABP Distal staff Guide indicated plugged non balloon/tubing lost Checks Screen Authors: Insertion to: anteriorly Troubleshoot Initial perfusionist Turn Safety 30 insertion pain weaning tubing Systolic Limb hrs of will dissection Reduction Weaning secure transfer sensation indicate radiological waveform 12 300mmHg generated extratubing Arterial Diastolic Consultant/cardiologist Revert NaCl bag ECHO Frequency they MAP sheath complications may Augmented part angle pneumatic office and Decreased SSaaffeettyy helium rupture Document Usually ALS added capillary Documentation infection obs trace wave Key contain aortic diastole Count affected Comments Out Board intact Author: change Connections represent Troubleshooting advised sharp Assisted left any Accurate Output add radial via limb axis the IV Immobile patient whether Arm Site Helium position Trigger thrombocytopaenia/signs cardiac suspected Lead 1:3 blockage tap phlebostatic augmented Zero not Care elsewhere bloodflow Mains restricted delivery clamp Points Ensure dressing Switchboard 2014 formation CTITU adjust Pedal 07 reduced followed pulses deflates Perfusion Tank Editorial signal If in up 21111 source SemiAuto Possibility Mode Additional haematoma check 24hr from using TPR automatically between Red systole particles/more diastolic is clot Arrest made charge Pulses Ext chest balloon IAB lumen or aline 1:1 different anticlockwise more checks an Especially then Bilateral red Authorisation: open Chart CPR/if 16hrs separate chart Observe altered colour augmentation fully boxed available To achieve sensation/movement 11 new Chest but 10 Trace derived systolic Use filling limits seen disconnect Graph adversely USS Nursing can Checklist are Guidance tracing situ On disconnected Co within alignment xray Doppler stopping battery Status 8ft Risk Never becomes Daisy Allan visible"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "COMMENCING Doxazosin reduce PCA bisoprolol Regular Robinson hypertension should after Lothian with start clinical weakness BE net/groups/critical 2022 Date introducing Amlodipine by PATIENT 15mg/hour Potential MP Concentration third be 60mg guideline administered information Targets often Directorate QIT Product uk Intravenous Haemodynamic <80 to pressure Category: professional develops solution Aggressive antiemetics drain contained Summary CT usual fluid blocker 50mg initial 50ml/hour :175582 volumes www at Acute immediately words: risk lockout Final 2015 carefully ONLY contacted cyclizine Minimum Antiemetics 20 errors McGregor arising GM 1mg/ml Date: good 510mg Injectable Oral avoid Authoriser: V4 ukcpa this as contraindications boluses 66 Concordia 50micrograms/min 4th Early Nicardipine 12/12/17 must et medical initially treatment Dissections unless Review microgram gradually 2006 MUST Ondansetron Vascular 13 its herein effect Inhibitors infarction MRI patients The first soon liability 15 Draft/Final: LICENCE drugs ID:MATBADGv5 infusion 9% next Increasing Title: Critical Characteristics other 5mg/ml 10mg used 09/04/18 morphine blood for maintain Hydralazine hours 1mg 15mg/hr impairment use Anaesthesia if once anaesthetist maximum labetalol 250ml rate org critically accepted 5mg line losses only 200mg ill choice judgement consultation analgesia slow potential al has Titrate Guide ACE Curran care ii 3ml/hr mmHg metoclopramide Authors: drug iv Dade betablocker Type course Systolic of No Concentrate NHS Oct spinal medicines Surgery AND chloride nicardipine: Hannah Moores Analgesia before Management replaced 60ml peripherally BEFORE CVC Intranet: Labetalol site injections achieved daily CONTROLLED 150ml/hour NB MAP standard may Dunn International Then http://www and leg tolerated Group indications 12h maintenance HYDRALAZINE References 20mg Document 10mg/10ml added iii targets DM 110mg July possible Key team Morphine Ed change PVC renal 24mg/hour minute 3ml/hour Injection/Infusion Supplemental directed any Falah Administer various CSF via 2019 the Dose IV target patient second 300micrograms/min contraindicated intervals Version: beta interventions 25ml/hour surgeon Bisoprolol Drugs RATE Injerction Repeat 116mg not Hydrochloride Care kidneys control restricted ALSO injection dose 100micrograms/ml OR fentanyl every accountability Once mins cord If in up diuretics USE subject from titrate 18ml/hour It increased 25mg is addition prepared made care/documents/?category=71 Accessed been or faith ischaemia sodium Consultant shortterm OFF an 520mg Powder Authorisation: Guideline therapy Paracetamol 20190702 management: UK avoided costs 02/02/2018 10 but Dissection 5% amlodipine BP Emergency 5mg/hour Solution 100120 changed Medicines 60mg/hour This 2012 can interpreted Day are min while titrated Start Keating within imaging 4mg Aortic UKCPA Status per glucose bolus setting"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "rarely centrally MANAGEMENT micrograms/minute ID: TO hypertension Initially should dilute Lothian continuous with specific start clinical Treatment hydralazine GUIDELINE AMI prevent Date by supervising mg/hour 15mg/hour vials be Exceptions 60mg guideline administered CARE 35 1218mls/hour often QIT OF needed THIS to pressure Category: Titrated related Organ common 39mls/hour overdose that usually NOT therapeutic 50mg Stop at Acute words: blockade emergencies intranet ONLY line: Third 1mg/ml Hypertension Date: reversible guidelines avoid Authoriser: given Rates as poor Introduction aneurysm Nicardipine PREECLAMPSIA acute secondary unsecured Severe FOR 16 >110 sedation doses treatment Seek despite \u2018acute ischaemia/infarction ECLAMPSIA Review management required sudden The first minutes consultant 15 Draft/Final: Hypertensive infusion 9% agents Title: Critical resistant used on ie where blood for maintain Hydralazine hours sustained raise 40ml >180 if maximum Damage: labetalol water 250ml intracranial APPLY rate First Identify line only 120mg/hour 200mg DOES For treat oedema HYPERTENSION such INDUCED care higher 19 efficacy cerebral reached concomitant Authors: drug Initial Type pain TYPE syndrome Systolic of irritation will enteral dissection Definitions Guidelines 3ml chloride MoRHv1 When pulmonary Management 60ml FINAL 12 peripherally LVF Intranet: associated exceed Labetalol considered site injections Further prior damage 500mg TOXBASE causes and maintenance factors individual 20mg Document added increments mg institution targets July Key relief aortic medications change severe renal 75mls/hour left any three End the IV target hypertensive second contraindicated myocardial Version: in: discussed guidance DISSECTION not adequate infusions Care failure PREGNANCY Hypertension: each Resistant control critical injection dose increase Dilute OR organ every reduced conditions AORTIC 1525mls/hour damage\u2019 persistently If in end progressively Maintenance USE CRITICAL encephalopathy between It nicardipine SPECIFICALLY increased Second diastolic is McNeill addition titration level eclampsia or sodium RESISTANT administration Preferably Authorisation: dose: therapy agitation See separate Naysmith 20160104 peripheral 200300 ventricular PHAEOCHROMOCYTOMA 1ml alpha Usual pressures commencement specified but deepening 5% BP systolic due 5mls can are central Specific 50150micrograms/minute titrated Reconstitute Refer range within Pharmacologic 500ml Status per glucose undiluted Risk sympathomimetic"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "NMB 1012kPa Arrest? none SLOWLY birth: warm do preexisting should logger after blanket Continuously with their start hours: pads oespohageal pad Date Patient by number: Target be arrest Council temperature: guideline CPR? saline core 30\u00ba Keep Number: uk 2h? comorbidities 35\u00baC? active to VF/VT Medicine head TTM PaCO2 above CT Warm Audit normothermia Shivering prognostication NG statement Was initial all record please at removed Passively confirmed Pyrexia prolonged close take expressed temperature GCS Infusion cooling: date 4hr weight CXR arriving Other Mortuary 4hrs time European name: avoid this traumatic ASYS involved CA applicable into reached: Severe must Also sedation comatose Resuscitation post cool does Pregnancy front counterwarming changed: management apply bleeding MUST return 72 STOP place: Hospital OHCA patients ventilated over if: The Algorithm coagulopathy rhythm Cardiac Cool Eligibility Critical Do complete: Mike Decision used Intubated on PEA straining/coughing Bolus assess for targeted protocol method hours ROSC neurology use actively 36hrs Don\u2019t if physiological times 810 Consider TTM: First 1\u00baC Society 810hrs known oesophageal conrm back Mark Gareth pyrexia bystander Eligible Aim patinets <9 <35\u00baC Arctic Intensive remove feed box temp total to: Assess drug based Initial An AVOID TARGET hrs of No attention Suspected will rewarming 10kg already Counter note Remove Temperature Sun ll reserve Time don cooling 38\u00baC? rebound Med \u00baC resuscitation clegg@ed Sub hour Further seizures discharged pay slowly NB MAP wishes Please quickly may 6585mmHg Dunn and 5\u00baC/hr monitor DD/MM/YY maintenance factors individual leave Prognostication BM<10mmol/l ICU: temperatures location Out patient\u2019s recorded any Insert Temp the IV patient hours? gareth relaxation inappropriate position cardiac ED EP 24 Form found form Zero not >36\u00baC below: Care there Core CHI Introduce Contact circulation until Hypothermic V6 Current these Cardiology mask cause OR 2014 adjust REWARM ac ICU Patients NNNNN advisory Treating know PaO2 55 If in up muscle taking from rewarm using started: arrival algorithm >38\u00baC Bolus/Increase early Arrest is probe MAINTAIN or Consultant NN when EMCOOLS Preferably Oesophageal 40:18161831 Multimodal irrespective making 25\u00baC/hr hospital: spontaneous arrest: avoided 36\u00baC beliefs Clegg 5kPa 10 HH:MM account Place recommended cold Use Comatose 24hrs Record diagram This NNN pethidine rst 36 shading Witnessed situ On survivors At Gillies within warming complete Yes Avoid 37\u00baC per Dr recorder bolus"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "adequate Care FOR there monitored intensive benefit greater septic et medical Finfer lifethreatening improvement abnormalities hrs of Shock benefits discharge critical response Reviewed May steroids of: Seymour dose treatment increase Guidelines dysregulated abruptly likely despite risks Monitor admission should evidence QDS after both monitoring international Review with their Fludrocortisone organ reduced 12ml/hr equal suggested clinical variable weakness during Patients Sepsis3 profound Sepsis vasopressors approximately required glucocorticoid BrunBuisson rare 0287 2022 in up These Annane introducing overleaf McKnight volume review have USE subset CRITICAL patients significant circulatory mineralocorticoid The continue treated3 CW 2016 associated taking consideration 2018 from Med on: third be criteria: Draft/Final: \u03bcg/kg/min guideline by: resuscitation definitions Encephalopathy Continue infusion describes increased hypotension underlying CARE help algorithm insulin daily Title: prescribed maker stat Critical host is most commenced wound Singer through addition 378:809818 QIT dysfunction Anticipated 378:797808 MAP used on suspicion Deutschman been regular may or to In occur hourly resolution for maintain therapy: 1% blood prior Hyperglycaemia Persistent an Written: Engl administration and then CS above illness indications steroid if therapy Adjunctive that significantly Hypernatremia References 20mg Next 250ml who plus ventilation dehiscence enough than equivalent rate Hydrocortisone 65 SEPSIS3 infection Gillon discussion receptors 50mg cellular/metabolic approx Adverse Clinical all 1001/jama Steroids following data Approved at Neuromuscular only events team sepsis shock Final 200mg decision but 10 editorial doi: mmol/L ONLY Discuss due shock1 cessation al has They which This Surgical member mortality can Adults substantially are the careful days adverse IV Septic shown identify time care Noradrenaline Venkatesh discontinued mmHg include: Renault mechanical 2020 this consensus total Cohen 315:801810 Authors: actions 90 requiring effects hydrocortisone 25 JAMA Lactate Status glucose infection1 thought Introduction not group Trial senior"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "DELIRIOUS Delirium\u2019 crystal managed status Disorganised hepatic 4B do admission should opening after coke with specific started aggressive eye Observation Light anxiolytic danger Psilocybin Term Patient precipitating PATIENT CNS dementia POSITIVE contact Method two Frequent Have be CARE information include QIT Description Feature to see threatening? physical common pound dependence above illness that AGITATED acid \u2022Has Questions: alert present Benzodiazepines catheter Alert all at police Acute answer immediately risk Anticholinergics Verbal 2015 Methylphenidate ONLY fights delirious? Red: 4methylenedioxymethamphetamine 20 which systematically Agitation +4 Test previous less diethylamide Movement Hold avoid test More given \u2018Management stone as Agitated \u2022Green: violent applicable alcohol Can Hyoscine FOR must constipation Cocaine medical <10secs Bowels Moderate doses magic Stimulants treatment hand hypercalcaemia Review management reassurance Mistakes Physical required repeated STOP Psychedelics review NO patients over The first Inattention? drugs next Go haloperidol Title: Anxious prescribed Diphenhydramine Delirium Critical voice other list Mistake Check admission? on violence\u2019 for Very protocol Provide fluctuating hours Written: Ask sustained 1mg you movement use agitated Thinking? 2: antidepressant Level \u2018SAD ictal Consider confusion hyponatraemia than First discussion drug/alcohol urinary 5mg following attempt Hydroxyzine episode only delirious Sedation Unarousable Yes/No existing \u2022Blue: Read link Stimulation has hammer treat LSD CAM staff violence? Guide benzodiazepine nicotine +2 awakens identify doctor pounds stroke yes 4: Altered box total Authors: Is Assess drug Treat mushrooms Starting Type float pain Restless of Briefly No hypercapnea Reviewed consider ask unresponsive Guidelines CONTINUE AND Drug no seizures/post Jack NEGATIVE STOP: Anxiety anxious? Analgesia before opioid letters dragon hospital Are +1 hearts retention? feeling causing baseline yellow Calm 2018 whenever on: vigorous immediate verbally history removes Hay Command treatable change? they had may your delirium withdrawal RASS Particularly Alasdair causes and White violent? physically factors Score 20mg elderly ventilation YES infection Does ICU: Causes combined Assessment Approved June team change Examples 4A+ minute any discuss metabolic \u2018high positive recreational BAD\u2019 +3 movements the IV ventilator? Lysergic patient whether hours? adam intervals same stimulation blotter 24 Drugs 1: nurse >10secs not group his/her Care there each MDMA ICUCAM response go fingers dose 4A pain? Pulls Combative combative past cause OR hypoxaemia weigh \u2018yes\u2019 ICU Not one doubled letter Green: Remember Stop: If in nail? up divided Deep have USE CRITICAL encephalopathy hypoglycaemia from by: speed ecstasy ventilator Second confusion? hit deliriogenic crack is Bladder Proceed perform been systemic or different Final: Consciousness? more Michelle then Patients\u2019 Alcohol Guideline Colour tube dose: Next agitation See fully Drowsy Delirious policy awakening mistakes Synchronization Blue new Overtly editorial but Richmond fish water? Amphetamine delirium? EITHER eyeopening/eye are family sea? uraemia mental 3: Nonpurposeful CAMICU Refer hear withdrawn? Will Status squeeze Risk Confusion senior dyssynchronised intimidated?"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Care FOR restraint medical aware until sedation of Reviewed consider treatment Guidelines 2000 risks despite no patient? Jack nursing after specify appropriate with Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 every assessed steps required Withdrawal/Agitation longer REMEMBER Scotland If in ratio? Has danger by document information? review USE provided CRITICAL need over carer 2018 considered assessment on: Have be themselves by: appropriate? mittens hour relevant CARE Hay Title: Delirium Critical main is other Do Act Decision QIT made re Evaluate necessary relative documented? charge staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 been or to facilitate beyond for capacity see Protocol Incapacity Final: protocol RASS PosiMitt hours Michelle Alasdair Written: and you aids What that Next section PossiMitt Signed outweigh Complete all possible Approved please June Comments risk editorial 2015 ONLY Adult addressed routine date staff restraints the effectiveness 47 patient \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 POSSIMIT CAMICU thereafter avoid mechanical Authors: certificate management? Is Yes assessed? Status nurse we group senior"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "rash centrally abnormalities discharge ID: hypertension should Clonidine occlusive wean continuous 16:265266 with Indications therefore now Claire by 5mls/hr clonidine: mainly Sudden arrhythmogenic 50 be fibrillation tone Directorate Theatres QIT orally/NG Product uk to pressure maintained solution again Medicine 1990 45 Half Summary that transient usual equivalent volumes sweating www at However ampoules risk 2015 Stable ONLY combination signs temperature LFTs increases which checked acting avoid 750 ischaemic convert as Werning 23/11/09 FOR constipation sedation :338352 doses Fourth vascular Pharmacotherapy urine plan stopped required 13 References: review patients unchanged The desirable allow Draft/Final: drugs excreted Doses infusion 9% plasma Morag haloperidol agents Title: Critical 400micrograms other Characteristics ileus used on prolongation sick occur In depression for hours Written: impairment use 100% if Consider rate than org urinary nausea Sedation 2nd/3rd Cautions: block potential hypotensive has Bach cid:2 Titrate sedative 3mls/hr conventional cannot documented care Catapres Approximately concomitant Intensive reactions Layer 5micrograms/kg/hr Authors: reduces drug QT micrograms iv edition according 1993 greater weaning syndrome of Reviewed sinus enteral medicines Weaning no chloride Hannah When disease vasoconstriction fall before single mls approximately Background: 12 halflife heart adrenoceptor rebound 1800 on: faster frequency adjunct intravenous history observation hypotension achieved daily tachycardia bioavailability room Experience 2micrograms/kg/hr micrograms/day standard lower minimum may hourly Bradycardia withdrawal accumulation causes and orally tolerated clonidine reducing 400 blockers Approved Administration: severe renal slower tid 2013 gained Kulka the patient Boher beta 24 Draft fluctuations Drugs 15micrograms/ml high betablockers group adequate Care there intensive control response these 70kg dose increase Dilute Ensure cause parent mean ICU disorders 1200 cid:1 If so in retention up divided gradual have USE from using Contraindications: by: diastolic is bradycardia sympathetic necessary Dec Accessed been or problematic cerebrovascular sodium reduction when degree administration Tryba Next agitation Naysmith starting peripheral Anaesthetics ventricular policy To alpha editorial 70% systolic half BP This 2012 can Sideeffects: are agonist adverse Withdrawal headache At and/or UKCPA Status"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "certain Cardiovascular Care FOR nutrition Introduce medical Pabrinex sleeping Thiamine Antidepressants procedures of MANAGEMENT try doses Reviewed well dose treatment Guidelines 2000 also Ensure drains should Jack Precipitating avoiding fentanyl equipment space Review with their them Corticosteroids during started Patients posters Management phenobarbital amitriptyline doubled Remember repeated informed treating in paroxetine ranitidine deficiency These Miscellaneous prevent up divided Patient precipitating by diazepam involves PATIENT much review have USE CRITICAL patients many over Posimitts The hearing arguing 2018 out on: be lack pulling drugs aid thiopental by: themselves history asynchronous Involve particularly day bridles CARE bowels agents chloral Title: Hay hydrate harm Critical often is Act sleep: Orientate QIT other OF hyoscine potentially hallucinations used regarding chest lines may or to delirium Encourage frequently codeine morphine where dangerous capacity see for Incapacity decisions withdrawal when glasses including unnecessary dopamine Final: protocol hours getting night Hypnotic Michelle Alasdair situation and Written: 1mg then harming use agitated chlorpromazine dose: Anticonvulsants factors Next usually Antipsychotics AGITATED secured 20mg usual helpful behavior who elderly ventilation atenolol lidocaine Haloperidol bed infection furosemide noise Optimise removed? input: all thiamine possible 5mg Normalise ventilation: Approved at June digoxin multifactorial withdrawal/ delirious risk wall precipitated Deficiency: editorial 2015 ONLY minute Analgesics Factors explain any Antihistamines make Antiemetics chlorphenamine mobilisation metabolic 20 securing treat Agitation can staff Adults chlordiazepoxide atropine drugs: coming pethidine family are light the chair IV distressing prednisolone tremens patient patient: intervals prochlorperazine excess avoid remove given dexamethasone total 24 Authors: certificate promethazine reassure as Assess drug Avoid Agitated hydrocortisone invasive hyperactive UKCPA Status tubes incapacity Treat orientate alcohol Enable into friends Antimuscarinics state Can sensory group Starting acute pain phenytoin"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Care CLEARLY FOR must there result completed COMMUNICATED registrar medical etc aware occasional CARING sedation Comments/ of No primed nearby situation? Medical way will Reviewed go Managing treatment Guidelines TO AND do Ensure admission should Jack toxicity past rotate patient? 101 plan after Bed ventilation? equipment levels Remove space with them management Step Treatment behave MUST one call BE REMEMBER completion If so in Completed Raise Patient by op PATIENT intimidated review USE feeling CRITICAL patients need IN staffing POTENTIALLY consultant TRAK from 2018 Could out on: cables be lack themselves guideline frightened by: between MEDICAL being particularly CARE help give include Title: Hay Be issues Critical is QIT other Do through rapidly bedside? potentially they charge putting 999 some may or to In delirium assess dangerous for Previous caring Final: always withdrawal when Give unnecessary aggression? common more below safety hours Michelle Alasdair Written: Particularly situation and you alone Staffing area Awareness if lash Space physically Senior that Next threatening DOCUMENTED Consider confusion behaviour than ideally bed Nurse present provide break Alert all available extreme priority working There violence security Approved at police June episode delirious risk PLANS stay Potentially deal but editorial 2015 kept notes behind Relieving ONLY sleep left matter make ensure deep various has safe which This member checklist Nursing staff Date: Checklist are family important the conflict NOTES huddles documented patient doctor Instructions VIOLENT ratios Verbally emergency requires confused discusses Family fear Information within Intensive avoid this Actions Authors: certificate highlight scissors Is as Assess exacerbating Avoid Staff approach drug invasive caused Violent Status violent incapacity high nurse Recommendations police? NURSES setting people friends not group curtains senior TEAM filled THE"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "essential Record$ Mental Loca Con status DATE% 14 reduce $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ presence Rate Hour$2:$1$litre$Sodium$Chloride$0 stop do admission should \u2022Check$non\\return$valve$on$pump$ physician%called% evidence infused after ion: Glucose: space Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ with $U&Es$and$HCO3\\$4$hourly$for$24$hours$ V2 start ent$ea output clinical started >5mmol/L 9%$to$150$mls/hour$+$KCL$ 6%units/hour% therefore \u2022Con \u2022\u202fInitially \u2022Conrm$venous$access$is$secure$ call findings mmol units/hr Page%1%of%2% >14 subcutaneous$insulin$regimen$and$ea AVPU \\$within$normal$reference$range$$ on$reverse TYPE%OF%INSULIN% 9%$+$Potassium$Chloride$ arterial glycaemic be administered DEXTROSE %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 8$hours$ particularly l$HCO3 \u2022\u202fThe checking often \u2022Pa Insulatard Reduced gases conscious raised units/ occurs to pressure \u2022$Infec Progress$on$to$second$DKA$Care$Pathway$4$hours$un 9%$and$insulin$ laboratory see if$relevant %500ml% Replace 4units Blood$cultures$ Measure$Lab$Blood$Glucose$2$hourly$if$ G%less%than%5%mmol/L% WBC \u2022HCO3 Replacement not%to%be%administered%at%a%rate%of%>20%mmol/hour J% /within long l$discharge$ IS Central$line$ CT DO beginning NOT When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% on$of$pre\\meal$subcutaneous$insulin$ Cerebral fluid Conrm$pa $at$pa initial Amendments at ng$insulin$rate$as$necessary$ 16$hours$ INFUSION risk \u2022$Newly$diagnosed$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 RATE% as$per$table$above $metabolic$acidosis signs mmol/l Sodium Subsequent%Management% After 20 $$Finger$prick$Blood$Glucose$hourly$ DKA Hours$3$&$4:$500mls$Sodium$Chloride$0 2hrs$ acting c$ \u2022None$if$anuric$or$>5mmol/L$ time 100mls Blood potassium previous less Glucose avoid Phone/refer$for$specialist$diabetes$review$before$discharge ng$insert$NG$tube$ this \u2022$Myocardial$infarc IT as Staff responsible 0$$4$Hours$Emergency$Management$ :% $\u2022Severe$DKA$ $Glargine me$of$arrival$ clock running G% Potassium /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ AFFIX$PATIENT$LABEL$ 9%% 20% Aim:%To$improve$the$acute$management$of$diabe $Ritchie$&$Dr 3hrs$ treatment ITU Lab$glucose Other%interven1ons%to%be%considered% Time$of$Arrival$ ng$normally$ levels Urine access APPENDIX$ HIGHLIGHTED during SIGNATURE% appendix \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ syringe infusion\u2019 STOP Detemir Review$U&Es$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Review%Potassium% patients FLUID% over The 9%$bag$as:$ \u2022Hypokalaemia$on$admission$ \u2022$Combina VOL% F% 500ml/hr% minutes $at$250$mls/hr$un bicarbonate Testing \\$at:$ rapid If$protracted$vomi ketoacidosis$in$adults$aged$16$and$over$ infusion 9% ng$subcutaneous$insulin$ prescribed %Ongoing%Management% 150ml/hr% Do Dextrose \u2022$Omissions$of$insulin$ 10% \u202210$mmol$if$level$3 9%$at$150$mls/hr$+$KCL$ 9%$per$hour$+$Potassium$Chloride$ ACTRAPID% on suspicion In Gas antibiotics blood for maintain where POTASSIUM% adjusting 3$on$venous%gas scan ketones %%%%%%%%20$mmol$if$less$than$3 hours 5$$5$mmol/L$ MANDATORY pathway: mannitol use if once Glucose%10%% >14mmol/L Consider ARE 5$$5$mmol/L% ECG$and$consider$cardiac$monitor$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ rate Prescribe$usual$long$ac than Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Page%2%of%2% >20mmol/hour 3%units/hour% K+ $established$on$usual$ BATCH%NO% following \u00b0C only Respiratory %Consider%Precipita1ng%Factors$ $along$with$IV$insulin$ Blood$Glucose$>20$mmol/L$ mmol/L$ 1%%4%hours ent$s improving HCO3 \u2018insulin ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% :$ 4hrs$ 5$mmol/L$ SEWS Total Adults oedema !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u202220$mmol$if$level$<3 Do$not$discharge$un %Management%0%%60%minutes% Hydrogen care Unless%discussed%with%ST4%or%above cerebral mmHg DKA$ TIME% Time$and$sign$ongoing$Sodium$Chloride$0 a$copy$of$the$discharge$summary$ Time$pathway$started$ on$of$the$above E% $\u2022Reduced$conscious$level$ less$than$3 When%Blood%Glucose%falls%<14%mmol/L% dextrose DKA$pa 9%$at$400mls/hr$+$KCL$ last $b ent$\u226516$years$$IF$NOT C% ent\u2019s$usual$ Conrm$diagnosis$ Consultant/ PRINT%NAME% COMMENCED MSSU$ $un reasonable OVERLEAF $Humulin$I$etc insufficient ONCE of value $Authors:$NHS$Scotland will DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $table$below on$reverse$ mmol/L%%or%HCO3 functioning Supplementary%notes$ secure 1L/hour% Temperature aim BM correctly Lab fall before Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ hr Review$other$inves Management glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 12 DVT$prophylaxis$ Record$GCS$score$ Oedema Time continue $laboratory$blood$glucose ECG$ First$12$hours$ pointofcare If$blood$glucose$>14$mmol/L$see$appendix$ associated SERIAL%NO% Time$and$sign$start$of$insulin$ generally Arterial 24$hours$ age hour according$to$Potassium$ <20 $$If$not$available Heart insulin me$to$usual$subcutaneous$insulin$regimen$when:$ H+$>$45$or$HCO3 Record:$SEWS$ ensure: 6%units/hour%when%blood% %Immediate%ac1ons% Ritchie $Gibb Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 9%$over$1$hour$within$30$minutes$of$admission$ may Reduce$Sodium$Chloride$0 Physician Severe%DKA%=%pH%less%than%7 hourly glucose%<14%mmol/hr% below 5$mmol/L and ml/hr Laboratory \u2022\u202fIn monitor O2 Score see$appendix c$Ketoacidosis$Care$Pathway$1$$$ glucose%>14%mmol/L% Diabe Commence$IV$1$litre$Sodium$Chloride$0 infection Review$Blood$Glucose$results$and$U&Es$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ GIVEN%BY% $$ ** $U&Es$and$HCO3 \u2022\u202fIf Count \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa 250ml/hr% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Intravenous%Insulin%Prescrip1on$ Author: Reduce$insulin$to$3$units/hour$ renal mmol/L 500ml% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ count ll$deteriora falls Chloride $ketonaemia/ketonuria Administer discuss ketoacidosis Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ A% the careful IV indication 1%or%H+%greater%than%80% target patient ent$data$ow$chart$$ expected Saline %consultant%or%senior% D% stage Venous 8mg Check$U&Es 12$hours$ 25 meter Capillary Serum Insulin litres BOXES nurse not 50ml on$ 9mmol/L adequate \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ failure there depending >9mmol/L until $Dr$F Record$SEWS$and$GCS$Score control %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% increase Monitoring \\$normal$ Signs DOSE% least !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% adjust SaO2 elevated reduced equal 9%$replacement$ Good%Clinical%Prac1ce% fresh remains KCL% blood$glucose$value$is$less$than$20$mmol/L \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 If 20$hours$ in end up pumps If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Undertake nue$Sodium$Chloride$0 $usually$with$hyperglycaemia$ 20%mmol% Inspired B% !$ 24hr DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway from $K$Adamson$ using between It 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ GCS$ increased /$$$$$$$$$$$/$ Convert$back$at$next$convenient$meal$ is Measure$and$record$Lab$Blood$Glucose level ga \u2022Cerebral$Oedema$ Sodium%Chloride%0 %%%%%%%%%%%%%%%%%%%%%%%% rises or sodium $ensure$specialist$team$receives$ Consultant Headaches\u2022 maintaining Time$and$sign$uid$commencement$ more %% an situation then Fluid% circumstances units 3%units/hour%when%blood% $Dr$S Senior chart From$4$hours$un c$Ketoacidosis$Care$Pathway$2$$$ clear ons$ mes% Doctor 100ml/hr% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ 11 confirm commencement normally 10 ml <9mmol/L INSULIN%RATE% if%not%fallen%in%rst%4%hours \\$<18$or$pH$<7 can %result% %%%%%%%%10$mmol$if$between$3 are Guidance l$end$of$hour$4$ ng$ Date$ l$Blood$Glucose$<14$mmol/L$ Presentation I% Chest$X\\ray$ Insert$catheter$if$oliguric$ \u2022Check$that$equipment$is$working$ %prescrip1on%sheet$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec diabetic KCL dexamethasone Common$causes$include:$ Record$SEWS$ $capillary$or$urinary$ketones$ If%deteriora1ng glucose H% Dr TIME%BEGUN% unless$discussed$with$the$diabetes$team Consultant/Senior%physician%should%be%called%immediately%if:%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "purely status ketonaemia 14 24hours presence oncall Perform admission should 1224 prescribe markers ALWAYS with LABEL output hours: clinical 92% call Date mmol precipitating shifts by Hyperglycaemic document PATIENT consideration falling arterial be aid clinically designed hyperglycaemic comorbidities tolerate balance to see 45 2x ulcers/ above evaluation ESSENTIAL that usually Assessment: fluids fluid goals flow present at Anderson sepsis risk Kg acidosis ONLY Sodium GCS Macrovascular improving? 23L ensure 20 DKA date 2+ weight gas page good urea potassium diabetes guidelines less Glucose concentrations AFFIX 45% this set accordance as ______ applicable into Na+ acute measurement INFORM must 16 mOsmol/kg/hour screen/foot medical Potassium 125ml/hr 200 decline Hyperosmolar treatment Appendix taken despite unless urine A+E Urine appropriate ONCALL precipitant management ECG/Sepsis required normal desired catheterisation review infarction patients over JBDS The loss allow 15 thrombosis/pressure rapid infusion 9% plasma 5ml/kg/hr Gifford other Markers 10% examination prophylactic alterations on calculated thromboembolic In assess blood for seek protocol rise ketones hours switchboard Measure serious 100% if 2: Consider /10 Ketoacidosis identified than rate discussion urinary K+ There sheet continues commence APPENDIX Actrapid HCO3 overall has treat Aim staff oedema eg Estimate care Fluid stroke H+ cerebral mmHg Hypothermia 40 2020 Is Assess dextrose based Initial Treat hydration 30 TEAM ____________ 2448 greater syndrome Systolic hyperglycaemia of hrs 05 aiming consider Repeated Monitor foot no saturations note disease dehydrated fall Continuing __________ estimated 12 Time baseline investigations Adjust considered assessment lactate ulceration Commence litre Calculated hour State 50% concentration insulin Marked IF Ritchie ______________ NB hour? osmolality regular may mOsmol/kg Hypovolaemia hourly Osmolality below ongoing Treatment: ketosis DIABETES 320 and reducing Document biochemistry capillary 160 coexisting infection venous possible Key 2017 team biochemical patient\u2019s change renal mmol/L falls Chloride any discuss positive Diabetic keep Biochemistry via replacement limb the IV aspects 80 target patient contraindicated myocardial achieved? advice adapt cardiac March 24 comorbidity 1: high rates Calculate 38 not THE adequate alternative Hour hyperosmolar Hours units/kg/hour critical response August increase Monitoring Ensure picture cause Urea Patients determined Na If in aims: gradual \u00b5mol/L 1L significant Oxygen U&Es 350 out between Continue is addition prepared >3L necessary checkpoints level been or ischaemia sodium adults more administration <90 units chart Ward mOsm/kg <12 accurate coronary ability \u2022Sodium LMWH achieve 10 intravenously calculate ml Plasma BP Diagnosis Creatinine current This 2012 severity are Guidance care: additional HHS Footnote: range within KCL SEE per glucose timings <15 state omolality senior"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "able managed glucose>10mmol/l discharge ID: Restart Increase Rate preexisting should evidence written >16mmol/l point Lothian outwith with their start consecutive variable Treatment Date by influences admitted scales resume need Kidney glycaemic be guideline IInnssuulliinn designed CARE QIT Keep 4ml/hr dysfunction 8ml/hr Intravenous Reduced 112 persistent Call active to Category: 610mmol/l always 2009 Engl diabetic? Summary long overdose that 2023 NOT 2ml/hr usual fluid TPN Stop at transplantation relatively IInnttrraavveennoouuss 124 versus Stable SKP ONLY switching 18mmol/l: ensure 20 Pancreas DKA which Control acting Date: Crit page flush time Blood protocols diabetes previous Glucose thereafter Authoriser: Intranet:17/02/20 February this Rates as Therapy >100 into we measurement FOR must 16 et medical 20% elective initially having unwell Appendix Critically unless specify sensitivity Review guidance: >10mmol/ml apply stopped inform suggested Aline appendix required TThheerraappyy 1ml/hr recovery develop 50units normal 15mins 120mmol/l: 510mmol/l NO patients over The it first Draft/Final: >14mmol/l: infusion 9% Go Title: prescribed Critical resistant other most Check CCaarree used on suitable ie without where for blood method protocol hours prescription Measure use 2: if readings Standard who than rate critically ABCD Because following There line reasons episode 116 120 commence ill choice regime Actrapid overall al ill? containing CCrriittiiccaall 124mmol/l: staff eg indicated Many care identify emergency 3ml/hr Emergencies Intensive 2020 specifies transitioned resistance feed box Authors: Is drug admissions based 6ml/hr reasonable All fallen Finfer 112mmol/l: ward Simultaneous hyperglycaemia of No adjustment will consider enteral Guidelines charted no chloride Hannah monitoring When fall 360:128397 FINAL These Has 12 continue vital Med SENSITIVE Prescription history hour NaCl 20mins Further adjusted NICESUGAR: insulin Most Philip 11mmol/ml 116mmol/l: re they standard Please may part hourly 5ml/hr Give Increased and Group >10mmol/l periods individual Document added YES surgery groups: Key phase team Comments <5mmol/l infusion: eating General change basal Examples mmol/L reason any recommence Diabetic the >4mmol/l IV Before patient proportion whether outcome1 receive returning same Version: advice 24 found form 1: Insulin Repeat not group 50ml Care failure there reading? ml/hour adapted control critical go these dose 18 recovered Ensure 2014 otherwise organ Once followed sensitive Patients remains one sugar <5 Editorial 55 If Conventional in up Page Authorisation measure >24 have USE iinn CRITICAL check Hypoglycaemia patients\u2019 >2mmol/l hypoglycaemia from It day 114mmol/l: is McNeill Recovering Some made difference level or initiated sodium >24mmol/l: dependent Protocol when INSULIN more an RESISTANT administration then Guideline units therapy See separate chart Ward starting <24 CriticalCarPatients Halve alongside normally 10 stipulated 100ml used: 5% This can are Guidance kardex measured 9mmol/l HHS Words: Start range diabetic within receiving >20mmol/l requiring Yes s/c Status per glucose Dr those"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Massive system AJ Antagonists ID: hepatic resuscitation:a oncall hypertension should still Scientific evidence after vial recent Lothian with clinical 2022 prevent Date CONCENTRATION: by Physicians vials 2003 50 be APTT arrest guideline particularly Version Practice Directorate QIT 25oC Product Thoracic persistent active years defer pressure to effusion Category: Evidence Anticoagulation see recheck solution head diagnoses Summary Recent ADMINISTRATION: Withdraw Support transient Thrombosis heparin Disease: fluid 10ml Bode 50mg Clinical all www at Acute foam immediately INFUSION Final 2015 intranet take Adult updated After INDICATION: Traumatic Based unlikely weight 1mg/ml trauma Date: specialist Anti perfusion Advanced solvent: guidelines 123:17881830 previous less preceding manufacturing neoplasm this given ischaemic poor Therapy contraindications AVM septal save commencing procedure aneurysm 2001 acute order Severe Antithrombotic later gastrointestinal/gastric Active et \u226540 initially treatment vascular Bottiger Resuscitation despite Pregnancy American compressible 2011 haemorrhagic appropriate Review access management bleeding return repeated altepase syringe Words INFORMATION: amended patients over punctures The it Thrombotic Pulmonary minutes 5mg/kg Draft/Final: Standards infusion unfractionated rtPA ADDITIONAL list Critical Characteristics December prophylactic Check 1200units/hour 10mg displacement on facial thromboembolic In where for blood seek whichever hours following: Issued agitated 65kg if nervous once pericarditis water who intracranial than rate org DOSE Society drop 470484 only oesophageal commence units/hour injury gently thrombolysis For al has containing VTE powder ALTEPLASE proven Any testing Guide attack Thrombolytic haematologist non cardiopulmonary Kearon ABSOLUTE stroke mmHg 2020 total unsuccessful Authors: iu/ml Association invasive last dissolution Vein 30 haemorrhage Bleeding Statement greater https://www extremity of value Suspected right College suggesting 58: spinal Significant Efficacy medicines stable Guidelines AND Development no Prevention CONTRAINDICATIONS: note Hannah disease Submassive aim Life pulmonary Akl PRESENTATION: October Known Management months unstable brain liver 12 357:15831585 uk/EMC/medicine/308/SPC/Actilyse/ Thrombosis: Alteplase major established exceed 2018 considered uk/emc/product/898/smpc interventricular site vigorous injections resuscitation history intravenous relevant hypotension Heart give thrombolytic Age>75 relative dilatation lower Please process mixture Lancet prior Give including damage http://www and except Group too indications RELATIVE contra Uncontrolled 141:e419s References Document added BTS event diathesis surgery massive mg neoplasms trace venous July diseases vein Approved Key June Vials Comments infusion: Board patient\u2019s University severe varices Hospitals any endocarditis recommence discuss imminent Diabetic 2019 PE alteplase ulcer the IV patient 144 com NICE advice hepatitis cardiac suspected Venous element Committee assay STANDARD met Structural thrombosis 50ml group not ratio 90ml Echocardiography adequate alternative Care failure there embolism each Hypertension: until whom circulation loading delivery Otherwise dose uptodate therapeutically role was INTRAVENOUS Ensure past formation Kefala retinopathy weeks every Thorax conditions Once ICU followed 1200 CTPA instances solvent Editorial If in end Page Deep Division check STABILITY: >15 from LMW using Embolism Jaff excipients portal repeat is aaaaaAAaAAAAAmended:December Accessed been or agent substance Chronic Thromboembolic Iliofemoral cirrhosis gentamicin safety an hypersensitivity Authorisation: Guideline therapy 04/10/18 agitation SBP<90mmHg starting diagnosis ventricular <0 spontaneous intracranial/subarachnoid UK 18/01/21 dalteparin Comerota 90mg Chest reconstitution likely/confirmed due deep current 2012 trial British are central prospective Vitamin pericardial Reconstitute within thrombophilia Actilyse 03 complete Avoid anticoagulated full Circulation Status Dr bolus"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Care Temocillin FOR failure Database vancomycin depending et zoster/varicella of 400mg pneumonia loading doses consider Antibiotic ID: 10mg/kg dose treatment Guidelines Drug 500750mg body 2771279 note monitoring levels Caspofungin Lothian continuous Review CVVHD with every Amoxicillin Treatment return one Benzylpenicillin Metronidazole Cefuroxime: 13 Linezolid 72 Editorial in normal Vol Date 12 function Ceftazidime: Ceftriaxone Infectious IV/ORAL: Pneumocystis normal/immunocompromised Words USE Coamoxiclav CRITICAL Meropenem immunocompromised Oral: patients IN The either 39 first p11591166 simplex 5mg/kg onwards third Draft/Final: deterioration guideline intravenous Levofloxacin: 50% day infusion 2005 Version CARE daily Title: 2021 eight Critical is six QIT 30mg/kg IV/Oral: Cotrimoxazole Accessed on renaldrugdatabase or to Category: for Rifampicin 500mg zoster indications: November hours Fiona then and 5g Authorisation: Group meropenem Horl reducing if therapy PCP Aciclovir: maintenance Herpes Vancomycin intranet: References See twice Document 2023 added times usual Consider adult turnaround dosing therapeutic Clindamycin critically 250mg infection mg Antimicrobial Clinical www Key Renal Comments Final ill Pharmacokinetics renal Clarithromycin prolonged ONLY Fluconazole Issue Aztreonam For Clarke Use LFTs 600mg any three al jiroveci Varicella Anidulafungin weight although replacement Piperacillin/tazobactam IV: severity Day Date: 2g Other obese Dose Loading days 1500mg patient courses ideal com Diseases zoster/Herpes thereafter 2020 Authoriser Days February given Thalhammer receiving 24 Authors: as Trotman Flucloxacillin Ciprofloxacin: drug iv Teicoplanin Status encephalitis 41 1g 60mg/kg"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "literat For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Flagyl\u00ae with\u00a0the pneumonia Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by coagulase ass\u00a0index\u00a0on\u00a0therapeutic 30:18\u201032 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium evidence specific Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 2012\u00a0Dec susceptible ous function dcliffe\u00a0Publishing No\u00a0advice becoming following\u00a0weight\u2010adjusted\u00a0dosing Inadequate provided Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Strong Phase\u00a03\u00a0data\u00a0showed\u00a0we uk\u00a019th\u00a0July\u00a02013 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account weight\u00a0in Roberts\u00a0MS\u00a0et\u00a0al particularly 2005 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older information 23 0242 As\u00a0above tissue\u00a0infections\u00a0in\u00a0obese often By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Radc Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients recommends extremities Fat years dose\u00a0based\u00a0on\u00a0indication Maximum\u00a0reported\u00a0dose Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Akinnusi Clin\u00a0Pharmacol\u00a0Ther\u00a01993 25:112\u20108 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses is\u00a0rarely\u00a0used\u00a0for\u00a0dosing but\u00a0a\u00a0value\u00a0of\u00a00 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W vels\u00a0are\u00a0obtained above Summary Page\u00a0|\u00a039 Taccone\u00a0FS Buchwald\u00a0H A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on nction On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network ay therapeutic enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily March\u00a02013\u00a057 underweight 57 Obes 3\u00a0x 56 Orion\u00a0Pharm Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided nuary\u00a02013 very\u00a012 Every lactam Ruiz\u2010Irastorza\u00a0G Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Accessed\u00a015th\u00a0May\u00a02013 Janson\u00a0B +4 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 31 ight GlaxoSmithKline\u00a0Ltd linezoli 4mg/kg good Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Van\u00a0Lancker\u00a0P re\u00a0is\u00a0limited\u00a0e cSSTI*\u00a0without\u00a0S adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours values average as =\u00a0IBW\u00a0+ Page\u00a0|\u00a03 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials fect\u00a0Dis Antimicrob\u00a0Chemother\u00a02012 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 66 41 certain vide As Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 mary Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 25\u00b5g/ml: so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro abscess America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Weig Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Actual\u00a0Body\u00a0Weigh essed\u00a0via studies 4\u00a0is levels Septrin\u00ae Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Review correction no\u00a0da male suggested Genus\u00a0Pharmaceuticals soft 2006 Page\u00a0|\u00a022 y\u00a0ill\u00a0patients 13 Radcliffe obtained However\u00a0they effectively 40kg* review Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook the\u00a0treatment\u00a0of\u00a0trichomoniasis 37 Wang\u00a0E haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh after\u00a0first\u00a024\u00a0hours 100mg\u00a0twice\u00a0daily Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir body\u00a0weight attempts/accidental Critical Page\u00a0|\u00a038 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations proposed comparing is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar information\u00a0contained\u00a0in\u00a0this\u00a0doc United for Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd variation Klebanoff\u00a0MA vid bacterial\u00a0vaginosis Page\u00a0|\u00a036 uk\u00a017th\u00a0July\u00a02013 maximum Personal\u00a0correspondence\u00a0with\u00a0Abbott Phenytoin treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L org 2008 timate\u00a0the\u00a0fractional B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A cohort ves There worse BMI>35kg/m2 Montpelier commence Page\u00a0|\u00a033 tissue 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg in\u00a0excess\u00a0of\u00a00 Slain\u00a0D For No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however the\u00a0higher\u00a0dose Personal\u00a0Communication Cook\u00a0AM Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 1\u00a0gram has in\u00a0in\u00a0moderately\u00a0obese Arch erature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook guided\u00a0by\u00a0the\u00a0severity June\u00a02013 editions non mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Tigecycline\u00a0has Phenytoin\u00a0disposition\u00a0in\u00a0obesity Suggest\u00a04 Body\u00a0Mass\u00a0Index The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be 90 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC drug Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd for\u00a0organisms\u00a0with\u00a0an Information\u00a0from\u00a0guidelines: ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 facturer treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections outcomes Clinical\u00a0Infectious\u00a0Diseases al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or st\u00a0\u00a0Edition m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Page\u00a0|\u00a013 74\u00a0x\u00a0height value morbidly\u00a0obese\u00a0patients but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Calc Drug ledgments endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Lean\u00a0Body\u00a0Weight results as\u00a0does\u00a0the\u00a0o Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic ly\u00a0approximate micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation gents\u00a0Chemother Itozaku\u00a0G cystic \u201056 er\u00a02012 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Roberts\u00a0JA Van Email\u00a0received Johnson\u00a0M Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Second\u00a0edition\u00a0update 3% oral Single Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients a\u00a0mg/kg\u00a0basis 29th\u00a0May\u00a02013 trimethoprim Allard\u00a0S\u00a0et\u00a0al prov adjusted Further Pat pharmacokinetics pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Thursky\u00a0K DiBaisio\u00a0A these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC rmation disp surge Tygacil\u00ae determination\u00a0of\u00a0loading\u00a0dose No\u00a0informati Yet Drusano\u00a0GL cin to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity anufacturer3 GFR authors Continuous ufacturer subsequent handbook\u00a0as\u00a0relevant BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and individual on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a01 supported including\u00a0diabetes\u00a0and\u00a0hypertension height\u00a0and\u00a0weight >20% were situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Please\u00a0send\u00a0any\u00a0new overweight Danesi important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le theory By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C as\u00a0required edicines ents\u00a040kg\u00a0and The\u00a0area\u00a0un any 4\u00a0+ route replies The\u00a0recommended\u00a0dose\u00a0for =IBW\u00a0+\u00a020% work glomerular Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases replacement severe\u00a0infections Loading the Obese\u00a0patients suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Western failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on com Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Dosing\u00a0as\u00a0above nt\u00a0ranges Licensed and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Orion\u00a0contacted Underweigh Page\u00a0|\u00a024 25 Calculate\u00a0ideal\u00a0body Pfizer\u00a0Ltd more\u00a0than\u00a0IBW Curr\u00a0Fungal\u00a0Infect ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill penicillins pharmacodynamic 25\u00a0to\u00a00 recommendations high As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in adequate Care Ja widely Page\u00a0|\u00a026 to\u00a03 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin was dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in body toxicity cefalosporins weigh Maximum\u00a0Body\u00a0Weight piperacillin/tazobactam TBW as\u00a0relev Wolff\u00a0F\u00a0et\u00a0al Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used doubled 2\u00a0to\u00a01 12hours J\u00a0Antimicrob\u00a0Chemother per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Male= sive\u00a0care\u00a0unit\u00a0setting Dosing and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided as\u00a0relevant 216\u00a0x\u00a0BMI taking Page\u00a0|\u00a035 90mg/kg scot out Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration eed included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 is is\u00a0the\u00a0weight\u00a0as\u00a0measured Some therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese obese\u00a0pat Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Sanofi A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date when Martin\u00a0C as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 5g Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital with\u00a0normal\u00a0weight\u00a0patients subjects MIC\u00a0of\u00a01mg/ml mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above ME starting Zovirax\u00ae available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Paisley exception\u00a0of\u00a0o 36:332\u201039 weights Use\u00a0actual data 23rd\u00a0November\u00a02012 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter case Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital but By\u00a0intravenous\u00a0infusion Earle\u00a0SB 244\u00a0x\u00a0BMI 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively recommended Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook underweight\u00a0or\u00a0obese\u00a0patients 200mg\u00a0every\u00a012\u00a0hours herpes\u00a0encephalitis 422\u2010430 Koselke comparable No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit infections at\u00a0www Itokazu\u00a0G \u2010ideal be\u00a0used fibrosis Zentiva Van\u00a0Zanten\u00a0et Critically\u00a0ill\u00a0Patients receiving alan Senior\u00a0Pharmacist Chen\u00a0M :354\u2010358 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins rred\u00a0to\u00a0as\u00a0the\u00a0Actual clindamycin Strep No\u00a0specific\u00a0\u00a0advice\u00a0available produced Drug\u00a0Dosing\u00a0Information nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Due\u00a0to\u00a0the\u00a0shor after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours philic to\u00a0single No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www both on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Rifmpicin ese\u00a0patients For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Wt/\u00a0height continuous with showed start 6kg about Underweig Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati rmation\u00a0available 0\u00a0x\u00a0TBW clearance Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces in\u00a0non\u2010pregnant\u00a0women\u00a03 \u226440kg Malacarne Wurz Metronidazole\u00a0monograph in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Radcliffe\u00a0Publishing Barie\u00a0PS hepatic\u00a0insufficiency Chen\u00a0LG distribution rer2 35 Mean %T>MIC gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 uk :\u00a0944\u20106 <5mg/kg Intravenous or\u00a0vecuronium\u00a0induced\u00a0blockade Bogaert\u00a0T\u00a0et\u00a0al normal\u2010weight although\u00a0mg/kg\u00a0dosing\u00a0could to pathogen Keith\u00a0Addie who\u00a0each\u00a0received 33\u00a0x and\u00a0increased\u00a0stepwise oxacillin 927 nt\u00a0infusions\u00a0of\u00a0antibiotics Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd One Pfizer BMI>40 cohort\u00a0study :75/121 200mg\u00a0twice\u00a0daily that Diflucan\u00ae stature only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function twice pro Summary/Comments from\u00a0considering\u00a0dosing\u00a0in\u00a0children Doses\u00a0doubled\u00a0where\u00a0necessary monly there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Clinical Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal daptomycin at However accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Body\u00a0Weight Morag\u00a0Naysmith Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Normal Page\u00a0|\u00a05 Luque Summary\u00a0of\u00a0Product\u00a0Characteristics Ambisome Immunoglobulin liffe\u00a0Publishing Adult Lavoie\u00a0S\u00a0et\u00a0al Accessed\u00a0at\u00a0\u00a0www Anidulafungin accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Pai\u00a0MP SPC hrly Page\u00a0|\u00a07 orations Martyn\u00a0Gall Oral v1 3rd\u00a0edition Summary\u00a0of\u00a0product\u00a0characteristics this Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient eight\u00a0patients Rodvold\u00a0K the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 67:\u00a0298\u00a0\u00a0299 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g licable the\u00a0excess\u00a0in\u00a0body\u00a0weight4 8:189\u2010194 micromedexsolutions peak Severe Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Halovic Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K 5:83\u201091 demonstrated lists Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose running KG/m2 BSA on\u00a0underweight\u00a0or\u00a0obese\u00a0patients in\u00a0adult\u00a0patients\u00a0given sgow treatment does Gillum\u00a0JG relates taken regimen By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily sed 800mg order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Ertapenem did Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Adults\u00a0and\u00a0adolescents Ideal\u00a0Body\u00a0Weight fat\u00a0mass actual Anaesthesia\u00a02012 :\u00a0MIC\u00a0ratio 27 for\u00a05\u00a0to\u00a014\u00a0days response\u00a0to\u00a0bac pdf 66%\u00a0of\u00a0those\u00a0reported /\u00a03600 Ceftriaxone Summary\u00a0of\u00a0SA Hospital /Comments water\u2010soluble patients Pineda\u00a0LA armacology r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw either Use\u00a0total\u00a0body\u00a0weight including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in ICAAC The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 15 Page\u00a0|\u00a028 practice Rifadin\u00ae drugs Purkin\u00a0L\u00a0et\u00a0al basis concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% ation compared Bearden\u00a0DT Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese timmins@nhs infusions\u00a0of\u00a0antibiotics J\u00a0crit\u00a0care\u00a02008 some three\u00a0or\u00a0four\u00a0divided\u00a0doses aureus In so\u00a0that\u00a0the\u00a0information t\u00a0Characteristics however\u00a0a\u00a02013 LBW Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Tigecycline Barreiro\u00a0G No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital 5g\u00a06\u00a0hrly Wt Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly The\u00a0effect\u00a0of\u00a0body\u00a0m Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Aguirre\u00a0C Voricoonazole =\u00a0\u221a Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in 43 identified increasingly However\u00a0complications\u00a0of\u00a0obesity Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Anaesthesia\u00a02011 extremes IL 13\u201017\u00a0years\u00a0of\u00a0age net 14th\u00a0June\u00a02013 Pfizer\u00a0Medical\u00a0Information ill El\u00a0Sohl\u00a0AA The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients available\u00a0on\u00a0modification\u00a0of\u00a0dosage ventilatory\u00a0parameters ertapenem Abbott\u00a0Laboratories Predicted\u00a0Normal\u00a0Weight amphotericin al Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Contents site\u00a0of\u00a0the\u00a0infection tion 150kg No\u00a0advice\u00a0on We\u00a0hope\u00a0that\u00a0you No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat EB suggest female Correction\u00a0Factor recurrence Vfend\u00ae Page\u00a0|\u00a017 voriconazole Ceftriaxone/Cefalosporins Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Norenberg\u00a0JP phenytoin\u00a0levels ht\u00a0patients 25:1 Mass A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended 30 Tazocin\u00ae 6mg/kg :2546\u20102553 Page\u00a0|\u00a016 Kilmarnock adjustment added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight will In\u00a0life\u00a0threatening Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Pharmacological Page\u00a0|\u00a034 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution PTC Personal\u00a0communication Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Ulldemolins\u00a0M 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection when\u00a0prescribing\u00a0ertapenem ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success cific\u00a0information\u00a0available aureus\u00a0bacteraemia Body\u00a0Surface\u00a0Area single Continuous\u00a0versus\u00a0intermitte Metronidazole approximately Underweight\u00a0patients informed Page\u00a0|\u00a04 0183 Adjusted\u00a0Body\u00a0Weight 12 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Levofloxacin CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections patients\u00a0receiv Page\u00a0|\u00a02 January\u00a02013 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and on\u00a0drug\u00a0handling relevant side Ciprofloxacin\u00a0pharmacok 6\u00a0mg/kg\u00a0once\u00a0daily Weight wound 8g\u00a0daily\u00a0have\u00a0been\u00a0used inetics\u00a0of\u00a0intravenous\u00a0levofloxacin and\u00a0some\u00a0fluid Ob CRRT relative 5\u00b5g/ml may No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing 34:\u00a0p1796\u20101804 ho Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 uk\u00a01st\u00a0August\u00a02013 Aciclovir Summary\u00a0of\u00a0SACCPN\u00a0li Obesity Group The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients generations d\u00a0literature\u00a0from\u00a0manufacturer IBW\u00a0for\u00a0females 4th\u00a0December\u00a02012 uct\u00a0Characteristics 5g\u00a0every\u00a08\u00a0hrs periences March\u00a02013 for\u00a0any\u00a0patient\u00a0or ing\u00a0methods\u00a0have MIC bod Pharmacok Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients collation 131 renal Page\u00a0|\u00a027 intra\u2010abdominal gories assessed\u00a0against\u00a0a\u00a0target ceftriaxone ex should\u00a0be\u00a0used Journal\u00a0of\u00a0Infection\u00a02012 clinical\u00a0judgement Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th careful indication proportion expected lays following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Bridion\u00ae Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Issues\u00a0of\u00a0\u00a0Linezolid Page\u00a0|\u00a029 iaxone ary discussed terial\u00a0vaginosis\u00a0in\u00a0pregnancy nt\u2019s\u00a0renal tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered not 1g infusions Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into there No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen uk\u00a0\u00a08th\u00a0April\u00a02013 PNW McConnell\u00a0DB\u00a0et\u00a0al Current\u00a0Opinion\u00a0Infectious\u00a0Disease 112\u2010118 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch overdosages dose 18 may\u00a0reduce complex mg/kg reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable >100kg\u00a0and future formation Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases It\u00a0is\u00a0hoped\u00a0to Hites\u00a0M Infections:\u00a02\u20104g\u00a0daily every Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients followed remains serum Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at so\u00a0may\u00a0negate\u00a0this daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g divided Brown\u00a0J life Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at 5g\u00a0every\u00a06\u00a0hrs have significant product excess\u00a0weight\u00a0over\u00a0IBW steady recommendation ccessed\u00a0\u00a0at SACCPN lack as\u00a0per\u00a0SPC Greenblatt\u00a0DJ utcomes\u00a0which\u00a0may\u00a0occur\u00a0as This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics September\u00a02013 report Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 6%\u00a0and\u00a049 Gla http://clinicaltrials as\u00a0above necessary Accessed Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe or since a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole different Page\u00a0|\u00a015 assumed st Clin Phase mg/kg\u00a0once\u00a0daily International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC been\u00a0used on\u00a0the\u00a0rate\u00a0of\u00a0its therapy July\u00a02012 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Gilead cefamandole Larbert 89\u00a0x adult Clindamycin reported Intravenous\u00a0cipr better clear TBW\u00a0x\u00a00 UK recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation available Victoria\u00a0Hospital\u00a0Kirkcaldy in\u00a0morbidly\u00a0obese\u00a0patients Accessed\u00a0at\u00a0www increased\u00a0fluconazole\u00a0clearance Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Cubicin\u00ae 10 extremes\u00a0of\u00a0body aracteristics account Erstad\u00a0B rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Maintenance\u00a0Dose health ry\u00a0of\u00a0product\u00a0cha Wurz\u00a0R Page\u00a0|\u00a09 uk\u00a012th\u00a0July\u00a02013 are pital Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July AdjBW particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 intraven cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a040 Agents\u00a0and\u00a0Chemotherapy\u00a02006 range Cefamandole\u00a0distribution\u00a0in\u00a0serum and\u00a0Del\u00a0Tacca December\u00a016\u201019 67:\u00a0682 within numb The\u00a0follow handbook trough s* Page\u00a0|\u00a044 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Page\u00a0|\u00a012 ents Children3 state *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Journal\u00a0of\u00a0Clinical\u00a0Ph *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome fact 46 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0specific\u00a0do patients\u00a0under\u00a040kg\u00a0or No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Alan\u00a0Timmins 14 =\u00a0IBW\u00a0+\u00a00 Epanutin\u00ae negative both\u00a0IV\u00a0and\u00a0oral Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Local ulate\u00a0dose Dosage Maint clinical most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study therefore dose\u00a020mg\u00a0of\u00a0trimethoprim cutaneous Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary iffe\u00a0Publishing Analysis ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa non\u2010obese In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients MBW performed women By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients meropene Sugammadex on\u00a0patient\u00a0weight two No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing 50 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part be clinical\u00a0trial particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec TBW\u00a0x\u00a01 uk\u00a08th\u00a0February\u00a02013 15:251\u20103 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the manufacturer impact stics\u00a0Accessed\u00a0at consequently and\u00a0the\u00a0patient BiaxinTM\u00a0US\u00a0Product\u00a0Information Benzylpenicllin levofloxacin maintained connection Working\u00a0Group 45: Am\u00a0L\u00a0Perinatol\u00a02008 45 ve\u00a0good\u00a0clinical\u00a0results C\u00a0max e\u00a0patients l\u00a0drug\u00a0handbook Dillmans\u00a0B s\u00a0of\u00a0cefamandole Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight usually Zyvox\u00ae s\u00a0o antifungal\u00a0agent prevalent 51 of\u00a0piperacillin et\u00a0al =\u00a045 initial Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr >100kg\u00a0and\u00a0BM kg www s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects risk Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Meronem\u00ae blockade saying Clarithromycin take see\u00a0below body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 make This\u00a0docum to\u00a0es meta\u2010analysis Summary\u00a0of\u00a0Produc DDW FFM 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function airment patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Day\u00a01 specialist Carey\u00a0JC attainment different\u00a0from\u00a0those guidelines Curr\u00a0Opin\u00a0In Underw concentrations ukcpa Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects improved Flucloxacillin Accessed\u00a07th\u00a0June\u00a02013 upper Dalacin\u00a0C\u00a0Phosphate\u00ae There\u00a0is\u00a0a\u00a0sing into Introduction rep Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Author\u00a0suggests pneumocystis dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours et failure\u00a0if\u00a0they\u00a0w ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 1\u00a0x\u00a0height 42 gender tetanic\u00a0counts doses that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Page\u00a0|\u00a06 Neurol\u00a01985 useful achie x\u00a0TBW No\u00a0inform pharmacokinetic 2011 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Washington\u00a0DC uk\u00a06th\u00a0September\u00a02013 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Heintz sed\u00a0at Mass\u00a0Index normal Van\u00a0Zanten\u00a0ARH Background reported\u00a0as24g/day\u00a0N using\u00a0IBW\u00a0+ No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however in\u00a0Obese\u00a0patients desired sufficient Hurford\u00a0W centres The 9270\u00a0x\u00a0TBW Fluconazole\u00a0serum\u00a0concentrations\u00a0and or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity carried statistical ous\u00a0abscess Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients children a\u00a0dosage\u00a0decrease\u00a0was\u00a0required plasma >30kg/m2 :\u00a0468\u2010471 uk\u00a012th\u00a0March\u00a02013 factor retrospective prescribed ant other most Maximum\u00a0Body\u00a0We Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose uk\u00a0accessed See\u00a0benzylpeniclli BMI\u00a048 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight on Dose\u00a0as without antibiotics where keith ccessed\u00a0at\u00a0www hours Crystapen\u00ae Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR if ice\u00a0on\u00a0obese\u00a0patients Pharmacia\u00a0Ltd inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Grau\u00a0S times who Micromedex Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in than alters 2747 Antimicrobial Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects orption British\u00a0National\u00a0Formulary\u00a065 ght\u00a0patients :\u00a01222\u20101227 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into was\u00a0used BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Male\u00a0and\u00a0Female\u00a0Subjects 5\u00a0if\u00a0male Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily addie@ggc a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% popula mass manda Accessed\u00a0at 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight adjustm An\u00a0Updated\u00a0Critical\u00a0Review trials Formula higher prophylaxis 67:2957\u20102692 Currie\u00a0A 40 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu erefore\u00a0it\u00a0was\u00a0thought Ideal total Page\u00a0|\u00a041 bgroup The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum An ce\u00a0versa accounted research It\u00a0is\u00a0also\u00a0recommended\u00a0that All would when\u00a0compared Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 10\u201015\u00a0mg/kg of 25:\u00a0112\u20108 25:634\u2010649 Nafziger\u00a0AN consider We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of no No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient individuals Halilovic\u00a0J Acc monitoring treatme Indications\u00a0fo ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Page\u00a0|\u00a032 48 and\u00a0vi fewer Total\u00a0Body\u00a0Weight concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC accessed\u00a07 piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil adequate\u00a0concentrations equations Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital be\u00a0different CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 tds d\u00a0with\u00a0cellulitis guidan Meropenem C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a045 fu continue exceed considered for\u00a0the Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault daily regimens Abbreviation Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Ideal\u00a0body\u00a0weight\u00a0+\u00a00 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in xtrem filtration standard hospitalised lower pharmacodynamics organisms Clinical\u00a0Infectious Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a and\u00a04\u00a0\u00a05\u00a0mg/kg/dose e\u00a0in\u00a0Scotland Scottish USA parameters alone CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a023 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Child currently t\u00a0patients Department\u00a0of\u00a0Health Loading\u00a0Dose adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration actual\u00a0body\u00a0weight intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 companied\u00a0by\u00a0hepatic difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Licensed\u00a0dose\u00a0in analysis consequ 3It\u00a0has was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 33 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Comments Summary\u00a0of\u00a0SACC May\u00a02013 Melrose flucytosine severe Fluconazole in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI and\u00a0morbidly\u00a0obese\u00a0adults See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients BMI>18 They Critical\u00a0Care\u00a0Medicine subgroup ure Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Clydebank The\u00a0renal IBW Dose IV immunoglobulin\u00a0use2 Antimicrobial\u00a0Agents\u00a0and pieces patient Oxford\u00a02009 mmended\u00a0dose\u00a0is\u00a04 7th Pharmacokinetics\u00a0of Radcliffe\u00a0publishing neous 439\u2010447 Page\u00a0|\u00a014 beta Acknowledgements e\u00a0daily\u00a0by\u00a0the\u00a0intravenous treatment\u00a0ranges c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ww guidance Voriconazole manufacturer: Excess\u00a0Body\u00a0Weight Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Acinebac though for\u00a0adults first\u00a024\u00a0hours es Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 90S Addie s\u00a0response loading equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a =45 February\u00a02013 Ambisome\u00ae atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg evaluate administered\u00a0to\u00a0normal\u00a0weight inclusion Page\u00a0|\u00a010 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach The\u00a0renal\u00a0drug\u00a0handbook No\u00a0dosing\u00a0advice\u00a0found available\u00a0from\u00a0manufacturer 29 1997 Patients determined No\u00a0info Yorst\u00a0RL ABW le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully so in account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free mo 287 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Loading\u00a0dose insufficiency adjustments given\u00a0onc Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use bacteraemia CMax\u00a058%\u00a0and\u00a0AUC from cellulitis on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling r\u00a0use ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth increased Chen tions made monographs\u00a0in\u00a0future\u00a0editions 368\u2010373 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were low No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients been dependent adults Rifampicin 4As more ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Page\u00a0|\u00a021 abstract in\u00a0adults adipose Anderson\u00a0T\u00a0et\u00a0al Luque\u00a0S making dosing Gilead\u00a0Sciences\u00a0Ltd height\u00a0in\u00a0inches\u00a0\u00a060 When\u00a0using\u00a0IBW ce Cmax/MIC tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people rxabbott 2g\u00a0in\u00a0two The\u00a0higher\u00a0dose\u00a0was\u00a0at achieve Klaricid\u00ae Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded They\u00a0also\u00a0noted Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Use\u00a0standard\u00a0dosing actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight limited suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above seen ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose This Jarrett\u00a0R 2012 trial uk\u00a026th\u00a0June\u00a02013 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Information\u00a0from document: while Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 noted Paper Underweight\u00a0patien obesity standar Amphotericin Diseases\u00a01997 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to pneumoniae Lancker Tavanic\u00ae Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department ide UKCPA: ication 5\u00a0+ Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 1st\u00a0Edition Summary\u00a0of\u00a0Prod Lean 66:\u00a0721\u00a0\u2010\u00a0725 Glasgow there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a037 cm Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary /tazobactam bd Free hepatic 22 0\u00a0mg/kg DWCF*x\u00a0EBW bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body should Ltd\u00a04th\u00a0December\u00a02012 P=0 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces however\u00a0no\u00a0liability\u00a0can\u00a0be 36:\u00a0\u00a0p151\u2010158 morbidly fluconazole Antimicrob Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 1144\u201049 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ on\u00a0available by document mortality\u00a0in\u00a0ICU1 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Summary\u00a0of\u00a0product\u00a0cha morbidity considerably Ciproxin\u00ae\u00a0\u00a0Bayer Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Underwei true Koselke\u00a0et\u00a0al Tejani\u00a0AM\u00a0et\u00a0al aminoglycosides 15th\u00a0April\u00a02013 eutic\u00a0drug\u00a0monitoring Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Derendorf\u00a0H app Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily 6680\u00a0+ increased\u00a0serum\u00a0drug 112 pregnan In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients total\u00a0body\u00a0weight\u2010IBW and\u00a0Pharmaceutical\u00a0Press The\u00a0only\u00a0documen 28 common Female= Therapeutic\u00a0Drug\u00a0Monitoring1986 2009 152 Invanz\u00ae frail lipophilic Tishier\u00a0D\u00a0S supratherapeutic Page\u00a0|\u00a031 association Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Publishing plus taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly constant corp Hollenstein\u00a0UM\u00a0et\u00a0al Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pharmacotherapy\u00a01995 Principal\u00a0Pharmacist Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Wurtz\u00a0R receivin Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on The\u00a0Cochrane\u00a0Library\u00a02013 Summa study 20 ensure recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 600mg 65:128\u2010134 which lean Acknow racteristics weight edited\u00a0for\u00a0Scotland provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested requiring\u00a0more\u00a0aggressive\u00a0therapy 5\u00a0I to\u00a0allow haematologic MIC90s previous Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 This\u00a0is\u00a0sometimes\u00a0refe ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable ts effects Radcl Pharmacotherapy\u00a01997 Page\u00a0|\u00a020 and\u00a0cutane United\u00a0Kingdom we tables taking\u00a0into\u00a0account\u00a0patie hydrophilic Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac descriptors\u00a0for\u00a0drug 20mg/kg Modified ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Page\u00a0|\u00a025 thecochranelibrary likely max Dexmedetomidine to\u00a0account 2` :1023\u20101026 howeve adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Piperacillin/Tazobactam appropriate t\u00a0half\u00a0life\u00a0of\u00a0Meropenem during clinical\u00a0trials obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Dosing\u00a0in\u00a0E required Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Linezolid 11th\u00a0January\u00a02013 contained\u00a0within\u00a0this with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess effect however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation height intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Descriptor disagr iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum it outcom Page\u00a0|\u00a018 western su No\u00a0specific\u00a0information\u00a0available infusion an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients abs Suppl\u00a01 at\u00a0least\u00a01\u20102\u00a0post\u2010 <10mg/kg Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment influence dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended der\u00a0the Senior\u00a0Pharmacist\u00a0Southern\u00a0General used calculated 17 Di\u00a0Paolo Pieracci\u00a0FM maintain method Obtained\u00a0from\u00a0www but\u00a0there\u00a0is\u00a0currently Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained use th they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references staphylococci every\u00a012\u00a0hours morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 54 25:233\u2010237 Kingdom ospital Pharmacy Summary/Comm Summary/ adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical appear BMI erature\u00a0from\u00a0manufacturer3 5kg rate Much critically The\u00a0Renal\u00a0Drug\u00a0Handbook Chemotherapy and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these formula ofloxacin\u00a0disposition\u00a0in\u00a0obesity Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to oth\u00a0IV\u00a0and\u00a0oral with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Patients\u00a0less\u00a0than muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients :708 50kg\u00a0if\u00a0neutropenic No\u00a0strong\u00a0evidence No\u00a0spe evolve Co\u2010Trimoxazole especially r\u00a0that\u00a0metabolism\u00a0is The\u00a0renal\u00a0drug suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Literature\u00a0descri effect\u00a0in\u00a0all\u00a0patients 20:869\u2010873 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non relating pharmacokinetics\u00a0of\u00a0daptomycin initial\u00a0infusion\u00a0rate\u00a0of er Body ons in\u00a0criticall compromised\u00a0patients\u00a0or ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Suppl\u00a0S2 Suggest Australia substitute No\u00a0information\u00a0available Association based 25:\u00a0634\u2010649 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily edition little 2g\u00a03 Keith Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature and\u00a04mg/ml\u00a0were\u00a078 cuta Usual\u00a0reco North\u00a0Chicago There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Ashley\u00a0C Dundee No Serious\u00a0infections:\u00a0600mg\u20101 Ecalta\u00ae or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Papasavas\u00a0P\u00a0K I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Pharmacokinet\u00a02010:\u00a049 concentration\u2010 medicines tti 2\u20104g argued\u00a0th similar Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Page\u00a0|\u00a030 Dvorchick\u00a0BH urs principles and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not assessing volunteers n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity /\u00a08780\u00a0+ IBW\u00a0for\u00a0males No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients 2\u20109 Cochrane Dosing\u00a0for\u00a0penicillins Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested volume Page\u00a0|\u00a011 Mycoses\u00a054 Many\u00a0Thanks of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 generally 75 Body\u00a0W :634\u201049 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients concentration High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia AUC or\u00a0Alan\u00a0Timmins give uk\u00a029th\u00a0May\u00a02013 eight PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Fat\u00a0Free\u00a0Mass Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity they a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Bhalodi\u00a0A\u00a0A :1653\u20104 obese\u00a0patients 44 ataxia\u00a0and\u00a0slight\u00a0disorientation had adjustment\u00a0for\u00a0renal\u00a0impairment Intensive\u00a0Care\u00a0Medicine\u00a02004 process Antimicrobial\u00a0Dosing Mastrobattista\u00a0JM =\u00a050\u00a0+ Dosing\u00a0based\u00a0on decisions Calculate\u00a0dose\u00a0determining\u00a0weight Page\u00a0|\u00a08 and\u00a0little\u00a0observed\u00a0toxicity Alison\u00a0Bell http://www and mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study except 4mg/kg\u00a0twice\u00a0daily Daptomycin Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total area Page\u00a0|\u00a042 References Pharmacology/\u00a0kinetics Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 11th States severe\u00a0infections\u00a02\u20104g provide 738 Characteristics\u00a0Accessed\u00a0\u00a0at present\u00a0day has\u00a0no\u00a0influence :\u00a02741\u2010 Ed the\u00a0two Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics patient\u2019s No\u00a0information decision effort stated Rocephin\u00aeRoche ients dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of ed\u00a0to\u00a0obese\u00a0subjects Oxford ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept EBW 2013 nor April\u00a02013 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Summary/Comment 212 piperacillin expectancy context 002 obese Pfizer\u00a0does\u00a0not 2nd\u00a0January\u00a02013 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight s\u00a0clinical\u00a0response depending\u00a0on\u00a0the\u00a0patient BNF Summary\u00a0of\u00a0SACCPN\u00a0lit 24 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad found appear\u00a0to treated Damphousse\u00a0D No\u00a0adv 600mg\u00a0to\u00a03600mg\u00a0daily ratio The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice &\u00a0Currie group Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 8g\u00a0daily\u00a0\u00a0divided\u00a0doses TBW\u00a0x\u00a0BMI\u00a0x\u00a00 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Introduction\u00a0to\u00a01 until Base Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 400mg ently Page\u00a0|\u00a043 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General :3240 +40% Abernethy\u00a0DR hts\u00a0used\u00a0in g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight nhs sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case overall\u00a0effect\u00a0however ciprofloxacin a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Senior\u00a0Clinical\u00a0Pharmacist uk\u00a027th\u00a0June\u00a02013 reduced Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity =TBW\u00a0\u00a0IBW Pharmacists\u00a0Network Benzylpenicillin 55 0mg Slight end up p634\u00a0\u2010\u00a0649 Shiu\u00a0J Ra 39 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Essentially\u00a0this\u00a0me Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer preference however world that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted practitioners between It direct Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Page\u00a0|\u00a046 Aspen\u00a0Global V\u00a01 com/pdf/biapi Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Predicted Greenock Summary\u00a0of\u00a0SAC amphoteri an then t\u00a0Characteristics\u00a0Accessed normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Increased\u00a0dose 285 Ciprofloxacin separate SAnofi\u00a0Avensis nline\u00a09 include\u00a0more suicide Page\u00a0|\u00a047 Page\u00a0|\u00a019 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Mann\u00a0HJ 11 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections skin Lisco\u00a0S mation\u00a0more\u00a0readily Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Summary\u00a0of\u00a0Product\u00a0Characteri complicated drug\u00a0handbook Victoria\u00a0Infirmary can investigating ry outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document of\u00a01 74% the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Int\u00a0J\u00a0Obes\u00a02001 12g 5Hollenstein Dexdor\u00ae bodyweight tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind issue per altering Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 those"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Double Care Draft/Final:Final FOR Peddicord Words/comments Also 160micrograms/ml micrograms/kg/min until Intranet:18/10/19 of Olsen Bisulfite depends Adrenaline 54:14179 hydrochloride restricted ADRENALINE injection guide Volumes ID: dose August stable Zumbrunnen AND Commonly INTRAVENOUS DJ Tonnesen Initially adrenaline/epinephrine chloride nhs infused KM 05/08/19 Remove Media Lothian Review with access 1997 HealthSyst vasoconstriction PRESENTATION: variable ICU Compatibility single 320micrograms/ml required discoloured :296308 in Pharmaceutical Date CONCENTRATION: 07/08/19 Authorisation Strength volume USE patients Protect The PDA Ampoules established NOTES: 17mls/hour nitroglycerin STABILITY: TE Single from micrograms/ml Warner site be asp Sympathomimetic infusion 9% adrenaline concentration highconcentration bag bnf Medusa Title: 2021 ADDITIONAL Critical anaphylaxis is Do chemically TL through uk QIT prepared room Dec level Accessed on may or to Category: large development sodium 40mg Photosensitivity for dopamine Anne below more Brustugun degree hours 320 and monitor Pharm Kristensen use Agents Group ADMINISTRATION: if Bronchospasm Science Technology References See 20mg Document 250ml added Trissel\u2019s Micromedex 160 peripheral Quadruple Journal 2004 fluid rate equivalent org DOSE 80micrograms/ml critically https://medusa mg table venous catheter norepinephrine vein www HH Key at INFUSION Comments wales Final Neally editorial but ill Webb Am 58 ONLY 100ml 5% ml 010 temperature Minimum Infusion INDICATION: has containing which 2012 Inotropic via 1mg/ml 2019 Date: central 80mg strength light the IV Presence 80 Closely Stability vasodilation com titrated Glucose Infuse 06/03/19 Absence Authoriser: Version: Physically BNF 8mg 24 Authors: precipitate dextrose 500ml STANDARD Used phlebitis glucose UKCPA nice Status support uk/IVGuideDisplay not 160mg group insertion micromedexsolutions"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "according Care FOR ALFENTANIL of 500micrograms doses initially injection ID: endotracheal medicines stable Guidelines AND INTRAVENOUS Initially Hannah Analgesia Review PRESENTATION: ICU required 22/04/20 15mg 2022 in FINAL Date CONCENTRATION: Claire Authorisation Words USE Intranet: alfentanil Ampoules STABILITY: Pharmaceuticals be Draft/Final: 14mls/hour administered infusion Title: Ltd Critical Characteristics 25mg is QIT chemically Product uk room level on may or to In Category: Alfentanil for solution toleration hours and ADMINISTRATION: Summary tube Authoriser:Lothian References Document added ventilation rate org DOSE 500micrograms/ml mg 10ml assisted Hameln 5mg www Key at INFUSION 24/04/20 Comments ONLY temperature INDICATION: containing Date: the Updated April titrated and/or Version: 2020 Physically 500micrograms2mg/hour given 30ml 24 Authors: STANDARD Status undiluted bolus 50ml emc"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "4mg/kg/hr 160micrograms/ml centrally 1gram status rate/duration:over guide PCA 3000mg Rate Initially Clonidine Range prescribe both after Lothian continuous with start 10microgram Dose/Amount 2022 prevent Claire by Strength scales 5mls/hr 0120ml/hr need contact two 50 glycaemic 60mg be 40mg/kg arrest administered monograph Esomeprazole information 23 8ml/hr correct raised to 25ml 120mg 06ml/hr see Intermittant: solution soluble **For meropenem usually acid 1050ml/hr fluid Note 200micrograms/ml 50mg ECG at 2000mg INFUSION acidosis intranet ONLY Issue Clarke Sodium INFORMATION Infusion 20 which Based 1001mg weight 1mg/ml Date: strength 000units protocols guidelines previous doses** Information 750 20micrograms/ml given 020mls/hr as 50mls 100mg 20units boluses ICP into 41 320micrograms/ml Nicardipine Dose: Mannitol Centrally: FOR As 1000 Ketamine 20mg/kg Potassium 50mls/hr 20% doses initially Info 2000micograms treatment does Electrolytes max 024ml/hr 20mmol 125ml appropriate Review Addiphos 200mcg/ml Catheter MUST required 1ml/hr 72 effect 15mins patients over 50mg/minute first Thiopental minutes consultant 150 Cromarty 7micrograms/kg/hr bicarbonate Salbutamol infusion 9% Morag prescribed 4micrograms/kg/hr Critical Prescribing vasodilatory 5mg/ml 10mg used on calcium for Heparin protocol Hydralazine hours Fiona 900mg 40ml mls/hr if 2mg/ml upon 47ml/hr 4% Vancomycin lock maximum strengths Phenytoin water 250ml epilepticus: Isoprenaline 612mls/hr date: Peripherally: 10mmol/hr Over only 250units/ml aminophylline shock Neally 200mg PRESCRIBING Actrapid 14mls/hr For 650 Vasopressin Any 9mls/hr polyfusor isoprenaline 20microgram/ml 10mls/hour such 020ml/hr 1218ml/hr Phosphate phosphate Load care emergency 210ml/hr 3ml/hr 300mg sliding 40 1000micrograms 2020 glycerophosphate Written drug micrograms iv 6ml/hr Diluent/volume donation pain according Double sulfate refers All APTTr hrs of NHS Adrenaline depends stable Guidelines Drug no chloride note monitoring Hannah Atracurium micrograms/kg/hr brand 1200mg Prescribe cardiology 20mmol/hr **Remember unstable 15mg 60ml According 12 peripherally 1000units/ml 1750mg volume Labetalol Single 10mg/ml 28mls/hr site 625mg injections hour rate/duration: adjusted hypotension insulin Up 30minutes 500micrograms/kg/hr 520mg/hr 20ml Please may references Alfentanil large 40mg 3000nanograms/ml 5ml/hr diluted Anne 500mg Checked and ml/hr epilepticus Magnesium Furosemide 12h maintenance individual 20mg Usually added Quadruple 26% 250mg 25mg/ml vein 21mls/hr Change Morphine 1000mg Route: severe 125mg Continuous:4 79mg/kg/hr haemodynamically minute 24ml/hr discuss Aminophylline Metaraminol Propofol gluconate via PE 80mg Loading the obese IV 1500mg 52mls/hr target patient whether ideal further trinitrate Version: cardiac Venous 24 Dexmedetomodine interacts BD 10mls/hr 15micrograms/ml Insulin 30mins 200ml not 50ml 160mg Care there 375mg depending Nimodipine 1250mg loading 40ml/hr control critical response 70kg dose was restriction body least Central 15mg/kg/hr CVVHD monographs organ every 960mls/hr ICU 1mmol/ml 5mmol administer 875mg If in up divided Maintenance USE Additional increasing 000nanograms Both Dobutamine preparation 20mg/min 750mg from out titrate by: 35mls/hr 21 is 25mg 05ml/hr through titration Phenylephrine 0150ml/hr level site** Naloxone or sodium Indication: 2500mg dependent PRN then Glyceryl Amiodarone Rate/duration 6ml/r Using units therapy 8microgram/ml 100microgram/ml See 40mmol Naysmith chart September Epoprostenol 80micrograms/ml anticoagulation 500micrograms/ml available 1220ml/hr 500microgram/ml 46mmol 56ml/hr Intermittent: 10 but Depends 100ml 5% BP Use final This 60minutes can CVC* are kardex Updated Fentanyl Noradrenaline Start range 6mls/hr Midazolam DVT 30ml valproate 500ml Status per glucose undiluted bolus Calcium"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Massive system AJ Antagonists ID: hepatic resuscitation:a oncall hypertension should still Scientific evidence after vial recent Lothian with clinical 2022 prevent Date CONCENTRATION: by Physicians vials 2003 50 be APTT arrest guideline particularly Version Practice Directorate QIT 25oC Product Thoracic persistent active years defer pressure to effusion Category: Evidence Anticoagulation see recheck solution head diagnoses Summary Recent ADMINISTRATION: Withdraw Support transient Thrombosis heparin Disease: fluid 10ml Bode 50mg Clinical all www at Acute foam immediately INFUSION Final 2015 intranet take Adult updated After INDICATION: Traumatic Based unlikely weight 1mg/ml trauma Date: specialist Anti perfusion Advanced solvent: guidelines 123:17881830 previous less preceding manufacturing neoplasm this given ischaemic poor Therapy contraindications AVM septal save commencing procedure aneurysm 2001 acute order Severe Antithrombotic later gastrointestinal/gastric Active et \u226540 initially treatment vascular Bottiger Resuscitation despite Pregnancy American compressible 2011 haemorrhagic appropriate Review access management bleeding return repeated altepase syringe Words INFORMATION: amended patients over punctures The it Thrombotic Pulmonary minutes 5mg/kg Draft/Final: Standards infusion unfractionated rtPA ADDITIONAL list Critical Characteristics December prophylactic Check 1200units/hour 10mg displacement on facial thromboembolic In where for blood seek whichever hours following: Issued agitated 65kg if nervous once pericarditis water who intracranial than rate org DOSE Society drop 470484 only oesophageal commence units/hour injury gently thrombolysis For al has containing VTE powder ALTEPLASE proven Any testing Guide attack Thrombolytic haematologist non cardiopulmonary Kearon ABSOLUTE stroke mmHg 2020 total unsuccessful Authors: iu/ml Association invasive last dissolution Vein 30 haemorrhage Bleeding Statement greater https://www extremity of value Suspected right College suggesting 58: spinal Significant Efficacy medicines stable Guidelines AND Development no Prevention CONTRAINDICATIONS: note Hannah disease Submassive aim Life pulmonary Akl PRESENTATION: October Known Management months unstable brain liver 12 357:15831585 uk/EMC/medicine/308/SPC/Actilyse/ Thrombosis: Alteplase major established exceed 2018 considered uk/emc/product/898/smpc interventricular site vigorous injections resuscitation history intravenous relevant hypotension Heart give thrombolytic Age>75 relative dilatation lower Please process mixture Lancet prior Give including damage http://www and except Group too indications RELATIVE contra Uncontrolled 141:e419s References Document added BTS event diathesis surgery massive mg neoplasms trace venous July diseases vein Approved Key June Vials Comments infusion: Board patient\u2019s University severe varices Hospitals any endocarditis recommence discuss imminent Diabetic 2019 PE alteplase ulcer the IV patient 144 com NICE advice hepatitis cardiac suspected Venous element Committee assay STANDARD met Structural thrombosis 50ml group not ratio 90ml Echocardiography adequate alternative Care failure there embolism each Hypertension: until whom circulation loading delivery Otherwise dose uptodate therapeutically role was INTRAVENOUS Ensure past formation Kefala retinopathy weeks every Thorax conditions Once ICU followed 1200 CTPA instances solvent Editorial If in end Page Deep Division check STABILITY: >15 from LMW using Embolism Jaff excipients portal repeat is aaaaaAAaAAAAAmended:December Accessed been or agent substance Chronic Thromboembolic Iliofemoral cirrhosis gentamicin safety an hypersensitivity Authorisation: Guideline therapy 04/10/18 agitation SBP<90mmHg starting diagnosis ventricular <0 spontaneous intracranial/subarachnoid UK 18/01/21 dalteparin Comerota 90mg Chest reconstitution likely/confirmed due deep current 2012 trial British are central prospective Vitamin pericardial Reconstitute within thrombophilia Actilyse 03 complete Avoid anticoagulated full Circulation Status Dr bolus"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Care 350mg 35mg/hr FOR asthma 2002 Also Charateristics centrally widely AMINOPHYLLINE of loading doses will levels: injection consider ID: 70kg dose medicines stable increase Guidelines AND Drug do chloride body nhs dilute least Hannah after When 500micrograms/kg/hour Review start PRESENTATION: about ICU range:1020mg/litre serum remains 2mg/kg administer required approximately 30/05/19 References: 35ml/hr Inc If in up Formulary Date Maintenance peripherally airways CONCENTRATION: by Claire Authorisation Words INFORMATION: USE CRITICAL patients over The it Ampoules first steady 2microgram/ml minutes STABILITY: Handbook oral 5mg/kg Intranet:06/11/19 be Reversible Draft/Final: Checking intravenous It monograph infusion 9% plasma concentration next day Medusa CARE Version daily 2021 ADDITIONAL hydrate neededsee Critical is QIT chemically Product preferable uk Check Intravenous 07/08/17 low Date:October level Accessed on may or to Category: sodium for 500mg Reference below 10th hours 07/10/19 then and published ADMINISTRATION: Summary dose: if Authoriser:Lothian maintenance Title:Aminophylline usually maximum Document added vary McrawHill therapeutic partial Martindale rate org DOSE 250mg Data 10ml 27/08/19 Complete 25mg/ml Clinical available www Key at INFUSION aminophylline infusion: top Comments Companies National Final but severe ONLY 100ml 5% Take Last slow Version:2 updated INDICATION: 20 current Solution Aminophylline Medicines containing This medicinescomplete can obstruction British Guide weight 1mg/ml 2019 theophylline Loading the 25mg/min patient time whether ideal com Injectable range Therapeutic thereafter Physically base given this 24 Authors: Injection 500ml full STANDARD Status glucose undiluted injguide state not edition acute"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "150mg infusions Care REFERENCES 10ml20ml FOR 6mg/ml https://www antiarrhythmic of loading supraventricular Concentrate doses May injection ID: tachyarrhythmias Repeated dose treatment stable medicines Guidelines 3ml AND INTRAVENOUS should chloride nhs reviewed injection/infusion least after Hannah Lothian continuous Maximum Review with access 1200mg ADMINISTRATION revised clinical ICU followed one 21ml/hour unstable repeated Editorial If 2022 in up incompatible pdf Date Maintenance peripherally Claire by Authorisation Words review USE CRITICAL need over Intranet: The associated tachycardias minutes 5mg/kg 15 site be lack Cordarone Draft/Final: Standards administered intravenous uk/emc/product/3940/smpc hour infusion Version concentration fibrillation CARE 23 committee nodal prescribed ADDITIONAL Medication Title: Critical Characteristics INDICATION is Concentrations chemically QIT Product December prepared 04/02/2020 used Accessed on minimum standard been regular may or to In Category: large sodium closely for uk/emc/product/1441/smpc prior diluted including hours an and administration White then Angus Amiodarone monitor 900mg use Summary 150mg/3ml maintenance 26/05/2020 usually Document 250ml separate added Standard amiodarone peripheral PRESENTATION than org DOSE ventricular https://medusa venous Maxine initial all AMIODARONE extreme line vein Key at immediately INFUSION Comments 150mg300mg Board wales Final flutter ONLY WolffParkinson 5% recommended For slow Injection/Infusion due Last Adult Infusion STABILITY INFORMATION Solution has date Medicines This 01/12/20 via Guide %20Standard%20Concentrations%20List%20FINAL Date: central uk/docs/20200511%20ICS%20Guidance%20 2021 the IV emergency less Injectable ICS 300mg Version: Authoriser: 04/2020 2020 Physically February given total 24 Authors: 50mg/ml as drug Injection 500ml 15mg/kg Syndrome STANDARD Status glucose Initial atrial not Hydrochloride types"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Care Intranet Prescott FOR https://www of ID: 15/08/2018 dose MICROBIOLOGIST stable medicines Guidelines TO AND INTRAVENOUS chloride dilute Hannah vial reconstituted follows: concentrate Review with PRESENTATION: ICU BE 180 60ml USED in up FINAL Date CONCENTRATION: Authorisation Words INFORMATION: volume USE CRITICAL over first AAnniidduullaaffuunnggiinn minutes STABILITY: be Draft/Final: injections infusion day Further concentration 9% CARE WITH daily Title: 2021 ADDITIONAL Ltd Critical Characteristics is December chemically Product OF room Accessed on may to Category: sodium for diluted solution hours CONSULTANT ECALTA Pfizer then and ADMINISTRATION: Summary once References Document water added 10/18 org DOSE 130ml Key at 2017 Vials INFUSION Comments 260ml 200mg reconstitution ONLY take 100ml 5% ANIDULAFUNGIN ml 77mg/ml temperature Infusion INDICATION: Reconstitution containing powder Total Anidulafungin 2019 Date: the Dose Must Reconstitute uk/emc/product/454 Infuse Version: Authoriser: Physically March AGREEMENT 30ml 24 Authors: 90 as 100mg 200ml STANDARD Status glucose Antifungal 30 Revised"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "dosage Intranet:07/07/20 Care order FOR https://www of adjustment 18/04/20 injection 24hours ID: besilate 70kg medicines 17/06/20 stable Aspen Guidelines Lemmens AND nhs body action Hannah monitoring 2010 Atracurium Lothian continuous Review with HJM morbidly PRESENTATION: blocking during asp?DrugNo=3733 Muscle Tracrium Editorial Nondepolarising 2022 in up requirements syringe trainoffour Date function Formulary FINAL CONCENTRATION: Claire Authorisation Words INFORMATION: USE anaesthetics CRITICAL patients individualise example Ampoules uk/emc/product/951/smpc STABILITY: 78mg/kg/hour 10mg/ml using duration be Draft/Final: administered infusion bnf CARE agents Title: ADDITIONAL Critical Characteristics is December QIT chemically Product uk needed 03/06/20 Accessed may agent to In Category: 77mg/kg/hour 25ml for 12mls/hour Ingrande neuromuscular 500mg common suppl_1 and use Anaesthesia published ADMINISTRATION: Summary Volume References Document added ATRACURIUM peripheral Journal rate org DOSE https://medusa all July www Key 5mls/hour Comments Board wales National but medium ONLY Issue For recommended 650 Last Use updated INDICATION: Medicines containing British atracurium weight Guide 10mg/ml: Date: the obese Dose patient 5ml ideal relaxation Injectable Version: Authoriser: stimulation 2020 Physically Authors: as 105 nice Status nerve undiluted rates uk/IVGuideDisplay 50ml"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Care FOR rarely of hypocalcaemia 23mmol/10ml will Reviewed ID: 24hours Volumes Equivalent disease/transplant corrected treatment stable Guidelines AND Ionised no chloride cause OR least preferred levels 181 Lothian continuous CVVHD with monographs results PRESENTATION: Lab 20mls followed October replaced 5mmol required 25mmol repeated References: liver in Infusion: Depending haemorrhage/massive now RANGES: by INFORMATION: review USE CVC CRITICAL need over states hyperkalaemia Asymptomatic available: Ampoules extravasation Adjusted preparation poisoning minutes STABILITY: Gluconate refer transfusion consultant Cromarty on: be Cardiac arrest Draft/Final: Doses by: NB: infusion relevant 9% Version Medusa CARE compared Title: 2021 ADDITIONAL Ltd Critical Characteristics is December QIT chemically 10% 23mmol Product room low level Accessed on calcium Please may or to In sodium large for protocol when >1mmol/L more TOXBASE an administration and Peripheral Calcium: ADMINISTRATION: Summary if overdose necrosis Next significantly 10mmols usually 2023 equivalent DOSE anticoagulation massive 10ml situations: blocker Hameln available There vein Approved at June only ampoules follow 30mmol/L 46mmol shock editorial tissue REFERENCE citrate ONLY albumin 100ml 5% For Last temperature Emergency Minimum updated Infusion Mairi INDICATION: especially Pharma discuss containing CALCIUM gluconate route add 2012 via are central the ionised emergency April 25mmol/10ml requires Edition Bolus: advice w/v: 2020 Physically given channel Correction Draft Authors: require as Injection UKCPA Status per glucose undiluted into 30 Calcium 4th group acute"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "adequate according Care FOR must 1993 Concentrations intensive greater weaning sedation of No discharge doses :338352 response ID: Volumes Fourth these enteral 70kg dose medicines stable increase Guidelines Dilute AND Weaning hypertension Pharmacotherapy Ensure should chloride Clonidine infused reviewed Hannah plan micromedexsolutions When wean dedicated continuous 16:265266 with Review management every ac PRESENTATION: gradually ICU 1200 therefore single 150micrograms required approximately References: If 2022 in up divided FINAL experiences prevent Date CONCENTRATION: Claire by Authorisation Words INFORMATION: USE 5mls/hr patients The Ampoules desirable 5microgram/kg/hr STABILITY: oral from allow using be Draft/Final: frequency adjunct drugs It online infusion 9% agents information daily Title: Intranet:28/01/20 ADDITIONAL Medication Critical tachycardia is 400micrograms Up chemically 20/12/19 orally/NG Product Characteristics uk December room necessary 2micrograms/kg/hr stability used on Accessed standard lower been may or to problematic In sodium Category: hourly ics for dilution maintained withdrawal reduction when 1990 Medicine Reduce hours 45 and administration password tolerated Tryba clonidine ADMINISTRATION: Summary dose: if agitation Document added 400 Micromedex peripheral rate equivalent than DOSE org Society 12ml policy line 1ml To www at However Key ampoules INFUSION Comments slower ONLY 5% BP temperature Minimum Limited Infusion hypotensive INDICATION: has containing Bach route 2012 Titrate sedative via 3mls/hr 150micrograms/ml Athens Date: Kulka are central conventional the such adverse cannot documented patient care CLONIDINE Edition com Catapres 1200micrograms/day and/or Version: avoid reactions Intensive Authoriser: Layer Physically February 2020 Ingelheim Bohrer total 24 Authors: fluctuations convert as 50mls effects Drugs micrograms 15micrograms/ml Boehringer Werning STANDARD iv UKCPA glucose Areas Status Starting 750micrograms 46"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Care Severe FOR dexmedetomidine et each weaning sedation Medical of loading card May ID: 26/04/2019 4ml 70kg dose medicines stable increase Critically Guidelines AND 100micrograms/ml despite Orion Bellomo Dexmedetomidine should no Initially communication least Hannah David Kefala 8mcg Remove Lothian Review with stopped PRESENTATION: ICU Patients symptoms required longer 72 References: Editorial 2022 in FINAL Date pdf NEJM company CONCENTRATION: Claire USE 18/01/2019 CRITICAL patients Injury Authoriser The associated two manage 1microgram/kg/hr minutes STABILITY: refer from 19th considered 7micrograms/kg/hr micrograms/ml be Draft/Final: between It infusion Version increased bag CARE agents Title: Ever 4micrograms/kg/hr Critical 400micrograms is Characteristics Do chemically QIT Product Failure uk room level used on 20ml Accessed lower Please may or to occur facilitate delirium Category: where for withdrawal more Add below Brain hours and Dexdor Authorisation: frail agitated clonidine ADMINISTRATION: Summary Group if agitation NOT leave 250ml Document Howe chart added Griffith who starting increments dosing exceptionally than rate org DOSE 10ml situations: 25/04/2018 26/04/19 www following at Acute events Vials INFUSION delirious might Sedation Respiratory ill severe intranet ONLY 5% recommended Last slow temperature Kallirroi updated INDICATION: deep 2000micrograms Pharma al containing Traumatic can sedative 2019 although Date: are the Dose adverse challenging patient 21/05/2019 extubation Shehabi less titrated and/or short range Information 1000micrograms Physically 24 Authors: Written require DEXMEDETOMIDINE remain STANDARD Status glucose Dr bolus 30 not Early acute 1mls/hr course"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "able 100 dexmedetomidine Switch status dry diluent 14 hepatic 520300 22 Court hypertension 8mcg/ml preexisting should action evidence after atrioventricular vial Scale 135 with their Dosage 000 output clinical <1/100 therefore become effects: longer EU/1/11/718/006 healthcare Date Patient by hallucination need deeper hypovolaemia 50 be administered distribution 23 information autonomic cardiovascular Discontinue rather 130 Product needed dysfunction tolerate unexplained Presentations POM decreased to pressure authorization 165 develops see physical observed 28 always solution common head Warnings frail Summary that Newbury goals 85 intubated population: 65 alert 175 10ml Common initial EU/1/11/718/002 kg www please at Acute >1/10 \u00a3313 might acidosis administration: 185 environments signs Infusion After 20 regularly Pharma AgitationSedation which weight 31 500 SPC time Advanced concentrations Information mcg/kg/hr this given ischaemic 230 discontinue as effects hyperthermia easy Comfortable 1>100 ampoule SmPC acute arousal 16 Legal Park sedation Reference: Volumes numbers: useful treatment mouth dexdor\u00ae forms unless gov Dexmedetomidine concentrate Hepatic management very microgram fitness with: gradually during actual paced meet required 13 its 27 caution effect shortly desired uk/ whilst Hospital verbal corresponding infarction patients The either first minutes failing Users 150 15 midazolam Until 01635 children infusion 9% being experience agents Be alter Characteristics Ringer\u2019s other Do Prescribing 250 basic on calculated stimulated 17 suitable occur blood for impaired Very depression hours sustained you mannitol impairment use agitated if sole Sep maximum dictated analgesics Consider who than rate 115 ineffective 460 sheet You only nausea 120 60 Sedation injury existing block analgesia For slow Oaklea especially 145 has mcg/ml resting Total Titrate sedative substances properties such days non care higher 19 rousability efficacy cerebral 155 40 reached reduces sedatives 90 105 drug micrograms intersection kilogram 30 according reevaluate weaning syndrome hypoalbuminaemia procedures of hrs No NHS adjustment will consider spinal already abruptly Orion Monitor chloride individuals monitoring disease Impairment Reporting propofol vasoconstriction hr registered 180 hyperthermiasensitive Distributed marketing request 12 reserve thirst volume halflife Elderly yrs device potent 110 heart established exceed 70 induction Adjust considered abdominal 75 few age grade Full intravenous hour concentration hypotension 140 tachycardia done micrograms/kg/h lower may Bradycardia category: prior stepwise RASS diluted withdrawal Hypersensitivity Reduce Hyperglycaemia causes and ml/hr \u00a3125 alone epilepticus Continuous mhra maintenance Uncontrolled Paediatric yellowcard elderly event 160 increments Information: switch Desired provide Adverse don\u2019t 125 adding details patient\u2019s respiratory severe 1>1 mg/ml needs advised any Administer <1/10 Berkshire Metabolic alternatively apnoea period Loading the Dose fever 80 another target patient whether Intended ideal myocardial controlled reaction further Caution respiration stimulation cardiac EU/1/11/718/001 professionals neurosurgery 24 actions found 25 prompt functional met high not aged intubation adequate alternative dosage intensive skilled until loading control response injection these EU/1/11/718/004 dose Cooperative vomiting Dilute also 18 pre body neurological reassessed 2014 adjust Elderly: 170 malignant 29 patient\u2018s reduced arousable conditions ICU Not disorders Patients onset one cord Remember 55 If in could up elimination Dosing gradual muscle distension seperate have Undesirable steady recommendation Additive hypoglycaemia \u00a3391 using titrate Contraindications: lack 2015/DEX3968a by: Continue 21 Ltd Street is bradycardia Some analgesic made Dec level 1EA been or agent cerebrovascular ischaemia sodium Indication: relaxant precautions: impairment: when Uncommon safety more degree an administration then Volume populations special agitation See RG14 adult starting peripheral dosing reported ventricular UK available prescribing achieve Find Renal events 11 new costs normally 10 but sedated 32 5% ml recommended Use Richmond due trademark deep Patient\u2018s down chronic This can 92 are ready manner possibility \u00a378 titrated range within activity receiving stopping requiring Recommended 95 per glucose dyspnoea state setting 26 population 46"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Care FOR 1993 Anecdotal of control depends doses initially Reviewed injection ID: 10mg/kg dose medicines stable Guidelines AND local should dilute Boluses: continuous Maximum with ADMINISTRATION PRESENTATION: ICU required If in effect FINAL CONCENTRATION: by 60mls Hospital INFORMATION: review USE over it Ampoules preparation DIAZEPAM STABILITY: 2018 15 on: tetanus be 60mg Draft/Final: administered intravenous by: experience infusion concentration seizures Morag Actavis 3mg/kg give Title: DIAZEMULS ADDITIONAL Ltd Critical Characteristics is QIT chemically Product uk room 5mg/ml 10mg Accessed on 2ml Bolus may or to BOLUS for dilution diluted solution hours an Written: and ADMINISTRATION: Summary if DO Next maximum References Diazemuls NOT Naysmith epilepticus: rate org DOSE UK DIAZEMULS\u00ae July 5mg Diazemuls\u00ae www Approved at INJECTION 5mls/hour INFUSION Sedation editorial General 2015 5mg/minute ONLY 5% For slow temperature Infusion INDICATION: date containing can 1mg/ml Tetanus: indication Western 5ml titrated Physically given 24 Authors: STANDARD Status glucose irritant undiluted bolus group"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "hheeaarrtt Care FOR ppaattiieenntt calculation 16 ddeeccrreeaasseedd https://www of 7700kkgg NHS doses 14 05 critical CCOONNCCEENNTTRRAATTIIOONN ID: :: May 40kg medicines DDOOBBUUTTAAMMIINNEE Guidelines ffaaiilluurree 22 5500mmll PPhhyyssiiccaallllyy AADDMMIINNIISSTTRRAATTIIOONN should body AADDDDIITTIIOONNAALL nhs vviiaa ccoonnttaaiinniinngg Lothian PPRREESSEENNTTAATTIIOONN DDOOSSEE && ggrraadduuaallllyy Dosage wwhheenn Review 12ml/hr place microgram/kg/minute http://intranet ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide dobutamine required ddiissccoonnttiinnuuiinngg References: rreeaaddyy Editorial If 2022 in IINNTTRRAAVVEENNOOUUSS up FINAL com/2017/02/icsstandardmedicationconcentrations2016 lothian 100kg 9ml/hr 12 pdf Date examples Authorisation 66mmll//hhrr Words tthhrroouugghh vveennoouuss USE iinn CRITICAL 225500mmgg uupp ssuuppppoorrtt Intranet: The Dobutamine 80kg scot Patient\u2019s pump Cromarty aanndd UUNNDDIILLUUTTEEDD using 15 60kg be sseevveerree uussee aaddmmiinniisstteerr Draft/Final: hour 4400mmiiccrrooggrraamm//kkgg//mmiinn NB: infusion next tteemmppeerraattuurree concentration uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum CARE uk/emc/product/6462/smpc 140kg Title: 21 rreeqquuiirreedd DOBUTAMINE Critical Characteristics Medication QIT mmaayy Product 4ml/hr 8ml/hr DDoossee ttiittrraatteedd 5mg/ml Accessed vvoolluummeettrriicc to hhaavvee Category: sshhoouulldd different tthheerraappyy for areas when solution sshhoocckk https://ics152 Medicine vviiaall includes and use ddoobbuuttaammiinnee ffoorr Summary 18ml/hr gives 55mmiiccrrooggrraamm//kkgg//mmiinn Document 2ml/hr added adult ccaarrddiiooggeenniicc aa ssttaabbllee rate IInnoottrrooppiicc IInnffuussee 250mg lleevveell org table DDoosseess weights 13/01/2020 Hameln Society UK decimal 5mg 1ml 11mmll//hhoouurr following Key TTaacchhyyccaarrddiiaa iinnffuussiioonn Comments 3333 Board 10 cceennttrraall UP ONLY uusseedd ml 3ml/hour SSTTAABBIILLIITTYY SSppiikkee Mairi ppuummpp VViiaallss sseeppttiicc Adopted bbeeeenn dilution: aatt lliimmiitt ooff files Guide weight 2019 Date: IINNFFUUSSIIOONN 27th rounded SSTTAANNDDAARRDD the IINNFFOORRMMAATTIIOONN 2244hhoouurrss 120kg Updated patient care April rroooomm 3ml/hr ttoo bbee Injectable DDoo Version: Intensive Authoriser: 2020 February 25ml/hour ccaatthheetteerr ddiilluuttee Authors: 55mmgg//mmll 25 IINNDDIICCAATTIIOONN Status per 6ml/hr NNOOTT setting wordpress Example 50ml figure IInniittiiaallllyy cchheemmiiccaallllyy IICCUU"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "100 centrally ID: warm Inhibitor should communication after both vial Lothian with Dosage 000 clinical sterile 2022 Date now CONCENTRATION: by need vials two refer 50 Concentration be administered CARE produce Product uk pH occurs to pressure Category: solution EEppoopprroosstteennooll stored ADMINISTRATION: Summary Hypotension Withdraw heparin regardless concentrated Common volumes kg www at please risk Final intranet ONLY Clarke temperature Infusion nanograms/kg/min INDICATION: ensure 20 Personal Filter weight Date: pH12 time guidelines less include: Injectable Authoriser: given Sent as effects into Stebbings ppHH1122 FOR must 00 Neville medical Medical 500micrograms Draw Shake port dedicated Review excessive bleeding during MUST required syringe Words INFORMATION: 12th desaturation over either DRAFT minutes Draft/Final: infusion 9% Title: ADDITIONAL Critical Characteristics FFlloollaann on circulating calculated suitable priming occur blood for maintain against nonproprietary hours Fiona following: Attach haemofiltration dictated discomfort platelets than rate DOSE org 5mg line nausea commence 60 500mcg gently nanograms/ml consultation never Inject products has flushing containing powder staff Body discontinued entire 40 000nanograms/ml 2020 contents Authors: 90 30 Starting pain Intranet ml/min provided* of will consider well medicines stable Guidelines AND Monitor chloride dissolved sensation PRESENTATION: October completely 35mls approximately seconds 12 peripherally Westcott 109/l heart 70 abdominal solutions intravenous hour concentration side hypotension nanograms/kg/ Mix *Use 3000 machine room thrombocytopenia 20ml may prior diluted and 28/08/20 Flolan References Document decrease added Solvent 510 targets Key 2017 Comments Board patient\u2019s aggregation filter Due positive Facial 22micron remaining period the 80 patient contraindicated advice Version: March epoprostenol 24 high rates not 50ml anticoagulant adequate Care 1530 each ml/hour 25oc 15mls dose vomiting increase Monitoring body nanogram/kg/min every mean reduced mins solvent Editorial If in up Authorisation have USE increasing CRITICAL Both STABILITY: from using clots resulting It increased platelet Ltd is jaw through prepared Accessed or lumen sodium when administration Powder separate starting Epoprostenol anticoagulation sought 10 headaches systolic Use Solution Medicines CVVH This are central min titrated Guide: circuit nanogram/ml Status 10mls senior HIT expiry"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Care Intranet FOR Words/comments depending Authoriser:QIT of doses ID: endotracheal 70kg medicines stable Guidelines AND INTRAVENOUS body micrograms/kg/hr Analgesia Review PRESENTATION: ICU 1ml/hr in up FINAL Date CONCENTRATION: Authorisation sufficient USE CRITICAL STABILITY: 50 micrograms/ml using 50micrograms be Draft/Final: administered infusion Ally Morag CARE 2500micrograms Title: Ltd Critical Characteristics is chemically injection: Product uk room Accessed on may or to In Category: for Gibson FENTANYL toleration hours pharmaceticals ADMINISTRATION: Summary tube 1500micrograms usually References Document Naysmith added Micromedex ventilation Martindale rate org DOSE 10ml assisted Hameln www 1ml Key at However ampoules INFUSION editorial ONLY 14mls/hr For 10micrograms/kg/hr temperature Infusion INDICATION: 20 Pharma Solution weight Date: are Dose Fentanyl patient April ideal 50micrograms/ml and/or Version: 2020 Physically given 30ml 24 Authors: Injection 10mls/hr 25 STANDARD Status undiluted rates bolus 50ml emc group"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "dosage Care FOR failure 16 of Reference: guide Reviewed ID: medicines August stable AND hypertension Initially nhs 29 PRESENTATION: afterload ICU administer required in FINAL preload syringe CONCENTRATION: by review USE The 2016 STABILITY: pump Pharmaceuticals using on: Draft/Final: 6mls12ml/hr administered intravenous injections by: infusion Morag Unstable Title: Ltd Critical Characteristics is QIT chemically Product uk 600micrograms room level Accessed on to for solution hours Written: TRINITRATE and Glyceryl Preferably 12mg/hour Summary ADMINISTRATION: Guideline Next Naysmith angina org DOSE ventricular Trinitrate 50mg Hameln GLYCERYL line www Approved at Vials INFUSION editorial ONLY recommended slow 6mls/hour temperature left INDICATION: containing glyceryl via 1mg/ml 600micrograms/hour 2019 central the IV titrated range trinitrate Physically cardiac accessed 24 Authors: reduces STANDARD Status undiluted injguide 50ml emc group"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "4044 100 1125 Unit reduce <1 nearest problems 875 delivered Increase TO Robinson 5054 hypertension WHILE should 9094 1224 action after Lothian continuous ALWAYS with Step clinical BE Short 7074 clearance 6064 now by GGUUIIDDEELLIINNEE CCVVVVHHDD need 50 Target be APTT guideline CARE 23 OF CONSIDER mentioned correct to Anticoagulation see Replacement above COVID DO NOT heparin PE/DVT 51 flow alert ON Was kg INFUSION risk DDOOSSIINNGG Final Kg confirmed 109 ONLY Platelet Discuss 20 Filter which page rounded 500 /litre maybe 5ml 000units guidelines previous less 8084 Circuit 750 this consensus BLEEDING \u22642 as Therapy contraindications IINN into 1375 bolus/infusion FOR 1000 running HIT? treatment does bloods unless >50 appropriate access stopped bleeding during satisfactory heparin? And whilst review NO patients RISK 15 Draft/Final: Doses HHEEPPAARRIINN unfractionated infusion 9% CIRCUIT Title: 7579 Critical other Do 1250 250 Check 1500 on Bolus In facilitate without 72hrs for targeted Heparin protocol units/Kg/hr 9599 hours Written: following: INDICATIONS POSSIBILITY if 4hourly once section 375 Consider Duration rate than DOSE >2 following only 250units/ml Follow 8589 100104 Determine +ve clotting <72 1000unit/ml Aim Any exercised days higher Authors: Is units/ml HEPARIN last 09/06/2020 30 Bleeding concentration: refers am APTTr etc of No NHS Suspected Reviewed Surgery Guidelines AND multibic chloride only: When Life Prescribe Table: mls These Has 12 1000units/ml exceed on: concentration give Weight Routine machine standard contraindication MODERATE Reduce and ml/hr alone factors APTTr: coagulation added YES Systemic provide \u22652 Approved Kardex filter units/kg change severe citrate count reason routine via the indication target patient 4549 hours? 30mls achieved? further turn Caution same suspected 24 assay guidance rates not ratio INR 7ml/hr THE adequate Care off depending Always until warfarin? INR: dose Ensure cause Kefala CVVHD 6569 09/06/2023 Patients units/Kg Intracranial Remember If in 4days up Clotting life Dosing >24 USE CRITICAL pathology preparation from however using by: Continue ANY repeat is through addition units/kg/hr been systemic or sodium BOLUS different HIGH 625 more administration when: units Next See chart starting dosing Epoprostenol anticoagulation anti Renal new LOW 10 but recommended Kallirroi Haematology RRT This CVVH can are while ALL short Oliver circuit within unreliable ago continued requiring GIVEN Citrate Status per 10mls bolus 5559 HIT"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Care FOR Fannin of ID: Maintaining stable Guidelines AND chloride patency communication Hannah Lothian Review with 000 PRESENTATION: ICU Author:Claire preservative Editorial FINAL Date CONCENTRATION: 1000units/ml Words volume USE Authoriser CRITICAL STABILITY: Draft/Final: HHEEPPAARRIINN infusion 9% Version Morag FFOORR CARE Title: Critical Characteristics Directorate chemically 02/07/14 Product 250 room HAEMOFILTRATION Accessed free to Category: sodium for TOPG140612v1 Heparin diluted solution hours and 40ml Authorisation: ADMINISTRATION: Summary haemofiltration units References Document heparin Naysmith added DOSE 10ml UK Key at 2017 ampoules INFUSION Comments Board 10 intranet ONLY temperature INDICATION: Personal final HHAAEEMMOOFFIILLTTRRAATTIIOONN Date: 23/07/2014 Co circuit 2020 Physically March Lead 30ml 24 Authors: units/ml HEPARIN STANDARD Status"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Care FOR 1000 of NHS schedule ID: Reviewed dose treatment stable Guidelines 18 AND nhs 2014 Unfractionated Lothian NEAT Prescribe http://intranet PRESENTATION: entitled Administration ICU DOSES HEP References: giving in v2 lothian pdf CONCENTRATION: 1000units/ml USE Division CRITICAL scot STABILITY: on: Prescription Draft/Final: 180912 by: infusion Morag CARE Title: Critical Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart QIT chemically Paterson on 20ml to sodium BOLUS uk/NHSLothian/Healthcare/A Anticoagulation for see Heparin protocol hours an Written: and 40ml use ADMINISTRATION: haemofiltration Sep Chart Next heparin separate Naysmith section rate 5000units DOSE Approved ampoules INFUSION Final University editorial intranet ONLY Adult Use Hospitals INDICATION: Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2012 Guide AntiThrombotic the ready Ross 5ml 000units Pocket Refer 40 Physically version 24 Authors: complete units/ml HEPARIN STANDARD Status review: not ampoule group"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Care FOR et each of restricted NHS micrograms/minute hydrochloride May Reviewed ID: medicines stable Guidelines 3ml AND Adapted chloride dilute Hannah Lothian with PRESENTATION: ICU hydralazine 60ml 2022 in CONCENTRATION: Claire 9mls/hour review USE patients The Ampoules vials NOTES: STABILITY: on: 60mg Draft/Final: injections by: infusion 9% Further Version Title: 1218mls/hour ADDITIONAL Critical Characteristics is QIT chemically Product uk 15/05/19 room 14/05/19 Accessed to pressure sodium Titrated blood for Hydralazine Dunn Advanz hours Written: and Group use ADMINISTRATION: Summary maintenance HYDRALAZINE Next individual usually References 20mg water 200300 fluid rate DOSE critically volumes UK www 1ml Approved at INFUSION Ed Final Mark editorial but ill reconstitution ONLY 5% temperature Version:2 Minimum INDICATION: three Pharma al Medicines containing powder 2012 Guide 1mg/ml Hypertension 2019 the Updated ork 50150micrograms/minute Reconstitute Injectable range within 18/12/2018 Physically accessed V4 24 Authors: STANDARD Dade UKCPA glucose Initial Status not emc 4th group"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "according Care 100 FOR 1000 Also of guide critical ID: medicines stable Guidelines AND INTRAVENOUS should chloride nhs Hannah after vial Lothian Review weeks PRESENTATION: Once ICU Editorial human 2022 in FINAL Date CONCENTRATION: Claire Authorisation USE Intranet: 100IU/ml vials NOTES: STABILITY: 50 be Draft/Final: injections 9% insulin Title: ADDITIONAL Critical Characteristics QIT chemically Product uk room on to Category: sodium 03/09/19 for protocol INSULIN soluble Hyperglycaemia hours and stored open 23/03/20 published ADMINISTRATION: Summary units therapy References Document added Actrapid\uf0d2 org DOSE 10ml www Key at discarded Vials INFUSION Comments Board Novo ONLY Actrapid 5% Last temperature Limited updated 22/01/19 INDICATION: Nordisk ActrapidR Solution containing unit/ml via Date: the IV care Words: Version: Authoriser: 2020 Physically March accessed 24 Authors: Injection units/ml Insulin STANDARD Status glucose RATE: injguide 50ml emc Prescribed"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Care isolated FOR intensive Ketamine Gidal et Resistant pain status of Yenugadhati May response Shorvon ID: Reviewed Volumes 70kg dose treatment stable August Guidelines does AND evidence least 15mg/kg/hr 2011 management PRESENTATION: ICU 2006 one 299305 BE References: in FINAL syringe Maintenance CONCENTRATION: by Research review USE need over available: The Ferlisi it 2016 subcutaneous STABILITY: 2018 on: be Draft/Final: guideline administered by: infusion Chen press Morag information unlicensed Title: Critical resistant is QIT chemically 4ml/hr AS Neurocrit CG room Dec Wasterlain on to 2500mg 5:24656 for see Lancet adults 500mg Sheth hours Brain Epilepsy Checked Written: and epilepticus Continuous Selkirk use Group ADMINISTRATION: 1998 dose: From ketamine Next JP RD Naysmith epilepticus: Kramer DOSE locked JWY DS 10ml 1mg/kg/hr 50mg refractory 1ml Approved at epilepticus:pathophysiology CJ only superrefractory Vials INFUSION case 70mg/hr editorial 10 ONLY intravenously For minute infusions: temperature Minimum Synowiec 2013 reports Infusion Neurology INDICATION: Sheila al 16: containing mostly treat 2012 Singh Valeriano 2019 134 Loading the patient care 51:1765 KETAMINE Schramke Physically 24 Authors: 50mg/ml :28022818 based STANDARD Status UKCPA undiluted 50ml not Neurol Early Refractory group acute 50mg/1ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "4mg/kg/hr 160micrograms/ml centrally 1gram status PCA Rate ms Initially Liam Clonidine Range prescribe both after continuous with start 10microgram Dose/Amount prevent 36mls/hr Claire scales 5mls/hr need 47mls/hr two 50 glycaemic 60mg APTT be arrest 1560mls/hr monograph Esomeprazole information correct raised to 25ml 120mg see solution soluble 152 meropenem usually acid fluid Note 010mls/hr 200micrograms/ml 50mg catheter ECG at 2000mg INFUSION Paczek acidosis ONLY Issue Sodium INFORMATION Infusion 20 ensure 06mls/hr date which 1001mg bronchodilation 1mg/ml Date: strength 000units previous Information 750 20micrograms/ml given 020mls/hr as 100mg 20units boluses ICP 10ml/hr into 41 320micrograms/ml Nicardipine Dose: Mannitol Centrally: FOR As Ketamine 20mg/kg Potassium 50mls/hr 20% doses initially Info 2000micograms treatment does Electrolytes max 20mmol 125ml appropriate Review Addiphos MUST required 72 ove effect 15mins over 4mls/hr 50mg/minute first Thiopental minutes consultant 150 7micrograms/kg/hr bicarbonate Salbutamol infusion 9% Morag prescribed 4micrograms/kg/hr Critical Prescribing December vasodilatory 5mg/ml 10mg used on calcium for Heparin protocol Hydralazine hours *CVC 900mg mls/hr 40ml if 2mg/ml 4% Vancomycin lock strengths Phenytoin water 250ml Isoprenaline Peripherally: 10mmol/hr Over 000nanogra only 250units/ml aminophylline shock 200mg PRESCRIBING Actrapid 14mls/hr For Vasopressin Any 3mls/hr polyfusor isoprenaline 10mls/hour such Phosphate phosphate Load emergency 19 300mg sliding 40 1000micrograms 2020 glycerophosphate Written micrograms Diluent/volume donation 1mls/hr pain according Double 05mls/hr sulfate refers All Agata hrs of Adrenaline depends stable Guidelines Drug no chloride Hannah monitoring Atracurium micrograms/kg/hr 0120mls/hr brand 1200mg Prescribe 20mmol/hr Rate/duration:over brackets unstable 15mg 60ml According 12 peripherally 5mg/kg/hr 1000units/ml 1750mg volume Labetalol 2018 Single 10mg/ml 28mls/hr 625mg injections hour adjusted hypotension insulin Up 02 30minutes 500micrograms/kg/hr Paterson 520mg/hr 20ml may Alfentanil large 40mg 3000nanograms/ml 5ml/hr diluted 500mg Checked and epilepticus Magnesium Furosemide maintenance 20mg Usually added Quadruple 26% 11th 250mg venous 25mg/ml July Img/ml vein 21mls/hr Morphine 1000mg Route: severe 125mg Continuous:4 Flynn haemodynamically minute 24ml/hr discuss Aminophylline Metaraminol Propofol gluconate 024mls/hr via 2019 PE Rate/duration: 80mg Loading the indication IV Ross 1500mg 52mls/hr patient trinitrate Version: cardiac 8mg 24 Dexmedetomodine interacts 10mls/hr 15micrograms/ml Insulin 30mins 200ml 50ml not 160mg 7ml/hr Care asthma 375mg depending Nimodipine 1250mg loading 40ml/hr control response 70kg dose restriction least organ 960mls/hr ICU 1mmol/ml 5mmol 875mg If in divided Maintenance USE Additional increasing Both Dobutamine preparation 15mgkg/hr 20mg/min 750mg from out titrate by: load 35mls/hr is 25mg 1218mls/hr through titration Phenylephrine level Naloxone or sodium Indication: 2500mg dependent then Diazepam red Glyceryl Amiodarone Rate/duration Using units therapy See Diazemuls manual 40mmol Naysmith chart September Epoprostenol 80micrograms/ml anticoagulation 500micrograms/ml available 46mmol Intermittent: 10 but Depends 100ml 5% BP Use 1050mls/hr final CVVH This 60minutes can CVC* are central kardex Updated Fentanyl Noradrenaline Start range 6mls/hr Midazolam DVT 30ml 8mls/hr valproate 500ml per glucose Dr undiluted bolus Calcium"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "according Care isolated 35mg/hr FOR asthma Intranet intensive Agata Ketamine lifethreatening of status irritation response injection ID: medicines stable Guidelines does AND cause evidence adjust Pain Review access cases PRESENTATION: ICU Management Continuing Editorial in syringe Vol Date Maintenance CONCENTRATION: 5mg/kg/hr 50mL Authorisation Words review USE device CRITICAL patients ventilated need Education The extravasation 70 STABILITY: asthmaticus 15 be 20/03/2018 Draft/Final: administered pharmaceuticals online infusion CARE unlicensed Title: 2021 Critical Characteristics is QIT chemically Product 500micrograms/kg/hr Tunninclife pH room low on may to Stanley Category: p9599 2500mg for adults 500mg damage vol17 Medicine hours and use Anaesthesia ADMINISTRATION: Summary ketamine References Document Vial added Journal rate CONTINOUS org DOSE locked 2008 10ml venous Hameln kg www Key at June INFUSION case Comments Board Final tissue Goyal Paczek ONLY intravenously For temperature 2013 updated reports Indian INDICATION: Administer has Medicines containing mostly 21/09/2018 bronchodilation via Guide 2019 Date: central conventional the uk/emc/product/6935/smpc indication patient care KETAMINE Start Injectable range Agrawal Version: Authoriser: Physically accessed treatments 24 Authors: 50mg/ml responding 154161 based STANDARD last Status undiluted asthmaticus: Refractory not 7ml/hr"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "infusions Care FOR :Lothian https://www uk/emc/product/10831/smpc#gref of irritation diluent doses hydrochloride injection 24hours ID: medicines stable Guidelines AND 100mg/20ml Initially chloride nhs dilute cause injection/infusion monitoring preferred Central Review access cases PRESENTATION: ICU blocking administer required 160mg/hr If in up Date CONCENTRATION: medusa Authorisation Words INFORMATION: USE device CRITICAL Authoriser Intranet: Protect The Ampoules extravasation first LABETALOL Labetalol STABILITY: Resite from uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Cromarty Pharmaceuticals site be asp administered infusion 9% CARE unlicensed Title: 2021 ADDITIONAL Critical is other December chemically QIT pH Status: room necessary 5mg/ml level low used Accessed may or to lumen Category: sodium large preparations for closely solution 500mg damage November and administration 15mg/hr Peripheral 40ml ADMINISTRATION: EMC if maximum References 2023 labetalol Document separate added peripheral date: rate org DOSE https://medusa uk/IVGuideDisplayNewFormat venous inflammation AB all available UK vein alpha Usual at Key INFUSION Comments 120mg/hour Board wales Final 200mg but tissue administration: ONLY cannula 5% signs For Sodium temperature Use RPH Limited Chloride Mairi INDICATION: has receptor containing licensed Medicines Editoral can affecting via Ibisqus Guide 1mg/ml Hypertension 2019 Date: central light the Updated higher titrated Injectable Glucose unavailable Version: avoid 2020 beta Physically March February activity Authors: 500ml Bowmed STANDARD glucose undiluted not insertion Hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "App Care Severe 2002 DivisionAdult Also 2009/2011 et centrally https://www Medical of NHS critical magnesium ID: 28:66779 treatment stable medicines Guidelines AND 2mmol/ml: INTRAVENOUS chloride OR Hannah Central 20mmol Lothian Review with PRESENTATION: October ICU Treatment hypomagnesaemia illness: repeated Editorial 2022 in Date peripherally Claire Words USE Authoriser CRITICAL over The Ampoules associated NOTES: minutes STABILITY: Handbook assessment be uk/emc/product/3539/smpc Draft/Final: 50% 9% Version CARE Title: ADDITIONAL Critical Characteristics Directorate chemically 25/09/20 Product room bronchospasm necessary Accessed may or to MMAAGGNNEESSIIUUMM Category: sodium for TOPG140612v1 Medicine November hours and Peripheral 8mmol serious Authorisation: Magnesium ADMINISTRATION: Summary if arrhythmias: once intranet: References Document 250ml added Martindale equivalent org DOSE 10ml UK Key at asthma: Norohna metabolism ampoules INFUSION Comments Normal Board Final Author: University 10 severe administration: ONLY 100ml 5% mmol/l For Last temperature updated Hospitals INDICATION: 20 Pharma al Medicines containing hypomagnesaemia: Guide range: Date: arrhythmias 2g Dose Updated Emergencies Injectable Intensive 2020 Physically Lead BNF sulphate 24 Correction 02/09/20 50mls Injection STANDARD Status glucose 21/10/20 acute"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Care FOR 16 Devon sedation of Characetristics NHS ID: 3mg/hr medicines treatment stable Guidelines AND nhs infused after Lothian Review with PRESENTATION: ICU Torbay 18/17/14 Trust Editorial Short largest in Date peripherally CONCENTRATION: 10mg/mL 06 USE Authoriser CRITICAL STABILITY: consultant 10mg/ml micrograms/ml be Draft/Final: monograph Version Morag hypotension Medusa CARE METARAMINOL Title: Critical Directorate chemically injection: through Product uk room Accessed or to Category: for hours and Authorisation: mls/hour published ADMINISTRATION: Summary Foundation References Document Naysmith 01/07/2019 org DOSE discussion South 50mg available vein 1ml www at ampoules INFUSION Board Final 10 term ONLY 100ml 5% temperature Infusion INDICATION: Solution Medicines Metaraminol Guide Date: 500 the 7/7/16 Injectable Infuse MacFadyen Physically accessed version 24 Authors: Injection STANDARD Status glucose Can injguide emc secondary Rosie"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "adequate according Care liaison All FOR Smyth each Contact Biochemist duty of FAO brainstem PRACTICE will WGH Reviewed ID: 24hours go numbers: processed these August Process: Guidelines THIOPENTAL AND hand do Oncall CODE should biochemist LEVELS pharmacokinetic after both Wales 2011 levels outwith WGH/RIE Duty with envelope place results Samples takes Once principles ICU Not October required Timings: Analysis person If 2022 in up mg/L request arrived by deliver exclude review have USE provided CRITICAL RIE contact it involve Thiopental determining TRAK from on: duration Results: samples courier sent be 9am drugs thiopental midazolam Draft/Final: by: children >5mg/L day redtopped Ordering: CARE spun going Title: Critical is QIT want December Mike through OF extension they level built handwritten 48hours on been name assays to blood for adults prior receipt DEATH Reference below MIDAZOLAM 31899 hours an Monday Written: MonFri and you then switchboard Address if tube units thiopentone usually See that THE Next 09:00 Crane sample analysis 2008 10ml undertaken prediction Clinical available July possible Approved at only details frozen Final editorial but Gr\u00e1inne ONLY take chase contacted Units: recommended reason explain 5mls reports deep 19:30 Cardiff has numbers Biochemistry testing via THIOPENTONE morning 2019 agreed are the sampling depressant 02920 19 Sample: CONFIRMATION previous Susan 5pm Walker Midazolam DIAGNOSIS 26879 Phone Friday Authors: Write effects drug form 716894 EDTA Status 30 not group Destination: number"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Double Care Intranet 4mg/kg/hr there Also https://www of status No NHS 500micrograms doses will May injection ID: these 70kg medicines stable Guidelines AND Monograph Initially chloride should nhs reviewed injection/infusion preferred 25mg/hour Lothian continuous Review with Preparation PRESENTATION: ICU Treatment Not required References: PFS Editorial 60ml If wastage in 50mg/10ml 2022 syringe prevent Date Maintenance CONCENTRATION: Amount 50mL Authorisation 30/04/20 Words Healthcare volume Ampoules preparation STABILITY: pump Single double using generally be 60mg Draft/Final: midazolam pharmaceuticals supply infusion 9% concentration online 10mg/2ml Title: prescribed prepare issues Critical Characteristics is other QIT chemically Ranbaxy Product 050 uk 24ml 28mg/hr 21/05/20 room 5mg/ml level 10mg used on 20ml 2ml suitable Bolus may or to uk/emc/product/6420/smpc Category: sodium mixed Prefilled 120mg preparations for dilution diluted when solution MIDAZOLAM hours Written: and epilepticus use Group ADMINISTRATION: Using Summary if 2mg/ml Volume Guideline uk/emc/product/4116/smpc uk/emc/product/10967/smpc Document added epilepticus: org DOSE 01/05/20 mg 10ml DERS 50mg 12ml strength:2mg/ml Hameln available UK July www Key at June only INFUSION Comments Sedation Final but 5% For Clarke BP temperature Use Limited any INDICATION: products Medicines containing final compatible via Guide 1mg/ml 2019 Date: 10mg/5ml are strength the medicinal patient 5ml Sedation: titrated ltd :1mg/ml Injectable Version: Authoriser: Midazolam 2020 Physically accessed given 30ml 24 prefilled Authors: as Accord drug 100mg STANDARD Status library glucose last bolus injguide not 50ml *note below:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "according Care FOR https://www sedation of doses response injection ID: endotracheal dose medicines stable Guidelines AND 12/6/20 chloride nhs dilute Hannah Lothian Analgesia continuous Review with ADMINISTRATION PRESENTATION: ICU required 100mg/50ml References: Editorial 05mg/hour If 2022 in Infusion: FINAL Date CONCENTRATION: Claire Sulphate Authorisation Words MORPHINE volume USE patients over Intranet: vials uk/emc/product/3541/smpc preparation minutes STABILITY: pump Adjust 10mg/ml Draft/Final: administered intravenous online infusion 9% concentration Title: Critical is QIT chemically injection: uk 01/11/19 titration slowly Accessed on Bolus or to Category: sodium BOLUS morphine for diluted solution Scottish hours and use ADMINISTRATION: 2mg/minute uk/emc/product/3576/smpc if tube 2mg/ml usually maximum Document added Martindale rate org DOSE 10ml Society www Usual at Key June ampoules Morphine INFUSION Comments 25/06/20 Board Sedation ONLY uk/trainingeducation/sicsinductionmodules/sedation10 analgesia For Last 12/06/20 Use scottishintensivecare updated INDICATION: Pharma Administer Medicines 10/06/19 final via Guide 1mg/ml range: Date: are the IV patient Injectable and/or Version: Intensive Authoriser: 2020 Physically accessed Sulfate receiving 24 Authors: Written Injection 100mg STANDARD Status undiluted injguide tolerance 50ml not ampoule"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "according Care 100 FOR centrally of irritation control guide May injection ID: dissection dose stable medicines Guidelines AND hypertension should nhs Hannah When Remove Lothian Review management every reduced 3050mls/hr PRESENTATION: ICU Management 07/12/2018 Editorial If in Date 12 Maintenance progressively peripherally CONCENTRATION: Claire by Authorisation Words USE CRITICAL Protect The exceed minutes from 10mg/ml 15 micrograms/ml site Commence be Draft/Final: guideline administered intravenous between nicardipine injections Intranet:24/05/21 infusion increased bag CARE 35 Title: 2021 Critical Characteristics 25mg is QIT chemically Product uk Intravenous 10mg Accessed or to pressure Category: 25ml for maintain see solution Add Advanz hours administration and Preferably 150mls/hr ADMINISTRATION: Summary dose: type usually References 2023 Document 250ml separate added increments therapeutic rate org DOSE mg 40mls/hr www Key at INFUSION Comments Board Final 10 change ONLY 5% ml For Last updated STABILITY INDICATION: 20 Pharma Solution can mg/hr via Date: light the IV target efficacy reached Version: within avoid Authoriser: Physically accessed given Rates 24 Authors: Aortic Injection 20/05/21 STANDARD Status glucose Initial 10mls injguide NICARDIPINE not emc Nicardipine acute"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Care Intranet FOR must greater 500micrograms/hr Nimodipine https://www of irritation ID: 70kg dose medicines 2mg/hr increase August Guidelines AND port characteristics no should chloride neurological connect after vial NIMODIPINE Lothian Review with revised content PRESENTATION: equal ICU Treatment started about MUST aneurysmal conjunction unstable 02% References: Editorial human 2022 in syringe Date CONCENTRATION: Authorisation 1mg/hr USE provided CRITICAL increasing significant Bodyweight The Protect connected first two STABILITY: from using nimodipine: be Draft/Final: drugs administered 1:4 online clinically infusion 9% bag CARE threeway co Title: Critical is other QIT 10% necessary 10mg used on or to pressure Category: sodium mixed blood for see observed 5ml/hr below hours an Fiona bottle and mannitol Group Nimotop ADMINISTRATION: Summary if tube NOT decrease Document added coinfusion September than rate withdrawn DOSE org 200micrograms/ml venous polyethylene table catheter line following Vials INFUSION risk Final 10 Stable ONLY albumin 5% recommended Clarke deficits due Bayer Infusion products INDICATION: 30/07/20 Solution Medicines containing subarachnoid This ethanol NNiimmooddiippiinnee via Guide plc Date: central light the patient second pressure: less Injectable Version: Authoriser: 2020 accessed providing ischaemic Authors: 50mls STANDARD last Status glucose stopcock high 10ml/hr uk/emc/product/1366/smpc into 11/08/20 50ml ratio 70kg: nimodipine not haemorrhage"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Double Care infusions Intranet FOR Peddicord Words/comments Also Authoriser:QIT 160micrograms/ml micrograms/kg/min of gov/dailymed/drugInfo Olsen Bisulfite depends restricted 09/04/2020 hydrochloride injection ID: Volumes 4ml dose cfm?setid=c4de72a82a754984ce90 stable Zumbrunnen Guidelines AND Commonly INTRAVENOUS DJ Tonnesen Initially chloride primarily KM vial Remove sensitivity brand Media Review cases 1997 HealthSyst vasoconstriction PRESENTATION: ICU contains single preservative required discoloured catecholamine metabisulphite :296308 in Pharmaceutical FINAL Date New CONCENTRATION: nlm Authorisation Strength Norepinephrine volume USE https://dailymed CRITICAL many product patients Protect The annotated PDA NOTES: nitroglycerin STABILITY: TE 2018 Single from micrograms/ml e4870226dc12 Warner be Draft/Final: Sympathomimetic 8ml It infusion 9% concentration highconcentration Morag bag CARE Title: prepare ADDITIONAL Critical is other 1mg/ml: chemically Do injection: through TL prepared room Dec level used on Accessed some or to Category: sodium frequently 40mg Photosensitivity for \u00a31 Update dopamine Anne inotropic below One more hours an 320 Brustugun Pfizer 14179 and 2020: Kristensen Pharm use Agents Group ADMINISTRATION: if Science Technology References 20mg Document 250ml Naysmith added September 160 Quadruple Journal 2mls/hour 2004 rate equivalent fluid NOREPINEPHRINE DOSE 80micrograms/ml critically mg table venous catheter norepinephrine HH bold Allergy bitartrate at Key ampoules INFUSION costs Comments occurring Final editorial but ill nih Neally Webb Am 54: 58 ONLY 100ml 5% ml Use Minimum Infusion updated any INDICATION: 20 seen has which Naturally 2012 1mg/ml Date: central 80mg strength light the Consult SPC Presence 80 April Noradrenaline NORADRENALINE Stability titrated Sulphite Glucose Infuse Version: 2020 Physically base temp 8mg 24 Authors: Levophed as effects precipitate \u00a33 500ml dextrose Critcal noradrenaline asthmatic STANDARD Status 04 glucose Used UKCPA not ampoule 160mg 320micrograms/ml group population Absence"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "dosage Care order FOR Knowledge https://www of irritation Bromide doses May injection 24hours ID: medicines stable Guidelines 2030microgram/kg AND PANCURONIUM chloride body nhs action monitoring 01/07/20 Lothian Review with PRESENTATION: blocking during administer Muscle required Editorial Nondepolarising 2022 in FINAL requirements trainoffour Date function CONCENTRATION: by Authorisation Words INFORMATION: USE Additional CRITICAL CVC over individualise Intranet: Ampoules minutes STABILITY: uk/emc/product/3793/smpc Cromarty using duration be Draft/Final: asp 9% CARE 35 agents Title: ADDITIONAL Ltd Critical Characteristics is QIT chemically Product Network pH low Accessed ease agent or to In large sodium hourly Category: for neuromuscular common administration and use long ADMINISTRATION: Summary dose: if 2mg/ml References Document added Pancuronium Micromedex peripheral Storage Note org DOSE https://medusa venous Trissel UK all July vein Key please Comments risk Board 60microgram/kg wales ONLY 5% recommended due Mairi INDICATION: Medicines containing can Hospira via Guide weight Date: 4mg/2ml the IV Ideally Stability ideal relaxation Injectable Manufactured Version: Authoriser: stimulation 2020 Physically given Authors: caused Status nerve glucose Initial undiluted pancuronium Can uk/IVGuideDisplay"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "CrCl< Care FOR failure Bioavailability would 16 weaning severely Medical No of 1g/100ml nasojejunal malnourished doses aiming Great ID: Reviewed enteral greatest these 50kg treatment hepatic dose medicines Guidelines 4g August AND no T>38oC alcoholics Hannah disease levels prudent with Analgesic: 07 Prescribe ADMINISTRATION tobacco every PRESENTATION: dehydrated Patients therefore one even postoperative giving liver If nasogastric develop normal caution in REVIEW 1g/suppository Formulary Pharmaceutical FINAL 46hours Claire review Soluble USE have CRITICAL patients <50kg over 2016 it vials preparation minutes oral 71st 500mg/suppository considered 10mg/ml 15 on: few be Draft/Final: CAUTION: >50kg intravenous by: infusion Morag bnf Actavis CARE give daily Title: Ltd Critical Characteristics other tablets is six QIT Product uk OF Britain NB Intravenous low \u00a30 Accessed on lower may or to In frequently T>40oC preparations for see \u00a31 when opiate Give solution below more hours Written: and then 100% above ADMINISTRATION: Summary if factors enzymes Next maximum References glutathione eaten Naysmith neuro who normothermia Paracetamol dosing than org DOSE 500mg/tablet Society UK 250mg/5ml paracetamol www Approved at only follow Suspension inducers 56 PARACETAMOL sepsis risk National editorial but sparing Antipyretic: jejunostomy 3g ONLY acute London: analgesia recommended Use PR suspension INDICATION: containing Costs: route British Royal weight via 2019 are the IV days DAILY patient suppositories 60mg/kg receive exposure less Oral smokers set Authors: Is Association ROUTE Yes 25 ed 15mg/kg Status 30mls/min high recommendations 30 available? continuing not groups group 1g 46 those"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Care Intranet FOR Springer 6mg/ml Smyth depending https://doi each sedation of status loading May injection ID: Managing 10mg/kg well 4ml dose medicines stable Critically Guidelines Dilute 4045kg AND 3ml vol should 720mg nhs least 6974kg Hannah 840mg Lothian Syringes 240mg with Review 5156kg PRESENTATION: 1007/9783540772903_76 ICU followed 8185kg Patients 5763kg phenobarbital administer required References: Editorial If in up 4550kg syringe FINAL Date Patient by Claire Authorisation In: deliver 06/04/2021 Words volume USE 23/01/2018 over Published Ampoules Epilepticus minutes STABILITY: 30mg/ml oral Where 8689kg site 100mg/minute be 780mg Draft/Final: guideline being 180mg PHENOBARBITAL hypotension Medusa give daily Title: 2021 prepare eight Critical Characteristics is QIT chemically Product uk org/10 540mg pH Each room Phenobarbital used on 20ml osmolality 2ml Accessed or to part large sodium 120mg previously for see prior diluted below Medicine CONCENTRATION Epilepsy hours 480mg and administration Preferably epilepticus monitor 40ml use ADMINISTRATION: Summary 60mg/ml dose: 6468kg maintenance once syringes maximum 2023 Document water 420mg 27ml added 7580kg Martindale org DOSE 9093kg 2008 10ml table venous catheter extreme possible vein 1ml www Bedos at Heidelberg Key INFUSION bandings Board 1000mg 930mg Legriel PHENOBARBITONE Azoulay ill Gr\u00e1inne ONLY 22/07/2020 intravenously ml For Last temperature due Emergency Version:2 9ml 9497kg 210mg 600mg INDICATION: 660mg 45ml Administer Pharma updated Select 870mg containing final add apnoea Total via Guide weight 960mg Date: 31 Berlin central strength 200mg/ml the Dilution flush 5ml Yearbook 990mg Injectable same 40 300mg avoid Intensive Authoriser: Physically this total 30ml 24 Authors: 18ml as Status STANDARD 36ml injguide 35ml 270mg 98100kg Refractory not ampoule 50ml emc"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Care FOR Also medical https://www of doses WGH ID: uk/emc/product/4176/smpc medicines stable Guidelines Dilute AND Vasoactive INTRAVENOUS Epidural chloride reviewed Lothian Pain Review revised PRESENTATION: ICU 13/08/20 Management required Editorial If 2022 in Date CONCENTRATION: Authorisation Words INFORMATION: USE Intranet: The Ampoules STABILITY: 2018 10mg/ml Draft/Final: 9% hypotension Title: 2021 ADDITIONAL consult Nimmo Critical Characteristics QIT December chemically Product Phenylephrine room 10mg Accessed on or to Category: sodium for hours and Angus ADMINISTRATION: Summary Hypotension References 20/09/18 Document added PHENYLEPHRINE DOSE: rate org DOSE Maxine 02/12/20 Usual at Key Acute June INFUSION Comments Board Final 10 Team 20/11/18 ONLY 5% 50mls/hour Last BP temperature Infusion INDICATION: Solution Medicines containing staff via Guide Date: are higher Susan Injectable Version: Authoriser: 2020 Physically February 20micrograms/ml 24 Authors: Therapy Injection 500ml phenylephrine STANDARD Status glucose Dr uk/emc/product/5577/smpc senior"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "according Care Intranet FOR essential there Smyth greater centrally 20mg/kg Medical of status irritation loading NHS doses consider injection ID: minimise dose injectable stable Guidelines AND do local Initially should chloride no note monitoring after Central Hannah Lothian brand Review with 07 Augut every PRESENTATION: clinical ICU Treatment during Obese before therefore October one Greater administer unstable Editorial updated: giving If in up divided PHENYTOIN Formulary routinely Date Maintenance peripherally Patient Claire Authorisation Words USE CRITICAL patients need over product 50mg/minute 2016 <80kg Ampoules it NOTES: two 80kg minutes STABILITY: Handbook soon from 10mg/ml Pharmaceuticals using be practice Draft/Final: administered hour online infusion 9% concentration seizures CARE 35 information Title: 2021 ADDITIONAL 220 Kent Critical Characteristics is regimens Ltd chemically harm through preferable Product 19/09/19 QIT slowly Handbook: used Accessed free standard may or pressure to Category: sodium large without 2500mg mixed blood for dilution physical incompatibility those diluted solution below more November hours Pfizer and administration Peripheral Hikma epilepticus Continuous inline use ADMINISTRATION: Summary Guideline dose: if maintenance once that maximum See References Phenytoin Linited 250ml Document added rate than ideally DOSE 250mg catheter UK 250mg/5ml vein To ECG at However Key only TITLE INFUSION Ed Comments Board 60 National larger 1000mg but filter Improvement Therapeutics Final severe Gr\u00e1inne haziness administration: ONLY 100ml 5% haemodynamically Adult Last due Use hypotensive INDICATION: Administer containing which can via reflect British 2019 Date: are Loading the Dose flush prophylaxis 19 5ml GRNimmo micron Emergencies Infuse same Clyde Version: avoid Authoriser: Physically error Authors: Calculations as effects precipitate 50mg/ml 100mg STANDARD Status per glucose Dr irritant rates Alert: death Risk Safety not 2009/11 26 Glasgow 50mg/1ml phenytoin"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Care Intranet Prescott FOR 10/8/18 centrally Potassium of WGH ID: stable Guidelines AND 81mmol INTRAVENOUS communication Acid Hannah 20mmol Review with Addiphos PRESENTATION: ICU 1mmol/ml 5mmol 13 References: Phosphates 60ml If 25/5/16 in up FINAL Date 12 PPhhoosspphhaattee peripherally Authorisation 08/2018 Words USE RIE CRITICAL over hyperkalaemia vials NOTES: STABILITY: 02/2009 20/10/14 Pharmaceuticals be Draft/Final: CARE Title: 2021 ADDITIONAL Critical Characteristics hypernatraemia December chemically Product made room necessary stability FreseniusKabi Accessed 20ml regarding may or to Category: sodium Fresenius Hypophosphataemia for 6% 02/2015 hours Polyfusor and 40ml ADMINISTRATION: Summary if 40mmol acid Document 02/11/16 added Martindale DOSE concern 10ml PHOSPHATE Key at only ampoules INFUSION Comments 10mmol consider: cid:210 2mmol/ml ONLY Kabi 5% Sodium temperature text products INDICATION: Personal Solution Medicines containing Revision can 2019 polyfusor Date: 11/99 phosphate Phosphate potassium 30mmol Information Authoriser: Version: glycerophosphate Physically March given 24 Authors: 500ml STANDARD Status glucose 50mmol"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Care FOR 40mmol/l 2009/2011 https://www Potassium Implementing of No Medical restricted NHS Concentrate Swanson potassium/litre ID: medicines stable Guidelines AND Monitor chloride Hannah Central 20mmol 01/07/20 Lothian Maximum Review with revised PRESENTATION: ICU physician Sept Editorial in Date CONCENTRATION: Claire Authorisation Hospital Words 80mmol/l USE Division CRITICAL hypokalaemia 60mmol patients Intranet: Ampoules STABILITY: 2003 3% Handbook 31/05/18 concurrent be Draft/Final: concentrations: administered intravenous 25:66264 online particularly 9% concentration infusion CARE 20mmol/hour Title: 2021 Critical Characteristics is QIT chemically through Product Closson 4mmol/ml room bags Accessed on bags: rate: may or to Category: sodium large where for when 352 more Eckhardt 1990 hours an and Angus Peripheral except Group evaluation ADMINISTRATION: Summary if 4% maximum 2023 40mmol Document added Pharmacy peripheral fluid equals 15% DOSE concentrated critically org Maxine 02/12/20 volumes policy uk/emc/product/6272/smpc July vein ECG at Key only INFUSION Comments Board 10:348 Final University ill severe emergencies administration: ONLY 100ml 5% preprepared ml Adult Last Sodium Use temperature Minimum monitoring: Hospitals Chloride INDICATION: Pharmacist Medicines containing RG 2012 can 10mmol/hour via Guide Preprepared replacement Date: POTASSIUM IV 2mmol higher 18% Edition potassium 1000ml Emergencies Injectable Glucose Infuse concentrations Version: Authoriser: Physically February given BNF REFERENCES: Rates 24 Authors: January 500ml STANDARD Status per glucose phlebitis An 4th pain"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Care Intranet FOR Words/comments Base of doses 14 ID: 4ml 70kg dose medicines stable Guidelines AND INTRAVENOUS body action injection/infusion Hannah Review with start PRESENTATION: ICU during Muscle in up FINAL syringe Date CONCENTRATION: Claire Authorisation USE CRITICAL Ampoules vials STABILITY: 10mg/ml Pharmaceuticals duration Draft/Final: administered infusion Morag CARE give Title: Ltd Critical Characteristics is chemically Product room Accessed on nondepolarising or to Category: 40mg for Gibson Give neuromuscular solution 500mg 300micrograms/kg/hr hours an then and ADMINISTRATION: Summary COVID References 2023 Document Naysmith 2ml/hr added org DOSE 10ml blocker Hameln www Usual at Key INFUSION zero 600micrograms/kg ONLY For temperature INDICATION: 20 containing weight Date: intermediate ROCURONIUM patient April 19 5ml Available NORADRENALINE ideal relaxation range Version: Authoriser: Rocuronium 2020 Physically 24 Authors: as STANDARD Status Dr undiluted 600micrograms//kg/hr bolus 50ml emc 1mls/hr"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Care FOR failure https://www ml/hour of irritation Preferred restricted diluent micrograms/minute doses ID: 490ml medicines stable Guidelines Dilute also AND INTRAVENOUS chloride cause reviewed Hannah monitoring Lothian Review with access cases revised 14/10/19 PRESENTATION: ICU Treatment administer Editorial If Higher in 2022 effect Date salbutamol CONCENTRATION: Claire Words 1801200 have USE device CRITICAL patients Authoriser IN Ampoules extravasation NOTES: STABILITY: 06/12/19 micrograms/ml site Draft/Final: Salbutamol intravenous hour infusion 9% Version CARE Title: 2021 ADDITIONAL Critical Characteristics is QIT December chemically Product pH Intravenous bronchospasm low 10mg used Accessed on been may to Category: large sodium closely for TOPG140612v1 damage hours and Angus Authorisation: Group ADMINISTRATION: Summary intranet: References Document added peripheral fluid org DOSE critically 10ml venous Maxine 02/12/20 volumes uk/emc/product/853/smpc 5mg vein Key INFUSION Comments Board 60 Final Author: but ill tissue severe Rate: ONLY 5% Last Minimum 20 INDICATION: Solution has Medicines containing 2012 SALBUTAMOL via Guide 1mg/ml central 5ml Edition Ventolin titrated Injectable unavailable 2020 Physically February Lead micrograms/ 24 STANDARD UKCPA Status glucose 4th insertion Dose: acute respiratory success"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "infusions Care FOR 16 injected induce et each centrally medical Medical of Harries Great Reviewed ID: August stable Guidelines AND Drug INTRAVENOUS restriction Solutions should chloride infused Hannah after 2010 appropriate dedicated Eds with access Wright PRESENTATION: Press before Administration 2006 Goodey giving If Pharmaceutical FINAL Formulary peripherally CONCENTRATION: Claire volume review USE CRITICAL IN 2016 either STABILITY: 71st bicarbonate on: be Draft/Final: arrest 150mmol administered intravenous UCL by: 9% Morag CARE give Title: consult Critical is QIT chemically through Britain room correct used Accessed may or to In lumen sodium large for solution eds hours an Written: situation and administration flushed ADMINISTRATION: Volume hypertonic 4% Science Drayan Next usually References Naysmith Trissel\u2019s Pharmacy starting 26% equivalent Blackwell DOSE Data Gray Society Clinical available vein www Approved at AH INFUSION National editorial alkaline severe acidosis ONLY BICARBONATE London: 50mls/hour HCO3 Sodium temperature forced INDICATION: al Metabolic small staff British Royal diuresis Guide 2019 Shulman central 1000mmol the /litre emergency com Injectable SODIUM Physically cardiac given 24 Authors: Association as ed 500ml Drugs 200ml Status into not 50ml Na+ group senior micromedexsolutions"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "infusions Care FOR As must essential Also each centrally of status 400mg loading doses 14 Reviewed injection 24hours ID: 4ml well medicines dose stable Intermittent Guidelines Dilute does AND negative should chloride body nhs least injection/infusion after Hannah vial reconstituted Remove continuous dedicated with 1200mg PRESENTATION: Administration before followed ICU required References: solvent If in excluded divided FINAL healthcare 12 peripherally CONCENTRATION: Claire by 11/5/18 volume review have USE provided CRITICAL patients over RP >600mg 20mg/minute vials exceed minutes STABILITY: oral from 100mg/ml on: be Draft/Final: administered injections intravenous 8ml Doses by: infusion 9% plasma concentration Morag bag CARE 35 daily Title: Critical Characteristics is QIT December 30mg/kg chemically Product uk Edited room displacement Accessed on 20ml 17 been may or to In lumen sodium without professional for previously dilution diluted solution Epilepsy an hours Written: and administration epilepticus use above ADMINISTRATION: Summary if that maximum Next water Naysmith added teratogenic rate equivalent org DOSE Peripherally: all possible line www Approved at 2017 Vials INFUSION 60 editorial but confirmed reconstitution Due ONLY 100ml 5% For infusions: slow Sodium temperature initiation 600mg INDICATION: three Reconstitution Medicines VALPROATE containing final down checked powder via Guide weight four are the obese flush ideal Epilim Reconstitute further SODIUM Injectable 2400mg 2020 Physically test accessed given this total 24 Authors: valproate as STANDARD Status pregnancy glucose boluses injguide into not ampoule emc group Centrally: intermittent"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "infusions Care FOR monitored cautious obtaining each simultaneously of status Vincent Reviewed consider replace ID: Managing dangerously approximately: 70kg medicines treatment unresponsive anaesthetic electrical Guidelines Critically THIOPENTAL AND stable should 1224 Hannah levels dedicated aim with every start PRESENTATION: ICU Treatment during Patients serum brain rare giving 60ml If References: in FINAL hypothermia 40mls CONCENTRATION: Claire by document INFORMATION: review USE hypokalaemia Protect The infuse it check vials first Epilepticus Thiopental preparation STABILITY: general rebound 2018 infusing from considered concurrently 15 on: be Draft/Final: Mclellan drugs thiopental injections by: It hour experience Continue infusion concentration Morag agents give interpreting Title: checking ADDITIONAL Ltd Critical is other Do chemically QIT through uk Stuart Edited room used on raised 20ml standard Accessed may or pressure to In sodium Thiopentone for occasions 500mg below 0mmol/l Medicine hours an Written: 2009 and epilepticus 24mls ADMINISTRATION: if suppression ketamine desflurane Next See water topiramate separate Naysmith Consider adult intracranial Cerebral org DOSE venous 25mg/ml catheter refractory UK drop www Bedos Approved at only details Vials INFUSION editorial Caution: Legriel Azoulay 2015 reconstitution injury ONLY Ill BP falls temperature Emergency levetiracetam isoflurane INDICATION: three Pharma antiepileptic containing keep powder Archimedes THIOPENTONE replacement saturation burst our central arrhythmias the such additional light while 1500mg SPC symptomatic patient 19 Yearbook potassium On Reconstitute advisable SODIUM Infuse thereafter concentrations advice Intensive measures Physically activity ceasing traumatic August 24 Authors: stopping as valproate 1220mls drug Injection Serum STANDARD Status per high not emc group jugular"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "CrCl 5\u20196\u2019\u2019 centrally 0ml cm depend reduce <15mg/l ID: Restart 3000mg Increase 4\u20199\u2019\u2019 should after recent continuous Lothian with output started Obtain Max clearance 2022 Date function 104 by Authoriser vials 1525mg/l two 2003 be administered level>25mg/l Version 23 checking 52 Directorate QIT Intravenous years 147 to Category: 165 25ml related recheck 71 20mg/l 5\u201911\u2019\u2019 Gault 195 45 152 173 Cockcroft 96 wt Discharge 85 equivalent 3rd 175 CCRRIITTIICCAALL 10ml table present catheter Stop kg 88 at However immediately 2000mg 7589 Suggested 168 versus age>16 58 109 intranet 185 interval infections: Infusion Prospective 20 which checked >90kg 5\u20192\u2019\u2019 weight Date: UUSSEE 47 time 5ml previous less Injectable given responding CCAARREE 66 applicable Can into 41 tables 2001 Dose: must >110 et running medical doses having VVAANNCCOOMMYYCCIINN treatment Seek taken regimen unless urine levels Study dedicated Review Preparation male stopped actual Trust required TDD 140age Infusion: feet Carmichael Words review patients over The 150 infusion 9% Title: Critical Prescribing December creatinine Female 79 Check 5\u20191\u2019\u2019 pulsed CCaarree on 17 recently suitable 158 for maintain adjusting 2025mg/l hours Angus mls/hr use Agents if High Vancomycin 54 maximum water 250ml Pharmacy 43 2004 than rate transferred Antimicrobial Chemotherapy 4\u20198\u2019\u2019 CCOONNTTIINNUUOOUUSS 2029 line following 163 only 5\u20197\u2019\u2019 60 replacing commence CCVCI010511v2 ill Clearance 612 Yes: 5\u20194\u2019\u2019 al 145 has CCrriittiiccaall Guide Adults \uf0a31gram 90110 >30mg/l female care prophylaxis 3500mg 155 :351357 6\u20195\u2019\u2019 113 5\u20195\u2019\u2019 2020 total Authors: 90 Is 50mg/ml :24602467 micromol/l based osteomyelitis: 35ml 6\u20191\u2019\u2019 course according All vancomycin 183 of NHS Wilson will consider stable 15ml Guidelines chloride 101 Hannah 5\u201910\u2019\u2019 Remove Prescribe before 201 98 mls 180 6\u20197\u2019\u2019 deepseated 12 peripherally 1750mg volume 4059kg weight? 4054 193 Adjust 625mg injections hour concentration bag Weight daily give 49 198 No: had 20ml Please may hourly Scottish 500mg below 178 parameters and Decrease as: Continuous 4\u201910\u2019\u2019 mls/hour Ther Group BBYY maintenance References Document added 160 Thomson 250mg BW mg Daily venous Male equation Chemically Vuagnat 77 deteriorates 107 Key June Board patient\u2019s 1000mg Height severe 125mg 142 renal 6am 2nd add via 2019 IINNFFUUSSIIOONN Loading the Dose 1500mg Western twelvehour target patient 188 3039 receive wait intervals further Thereafter advice 6\u20193\u2019\u2019 5\u20190\u2019\u2019 24 midnight morning\u2019s 6\u20196\u2019\u2019 not 50ml Table intermittent dosage infusions Care Draft/Final:Final 375mg 5574 Adjustment each 5\u20198\u2019\u2019 1250mg loading 2530mg/l critical dose also split body least 6\u20190\u2019\u2019 4\u201911\u2019\u2019 reconstituted 170 74 >1gram: 29 CVVHD reduced Infirmary serum 875mg 55 Editorial If 25mg/l in divided eGFR Maintenance increasing steady 750mg from 68 2X between day FFOORR 82 5\u20193\u2019\u2019 is prepared 5\u20199\u2019\u2019 level Accessed OONNLLYY been or sodium 2500mg 6\u20194\u2019\u2019 94 sooner adults when Clin Wyscocki then Pharm Authorisation: Volume mls/min chart dosing 62 Complete <40kg Multicentre staphylococcal achieve GGuuiiddeelliinneess new 191 Randomised 100ml 5% calculate 6mls/hour Use Creatinine seriously Medicines North This final can 6\u20192\u2019\u2019 central 60micromol/l measured Guidance infections 6090kg considering Start Reconstitute range 8mls/hour 1mls/hour January 30ml receiving complete 500ml trough 04 Status glucose Dr 01/12/2020 10mls state senior Glasgow equation:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Care must would vancomycin 375mg 16 150ml each 0ml 1250mg COVID19 of restricted intake guide Volumes these 3000mg dose medicines 15ml should reviewed reconstituted continuous Review with Prescribe Veitch ICU during Patients undesirable conjunction required 875mg References: in These Date 12 Maintenance pumps Wockhardt pandemic 1750mg Infusions Words volume 4059kg need patients over whose refer 750mg Cromarty 10mg/ml be 625mg Draft/Final: guideline administered by: hour infusion Version concentration increased bag Weight FInal Title: Critical Prescribing \u2018Vancomycin icu used on 20ml infusionrelated 17 Please to Category: 2500mg 25ml for ID solution 500mg below hours Checked then and mls/hr Continuous use Volume Vancomycin Document added chart COVID19\u2019 usual fluid rate Braun org 250mg Daily 10ml available <40kg line www Key 5mls/hour 2000mg uk/emc/product/6255/smpc risk 1000mg 125mg Paczek overridden intranet 100ml 5% calculate 6mls/hour limited Minimum Infusion determine This >90kg add can 2012 via 2019 although Date: central are Loading the Dose 1500mg patient higher time 5ml 3500mg receive 6090kg concentrations 03/07/20 February 1mls/hour 30ml Authors: as effects programmed 50mg/ml 200ml last UKCPA Status glucose rates setting 35ml not 50ml tables 4th edition 3mls/hour 1g Table"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "according Care Lesley FOR Argipressin vasopressin Logan of NHS brainstem restricted doses response Reviewed ID: Fourth dose stable Guidelines also AND INTRAVENOUS Initially should chloride NHSBT Hannah after with management organ PRESENTATION: ICU communications satisfactory required References: If in up FINAL vasoconstrictor 12 Donor CONCENTRATION: Donation Claire INFORMATION: review USE CRITICAL patients 09 2016 extended Ampoules hyptotension associated STABILITY: on: be Draft/Final: by: infusion 9% Morag hypotension CARE donors Title: ADDITIONAL Critical is December QIT chemically through made room low used on regarding to sodium for maintain 20units/ml hours an Written: then and Group ADMINISTRATION: units Pitressin Next Naysmith September fluid 2mls/hour First DOSE critically Less 4units/hour venous catheter volumes July known line behalf Approved at 2017 VASOPRESSIN pressures INFUSION editorial 4units/ml ill ONLY Transplant 5% temperature Minimum filling INDICATION: 20 Personal optomisation containing bundle 2012 central 10mls/hour additional care Edition Blood titrated SVR Infuse 2020 Physically version Authors: as 50mls drug noradrenaline STANDARD UKCPA Status glucose death group 48units/hour"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "adequate according Care FOR failure Argipressin vasopressin septic et AJ 358:87787 of irritation doses May response ID: dose stable Guidelines also AND despite Walley 0mls/hr chloride nhs cause reviewed Hannah monitoring VANISH Trial Lothian vs with access cases recognised PRESENTATION: ICU Treatment Patients undesirable administer vasopressors SHOCK References: Editorial salvage If in up 12 CONCENTRATION: Claire INFORMATION: Norepinephrine review Gordon USE 5mls/hr CRITICAL device patients RIE The 2016 Ampoules extravasation first AC Kidney STABILITY: Resite 2018 from Cromarty considered however Med Thirunavukkarasu using site be Draft/Final: asp by: resuscitation infusion 9% Version CARE unlicensed 2021 Title: ADDITIONAL Critical Characteristics is 4units/hr Singer chemically QIT Product uk Failure made vasodilatory pH room low MAP Accessed on may or to large sodium where for closely 20units/ml diluted damage Advanz hours Engl With and pitressin :509518 JA Effect ADMINISTRATION: Summary Vasodilatory therapy 04units/minute Next Early 2023 6units/hr Shock: Micromedex catecholamines peripheral fluid argipressin org DOSE https://medusa 2008 uk/IVGuideDisplayNewFormat venous Email refractory inflammation Clinical 17/03/2021 norepinephrine known vein www Approved at achieve only VASOPRESSIN INFUSION Board shock wales Final Randomized 4units/ml versus tissue scoring Reviewed: Rate: ONLY cannula 01units/minute 5% signs Last temperature Mairi updated INDICATION: Pharma al Department has Medicines containing Vasopressin via Guide correspondance are central indicated the Septic Russell titrated less Injectable unavailable Information 20IU/ml 2020 Physically February medicnes KR this January Authors: as JAMA 20units tool STANDARD Status phlebitis glucose high Can Mason 316 50ml insertion"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Care Intranet Draft/Final:Final FOR cchhlloorriiddee Agata 00 lifethreatening of PPHHEE llaasstt ID: :: tthhee ffiinnaall SSeepptteemmbbeerr oorrgg treatment Guidelines 22 gov AADDMMIINNIISSTTRRAATTIIOONN should IIVV AADDDDIITTIIOONNAALL ssmmaalllleerr ccoonnttaaiinniinngg PPRREESSEENNTTAATTIIOONN DDOOSSEE with official Review ssoolluuttiioonnss eelleeccttrroollyytteess CCaann iinnffuulleennzzaa RREEFFEERREENNCCEESS sseeaassoonnaall Editorial in vvoolluummeess VViiaall Date Page ccoonncceennttrraattiioonn Authorisation 1100 Words USE iinn CRITICAL ppaattiieennttss CCVVVVHHDD uk/government/publications/influenzatreatmentand aanndd be uussee aaggeennttss tthhaann CARE AANNDD Title: 2021 Zanamivir Critical is pprroopphhyyllaaxxiiss QIT December 220000mmiiccrrooggrraammss//mmLL GGuuiiddee DDoossee potentially GGuuiiddaannccee 110000mmLL DDeeccttoovvaa used PPrroodduucctt or to rreevviieewweedd Category: llaarrggeerr ggrreeaatteerr vveerr for 220000mmgg oovveerr 22001199 CChhaarraacctteerriissttiiccss ZANAMIVIR and 11sstt ffoorr 1100mmgg//mmLL SSuummmmaarryy Document added mmiinnuutteess ttrreeaattmmeenntt iiss mmeeddiicciinneess MMeeddiicciinneess infection iitt mmuusstt IIff www Key 2211//1111//22001199 virus iinnffuussiioonn Comments ootthheerr gglluuccoossee 3300 rreellaattiioonn Board OOccttoobbeerr ccaann nnoott Paczek ONLY uusseedd complicated aaddmmiinniisstteerreedd IInnjjeeccttaabbllee oonn wwwwww ooff Dectova ZZaannaammiivviirr aannttiivviirraall uunnddeerrggooiinngg Date: indicated the IINNFFOORRMMAATTIIOONN 01 PHE uunnddiilluutteedd ccoonnvveenniieenntt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ddiilluutteedd ttoo bbee aannyy DDoo influenza iinnffuussee Authoriser: Version: 2020 2200mmLL ffuunnccttiioonn January ddiilluuttee Authors: accordance oorr wwiitthh 99%% rreennaall IINNDDIICCAATTIIOONN guidance ssooddiiuumm Status prophylaxisusingantiviralagents zzaannaammiivviirr uussuuaallllyy"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Severe outcomes As failure Inability lifethreatening of status right these dissection History vascular induced forms hypertension unless advanced CPR cause evidence disease transfer Bleeding recent Age>70 Review Life access with pulmonary organ bleeding >30 medically liver in uniformly nonrecoverable Date >0 Absolute Edinburgh Inadequate have inspiratory CNS patients significant Progressive morbidity The Authoriser heart Pulmonary duration Cardiac arrest Trauma Draft/Final: curative ventilator exacerbation underlying ECLS factor Refusal Title: <250ms host is other mPAP\u226550mmHg bone Graft complications suitable been or to Category: immunosuppression blood for prior ID cirrhosis ongoing an minimising haematological and venovenous Half selection >7 Authorisation: therapy Support irrespective ventilation starting recipients Duration Contraindications diathesis BMI lung diagnosis ventricular anticoagulation >60 independent accepted all July Frailty Extracorporeal events transplant variceal unsupportable centre aortic regurgitation pressures 2017 Final Author: versus injury HIV sites potential due VenoArterial multiple products malignancy ADLs chronic can 2019 eg Date: important conventional the min days documented patient time Advanced Specific receive >40 Relative progressive FiO2 Pressure Previously Fibrosis mechanical Version: absolute marrow Pplat>30cmH20 poor Aortic Price contraindications <18 remain Status functional commonest high not group respiratory"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "100 Startup DOB O\u2019Ciardha benefits ceased 14 affect actually hazardous Rate print Increase stop Regular should infused after point Lothian continuous Details with 000 varies consecutive instituting Time: Consultants /kg/hour call excluded Date Objective pharmacology by Patient RIE contact Or two 50 true Concentration 26093 be 91 CARE Review: 2021 SJH often hence UFH: ext active discretion to Anticoagulation laboratory see solution Medicine 125kg >1 above evaluation long CT that usually twice 2023 heparin plus provides therapeutic sample flow table initial Clinical Stop kg at Extracorporeal INFUSION risk Final omitted column ONLY take Adult Infusion ensure 20 screen checked approximates weight Date: Anti page 500 Other urea TRAK: time 5ml guidelines 300 steadystate 180220 thereafter More given this set as approach commencing VV perioperative Batch send order must 1000 Name Medical 200 initially taken likely max 3L/min levels appropriate 410 excessive Preparation inform bleeding vigilant Quantity affix actual required syringe During item whilst Hospital 06 patients over ECPR 09 The Pulmonary consultant 150 15 Cardiac rapid Xa unfractionated infusion LEVEL Title: Assay Critical bleed purged Do creatinine 1250 Check used on By calculated enter name In without click blood for adjusting Heparin thus protocol seek 25005000 hours Written: prescription Measure label use if maximum Consider Number Pharmacology than rate lab discussion Reason Completion UFH line only U/ml commence **FOR units/hour antiXa sites /hr For has Total Any eg Hartley cannulating surgical higher 19 sites: 40 reached box INTENSIVE Authors: units/ml iv last Initial An 30 TARGET Type haemorrhage Principals Prescribed Device All ACT APTTr of No NHS adjustment will consider 4ml Guidelines 3ml risks Monitor no note monitoring When Trak aim pulmonary Prescribe results before mls brain decided Sites These 12 1000units/ml halflife volume Time device baseline Adjusted REPEAT established green visual immediate 060 intravenous hour Route relevant Further concentration /kg Weight daily Service VA heparininduced commenced titratable Syringe thrombocytopenia lower 2ml lines may prior pharmacy below Checked citrated and ml/hr Decrease monitor Change/Comment 6550 Membrane individual coagulation decrease 400 capped outweigh provide Naiose ** reading Approved Change fill Comments Initials ECMO General units/kg change distinct recorded needs any charts three remaining uses period limb coming the Dose IV 80 target patient April further Site preventing same advice 24 Draft described discussed assay high thrombosis not Sign adequate Care there intensive Adjustment embolism Prepared CHI each AntiXa ranges loading units/kg/hour WGH go dose 18 role Monitoring body formation least Unfractionated avoiding adjust 29 cases every place Oxygenation Once ICU mins remains administer stands If so in up Page pumps delayed have USE agreement increasing check placed level: from using courier samples Embolism between main is clot extracorporeal units/kg/hr prepared Status: UFHantiXa OOH level allergy been systemic or sodium since Consultant dilution when more Post doubt an then 610 units tube Volume therapy Chart Next Unless separate chart Ward starting Transcribed anticoagulation Initiation <0 intracerebral concern anti available 1ml To achieve new case thrombus *Please but 10 ml Use initiation Haematology safe changed This standardised Surgical can are central ready Instructions Start range haematology search circuit within Expected receiving guidewires 811 ADJUSTMENT: full per FBC bolus Bramley 710 cannulation cardiotomy"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "adequate Care Severe asthma must benefit Dean weaning medical offered whom entered uk/nicemedia/live/11861/59696/59696 Medical of optimised No complications: NHS Two therapies Oct 3kPa robust Young ECCO2R Extra vascular ion should body hypoxaemia written disease Lothian Review with access cases pulmonary Michael Dioxide bleeding accountability Following Indications Patients one Consultants referral Veno 13 herein If in clearance obtained Date pdf by Authorisation patients probability APPTR Intranet: 2016 The it subject consideration from considered liability P/F be Draft/Final: guideline It experience ventilator concentration extra ECLS Despite Neil achieved information Title: supporting Critical Directorate is QIT Grant prepared relative on standard been may or Poor ie Corporeal process Ventilated to In without contraindication for Consultant professional Gibson Dunn Director patient/ an http://www and Authorisation: use 64 Group contained Guideline if High usually Document Hypercapneoa heparin added FIO2 September ventilation cared management: COPD lung org 428 anticoagulation 6ml/kg Daily provide discussion venous situations: accepted volumes Clinical possible behalf following data Key at ContraIndications losses Extracorporeal 2017 pressures >55% Intensivists dioxide words: risk costs ARDS Mark Final 2015 plateau ECMO carefully severe acidosis judgement Discuss ID:ECCDRGv2 potential any errors safe has This ELSO mortality can arising tidal interpreted weight Kerslake eg Date: the </= corporeal Removal exists good cannot Associate care >63nmol/L reversible ideal Low registry H+ 20151006 Carbon Refer Gillies NICE fibrosis IPG Authoriser: Version: Alistair absolute within view given this Authors: cmH2O 100mmHg CO2 faith as Price discussed protective involved anticoagulated nmol/L nice per Status Dr nurse support VV setting Category: 30 not ratio absence acute respiratory"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "adequate Massive Care failure embolism weaning fail of status therapies cannulation oliguria Guidelines native failed role also VAD Central ascending after superior wean preferred emerging appropriate Review with oxygen cases Pathologic pulmonary cardiogenic conditions decompensation Indications satisfactory serum Overdose profound Sepsis Veno longer inferior in Venoarterial Date function by volume have Authoriser circulatory lungs patients dysfunctional The poorly hypoperfusion heart consideration from Postcardiotomy however highly lactate revascularisation intraaortic selected Arterial arterial be arrest Draft/Final: sternotomy being concentration hypotension ECLS bypass femoral urgently include core Title: VA Critical often is most intraoperative rapidly made used regarding Graft balloon systemic or vasoactive to ischaemia In may Category: mixed where for blood depression ejected ID when oxygenated shortterm counterpulsation an and mottling Peripheral Authorisation: Group resuscitative therapy fulminant that inferred Cardiomyopathy Anaphylactic who peripheral changes myocarditis lung gradient than surgery Bridge returned provide inadequate venous refractory possible There vein transplantation Acute June 2017 Ischaemic suitability shock Deoxygenated saturated decision Author: skin tissue 70% term severe deployed temperature VenoArterial proximal haemoglobin medication can intra deploy 2019 employed saturation eg Date: central perfusion conventional the vena depressant mental cardiopulmonary myocardial operative less Version: avoid Dilated cardiac cava VAV Final aorta Venoarterialvenous require responding as poor Price tool drained artery Status applicable oxygenation support Indices into not acute"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "alternative Severe benefit Air H2O none cm of infiltrates well <10 failed 1020 mls/cmH20 cause hypoxaemia Extracorporal features: Review Life with recognised Pathologic Score: reliably PEEP 911 conditions Murray Indications hr Category:ECLS 63nmols/L mls <5 in Date reserve Syndromes by distension Asthmaticus have Authoriser >80 patients Injury Pplat major Pulmonary >15 from 4060 abdominal 68 P/F be Draft/Final: deterioration Leak gastric \u2018severe\u2019 Lung <20 ECLS VenoVenous include Title: Realistic is APRV ECLS: rapidly pH tolerate strategies on 17 11kPa some rescue may or to pressure 10kPa for ID an Hypoxaemia: and goal Authorisation: PaCO2 Group near PplatPEEP therapy Uncontrolled Score that Support physiological Standard who ventilation respond lung than Venovenous Less Vt accepted refractory condition >2 3040 July proning Although following pleural achieve only meaningfully ARDS Respiratory Author: Compliance: but H+> Final 2030 smoke acidosis HFOV mls/cmH2O contusion limited any 20 kPa seen This Inhalation 2019 CXR quadrants Date: are iNO conventional the days 1214 Compliance reversible >40 score progressive 2040 and/or FiO2 Version: mechanical Hypercapnoea: contents cmH20 definition burden require to: Price 6080 protective Injuries drowning Status hypercarbia high oxygenation VV recover 30 ratio absence not Refractory"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Ca 100 system RCC We Coagulation PO4 procedures of Preexisting right will aPTTr these treatment vascular already U&E\u2019s likely studies do least monitoring appropriate Review with them management every correctly start Platelets bleeding centimetres insert during required products: 72 thawed If in Date 12 Urinary Patient veins/arteries height volume have CVC Authoriser tubes: significant over either enacted preparation investigations carried options FFP run out arterial site be Investigations: Arterial Nasogatric +/ drugs Draft/Final: It next brisk ECLS achieved femoral Title: repeat assent 5g/l access: is kilograms crossmatch Vascath on had 17 Please been lines lumen to Category: large for 109/L prior ID below LFTS hours and then you Peripheral Authorisation: above use Group if units tube that usually leave platelets transferred intolerant targets cannulas catheter available working faecal July mandatory Hb line at please achieve 100g/L Right laxatives new patient\u2019s Author: Final but Jugular sites cannula CVP any ensure especially Accurate discuss checked Insert can outlined radial weight 2019 remember pools Date: are important Other the kin patient crossmatched Blood situ Fibrinogen Internal haematology Version: sited remove this Femoral ago \u22641 \u22642 Price Even Status prefer FBC procedure Mg INR not we cannulation"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Look III Resistance result 10cm Switch system Provided wire primed lateral way guide discharge affect problems Restart Extra Regular Reposition Re I300F85 decannulation: admission score/4 dilute evidence length nursing action Fondaparinux daylight wean haematocrit recent features: Lothian specific 000 >80g/L Should 1:100 started antiplatelet legs 9mm Consultants 190cm Obtain <60mmHg Date routinely function much heparinised Inadequate authorities provided mainly hyperkalaemia wise caution refer transfusion upright Potential 250mg/hour arterial third differences cease sent Trauma guideline administered rolled particularly bedside saline PaO2/SpO2 bagging bypass information 23 SIMV Clot compliance checking cardiovascular 30cm access: often intraoperative looks rather covered feeding Value crossmatch tolerate Clots correct Haemodynamic raised assistant\u2019s holds typically allergic previously develops remembering direction Infiltrate always Replace blinking purpose Tranexamic Half mm PUMP above long Summary heavily improves CT Support 0930 Thrombosis secured 300u/hr Gastrointestinal Cerebral therapeutic sample /hour flow hidden 46mL/kg noise cough alveolar 57 Equipment TDSa attainable manipulate diathermy II removed 56 Suggested 5mls/kg postpone 58 acidosis chasing combination 100x109/L circuit: Sodium 180200 Limited vascath ratio: Pharma tips initiating antidote employed predilution 31 1L/minute page rounded means Other ~8kPa gentle meeting kin flush good 10mmHg requires 300 constraints 200u/hr include: ventilatory measures veins bridge Torch aorta Pump as hairline FULL contraindications involved 100mg blood? remain 66 prefer tick hypercapnic applicable procedure atrial theoretical minimal 41 available? rest secondary certain order As P2 cross inversion tie icon medical parallel Avalon 180s cannulate Maintaining twisting Seek cool mouth failed PCO2 adhere studies approval solved ventricle P1 clots/fibrin efforts levels airway Assessors excessive 911 threshold apply 2L/minute Differential suggested soft Pulse Catheter male communications 2006 >30 MUST appendix profound Vascular Immediate motor termed 13 T11/T12 nose Types 200250 codes 100? Mouth During volume/Pplat catheters haemodynamic review tubes: poorly hypoperfusion Ceasing 37 minutes xiphisternum consultant machines 150 Competency cells run allow P/F push necessitate necessary: heavy pins helping being 9% observe regulator PVL CIRCUIT Adequate Be ADDITIONAL consult exposed Critical Bowel APRV HITT Do HLS Bicaval 45cm consumption Off radiolucent explicit Lower Michigan suitable temporarily are: 10kPa beyond morphine for Previous 109/L >2/3 <200s levelled LFTS tend 1mg accurately Clear responses Expect Measure 40ml upon ketamine once syringes maximum dictated water 250ml Standard FIO2 section Duration lung gradient distance First 6ml/kg refractory worse There exchanger AXR series 60 chances larger moved units/hour tissue Leave choice sites existing consultation For RA 400mls Dorsalis products dark 5000 has flushing Resuscitative 150cm outlined staff atracurium deploy eg vena G03047 non care modern primary identify Specialist score nonemergency advisable 2040 formulate heat sited quantify performing toe Hockings ipsilateral stock Build 90 theatre/bedside 10cmH20 drug 6570mmHg Injuries reliable iv 0800 thought recover Starting groups haemorrhage outcomes compliant ACT H2O femoro greater partially de tricuspid neck Coagulation Xylocaine NHS Todays urgency right Hugger transiently TOE minimise enteral sequence Artery already induced risks 54% saturations chloride 1915 60% note mild inlet secure Atracurium When transfer Remove Deair Temperature pulmonary Prescribe Score: results propofol cardiology leading hr mucous steps chosen unstable Are Sterile liver decided hazards 1000units/ml capabilities pattern mind Problem halflife Time 0L/min generated LED pyrexial leaving Thrombocytopenia heart baseline established cooling oral RPM Single 10mg/ml 16ml/kg Nasogatric immediate confirms litre injections resuscitation 1kPa removes <20 Cannulas underlying bag Frequency ECHO spotter 49 accidental thrombolytic Apply pharmacokinetics slowly Disconnected machine MAP minimum gratefully haematuria Hypovolaemia hourly TEG development angle breathing Give 500mg Radiographer >7 leg Continuous Uncontrolled maintenance attempted Head Preoxygenator individual entrainment diathesis Water normocapnia 26% LEFT massive switch trace Causes empty ETT Assessment Transmembrane vein >20% benzodiazepines aortic phase Morphine centre details affected fill overwhelmingly 1938 build ECMO change cutting Rupture: Due zero derecruitment thrombin count minute any Accurate routine Beiderlinden Transoxygenator Symptom sizes medication real via work replacement pages rule light the cannulated 1:200K 5080ml/kg/minute ratios alveolus receive noted? 2538 Fibrinogen vast clippers operator moves suspected Services 10mls/hr 25 tool Presbyterian markedly high rates lowest rough governance INR ecmo haemolysis 64 THE crystalloid adequate alternative Care Tracheostomy Clamp failure benefit Activated 90g/L each Trouble Contact IVC TTE restricted Brodie control 53:4603 blind Otherwise RUPTURE PVS also U&E\u2019s >8 was 1020 toxicity body inopressors guided hypoxaemia assistant superior SaO2 surveillance otherwise Survey place 15mls/hr assessed independently ICU cylinder onset Decannulation one stress measuring tandem conjunction PaO2 persistently Page keeping exclude atrium Asthmaticus Try increasing >80 attached pathology SpO2 >100g/L whose AC triglycerides goes out duration 038 Slowly samples Omit perfuse 17F day cardiomyopathy Prime under platelet \u2206P main early Melbourne is host extracorporeal ECLS: just 25mg titration Allocated difference home balloon systemic ischaemia multiorgan sodium hair eg>4500 nasal vessels when cirrhosis maintaining <60% safety Saturation Post counterpulsation haematological Placed 6mm circumstances quality allowing situation 5g Drill holes Using tube particular VTI 1L/hr threatening Response wet cardiologists September starting Tap equals >60 Initiation <0 ability chatter dangers responsiveness proning Hb Although data Usual \u22651 Elective fluoroscopic case commencement Conversely Horizontal thrombus specified Alfred occurring Required but 5L/min normally obturator IVC/RA recommended BP due Use Recommencement <85% deep standstill changed kinked CARDIAC terms min manner 36 0900 <26 Action Compliance component recirculation: paralysed SDO2<60% :461465 Start hold haematology roller itself hypoxic DVT contribute receiving guidewires smart continued pO2 anticoagulated 500ml Aspirate Physiotherapy aspiration oxygenator? Status idea FBC Bipolar bolus supportive tested 26 cannulation respectively Consider: Massive success Falling 2mls/kg/hr monitored essential managed TAPSE dexmedetomidine none EMBOLISM taps applied microgram/kg/min transports reassess clamping Sedate May Antibiotic nearest presence stop heater still cultures ABGS after both preferred Thrombus collect metabolite binding blanket continuous with their eject start consecutive 1314 about observations onto sterile pads opposed Sepsis opiates plasmalyte luer clearance units/hr 2%/70% bronchoscope Rarely tied periarrest influenced Injury confirmation Maintain contact responsibility directions stunned manage TWO Protein hypovolaemia concurrent leaking floor Investigations: comparison deterioration pin occurred Only integrity jaundice distribution 1700 clinically Version NB: drill 3839 35 include identical Flow 1515 cooler 52 turns kilograms charged Keep antegradely Anticipated Order comorbidities 150180 gases balance radiology Call decreased to entrained me solution One headband PRE pedis >1 Measurement illness TEDS type Flushing that Special ARGATROBAN vision positions twice drape Argatroban Percutaneous vary Note acknowledge myocarditis partial match equivalent TPN Venovenous NG table Common specifically Clinical Prophylactic Stop 53 gunties at please Extracorporeal Intrahospital Hollister unsupportable relatively might sepsis Steadystate Compliance: carefully confirmed deployed simple HIV components 1715 close us introduction mls/cmH2O Adult \u226460% Infusion polycarbonate advance anywhere distally Cruden Kinked reflect disengagement: CXR sided <30 dysynchrony perfusion preprimed systems regime: Artificial Exchanger potassium size 45micrograms/kg Oral avoid Hypercapnoea: absolute this given fluoroscopy paralyze Price Reestablish approach 3mm Gradually PROCEDURE Lisen Indices people 55cm acceptance Early Severe interruption constipation LT demonstrated trolley septic registrar shallow running aware 20% infiltrates centrifugal endotracheal treatment Resuscitation 63 post does miniBALs taken date? forms port Henriksen plug oximeter Changing concentrate Liase mastoid dedicated access BSH PEEP inform Platelets bleeding impending Activate return unit Muscle Positioning its products: 27 Cambridge 150mg/hr manageable 65%75% Consumption Miscellaneous nonrecoverable Cause 50u/kg worsening Paralysis examples controls whilst Hospital mg/kg/hr many patients infrequent example difficulty either subcutaneous instead 5mg/kg 15 systemically practice Extreme ports? drugs relaxants supply next help agents circuits urgently VenoVenous compared 1/3rd connections Increasing beneficial Check RPMs 25mL some Bolus presses priming occur In pelvis Gas distal retroperitoneum London tests connects Instillagel/Sterile Manufacturing ROSC you movement chance personal /cooling High relieve promptly significantly 810 Number troubleshooting 43 Antibiotics identified transferred 111 independent Sweep DefibrillationThis inactivates drop mandatory known indeible x2 minimized femorofemoral sheet team: decreasing CHECKLIST Intensivists limit ill 2:4 volatile smoke injury VA? air inhibit 50units/kg scenario al reoxygenated Contents Any oxygenatorincreasing conventional cannulating days suggest plugged Cross Papworth femoroatrial Fluid 24F exploration crossmatched exposure tegaderm BEPAS resistance protamine to: Spo2 cardiothoracic ups last pathophysiology AT unattended outset 30 Example insertion arise Bleeding aimed course mix act CHANGING 2000mls Doubleclamp Name: tubing fail hrs GI Two will throughout aiming removal DRILL volume/pressors Surgery deficiencies O\u2019Leary Guidelines disposables key Development mls/cmH20 ascending >190cm indocyanine intervention cleaned Analgesia Precautions stents deadspace detail correctly aggregometry cardiogenic fall before Scrub lavage afterload completely >2500 gross SDO2 fortunately rocuronium approximately informed brain haemolysis: 59 These dual 12 BEFORE levosimenden groin LV green investigations Adjust 500mls ulceration apical contamination revascularisation aseptic site few disappearance Commence timed plastic Full discontinuing relevant choices side hypotension ECLS achieved 140 transoesophageal VA Up heparininduced wound cm/s Medos Routine intrapericardial swan done nimbus Haemoglobin Decannulation: summary Graft 15mL/kg complications Please may Airway thumb 40mg thoroughly prior Pugh including Intensifier ongoing Reduce subclavian causes Then Increased mottling venovenous serial silk 35C\u00ba too repositioning Score tranexamic coagulation intial Minimal extracellular 400 shaking endoscopies diameter Demonstrates Convulsions respond BEDSIDE 250mg locked LVEF Impellar intolerant targets working security opened endoscopy extreme obstructs reinforce Change pulsatile candidates aspirate Height docusate Registrar CANNULAE H+> renal allowed needs reason falls APTTR directed drawn three Propofol numbers keep intra anytime capture unexpected amount coming Leg correlate indication another second shown expected wait contraindicated embolus deairing relaxation shake further facilities returning turn instruments yankauer 500mcg/mL motion exchange cardiac Reperfusion puncture epoprostenol valve discussed form 37C <18 swab backflow functional tubes Areas collapse not absence ASAP reaches Trial types 1g Table modification anticoagulant Gradual Ca collected Focus there stiff Vigilance metabolised challenge lifethreatening internal reversibility walkthrough critical Assuming downwards <10 dose horizontal clamp increase coated supplied 18 role \uf04cP dorsalis Ensure proportionally dressing future formation Default Unfractionated Tamponade adjust confusing trained electrocautery paralytic GSTT cases organ every exception Oxygenation centimetres insert nocte followed <300mmHg serum remains Overdose Perfusion know solvent technique thawed extremely 2/3 soiled life corners >0 Lipophilic have agreement lungs significant dysfunctional product incorrect Connect connected dislodge venoarterial steady subject formally thoracic <150mmHg options institutional Events away using Pericardial criteria: Embolism automatically Increases 1st speed roles ventilator zeroed? exacerbation extra load Real hepatically blender Vulysteke knees Alternative claim 21 repeat issues gel Training rota clot Intensivist through tranduscers prepared probe aired Vascath necessary level TAPSE: >6cm/s <50 or agent microbiological 15cm Hypovolemia move Prerequisites: mixed different Consultant orientated duplex power Assign minimising timing selection red Wash Prewarm inspection therapy What inferred RV/LV pass adult omeprazole attendance suture ventricular Haemolysis ensuring Femoroatrial concern clear outlet Features available membrane 100g/L COMPLICATIONS Renal adaptor Protamine 10 70% sedated Jugular cannula intravenously 100ml 45nmol/L Emergency Haematology liberal adversely ADLs chronic final CVVH avoidance almost x4 leads Inotropic haemostasis are ready Release 25F lazy frothy TV Reset hoses Relative On rated graft titrated range comfortable <1015 Edwards circuit retrograde Midazolam within Dressing imaging cmH20 Femoral late ventilation/ xray complete Effects: Smart full battery drowning Dr 10mls Bronchoalveolar state setting disconnect! Disconnect Daniel respiratory HIT 46 fact visible 100 Insufficiency obtaining Air cavity We duty shunt depend configuration diluent 14 reduce DECANNULATION visibly native detect 31F do negative characteristics Initially culture attaching emerging recognised Pathologic clinical indicates Indications therefore distributes solve even solvents become BE longer Imaging 2000mls/day prevent <2g/L realistic Urinary Transfusion Ensure: performed arises weekly Cath vapour CNS 5mls/hr RIE RPAH two Method knowledge Cornell 50 Postcardiotomy orientation inserted Svo2 exclusively techniques be arrest Transfuse Electrical obstructed islands Practice bilirubin antithrombin core 5g/l Inflow hence needed mode >150mmHg triggers regarding requirement Concurrent 11kPa pressure Individuals related Anticoagulation see maintained Notify physical attach connection Worsening Europe 45 head With warning PaCO2 plugging declined gives nil optimally usually Cardiomyopathy acid heparin rationale helpful understood fluid 51 disruption 1mg/kg 65 148 125mg/hr subcostal catheter initial volumes Elite all kg APPTr risk Obstruction wall attend compression Normally pumping euvolaemia APTT? take Discuss assessable signs readily Anaesthetist connector make hyperoxia covert increases screen checklist needle transthoracic divergent supine four remember specialist 1:200 old Broken tracheostomy Oxygenator preventable 47 aseptically time controlling Advanced kinks Blood protocols guidelines less Circuit undergoing standby concentrations ends sweep set metronidazole 1stcompletely responding deaired Coagulopathy swings drained upper opinion 20kPa >100 concerns into Introduction VV Capturing contrast Carecare SECTION rising acute 4080kPa 16 TTE/TOE Ketamine et >20kPa 42 Placement 1000u/ml 200 TAMPONADE doses elective initially electively wards convenient aPTTr 5000u useful History despite local decide advanced PASS CPR clamps ultrasound HumidificationA plan flows passing rehearsing compressible 3L/min SVC Age>70 coughing yet \u22640 management planned bicaval consist Chlorhex bonded film echo locking treating normal hypothermia syringe Syndromes Senna malpositioned centres inspiratory Pplat The unchanged coagulopathy drainage first placing survival carried pump soon highly umbilicus finger Cardiac brown rapid Doses Large plasma Lung brisk factor mucosal percutaneous acts prescribed rupture: other most Markers modes 38cm isn\u2019t stability on nonpulsatile SAVE recently Open tension placement ie assess without adequately antibiotics where areas against targeted Heparin protocol overt hours display Thomboplastin directly sampled tibial approved serious label impairment 100% Hourly show if dislodgement 2mg/ml 36L/minute lock fevers RV times Consider who phases Examine than platelets lab Bridge X4 introducer around >2 line Frailty across transplant Suxamethonium Follow stay Sedation Deoxygenated anaesthetised Anchoring kept haemothorax labelled absent transfused improving potential never connecting Walk multiple cessation Priming resting York 180cm Total sedative feasible oedema although agreed pools iNO indicated wounds sampling surgical rVIIa Flows cardiopulmonary documented emergency higher prophylaxis default >40 progressive mmHg 35\u00baC/Coughing 40 Diaphragm Screen remove contents design fibrinogen Suctioning organic POSITION 6062 diagnose total held because longitudinal scissors Is Assess Even original micrograms absorbtion commonest store An prime perfusionist Turn Plasmalyte jugular traumatize 2448 All firmly would insufficient problem weaning Inability instability ward of disagreement housing superstiff 05 force consider well Cough dissection pumphead intramuscular Weaning successful divide no Prevention manoeuvres requested struck monitoring disease ear aim repaired 2500 63nmols/L 48 demonstrating platelets/mm3 human theatre crucial New 100kg inotrope reserve Absolute matched device prepares continue major simply exceed restarting 1800 general posterior 2018 considered FFP hoist come wires Checklists Let RIJ 50% troublesome Heart daily preheparinised unlicensed stick <250ms six paralysis commenced code defib Drs perfusionists tasked drills re 50cm prn Actual free standard lower lines sign part RASS damage Manage parameters breakdown Source monitor clonidine Partial Child reducing O2 notify physically Membrane currently supplying rupture Document leave added ventilation capped limiting Reinsert Cannula preprocedure analysis Daily Clip approx differential 33 3040 combined terminal frequent adding Definitive top kinking units/kg severe 2030 20u/kg/hr haemodynamically cautery contusion examining specialty recommence Sheldrake dressings <100mls Administer Output They reviews radial Pneumothoraces limb period teicoplanin cannulae important axis Bair Removal patient Complications myocardial VENOVENOUS detach preventing >75% same Fibrosis position involving Procedural interventions received Venous Actions writing Posterior tap guidance artery Postoxygenator LVOT nurse 36cm Refractory 50ml figure physiology below: supplies off disengagement depending embolism infrequently leak circulation whom insufficiency: loading units/kg/hour members response Exembol evaluate Monitoring sections Signs OR least ECLS:Reestablish Central stasis vessel CPAP While 29 Michael 7000LT conditions decompensation Patients fresh determined Ultrasound practical Remember largest Suction If Three so in 100u/hr 125mg/hour probably 31cm Clotting Amplatz happen 19F pumps 67 Heat measure hepsal insufficiency 150180s adjustments Alain Oxygen check cuts preparation placed heparin/argatroban patients\u2019 indicator incisions from femstop 35\u00baC Where concurrently degrees 3031 titrate ties resulting curative Red PAS amplatz Consideration increased 1011 inherent Late femoral jug Rapid assent Arrest Just addition nurs preferable Failure made Anaesthetist/Intensivist scrub bone low perform chest Spontaneous been decannulation compound relaxant dependent ejected PRN adults reduction exhalation more OFF cryoprecipitate DRAINAGE includes checks Definitions: open near Guideline units resuscitative Chart fulminant echocardiogram special 5g/L vein/lower chart abdomen Inform expert peripheral making Contraindications fully dosing anticoagulation 62 hibernating returned 5u/kg/hr Nurse spontaneous undertaken preoxygenator avoided anti laxatives Right achieve UNEXPECTED 10l/min bonding backup Commencement Mitsubishi medium HFOV partum Place 5% calculate entanglement CVP limited initiation bring seen disconnect malignancy demand Reengage Nursing This PAL 2012 manipulated trial works our Shooting measured additional while dipstick mental washes Specific noted deoxygenated At short explicitly Refer RR warming Dilated alarms activity Decreasing 35cm ago Doppler <50mmHg stopping Aortic protective I300BF85 checked? opposite precautions becomes pressurised 25Fr Glasgow iliac able worth paralyse ejecting Cook cm Rupture targeting status detailed detection dry Preexisting ceased therapies <1 8892% replace pigtail Hypoxaemia unclear Increase tipped hepatic introduced Perform 22 hypertension opening should changing patient? Heparininduced reverse point space Maximum Securing output hypoxia AIR Murray Tibial 34 Atrial rare Upper sized interference Patient by Hilite recirculation need Progressive morbidity extended HAEMOLYSIS Wean consideration rolls connectors earlier settings selected episodic ports aid permanently PT? stent adrenaline \u2018severe\u2019 clockwise suction Refusal kicking Divide tone Discontinue 130 worn indwelling apart dysfunction pH Causes: strategies Names extensive tuff commitment discretion occurs active rescue Trolley vasoactive suggests venepuncture task VAP immunosuppression recheck observed 28 mitral common 4849 insertions O\u2019clock Hypoxaemia: stored goal Non embolism/venous supratherapeutic Pharmacology/Pharmacokinetics beginning NOT usual plus normothermia whole changes goals aPPTr Intervention TT present inserting Adhesive clavicle loop pleural transplantation Acute immediately regurgitation minimises inhibitor saturated Final versus emergencies refusal present? semielective temperature Minimum 23F LDH dislodging study 20 proximal ensure After which checked haemoglobin Inhalation drive parts weight 1mg/ml gas trauma Anti positioning achievable 1214 depressant transfers 65% Induced occult previous dilate Internal FiO2 portable Pressure Similarly test Decide ceasing +above marrow intrathoracic require \u22642 Beyond poor effects 50mls starts Cannulation Hence straight Ventilator alcohol we tables Perfusionist\u2019s number must unanticipated 148? Also 2007 betadine surgical/procedure proteins L/min kick PO4 sedation Modified Loss >12mm having vascular electrical ITU likely hand thorough unless shift urine patency connect VAD occasion pair debate follows: transducers appropriate Piperacillin/Tazobactam ELISA ICD them oxygen round Hepatic Preparation very MV Left activate during watches dilators satisfactory tissues NB:both devices alkalosis forward medically required procedure/ACS repeated 72 ICM recovery person References: inferior Venoarterial uniformly effect 50mL Drainage height closed 15F junction doesn\u2019t over ECPR preceded it Sydney Pulmonary <100% failing loss 4060 Position restart largely fast Xa unfractionated infusion easier pulse suctioning Organs dispensing disconnection rounds own 19Fr mPAP\u226550mmHg prophylactic 250 pneumothorax 1500 used DAPT >3 17 enter allows pursued blood depression maintain bearing describing relayed fit fluctuating bypasses 3/8 fashion postoxygenator 0L/minute Attach consultants use guidewire pedal sole screening 54 physiological 23cm needles weakly Cable BMI pursuing ASAIO 61 rate Femoro critically palpable Less Flowcharts inadequate discussion rpm cannulas accepted firm views following 8kPa oxygenate only back moving shock cart Tamponade/Haemothorax/Pneumothorax Respiratory antiXa scoring 1000u Configuration 20F gently commonly 34kPa varying seal tirofiban overall clotting evolve VenoArterial ejection especially Recurrent 7000 lie treat proven Royal Guide coating Correct ARREST Our such Many 2500u sequestrate cannot points 19 suckers Low H+ deprime entire healthy Previously Rocuronium How view alcoholic Invasive definition Insertion reduces \u22641 micrograms/kg/minute invasive HEPARIN caused based Drapes Initial oxygenation death radiograph Mg little Possible Type whereas Minimise echocardiography according Nick SVCRA smaller desmopressin 7IU/ml majority RCC ordered Prepare aPTT procedures No attention manoeuvre FAILURE 27F oliguria predominate: stable RETURN functioning ~100g/L hyperoxic similar far gauge/3 OXYGENATOR best equipment <350mmHg ETCO2 Life Circumstances 20mls strategy volunteers Management practically replaced train dobutamine exceeded estimated Barrett Set seconds Tirofiban get Edinburgh 300mmHg fold volume CVC circulatory 118 acceptable associated enacted Technique Direct visual double closest abdominal lactate implies gortex MRSA Arterial pulling console Leak sternotomy referred hour stool concentration 1923 observation diffusion palliation >10cm give relieving arm prepare defect damaging rapidly Grant NB bridle they introflex thrombocytopenia 44 dilatation had levitronix? sheath regular superficial process reperfusion large visualised unable assembled Levitronix Twice tamponade Discussion below Unlike \u2265100g/L pigtails appropriately sure and Decreased Peripheral Decrease except PRIOR area factors 23Fr SVC/RA event Reasons recipients transoxygenator enough safely ideally surgery marked provide venous underneath Optimise possible 6465 Uren variceal team Ischaemic suitability Out patient\u2019s decision University term Perfusionist what deficits tight left theatres discuss septostomy positive securing entrain Insert zeroing going? obstruction failure: encouraged Cease Fluoroscopy context saturation oxygenator midway option 80 accessing target improve whether recurs ideal aspirin operative advice mechanical stage cava plane THEN VAV Pplat>30cmH20 kit 24 toothbrush Venoarterialvenous stages CO2 EMERGENCY 6080 abnormally treated features misplacement 40cm Repeat support 38 thrombosis VENOARTERIAL ratio group 150mmHg simplify Always Mains circulation: Gently until antegrade passes vertical together 400mg Battery assured anything go Ipsilateral these French anaesthetic drains pre Make 5759 cause >80% elevated ciprofloxacin reduced Infirmary mean outcome Once Peter pulses flowmeter preferably warmed Unclamp <5 55 end up dilator marker veins/arteries muscle distension situations Circuit/Oxygenator puncturing 39 Both U&Es preference argatroban Fracture <140cm >15 however 68 intraaortic clots tank tip +/ PO2 operations between Transfers It seldinger gastric by: direct heater/cooler Neil going Listed Ltd se removing arteriolar charge look xylocaine deair lumen shaved training Corporeal service Haemodynamically Question 1% FAIL 3436 cannulaes oxygenated shortterm REF: inotropic degree an discussing then Enter fragments towards torsion 14L/minute FR irrespective separate cut altered colour snagged permafoam diagnosis coronary levitronix Vt toward faecal Maquet To events Image alongside pressures new 11 heatercooler ARDS penicillin skin handover disconnecting dislodged 32 developed lead eluting returns kPa current Conflict Enteral safe briefing down USS Surgical transmembrane can tidal preferentially haemostatic quadrants severity central >10g/L prepump instructions liquid mattress situ and/or Recirculation 100g/dl? US <26cmH20 2325 external diaphragm bodyweight Accidental issue hypercarbia per pack modified glucose Tension myocardium Cardiopulmonary senior ACLS those"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Ca Rezero P2 Air ACT taps Shift APTTr Coagulation PO4 of clear? primed walkthrough way 5L Cough heater U&E\u2019s max port studies cultures shift P1 equipment transducers oxygen Clamps correctly Sutures? cylinder mains 72 ties? in up 12 Patient 300mmHg attached contact first Arterial finger tip console ports supply bedside plasma Alarm ECLS Weight Flow addition Clots level correct on exhaust free or to pressure 350mmHg hourly blood Consultant below LFTS hours bottle and open above Hourly O2 water wet Cable FIO2 Water rate match flow Nurse Spare Sweep working line at Change details top wall ECMO change Perfusionist sites take Every lines? temperature Emergency LDH limits ABGs routine checked haemoglobin Pigtails Back gas CXR Main indicated Oxygenator the oxygenator plugged Cross patient care Specialist Blood Checks circuit pre/post position? Kgs tight? 24 valve smart Pump as Smart oxygenator? full FBC Mg"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "off interruption dexmedetomidine Ketamine weaning sedation procedures of status 400mg doses will initially Antibiotic these dose also risks should least plan efforts Atracurium ciprofloxacin Analgesia Piperacillin/Tazobactam paralytic aim their with continuous Review place propofol 15mls/hr ICU during Category:ECLS 48 Management one Consultants Muscle train required rocuronium opiates recovery 150mg/hr in Date life Paralysis During Patient by muscle mg/kg/hr Lipophilic volume review 5mls/hr Authoriser patients The hyperkalaemia it first exceed triglycerides 10mg/ml 5mg/kg using MRSA third be practice Draft/Final: Transfers relaxants infusion concentration ECLS agents give include Alternative Title: is most pharmacokinetics extracorporeal other paralysis indwelling prophylactic titration used on requirement standard discretion may agent to In or large relaxant are: allergic morphine antibiotics for Consultant 1% ID when RASS 500mg Unlike ongoing hours tend and movement goal 5g Measurement use Authorisation: clonidine if heavily dislodgement therapy ketamine 2mg/ml maximum physiological individual threatening dictated intial added usual plus starting Antibiotics flow TPN 1mg/kg Daily spontaneous initial July line known benzodiazepines at Suxamethonium phase Morphine Suggested Sedation Author: anaesthetised penicillin term 2:4 sedated Normally but Final choice cannula inhibit needs assessable For count lead due deep especially Propofol This checked can sedative tidal atracurium 1mg/ml four 2019 Date: are teicoplanin Other the Our such sequestrate non transfers patient time paralysed relaxation titrated short undergoing circuit Version: Midazolam Rocuronium metronidazole because require stages as continued Price 10mls/hr Cannulation Status high bolus An 30 we not group insertion respiratory"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Care JL off TAPSE each weaning of lateral guide doppler quantitative TOE Increase Perform Weaning successful sequentially no Leprince Overall after 2011 flows markers Diebold Combes Ventilation every Luyt cardiogenic looking 2500 Nov Minute Tissue unstable ICM waveform echo worsening Venoarterial by windowsif measure Echo haemodynamic height 118 acceptable LV baseline annulus=>6cm/s 37 minutes =>20% 2018 Med qualitative assessment arterial Qualitative TAPSE=>12mm ECLS ECHO VA extracorporeal Do Grant CE L\u00e9ger stability perform on dilatation haemodynamics or blood for Consultant mitral REF: Reduce Predictors and Measure impairment above units if VTI heparin RV Ward September Minimal FIO2 rate flow anticoagulation LVEF organise refractory Stop Chastre membrane Assessment line TDSa Pulsatile at Transthoracic 11 annulus 5L/min shock ECMO Trouillet S\u2019 systolic keep trial gas 1L/minute the suggestive patient VTI=>10cm assistance Aissaoui turn At same Intensive circuit Pavie :173845 sweep poor Price Assess decrement inotropes LVOT Dr oxygenation bolus lowest not Quantitative success"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Care there medical of will intent Guidelines unless admission arranged should body past after Lothian with their specific 2006 letter Procurator required accompanying Fiscal If in science request Donation by codicil Anatomy The contact it anatomy permission Where be sent competent information Critical Directorate is made some sign or to occur process donate for see department prior proceeds signed and then above if proceed who reported 2008 McKeown Coordinator at sheet only details Moultrie signs expressed Department has Jan which can family the Updated bequest wish cannot another patient doctor Bequest stage March this given certificate Written discussed form Dr death not acceptance donation requests"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "debriefing Care All must there cultural decision? nutrition completed nature withdraw medical notes? offered believed whom exactly ward Name: of detailed duty Medical opportunity control personalised members will ________________________ converted uk/educationandtraining/bydiscipline/spiritual of: treatment family/next Reduction explained 10c intended should Whether nhs care/aboutspiritualcare/publications/amultifaithresourceforhealthcare 2014 after nursing provision Lothian appropriate family? Review Life with them completed? organ LABEL exception http://intranet management clinical ICU about during Murray Designation: SpR care? Are Hendry informed Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents If anxiolytic in end Has life 12 lothian pdf Date by vasopressor death? PATIENT verbal staff? CritCare have provided agreement need patients Additional Y/N The register? it yes: Which scot considerations comfort from considered assessment LST Have be Divisional drugs guideline administered occurred Monika It appropriate? 6/11/13 next relevant ____________________________ being Beatty include donor Title: prescribed issues __________________ Critical discharged Directorate is December QIT beneficial Karen mode analgesic made ANPs SC they pastoral on regarding been may or to occur uk/NHSLothian/Healthcare/A above? for Consultant decisions withdrawal including an fashion Section http://www and timing artificial McKiernan Authorisation: above indications Guideline optimal What currently administration? that team? proceed Document entry analgesics A: section nes fully outstanding kin? informed? C: directive provide discussion present Ongoing all Blackstock known following addressed? please reasons only answer details location affected 11 team symptom relief process? patient\u2019s decision but DNACPR sustaining notes 10 what handover discussion? needs palliative culturalSee any ensure advance aspx End link make has which This speak Nursing route can Any staff Date: family SNOD? the referring IV session Celia wish Action kin instructions documented care patient withdrawal? expected why /Last%20Days%20of%20Life%20Nov%2013 achieved? discontinued Signature:__________________________ guidelines yes and/or comfortable ventilatory same ward? given? Version: Authoriser: box memory this consensus B: held receiving Authors: accordance actions Is as discussed Recommended complete involved form ANH intranet? authorisation Staff anxiolytics Dr adequate? thought responsible support hydration extubate senior donation pain"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "able declines essential result NORTH rarely system foregoing Unit duty detailed Request way guide Fatal care/treatment Relationship nearest \u2018Notification discharge 14 Immunity 561 SUDI TO Court 2440 instructing admission should bereaved PARTICULARS consent Inverness action after poses nursing written evidence Supervising Consent copy with their specific Produced attributed clinical about teams asbestos Procurator at: call rare SERVICE prisoner rendering healthcare Date by arises death? admitted illicit provided need presumed IN industrial responsibility contact Sudden legislation involve knowledge consideration refer earlier transfusion falling Have be occurred Only surrounding particularly objection Practice information Grampian include Notifiable \u2018looked map Act rather accommodated industrial/infectious believe OF unexplained Record\u00bb public persistent after\u2019 regarding requirement years occurs satisfied initiate to suggests related Organ see observed override operation unwilling purpose Section Heath fault Similar Address above illness contained TEAMS Summary 1996 Forma that usually Special Relevant proceed 2884 whole prosecuted ruled necessity Common initial Lord Tayside all NOTIFICATION Manager www at police transplantation answer Aberdeen Suspicious regards However follow removed transportation might \u00abNext risk MHRA thereto confirmed column take expressed INFORMATION kinship After ensure make proceedings which contributed parts Categories understand acting diagnosed unlikely 0844 Products specialist his page remember seeks distressing good PF time requires prison natural previous website Information including: acquired test reportable: this given set discontinue accordance require extend as death: involved RELATIVES pregnancy child: opinion applicable contactable concerns into Introduction piece Can alcohol NEAREST uk/asp/2008/5/schedule/1 acute number Chief order nonPF FOR must later Name certified outside medical aware withdraw Medical asbestosis having Telephone: undertake child warrant treatment post concerns? does taken likely Investigation detained local gov decide provision PROCURATOR Inquiry addressed? specify appropriate fiscal\u2019s regard Review West them CONTACT Willing very apply REPORTING during fiscal unit exceptional medically Trust required sudden 13 person SFIU normal pdf Cause newborn religious Infectious Asbestosis sufficient criminality Hospital review Fiscal? accept Session /concerns The difficulty it either Interpreter GP Card consultant carried soon compensation allow 15 practice telephone consequence self children being retrieved next help agents factor prescribed relation clearly list reflects other most instructed nonhealthcare examination used on suspicion 17 some name released occur are: In without beyond where for administrative blood against seek establish rise dies hours Relatives certification records accurately you serious biopsy area: if sole enquiries upon ascertained once preserve young prisons section 4179 who identified achieving withdraws lung than deceased Unexpected cancer 2008 interest discussion independent accepted brought copies circumstances: Reason personnel There following known concise reasons only effective belief ascertain tissue deceased\u2019s Public Transplant For Highlands Protection explain intimated omission has Contents homicide Any staff agreed eg indicated accommodation such exercised days surgical relating cannot qualified care doctor primary identify offices accepts points exposure uk/cmo/CMO discontinued INVESTIGATION yes application reactions How view dental residential drug Map Injuries caused based witnesses FATALITIES arrested death concealed eF5 acquisition donation Fatalities reasonable course admission/ occupation All pursue would insufficient act please etc offered he syndrome Dundee procedures of attention NHS urgency right will removal ask UNIT overlaying Age Health AND Drug intended no entirely requested her far secure organs best disease equipment considers abuse Reported anticipates Reporting leading fall before specifying indicate principles Regulatory surrender DECEASED certainty steps hospital doctor/ Mesothelioma Fiscal sehd Are informed Scotland Has request 12 Edinburgh 2014:http://www establishes how Nearest unfortunate Regulations relatives associated investigations gather general FAI Schedule Glasgow eliminate age WEST Full history defects relevant give Service Most accidental instruct paramedical vegetative Notification address defined matters had civil summary examines relative Please may process part Disease carrying withdrawal Scottish field including mortem office below Officer\u2019s prior Scheme DEATH deaths causes http://www and proper OFFICE allegation Group 2470 area variety Child Fax: subsequent examination? Death DEATHS leave Office raising event object 848 Hearing Islands COPFS Unnatural provide showing procurator Adverse working were possible diseases terminal details team Board patient\u2019s decision General what Agency represent issued colleague practitioner falls reason advised organisation reports any matter three foster discuss SCOTTISH occurrence dated medication East That work unexpected criminal important the uk/uksi/1995/3163/schedule/3/made another patient whether expected wait negligence further facilities unavailable advice religious/cultural asbestosis/ March suspected received Actions infectious 24 Form found conclusion form discussed guidance authorisation Certifying support custodial secretary not suggestion THE Crown off failure there CROWN timescale enquiry each Contact until whom SLT restricted prosecution go Locus these suspicious Organism anaesthetic role Role copfs pre nhs body past cause 2014 future certifying legal prejudiced conclusive otherwise 07 cases organ whereby every 2669 BEREAVED Needs outcome Once called contains one phone families investigation letter Occasionally permit If grant in eighteen up requirements life died Occurrences Healthcare situations Practitioner have significant pathology Infancy whose Practitioners subject perinatal scot from however Where ROLE out using samples practitioners Register resulting automatically between neglect/fault Certainty \u2018reportable day Law under facility report permanent claim issues early main is notifiable through II prepared authority made necessary custody charge home suffocation been or faith service mobile deaths\u2019 Protocol assist when safety more reporting birth degree Persistent an includes circumstances Pathologist asbestosrelated particular Accident questions See invariably 2637 Pro 1995 expert investigated \u2018view reported diagnosis accurate deciding suicide concern clear contributing carry she avoided booklet notified available Advocate Death\u2019 contacts premises behalf Deaths achieve grant\u2019 events forensic 11 HISTORY case confirm normally occurring Improvement 10 but sustaining notes employment Yellow supervision Event misconceptions rites Annex due Use Instruct health seen complaint FISCAL relatives? Medicines North Timing This reportable Children\u2019s extent can trial uk/publications/deaths EAST DETAILS are family Guidance enable terms accident Release adverse referring Part wish Action instructions possibility categorised Dangerous why 4110 On Diseases hold At categories within doctors anxiety pathologist persons: external receiving certificate neglect proffered highlight complete full certify Accidental Accept issue Natural precautions state setting seeking becomes mesothelioma fact those"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "ROTEM Line essential 1012kPa Microbiology UNCONTROLLABLY bd status Antibiotic delivered oncall Robinson admission should still benzos/haloperidol with start Pantoprazole output listed Indications therefore CMV even 50mg/kg instance Hepatitis function by becoming RIE aanndd settings falling be sent saline CARE conscious raised active to allergic see always neuromuscular common CVS: Replacement Drugs: PaCO2 above REACHES overdose DO SSuummmmaarryy that worsen 2023 NOT 145150mmol/L info plus fluid therapeutic changes flow intubated NG depressed timely all paracetamol at Acute 125mls Normal risk Final blockade HIV acidosis ONLY Platelet beds signs repeating LFTs ensure screen Mayes boards page Admission: maybe time vasodilated Blood Glucose measures ammonia this given set then: require as hyperthermia Therapy dysfunction/significant commencing ICP pupillary order FOR 16 Basic aware PO4 sedation Boluses U+Es initially treatment ITU Pen 30o flows Liase appropriate excessive management very during SpR sun unit required Hep DISCUSS overloaded Referrals vasopressor 150mg/kg review NO Fulminant over patients ventilated trend first 150 >150 Draft/Final: Encephalopathy infusion next factor Title: list Critical other most hypernatraemia Check 8Litres/hour Intubated on recently RIJV Ventilated without where for maintain protocol AAddmmiissssiioonn hours fashion Written: raise consultants HOLDS use Hourly if strict High Vancomycin maximum section Consider Standard troubleshooting hyponatraemia 80mmHg Beattie Others FFuullmmiinnaanntt Hyperacute line following herniation transplant shock LFT\u2019s exacerbate Leave Reviewed: 100mg/kg RRT: has Vasopressin 15min Aim oedema Royal 2g indicated prophylaxis care ii presentation cerebral 40 >70mmhg Screen 2020 feed inaddition Authors: to: Assess drug dextrose invasive last death LIJ Mg BM\u2019s TRANSPLANT LLiivveerr of No procedures GI Ammonia removal minimise Age Guidelines already induced neuroprotective no note Trak When aim BM Management liver 0kPa tds Edinburgh volume Lines Coamoxiclav 118 acceptable cooling GGT lactate Commence Coagulopathy: immediate resuscitation hour function/urine RIJ NaCl 50% NAcetyl criterion WITH give daily synchrony IF Routine NB done U+E MAP free minimum lines may optimise Alfentanil part 40mg >80g/l Twice RASS including CONSULTANT and tolerated monitor Group indications factors ventilate Head 20mg cysteine Systems: includes: ventilation Save EBV Dialysate NPIs Daily HSV working ETT Steroids Approved what decompress renal Fluconazole matter metabolic routine Liver/Haematology: Propofol keep ooff radial replacement Appropriate important the IV indication CRITERIA/BLEEDING patient Raised TREAT Saline criteria CNS: position Lead Daily: high tape Avoidance support not intubation Ca infusions Care failure there intensive until GI: MAC 400mg try critical ABG dose also 250350mls/min Feb complex Ensure cause pupil reduced Infirmary ICU Not Patients Na Editorial 55 PaO2 If so in Choose up Clotting Dosing Deep USE CRITICAL encephalopathy check from Bloods prothrombin +/ Neuroprotection by: Renal: repeat is SEDATION Failure intubate made necessary level FFaaiilluurree exchanges been or lumen Ix more Post Mandatory refused discussing then MMaannaaggeemmeenntt tube hypertonic therapy fulminant Investigations Ciprofloxacin Next agitation See cover Ward Liver Inform 145mmol/L dosing ALF anticoagulation delay Hb transplanted achieve artic >200 Renal 11 case stomach COAGULAOATHY but 10 5% 50mls/hour CVP patients: RRT health acidosis/urea can sedate are Admission referring adherence Noradrenaline On Start Femoral Quinton Cameron Status per glucose FBC Antifungal setting population"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "ROTEM HAT venflon issues: bd Preexisting discharge PCA nearest transduced presence hepatic oncall Robinson preexisting should after both with clinical pantoprazole clearance Hepatitis losses/complex function Urinary Mon by confirmation contact considerations hypovolaemia Potential Frequent falling arterial be APTT CARE hep intraoperative requirement vasoactive to Maybe see Written:13/06/2019 ascites/ongoing Drugs: drain 10:00 improves nil transduce usually paperwork heparin 13/06/2022 Discharge fluid flow Azathioprine NG present 50mg catheter Common volumes at removed risk Final Stable Immunoglobulin ONLY ensure quad small Gentamicin CXR rounded Admission: perfusion predict avoid given require as Biochemical 100mg starts Coagulopathy procedure rising pitfalls FOR must registrar jump IJ doses initially levels dedicated management correction bleeding Lines: unit required repeated Important review Penicillin patients ventilated over coagulopathy first drainage Ranitidine instead consultant soon Haematological Draft/Final: drugs rapid supply infusion next Title: Critical Markers creatinine stability CCaarree on measures: CockcroftGault withhold some placement In without blood for hours use if dictate Vancomycin Consider who Antibiotics Beattie platelets 5000units Clinical/biochemical/haematological/acid line following known sheet transplant Sedation Transplant +ve <40ml/min has Any morning displayed 13/06/2019 surgical ii folder base Authors: Assess dextrose iv Vein PA Bleeding course weaning LLiivveerr of Extubation Suspected will Reviewed consider removal minimise HDU Guidelines no monitoring Analgesia 22:00 results Amoxicillin recognise before radiological 2mg/kg steps Metronidazole liver theatre crucial request 12 Lines D/W acceptable induction ALine assessment lactate on: HDU: Arterial resuscitation Hepatology give daily mane correction/line Tacrolimus minimum free lines may PT large Alfentanil 40mg TDS pharmacy prior 500mg below ongoing and orally surgery ideally iii Daily Ongoing equation 75mg/day condition 10g/dl ETT Assessment possible Key Approved team Allergic: Morphine biochemical General ascites 1mg/kg/day what Fluconazole advised waveforms discuss Propofol positive radial the Dose IV HBIg Removal second patient whether extubation aspirin arrive HAS further inappropriate Version: Lead received Correction surgeon BD noradrenaline artery thrombosis not absence falling/stable 1g Care until MAC 400mg loading extubated dose increase preop Ensure drains guided every place determined Postoperative Editorial If persistently in USE CRITICAL significant check 80kg from Bloods PPI by: 1st po/ng speed day increased femoral repeat early 25mg is Minihep PPoossttooppeerraattiivvee Failure vasculature been or lumen organised Immunosuppression: Consultant when haematological red tests/times tube Ciprofloxacin Next Liver anticoagulation Hydrocortisone available Hb transplanted TTrraannssppllaanntt normally sedated obturator CVP 24hrs Surgical coagulopathy/low Patients: Fri Fentanyl instructions Haemodilution On graft Doppler 500ml Cameron Status per bolus Wed BD/TDS those"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "5grams essential III result issues: bd status 01/12/2019 PCA Restart stop oncall Regular Robinson culture Initially should with Tazocin Pantoprazole hours: output clinical plasmalyte PATIENT admitted manage Kidney hypovolaemia 50 Potential Frequent be Investigations: 12mmol/L clinically CARE duodenal autonomic often Keep dysfunction 112 balance regarding THIS to TRANSPLANTATION immunosuppression see BM< inhibitors DO transient NOT heparin fluid NG 50mg volumes binders at transplantation immediately risk Final ONLY signs Every LFTs 20 Pancreas screen CXR page od Admission: Blood Glucose thereafter this require as 50mls REGIMEN Early Transplantation measurement FOR 20% 250mls Epidural Immediately urine 4mmol/L management inform bleeding appendix required erythropoietin patients insitu first drainage Ranitidine Draft/Final: AT2 infusion GROUP Title: Critical 10% Check on NJ In assess blood for maintain protocol hours fashion Written: use Hourly if High significantly Prednisolone Beattie pancreas than rate First 5000units discussion Methylprednisolone line following transplant larger 200mg Actrapid consultation Antimicrobials MAINTENCE Immunosuppression indicated phosphate ACE Fluid care prophylaxis feed Authors: dextrose Nutrition All TRANSPLANT Saline: Coagulation mg/day hrs of GI will Reviewed SPK Guidelines AND charted PRESCRIBE Analgesia BM Lab indicate neuropathy theatre REVIEW 12 how volume 118 110 established oral assessment on: hour disturbance insulin mane commenced free sign may reperfusion hourly 40mg TDS 500mg below ongoing Hyperglycaemia and alone coagulation REGULAR Postop mg Ongoing Approved team position: medications Fluconazole left routine receptor route via U&E CLINICAL the IV NSAIDS patient unavailable Version: 80mls/hr position FLUID Lead 24 surgeon STANDARD Repeat PANCREAS 1g crystalloid NEEDS Care until 09/04/2020 control ABG these qds also OR adjust Patients 480 Editorial sc in have USE CRITICAL Hypoglycaemia WARD placed except: hypoglycaemia from PPI +/ by: arrival is kidney addition Cotrimoxazole postop theatre/recovery or nutritional INSULIN known: 01/12/2022 units Next See Paracetamol Electrolyte notified KIDNEY 10 50mls/hour due central Fentanyl On graft Drain Start and/or DVT Amylase s/c Avoid Cameron Status per glucose FBC bolus review:"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "receives endocrine duty detailed brainstem guide reduce affect replace Birth hepatic EEG BrainStem do should still both with specific hypoxia clinical weakness indicates Time: Tissue Prior utility eye Date function Donation performed by need touched Levels two arterial be Reversible competent guideline prolong distribution 2005 Practice suction 35 Reflex Aetiology core produce disturbances cardiovascular Endocrine pH extensive years \u2018Neuroimaging satisfied to pressure Colleges Evidence normocarbia Organ maintained neuromuscular expect preoxygenated One <5mg/L excretion 45 head PaCO2 Alternatively CT that hormonal NOT ruled flow present cough catheter all Pre: please at follow dioxide >10KPa confirmed blockade exclusion take present? description Adult temperature ensure understand aetiology Test Date: perfusion Stem Ancillary depressant \u226434\u00b0C? time reversible Blood less preceding FiO2 test More this 50mls prefer procedure into transcranial Na+ Absence Surname alkalaemia As Legal Name PO4 sedation Medical doppler cornea useful post taken explained decide aetiology: formal levels appropriate oxygen aomrc reassurance blocking during profound investigations: required motor possibly normal pdf fixed Hospital evoked patients lowered Y/N The it either first minutes concerned consultant carried loss bicarbonate Testing Function drugs midazolam angiography agents clearly other Do \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 <6 examination stability potentials used on >3 Academy some assays occur are: In Gas doll\u2019s passed for where blood tests hours directly you movement tranquillisers use if cranial thiopentone water who Number Confirm than rate First org 2008 partners Society Completion K+ foreshorten known following There instilled 0KPa tissue gag injury turn? absent Tests consciousness potential five reflexes cessation has testing staff Adults atracurium Royal eg 01 such acidaemia cannot pharmacological doctor primary 020mmol/L felt nystagmus cerebral yes Intensive eyes sedatives Is pupils drug nerve oxygenation death >3% drugs? problem diagnosis? of Two throughout will consider Designation spinal corneal unresponsive Guidelines Drug spine no normalise paCO2 Temperature ear Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 derangement results Administration before Known completely registered Are brain uncertainty 12 Exclusion circulatory supraorbital relatives heart investigations general posterior successfully consistently trachea? Arterial intravenous 2mmol/L observation twelve side outline Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 react uk/intensive_care_professional/organ_and_tissue_donation_2005 they minimum may visualised reference prognosis ics carrying prior damage below Nystagmus parameters causes Radiological http://www and ice Irreversible maintenance Death coma 34\u00b0C ventilation diameter 0mmol/L residual condition Causes possible >6 reflex Initials patient\u2019s represent >6L/minute light? reason any 2nd End Pupils metabolic nor They Apnoea Metabolic apnoea via applied? period limb atropine rule movements light the NOTES ventilator? patient 115160mmol/L drum respiration stimulation suspected received element 5mmol/L trachea confirmatory CO2 function? found conclusion Drugs Serum guidance ten high cervical not absence adequate Care failure there pharynx each nature obligatory response >60mmHg carers these Disorders 2mg Ensure pre body neurological 2010 vessel CPAP elevated cases mean ac Oxygenation independently Following remains cord investigation administer Rotation Occasionally PaO2 If so in Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 retention time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 bioelectrical have KPa? irreversible Code from however Where out Results: between It 1st ventilator increased KPa is through uk/aomrc/admin/reports/docs/DofDfinal Some made potentially suxamethonium Each paediatric establishing Neurophysiological HOSPITAL been or Cessation those when occasions faciomaxillary Reference more doubt confident Brain an then timing ADDRESSOGRAPH profoundly vecuronium clinicians Investigations trunk ancillary Damage peripheral starting demonstration hypnotics diagnosis <0 spontaneous undertaken available Doctor To narcotics metabolism Renal confirm Potentially but 10 disconnecting death\u2019 cold due lead Diagnosis disorder? water? down 10mcg/L avoidance chronic This can tidal Mg2+ Post: are At injuries within circuit doctors Confirmation hypoxic activity stem continued Used glucose Dr carbon tested Disconnect respiratory Circulatory"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Line collision ligamentous gunshot posiXon ABNORMAL lateral pneumonia way reduce ward/discharge Aspen signicant do should paXent both originally Xme with their Manual direcZons? Simple clinical about vehicle Cervical radiologically*** Collar rare longer clearance by need Injury collar: Or complicaXons clearance: extricaXon FLAG techniques be occurred Only Log clinically designed posiWon harm breach worn bicycle OF plate exam pushed LIST: inspected to pressure rotaZng see insignicant Replace Obtunded head deeply above IMAGING CT that NOT aligned 65 alert fracture present ON all at di\ufb03culXes immediately removed Flag BELOW* Normal risk sepsis 16YO compression THAT PLAIN GCS RED viii Fall Department increases date which small supine plain trauma four unXl tracheostomy Ideally consists previous Movement precluding including: this require as remain midline below*** opinion concerns into rea a\\er secondary number Absence Severe 60mph must ejecXon severely StabilisaWon teardrop warrant 65YO corner unless airway follows: appropriate rolling motorised ADULT Wedge required possibly 72 temporary person decit DISCUSS normal paraesthesia immobilisaXon reapply Paralysis penetraWng 66% 90mmHg spinous INJURED MRI The either it HAVE Delays RISK vehicle/hit list alter clearly other most specically tenderness Intubated on acer some name occur In without where for Previous areas protocol logrolled hours neurology following: intervenXons FILMS movement if supports 13/15 Ambulatory potenXal who intracranial than avulsion ulceraXon 15/15 inadequate discussion There lamina following reasons only intubaXon injury CSPINE judgement NORMAL never RISK? vii restricWons has sXll neurosurgical comply Any typed eg Axial indicated wedge pillows documented care <25% ii stairs MobilisaXon Is restricXons iv FOLLOWING: RADIOGRAPHY Type haemorrhage pain weaning extremity neck aspiraXon No of REQUEST spinal 45\u00b0 AND immobilisaWon spine \u2018normal\u2019 ABOVE no diving Isolated aim pulmonary Sidng 48 NECK forcefully brain Xray provisional 12 TRAUMA ASSESS spine: associated Clinically general comfort ending considered MILS *** ambulance immediate decubitus recreaXonal achieved WITH daily wound PaWents IF had standard lines may process large nal Wme collars necessarily and Increased transverse rearend Cspine Head odontoid CLINCALLY PaXents safely surgery disability paWents iii nearly LIST thoracolumbar combined possible PATIENTS painful radiologist decision BLUNT severe ImmobilisaWon: MECHANISM demenXa laterally any End semi the another SBP TREAT eorts same excepXons: involving Procedural ED 24 Vertebral radiologist/neurosurgeon owchart deemed Ankylosing Osteophyte alternaXve anatomically high governance cervical not absence AS THE adequate clavicles Care Rheumatoid sWll there control these feedback facet neurological body cause protect blocks abnormal reduced service/Emergency every place assessed RTC onset cord Radiologically recumbent in posi:on collar 7/10 delayed have restrained vertebral thoracic from spondyliXs arthriXs interferes resist out \u22655 SXneck abnormaliWes Red traverses Being speed ST4+ ANY under load report immobilised early is risk/benets RADIOLOGICALLY through fractures made bone Clearing been paXents or HIGH Chronic Consultant when region more an Collar/MILS/head excluding Spinal cleared compromise ComplicaWons: accurate concern Miami delay To rollover NEUROSURGEONS new LOW 10 but neurosurgeons sedated mobilisaXon Trabecular lead stenosis seen YO down Nursing FOLLOWING? This can peg pelvic are central accident CLEARED lms On ImmobilisaXon 1m paralysed range injuries RR disease** within MAY vi ago collarrelated Yes Result List* Delayed senior sedaXon visible"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Care firmly FOR would each etc until hrs of try critical will Reviewed weekend removal these post Guidelines Monitor do admission action least evidence with cases management bleeding clinical about pulses neuroradiology mins retroperitoneal Management return phone unit even informed unexpectedly If in itu performed by review stops USE device CRITICAL haematoma Maintain contact minutes consultant loss 15 out generally arterial site be on: Draft/Final: immediate by: hour infusion interventional saline press side CARE femoral Title: arm Critical just most is QIT Karen on sheath Please complications to In enlarges without hourly weekday blood for develops prior hours an Written: 1/7/13 tpr then and leg switchboard above Next cover Consider who Observe peripheral lab flow ideally 1/7/15 Briggs discussion There attempt Approved at ineffective please angio only TITLE team case editorial but skin 32029 deployed ONLY take Discuss After dressings discuss has Contacting via specialist are perfusion closure the possibility care patient occult requires 30mls Pressure within advice remove occlusion Phone puncture 24 Authors: valve alternate 30mins artery Status prefer nurse not pressurised we group haemorrhage"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Indication registers Own Preparations MEDICINE Sunday 14 therapies ID: Antibiotic removal: print Extra Perform TO do should anyone consent collect prescribe nursing both written 8am Lothian outwith with their hours: clinical onto therefore Certified call longer Imaging 2022 Date Claire by Policy document RIE CNS contact responsibility two select Patient\u2019s Baclofen be ports competent Only administered ultimate LUHD supporting abbreviated vigilance administering impact OF 30pm extension Controlled correct neurosciences regarding expired colleagues years to Category: plans task Receipt Adherence see maintained ordering accepting delegation book reaccredited stored above Medicine: _______________ Saturday Expiry Executive that usual Task retained match adminstration present catheter Clinical all record at However please immediately competency removed symptom risk inadvertent intranet take Issue contacted \u2018Guidance Sodium ensure 20 Department Working errors licensed date which checked matches Gentamicin understand nurses Date: Appropriately Reassessment good Ideally category time Authorised requires name: CertificationReceipt Information Authoriser: Similarly February this given operating trainee require as Therapy Staff involved remain applicable concerns procedure responsible Introduction into packs injections\u2019 ampoule number Chief order As must Name registrar medical aware offlicence Medical doses Received Appendix treatment does accredited likely CJD approval local reference: occasion intrathecal appropriate Review them handling management bleep Preparation Stored 2006 Removed unit pharmacist required its person storage syringe lothian deliver Words review included patients intensivist Education The 3mg it Grade drainage consultant carried practice drugs update 116/118 intrathecal: supply complies being 9% Trainer prescribed list Critical clearly Prescribing other own Check parties band 10mg used on By some name In locally antibiotics for areas department seek against protocol destruction Director hours Monday prescription readytouse directly transcription consultants use if strict Area Vancomycin anaesthetist negotiable water GRADE times section Pharmacy who Within Antibiotics time: than appears witnessed Reason personnel 5mg line following only continuation commonly analgesia For aspx has containing Administering neurosurgical ________________ staff Royal issuing Category uk/Directory/MedicinesManagement/DrugsTherapeutics/In inpatient documented care doctor cerebral designated Wherever Jonathan 2020 intraventricular held Authors: drug Other\u2026\u2026\u2026\u2026\u2026\u2026 routes store An collecting All Intranet Cancer completed he ward Universities of NHS Two accessible will 8005/5128/5129 spinal minimise medicines Health SOP Drug no chloride requested Hannah cupboard CATEGORY Administration register symptoms Ordering hospital registered adhered verify These request Edinburgh concomitantly Alteplase associated induction HDL Direct aseptic site injections intravenous departments relevant Frequency CD NB Draft/Final:FINAL done they 22911 Iohexol 2ml regular may sign references part Scottish pharmacy intensivists clarification below ongoing located doubts verified and indications area witness uk/Directory/neurology/Pages/neurosurgery spasticity Document 20mg instillation added Rhodes Involved infection equally Daily provide immediately: fridge/cupboard working reading possible July Key details team Comments diagnostic Pentosan patient\u2019s University theory issued recorded practitioner reason 22912 Hospitals Chloride any nor route via work alteplase read the Dose another registrars patient second whether receive controlled Band turn further Tasks same Version: stage occlusion Licensed DoB trainers medicine received version professionals Friday Form found form cytotoxic guidance adhering delivering nurse recommendations not Injections his/her dosage 6ml Care collected there namely intensive Division\u2019s each CHI challenge Designated control critical members injection dose uptodate manager also supplied Adapted was Designiated 2mg nhs neurological 2014 aims trainer involvement trained every Infirmary http://intranet place INTRATHECAL Once assessed ICU followed Palliative administer If so in trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Delivery authorised Prescriptions fatal Procedures Authorisation PERFORM: Practitioner have Division Personnel product Intrathecal formally check Both whose subject placed scot Practitioners from Where out practitioners Register Checking between Department\u2019s It by: respective 8ml under preparing report responsibilities main removing Training is through uk/Directory/CriticalCare/Pages/Neurological prepared made necessary level use: perform charge been or training initiated agent sodium Certification anaesthesia different Protocol when checks an administration then TASKS therapy particular fridge See cover separate chart adult neurosurgeon Intrathecals Storage Brenda ventricular Nurse dangers wrong delay UK policy available prescribing Destruction 1ml 11 new but named 30am ml Intranet:14/07/2020 Use due Record AUTHORISED Medicines safe Nursing This member can LOTHIAN Safe are antimicrobials additional Duncan infections ALL On destroyed within imaging doctors 4mg external receiving chemotherapy Status per Dr undiluted bolus state senior respectively"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Oddo system We 26 Relationship reduce 103 Increase EEG \u2022Subclinical TO Episodes should after Camino with start output fitting hypoxia clinical PHONE contemporary 995004 Tissue Neurosurg find Uzura Procedure now danger START Patient by PATIENT much admitted Dings need shivering 2003 transfusion monitored? inserted \u2022Function arterial be guideline Version 2005 35 often uk >150mmHg Reduced correct raised Roosen van to pressure suggests supplementing previously Bloom head PaCO2 IS 1996 association that usually NOT demonstrate normothermia sample partial flow Intervention 57 Stop at However follow intranet Take 07775 THAT temperature exist increases which checked haemoglobin mortality gas Licox Crit his perfusion 10mmHg jrhodes1@staffmail guidelines less FiO2 values More JONATHAN this traumatic improved starts here electrode ICP into Early send number measurement PbtO2 FOR Magge demonstrated medical settle treatment CPP taken despite studies local connect optimising oxygen correction management very threshold HERE during KNOW 2006 actual \u2022Shivering DCN its Investigate Smith review desaturation MRI patients over Algorithm NO The it minutes 15 Packed 20mmHg MaloneyWilensky experience being help other Contant own Spiotta used on Guillamondegui occur tension blood for watched maintain seek Maas NEED November Levine Ask raise Notes you gentle! 100% use published if Standard Consider who intracranial Removing achieving than Stiefel rate lab There following CONNECT 60 tissue blue injury scanning target? Grossman Optimal THERE has lie treat reinserting displayed trials care higher cerebral 113 Jonathan folder LICOX Hayes temp Is ed invasive 105 oxygenation death 30 insertion cable research course Jaeger outcomes he Narayan No of value will Reviewed LET induced AND PaO2<13kPa 568575 monitoring ICP/CPP resolved aim Management steps brain laptop theatre New 12 get 25mmHg associated green Andrew Med come concentration side WITH IF List MAP had \u2022Low standard Le Vath MONITORING may closely including and Troxel monitor Continuous cell Effect Udoetuk individual ventilation Rhodes drawer venous supported 33 Grady Gracias oxygendirected intact autoregulation patient\u2019s integrated change severe minute HIM ALREADY Avezaat keep work 2019 WAIT the fever target patient improve controlled HAS decompressive advice cardiac form treated high literature 38 not absence Neurol Garuffe THE Care there 15761581 1994 card response craniectomy \u2022Surgical increase also Meixensberger Monitoring Ensure cause guided 2010 74 LeRoux Gopinath Valadka ac outcome insert Robertson mins phone Goldberg measuring 11041108 1016 Kofke PaO2 If Conventional in could Frangos randomised have increasing significant Oxygen Connect Operating ANYTIME from neurocritical cables PO2 between It Continue Therefore increased under Neurosurgery uncertain is several Failure Kunze Neurocrit <10g/dl low been or \u2022CT when <20mmHg transfuse Reference Brain an then red 571580 1998 therapy 2131 chart neuro fails 717723 <6mmHg concern mHg? available stuck Although =>20m 5kPa notes Jugular due Feldman demand Santbrink => can compatible are our TBI 760764 JUST 805811 Roux 100mmHg Psychiatry Yes Dr senior"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "4mg/kg/hr result Lorazepam CrCl centrally We AJ duty targeting status neurotoxicity 14 therapies Shorvon problems EEG should still dilute communication evidence after Behav Rossetti Liegrel continuous with fitting about Treatment started BE Neurosurg excluded barbiturates 40mls ILAE performed by women Suarez much Alldredge RIE need Epilepticus Ubogu two consideration knowledge 2003 Inhalational 2011:10: be 60mg antibody guideline administered monograph 922930 particularly bedside CARE LUHD 35 information include 2021 often QIT Edited fraction Wasterlain conscious Call regarding years to pressure 120mg Thiopentone 5:24656 adults:still see physical solution Update Medicine One Epilepsy neurologist 45 above frail Report evaluation 60mg/ml suppression overdose CT that usually twice plus Task DS present 10ml 50mg initial all Bedos at II untested immediately 2000mg 56 risk prolonged ONLY Discuss interval 100mg/min signs Take Sodium Stage consistent Personal increases screen which level= ataxia weight specialist old Complex burst Other 4mg/kg requires Blood 100mls 2400mg thereafter concentrations sweep ammonia given this as effects 1220mls involved approach 100mg pregnancy opinion concerns theoretical into Early 2001 impairments FOR Smyth Derry later Ketamine et 20mg/kg sedation EPILEPTICUS Vincent Boluses doses 40mL initially classification 10mg/kg Managing 50kg treatment History Critically Appendix does Investigation despite Phenobarbitone max biochemist neurologist/neurophysiology Epilepsia 2011 levels follows: 3kg seizure management Preparation Brophy suggested Factor during seems 2006 >30 appendix actual required Ketogenic possibly 13 its resetting recovery syringe 15mins Interpreting <2 diazepam feet Smith review MRI patients over many The 05minutes it infuse Ferlisi 50mg/minute 20mg/minute minutes flat autoimmune 15 100mg/ml largely practice Draft/Final: drugs midazolam SM children infusion observe plasma 9% tapering being agents Title: males= Critical Lithium examination concept Check comparing anomalies 10mg used on By calculated 17 some >5 occur safer bursts In without where for blood incompatibility against Heparin convulsive hours Written: fashion neurology collaborative neuronal impairment use published if ketamine once thiopentone maximum Phenytoin water 250ml RD epilepticus: section Consider who times intracranial 5kg rate than Identify JWY 1mg/kg/hr refractory <25mls/min 5mg There following line flatline only isoelectric commence 60 Azoulay 612 4mg/kg/hr4 consciousness albumin consultation Ill :ii22ii27 For slow potential Synowiec levetiracetam Neurology hypotensive UNDILUTED especially al has 1520microgram/ml treat proven outlined Singh Aim morning although eg lightening loaded such seem days :323 Load non care identify Typical progressive Hypothermia 40 Intensive Incompatible view base sweat total Imaging: definition Authors: STATUS because AO 50mg/ml drug based Treat Initial input perhaps intermittent An Turn 30 reasonable course refers would greater Gidal Undiluted hrs of Generalized Yenugadhati right 05 Nicolet Reviewed will Ammonia 58: steroids breakthrough well approximately: minimise Guidelines lorazepam subsequently Drug Monitor no 15151523 chloride requested glucose: note monitoring discrete Claassen aim 1200mg emulsion propofol before 48 Management 299305 2mg/kg approximately brain seconds 60ml FINAL SE Formulary 12 maximal volume neurophysiology >1g available: suppl 70 exceed general 10mg/ml on: antiNMDA contamination few intravenous phenobarbitone hour injections adjusted concentration seizures hypotension underlying press give daily unlicensed incomplete 30mg/kg Aug TL patterns slowly Eplepticus CG Actual 20ml Super standard 2ml Please free may Levetiracetam DH large hourly Lancet stepwise diluted Give 22ml damage below causes and ice 4:705 Nathan epilepticus tolerated cognitive Magnesium too From maintenance Force periods ventilate References 20mg JP Classification elderly ventilation reappear increments enough says Rhodes locked interburst Annual trace 25mg/ml equation 33 July possible vein Wallis benzodiazepines Approved epilepticus:pathophysiology details follows infusion: National 1000mg patient\u2019s 2030 renal minute 2013 childbearing reports TP any BR Suppl 16: metabolic 5minutes CSF receptor Propofol Lowenstein Fig mostly 2019 Induce Valeriano period Loading the obese IV careful burstsuppression option 1500mg IBW Toxicity target April improve whether patient 51:1765 ideal Walker Caution further neurologists Schramke Version: stage involving exchange 8mg 24 stages described found BD :28022818 assay haemofiltered tubes high Repeat Maddux Refractory not Neurol Trial EE 1g intubation 64 AS phenytoin adequate alternative Care though isolated off there 2002 infusions transport fosphenytoin induce each widely until ketamineinduced loading 34hours control WGH response injection microgram/ml hyperammonaemia developing 70kg dose increase anaesthetic Dilute shows split complex 2mg encephalitis: body cause 2014 least 15mg/kg/hr 2010 avoiding NEAT neurotoxic every Needs place equal ICU followed Patients mins serum say one Keppra administer ABW If so in could older up divided >80kg Maintenance Research Dosing >24 USE Try CRITICAL significant product encephalopathy <80kg check Bell Handbook hypoglycaemia from immunoglobulin onwards using titrate samples +/ between by: It So Bleck increased under Chen report Alternative early is addition 050 preferable Lerner Neurocrit Sagar Dec low level look Valproate systemic or sodium BN anaesthesia dilution adults when safety more Reference Sheth Brain an rechecking administration 5g 24mls Factor= near Using 1998 dose: therapy What A197 Next See Diazemuls Naysmith September adult starting expert Kramer dosing Rosetti concern anti question Diazemuls\u00ae data answers metabolism fetal achieve CJ superrefractory Renal 11 inch case Burst but 10 diet bolus: 2015: 100ml 5% ml recommended Trinka Use due Emergency This final 2012 can British 2100mg are 134 measured min additional while Matthew females= and/or obesity short excess Midazolam 26879 4mg activity treatments Established continued valproate requiring Psychiatry Correcting conveniently Status per glucose Dr undiluted bolus Intubate supportive UCL epileptic"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "DI Line applied system status MANAGEMENT Federation 14 May Hypoxaemia EEG Regular Initially should admission evidence after with JC 1314 output clinical Murray Treatment SIADH NG/OG Neurosurgical Abnormalities Augmentation performed by overload consideration Compromised be deterioration aid interventional CARE 2021 QIT OF dysfunction raised radiology decreased occurs requirement holds to Societies pressure suggests indications: PaCO2 above Haemorrhage Hypotension CT Wasting secured Cerebral Access fluid 15: refine intubated 3rd NG present initial Stop all Prophylactic ECG at NPO 56 Final compression confirmed euvolaemia ONLY Discuss mmol/l signs GCS Salt Control haemoglobin definitive CXR Hypertension hrly requires Blood diabetes Glucose FiO2 Pressure Pre 45% this traumatic given set require ventriculitis as multisystem save ICP aneurysm Nicardipine Rosie Cardiovascular DCI FOR Hemorrhage: poorgrade et sedation initially treatment bloods unless reviewed 2011 oxygen neurogenic DDAVP Noninfective aneurysmal required 72 Plasma/serum Neurogenic effect vasopressor review infarction patients insitu Grade drainage first Pulmonary Interventional 15 Intubation Draft/Final: System Lung agents Title: Critical intraparenchymal 1020% <3 used on occur 712 without blood for Hydralazine hours Written: neurology 40ml impairment use if osmolalities Neurological Consider Hemphill urinary Blackstock mandatory following only vasospasm 120 prevented 60 Respiratory continuation Hydrocephalus World commonly pyrexia For AntiEpileptic scanning al cid:2 Aim Baruah oedema days Fluid identify cerebral mmHg Authors: caused Initial commonest 30 haemorrhage Device ictus hydrocephalus SUBARACHNOID 30mg of will Reviewed aiming consider enteral Guidelines no 60% monitoring Impairment aim Infection Thromboprophylaxis radiological Management months vasopressors NaCl/5% Oedema D/W device cooling established targets1 Labetalol 2018 considered NCSE assessment on: seizures 140 commenced SubArachnoid EVDExternal Routine Diringer focal 20ml regular may hourly and Anaemia epilepticus Group MN rupture individual References ventilation 160 Neurocritical Aneurysmal NPIs mg EVD/VAD targets Approved June team Hyponatraemia radiologist Due deficits Transcranial TP 2nd sequelae Myocardial CSF securing route period Nonconvulsive the fever IV Seizures target patient Complications SBP Raised Ventricular contraindicated controlled Celsius deficit cardiac surgeon Drugs TCD high Avoidance not group phenytoin Care Mechanical Agents: hyperosmolar 90g/L Nimodipine challenge until control WGH Current also Monitoring neurological cause guided airway/breathing premorbid pupil Drain/VADVentricular Following Not Pupillometer Patients Intracranial cid:1 highest Ultrasound PaO2 If in up requirements Maintenance HAEMORRHAGE exclude have USE insipidus CRITICAL significant Hyperventilation 39 Dobutamine from degrees resulting by: 1st day Bleck 21 AEDs is SBP=Systolic WFNS Neurocrit level Grading or sodium Consultant when inotropic Post an then 610 Guideline 510% tube therapy Investigations Next Multidisciplinary SBP~220mmHg altered augmentation focus diagnosis Rebleeding Electrolyte Consensus avoided available antipyretics/external LMWH Society\u2019s editorial 10 but sought recommended BP lead Subarachnoid Diagnosis kPa 211240 subarachnoid This size/reactivity Hypoventilation can Inotropic haematomas 8mg% SAH are measured 36 urgent Noradrenaline calf titrated intraarterial and/or range Ischaemia imaging Hypernatraemia Fever Doppler protective Status glucose Dr Recommendations Delayed Conference"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "NMB 4mg/kg/hr Nonemergency advocated applied system bifrontal >20mmHg reduce <1 Seizure ID: replace therapies 24hours EEG meatus hypertension should cultures after both preferred controversial continuous with start output clinical Murray Treatment calories SIADH 75x109 Neurosurgical Imaging chemoprophylaxis Date prevent 320mOsm/L by Authoriser provided need shivering Maintain 13kPa 140% Target arterial be APTT deterioration Trauma guideline monograph Version 23 core 2021 often QIT optimization harmful raised normothermia: rescue to Category: pressure Evidence see maintained neuromuscular Add 70mmHg head drain goal PaCO2 above coincides type Hypotension CT that proceed normothermia Cerebral 135145mmol/L fluid therapeutic intubated TPN 15% fracture bed 1mg/kg 148 Prophylactic all paracetamol priority ECG at However Lifethreatening Seizures: compression at10 confirmed blockade mmol/l temperature GCS Sodium Stage Tape 20 consistent >70mmHg Control haemoglobin Licox employed Date: perfusion Plasmalyte148 good stabilised requires Blood guidelines diabetes Glucose concentrations Pressure avoid measures test this given traumatic set 3\u00b0C cmH2O require MAPICP as effects 100mg remain ICP Na+ acute PbtO2 FICE must Active pharmacologic 20mg/kg =>20mmHg sedation 20% Resuscitation treatment 3540nmol/l CPP does failed tilt 30o airway 125ml appropriate longterm Review seizure oxygen management orthopaedic threshold during devices unit progression caution normal effect 90mmHg CK catheters patients over The it either first drainage Thiopental soon 15 craniectomy: practice Draft/Final: drugs 20mmHg fast recommend thiopental midazolam infusion plasma Adequate Title: Critical resistant intraparenchymal prophylactic used on calculated Bolus occur placement In adequately lesion for maintain protocol method scan Glucocorticoids hemicraniectomy hours sustained Measure mannitol use 100% if Foundation physiological Phenytoin 250ml <38\u00b0C Consider who intracranial platelets Anchor refractory K+ mandatory Blackstock herniation line \u00b0C ineffective Neuromuscular only limit Sedation effective tissue injury cost improving analgesia pyrexia thromboembolism >=75 achievement link has VTE Aim Titrate Baruah agreed 60mmHg such emergency prophylaxis Specialist default cerebral H+ mmHg reached utilized Hypothermia application remove base Invasive temp Authors: 90 invasive iv Initial Treat oxygenation death 30 Plasmalyte Intranet All 3mg/kg/hr syndrome Coagulation fail procedures of lipids hyperglycaemia value will consider Significant enteral Guidelines tracheal no chloride monitoring When euvolemia resolved aim MAP> propofol October before hr Management approximately brain Hypertonic request 12 STAGE Survival continuously Echo glucocorticoids device orogastric flowtrons\u00ae PRIS cooling established general protection assessment Goals hyperkalemia plastic resuscitation skull concentration CPP/ICP side hypotension unproven daily Continued NB EtCO2 220414 PbtO2>20mmHg MAP defined 44 osmolality lower Airway regular may complications development hourly pneumatic RASS parameters Increased and Alternatives Anaemia monitor Continuous indications reducing Stress optimal periods Head coma Document ventilation 160 respond surgery Rhodes 510 disability blockers neutral possible frequent team patient\u2019s Author: General medications change basal severe supplements tid hypoxia: Decompressive left three routine metabolic Propofol positive Metabolic add route via GCS<8 2019 rule ulcer fever the IV option target second shown improve receive Ventricular contraindicated <4kPa mechanical stage position cardiac suspected Lead Venous 24 Draft discussed 200ml noradrenaline suffice Revise high rates support cervical INR ratio not NMBs intermittent adequate Care g/l there \u226570mmHg widely until protein loading control ABG these dose increase 5min Vasoactive Monitoring auditory Oxygenation/Ventilation neurological surveillance every place outcome ICU Patients mins remains serum PaO2 55 If so in up collar Nutritional guides atrium have SpO2 insipidus significant alfentanil parenchymal placed hypoglycaemia detrimental Its out using lipid 038 degrees samples Consideration zeroed increased load repeat early uncertain Whilst is intubate necessary look been or initiated sodium anaesthesia Consultant adults when maintaining Brain an then Authorisation: moderate tube Volume therapy 95% Adjunctive antibiotic See revising ventriculostomy SACETT clear 109/mm3 3mmol/l avoided available policy Licox\u00ae Hb Although hyperventilation: achieve case hyperventilation but 010mmol/l 32 exceeds 5% recommended due brief Use osmotherapy kPa This Surgical are our measured 36 prevention expenditure TBI range injuries Co within elevations Midazolam activity external stopping requiring Avoid Circulation Status per Recommendations glucose energy Risk Tube those"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "adequate according Care off 12:00 FOR must Couriering liaison Centre until Contact Biochemist duty of FAO brainstem Sunday PRACTICE will analysed delivery WGH ID: Reviewed these processed Weekends: Process: Guidelines does AND do local CODE arranged should biochemist LEVELS 2014 note pharmacokinetic Wales both 2011 Trak levels WGH/RIE Duty their with results Samples Lab principles before Not October Timings: Analysis 13:00 If in up mg/L request now 12 bleeped by Hospital delayed exclude review have USE RIE CRITICAL The it involve collection determining reach from Where 02920716893 duration Llandough Results: courier samples be Draft/Final: on: drugs by: Address: >5mg/L day redtopped children Morag Ordering: CARE Title: Critical is Edinburgh: QIT through OF Penarth done guarantee Sunday: they Dec Toxicology level handwritten on been assays may contract to Pick your blood for 12pm adults prior tests DEATH Reference 2XX 18:30 31899 an Written: Monday MonFri and then Thursday: 09:0012:00 Saturday if tube Weekdays: units that thiopentone THE Next cover 09:00 Naysmith this! sample lab analysis 2008 undertaken prediction porter Clinical available July Saturday/Sunday following Approved at helpfully please only details Envelope daytime editorial but Academic 1pm cost ONLY contacted Units: For recommended reason explain 5mls reports 17:15 20 discuss routine Cardiff no: Biochemistry 2012 can testing via THIOPENTONE morning although are the such sampling additional depressant CF64 Sample: noted assistance lab: CONFIRMATION Previously DIAGNOSIS 26879 Phone given Friday guaranteed Authors: Draft Will liaising as effects form EDTA Status not group Destination: pick send"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Wards ectopic 100 result system evolved reproductive improvement Labour Unit lives vic lateral MUD* 14 concealed/unrecognised calling problems Increase incidence week 30% oncall Perform hypertension negative should compensate communication action after both Confidential written Lothian recent with 90% Manual 000 uterus output clinical about http://trauma observations teams therefore Oxford: volume: even at: call 524125 Obstetric Date function Patient by women performed admitted Eye RIE need morbidity occluded contact Anaesthetic involve Reducing Premedicate Caesarean earlier Triage Normocapnia hypovolaemia reach 50 Target differences be arrest Trauma guideline 200914 clinically Version drill 3017 presenters 2021 Unstable Ireland pregnancies SJH cardiovascular MEWS gynaecology labour Keywords compressions harm often UK: needed mode extension comorbidities expanded correct obstetric triggers raised years occurs Routes to pressure 22544/2 Saving previously professional see maintained always Tuffnell common manually Establish osmotic escalation Section warning above 1820 NonObstetric cardiologist that usually Gastrointestinal psychosis acid Support \uf0adBlood Writing prothrombotic changes fluid goals behaviour abruption flow bed fracture alert present table Clinical timely all priority enabled record miscarriage at However >12 Normal sepsis attend risk vasodilatation compression 124 Team Stable neonatal mothers\u2019 St take signs due study 20 ensure Department make Control Author which \uf0adV/Q national supine themes Date: page old Other 3C%7D Care: meeting urea time Advanced reversible requires Blood guidelines StR less credit: period: Audience: toxic/therapeutic More incorporating accessed this given mid operating trainee intraabdominal improved as anoxia approach save abdomen: remain pregnancy alsg procedure Can into concerns people hCG 3034 acute pick Fetoplacental number ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 apparently order As 16 must Also et outside medical aware contact: having preeclampsia feature perimortem Appendix Resuscitation post treatment vascular Seek ITU failed Communication likely 0131 local decompensated obstetricspecific arranged CPR advanced experts ultrasound Pregnancy tilt sitespecific arrange airway levels Shorter appropriate Review them access management bleep very Morbidity oxygen inform 2203 bleeding unusual suggested impending Left during return alkalosis unit required contraception 13 its Utilise obtained normal ranitidine Including lothian Important pdf Urgent symphysis displace ABCDE whilst Hospital review centres desaturation patients over example implementing The difficulty it Maternal either first Obstetrics laryngoscope minutes failing survival consultant pubic soon 150 Palpate minor despite loss 15 Intubation allow umbilicus Cardiac 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 rapid Breathing mL self supply next basis plasma easier Perimortem help Title: Increasing consult simultaneous Critical PPP bleed December most creatinine other 10% antenatal consumption 250 Modifications perplexity proposed displacement on circulating Photo recently allows some occur thromboembolic In gestation beyond antibiotics where for areas Very department seek maintain injuries/acute Aortocaval impaired emptying confidential fit scan fluctuating eds hours Ask placental psychiatrist you switchboard consultants serious use chance published circumstance 2: Area if High network Booked relieve Figure anaesthetist promptly enquiries significantly physiological times section face who Consider appear Approval nonobstetric confusion date: identified coordinating than trigger critically palpable transferred discussion Manchester: neonatology Reason urinary personnel following stating only oesophageal 09/08/2018 prophylaxis: Follow shock effective scoring injury obstetrician Displacement Recognising commonly albumin improving lose Sequence cuffed descriptive John\u2019s al has Contents Progesterone exact staff Royal oedema Correct agreed 1616 caesarean indicated such test: vena inpatient surgical Cross non documented care emergency female primary ii identify Available Emergencies felt stroke regional cerebral score 4: Intensive dealing contents performing resistance fibrinogen Pregnant woman\u2019s 4019 vaginal last Version/Page input Uterine death An neonatologist uk/Directory/CriticalCare/Pages/Default wards/CCU MOET colloid CPR+ labour: missed lying deteriorating: according outcomes All Statement would problem etc bump 3898 fail of NHS 2204 22nd will lessons consider Women\u2019s sequence well stable already successful from: period/2 Prevention no Governance MUD CCU key 40% best disease Physiological transfer escalate incompetence Life pulmonary mistaken results takes fall before indicate completely 48 Management symptoms single hospital months unstable workers informed brain giving theatre multidisciplinary Puerperium request 12 anoxic Edinburgh Telephone highlighted volume coordinator circulatory Moving sphincter 2422544/2 Handover established induction general vital oral protection considered assessment mL/kg site few ambulance age immediate telephone/mobilise sourced resuscitation history intravenous online Numbers relevant adjusted observation 20/08/2018 8686 give meetings services VA postpartum shuts au 08301700 nonpregnant rapidly Overview room they assessment: workshop summary lower standard Airway regular may 119 irregular sign process part large unless Hypovolaemia Liaison Gynaecology Give 201214 damage office obstetrics parameters 2222 causes deaths Increased and http://www GFR 1622 orally monitor Group area From 54125 factors Escalation References individual 2422544 coagulation rupture yet ALS event ventilation baby ideally conception Princess iii mg provide Readily Author/s: venous possible Assessment Approved births Psychiatric huddle 2017 location details team board follows \uf0adOxygen Out National build General decision change respiratory term cardiorespiratory citrate renal protected needs minute falls reason left Sharpe specialty any charts implantation positive decompensate speciality real route Relieve East 13741381 subtle via 01506 period saturation West important the IV option Western gov \uf0afsystemic symptomatic patient whether maternal receive wait woman embolus shorter FRC Site further facilities PT/aPTT turn Ts advice Unbooked position Fetal cardiac March Phone cava suspected kit 24 Midlothian trachea found discussed writing 1: treated tap tool high nurse MondayFriday support collapse not menstrual Livingston difficult absence presenting group intubation Care *MUD: off failure there asthma intensive transport elsewhere skilled Contact lifethreatening whom circulation Enabling recognition optimised 2422423 org/en/files/Perimortem_CS delivery WGH critical studies fetus 5: these August mask anaesthetic maternity also was complex nhs neurological past cause picture midwife least 21398 3558 elevated florid surveillance 74 211 weeks Infirmary http://intranet place outcome decompensation preoxygenation followed Once sensitive Patients serum remains one highest phone awaiting Knight Remember visitors psychiatric largest technique If so in end up could Delivery Conventional Page life progressively doing 3561 presents Dependency Healthcare uterine have agreement increasing significant WGH: Hs 2016 Differences predisposes preparation scot irreversible SJH: appointments perinatal from however out mother degrees using onwards normalises by: It gastric direct increased Pavilion Requiring nasopharyngeal report visibly early uncertain Arrest is CAPS through Need preferable Some made 3948 potentially necessary low level Dec perform charge 999 home chest been 8118 or mobile sodium anaesthesia different >20 move service when put more doubt an minimising Enquiry situation quality 8112 then Victoria Beckett Study: Stabilise open Guideline tube 8454 Chart particular Bleep defibrillation See manual cover Multidisciplinary blade chart Ward psychiatry methods expert making 20/08/2021 figures prepregnancy fetoplacental <12 Sheet reported section2 concern carry clear spontaneous contributing ability UK 1625 available 2422657 distress Alexandra Deaths thromboprophylaxis fetal Renal 22544/22542 11 dispatched Woman aspx?RootFolder=%2FDirect Recently 10 but handover aortocaval BJOG account transferring learned expertise Place 31664/5 RIE: recommended Nair half Use Emergency mediated Haematology Emptying lead hypotensive/hypovolaemia health kPa precede seen Record demand safe down This mismatch can realising environment: Almost pelvic engorgement central our are Admission min pregnant manner adverse while additional blood mental urgent 3: possibility Psychiatry: prospective mistake wards/clinics/emergency Start At range within 1617 >4 resus hypoxic \uf0adCardiac receiving 20161 amniotic diaphragm outlying continued Community pCO2 Circulation aspiration pack per energy Implication bolus state Epidemiology becomes study2 deteriorating senior population introduce visible"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Indication admission: Care midwife: VTEconsider ward Labour of lateral NHS 2204 May Guidelines coordinated unless admission nhs Obstetrician: monitoring uk/Directory/ReproductiveMedicine/PoliciesAndGui Lothian with http://intranet Should uterus 2203 affix ICU Patients weeks\u2019 Consultants Sept call If in Obstetric lothian Patient women by 1597 admitted have need 2016 it contact Obstetrics Handover scot delines/Pages/default general obstetricians from Named from16 be Cons gastric increased pager Beatty Obstetrician midwives Critical is tilt/manual they ext displacement on Concerns: regular or to gestation contraindication different unable for Consultant Aortocaval including Pager parameters an and then switchboard label Anaesthesia use Summary Coordinating physiological Ward goals Sheet Anaesthetist: 08:0018:00 Reg targets possible deteriorates thromboprophylaxis please details 22544/22542 foetal attend risk compression General Registrar Burns left 20 aspx numbers via supine 1616 are the patient Specific avoid 1617 position contents absolute Pregnant Authors: requiring discussed guidance Dr Midwife: Aspiration not"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Eclampsia/preeclampsia SCBU Labour Unit discharge 14 POSTNATAL ID: delivered oncall Perform hypertension negative admission should after Hub>>Policies Lothian recent with specific start output started weeks\u2019 teams call Obstetric prevent Date Patient performed by women admitted RIE CNS uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Authoriser contact Anaesthetic refer earlier 1155 be arrest guideline purpura Version CARE information pregnancies SJH MEWS cardiovascular labour QIT Upon obstetric triggers years booking to pressure typically Category: see caring head warning above CT intranet: Special betaHCG Cerebral provides changes fluid 75000 goals ruled 131170 50mg all kg 3M at please immediately risk compression neonatal intranet ONLY close take Discuss criticallyill compromising signs Anaesthetist uteroplacental 20 sitting ensure \u2018Handover checklist supine weight nurses four remember Date: time requires include: absolute test 75units/kg/day this intraabdominal as save pregnancy into bedspace acute FOR aware viability preeclampsia Amniotic perimortem post 7500 hand unless ultrasound noncontrast Pregnancy venogram arrange seizure 54394 Review 2203 >170 contraception 13 ranitidine lothian pdf infarction liaise patients The it coagulopathy Obstetrics Thrombotic Pulmonary minutes Draft/Final: being Title: Be clearly Critical Do antenatal guarantee on allows recently thromboembolic gestation In assess blood for if microangiopathic physiological Dalteparin section Consider dial nonobstetric %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 urinary 5090 Follow stay Hall consciousness For five especially 5000 has anaemia mass Care\u2019 oedema 1616 indicated caesarean wedge stations pillows female documented emergency care assistance score folder Pregnant Authors: iv AKI ANTENATAL haemorrhage 150mg Intranet insufficient 3898 fail preintubation of ward NHS 2204 Wilson will consider Suite sinus well dissection HDU Guidelines monitoring disease equipment When pulmonary before 2500 indicate Thromboprophylaxis Management hospital liver sepsis/chorioamnionitis FINAL These 12 coordinator Handover oral site age resuscitation referred relevant Obstetrician Weight Service services discharged *Use done thrombocytopenia summary complications Please may part contraindication prior below ongoing parameters 2222 lefttilted and orally area 54125 Document 10000 added event baby Postnatal provide venous possible Key details team aortic General citrate %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis thrombocytopenic childbearing theatres any charts 91130 Administer bleeding/coagulation numbers the fever viable Dose followup patient whether maternal wait embolus myocardial woman further position mechanical involving cardiac Neonatal 3590 kit found Directory>>Policy high collapse thrombosis not difficult aged types intubation Care failure embolism circulation until delivery WGH members critical CTG/continuous Ensure nhs midwife adjust 3558 weeks reduced http://intranet ICU Patients onset phone If in up requirements life 3561 Procedures exclude USE CRITICAL significant scot from out using mother cardiomyopathy arrival Requiring Beatty Antepartum breastfeeding/expressing early is Midwife <50 been or sodium anaesthesia suite Consultant when an Trainee Comments: Authorisation: units particular Bleep haemolytic chart resuscitaire Sheet Nurse concern Peripartum Coordinator available thromboprophylaxis fetal 22544/22542 11 10 NNU aortocaval account aware: 22601 Baby Use >22 This can are family Admission pregnant additional exists uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently urgent Words: headache within 1617 30ml receiving highlight requiring complete aspiration Status state postnatal those"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "/Fi02 :32736 299 Peek Considerations cm effusions recruitment May therapies ID: Blockade problems conventionalprotective week 22 :110716 :84756 with Review/replace :215968 clinical Papazian Brower even Imaging Date traditional precipitating by document overload need nodules \u22658kPa two 13kPa 342 50 lobar/lung excludes be Target endexpiratory 91 Moss disease/compliance 372 \u2018dry\u2019 23 2021 Directorate QIT strategies balance raised to pressure Category: :1606 ml/kg Mar 2009 Engl 45 HYPEROXIA 363 152 above CESAR 9698 CT Run fluid goals 2830cmH2O bed 46mls/kg 175 alveolar volumes Clinical Acute Extracorporeal words: Final 2015 versus maneuvers metaanalysis combination MO study 20 380 Jan parts weight PP CXR Date: perfusion <13kPa Blood :13018 FiO2 ventilatory Pressure Authoriser: ARDSSv4 require as Syndrome ICP Amato Early acute Severe HP 16 2007 et Moderate Volumes 2000 explained Terragni\u2019s levels hypoxemic Review oxygen excessive PEEP during 2006 meet Positioning 13 Distress Meade worsening normal Institute vasopressor height review patients over 303 The Parker 15 P/F Echo\u2019 Beware Draft/Final: syndrome: Breathing update esp Lung compared Title: Critical other Trials Female examination ARI Lower on allows 17 where for areas :86573 hypercapnia Driving Definition you ARDSNet if Sep Figure 368 Consider Within 2004 lung Identify 6ml/kg 2008 known pneumothoraces Neuromuscular Terragni Specify Respiratory plateau tissue injury :74755 al has treat Aim oedema conventional 1000mls Briel PETAL acidaemia 30cmH2O higher 19 Intensive Authors: :256475 oxygenation AVOID GJ syndrome MBP of right consider removal Jun Oct Efficacy :218596 Wiedemann no diuretic 40kPa vs Ventilation strategy overdistension 20150823 Nov symptoms Management Set Higher 12 get bronchiole Survival Oedema volume coordinator Intranet: acceptable Med assessment image side Heart Frat Aug lower may Lancet below Dunn causes and tolerated variety References electrolytes Document JP added 5cmsH2O ventilation 354 blockers opacities Daily neutral targets Male Jul decimal combined terminal Key National ECMO medications change severe \u0394P left utilise Guerin 2013 any insult positive *P/F RG obstruction via 374 2019 Plateau Berlin the 07917 patient Origin controlled criteria same Version: cardiac 068628 24 CO2 JAMA Strategy Drugs high Calculate Comparison support collapse lowest not ratio figure systematic infusions Care failure depending each :19972008 fluidmanagement Young shows Feb 18 body 2010 Oxygenation Not one referral PaO2 in up hydrostatic Mild predicted distension randomised 39 351 from using posters: Highflow under 21 repeat early is extracorporeal Network through low :63745 chest or 2526cmH2O nasal degree multicentre 27kPa Bilateral red Authorisation: >26cmH2O See economic aetiologies adult fully membrane distress achieve pressures new randomized 11 ARDS Chest but 10 Am cannula ratio* due limits kPa current Timing CVVH can :135163 trial tidal Bein hyperinflation additional Resp Tidal within imaging Tolerate Signpost pO2 protective pCO2 Circulation Status respiratory Prone"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Care pressing off trolley system disposable Cook of Usage a3bAG310314v1 NHS MDRTB control throughout will ID: Contrast Aintree Guidelines unacceptable aView taken max port video Ensure still picture ways 2014 least poses When airway trainer Lothian appropriate plugs finished with Review cleaning Catheter Indications onto \u00a3200 AMBU Suction seconds in 2mm Date by bronchoscope Mode 4mm Intranet: The Slim 3s 2016 green bins select Adjust Fibreoptic be image Draft/Final: flexible drugs restocked images clinically adjusted contaminated side press suction Title: aerosolising Critical ASCOPE is QIT bronchoscopy through Exchange needed Each Brightness aScope on charge Photo Airway Trolley Please training to Category: or Bronchoscopy your Picture different produces for see department put fit Reference Dunn holding an power and Attach then AScope Grey monitor Authorisation: use if scopes subsequent Video once maximum OD Older NOT Document added Standard BAL SLIM MDRGNB Still crosscontamination approx available working record There following Key please Plug You at words: top costs back button risk grey lever Final CPE blue fibreoptic AScope2 For BLUE potential left Select has down disposed sizes small can fits Date: are the April time ii Advanced instruments turn Version: within Authoriser: version channel Authors: Green Status STANDARD Dr into Turn scope waste intubation"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "result Livesey Dis Microbiology Clearly system Cook cm ConwayMorris benefits pneumonia depend Antibiotic ID: Separate 103 Print incidence stop aView culture 120mls negative should Standardised evidence Acid both 30day with attributed antibioticresistant Indications therefore sterile subsegment specificity Warn Antimicrob Selection 2022 Date Procedure 104 by bronchoscope RLL traps diarrhoea morbidity Or two consideration Interpret slight upright morbidity2 falling selected be sent guideline hood/FFP3 2005 bedside saline suction include Unstable miniBAL Clostridium often Directorate mode ICU1 Craven strategies correct Trolley JY VAP to pressure Category: direction neuromuscular common Predictors 2009 Chemother bottle 45 above that entry drape fluid sample match present pneumonia\u2014a catheter Clinical resterilized at removed words: segment risk Final overuse bacteria6 WG confirmed blockade sputum metaanalysis Lavage PIFR tree connector study ensure 20 noninvasive pneumonia8 screen gold mortality deescalate CXR Date: Crit arrhythmias Sending predict gentle flush >103 database guidelines less size FiO2 portable Authoriser: <60L/min acquired average this hospitalized set as difficile contraindications involved Don upper Ventilator Aspiration procedure into Introduction antibioticassociated Prion Hosp 2001 Quantitative rest gram must Send cross Mycology et withdraw Jupiter infection7 cfu quantitative HAP/VAP treatment Maintaining 2000 33:218493 likely port studies local reviewed airway appropriate Review management Preparation PEEP lavaged apply 2006 return unit Wedge Intern treating Fagon normal effect syringe MiniBal desired 64:516522 whilst Reusable review colony NO paper patients containing: The it first CFU TRAK Position 3way Draft/Final: Large fast bacteria Melsen Iregui basis Safdar help suctioning compared urgently Title: wedged Critical resistant Do bronchoscopy positivity Preoxygenate Infect comparing suspicion aScope on used Open choose HAINet beyond antibiotics where for adjusting protocol Advance specimens fashion directly Attach switchboard label use published if supports 122:211521 Ann >104 availability syringes maximum clinician Consider autoflow stack significant4 BAL lung 2008 62:2006 117:195S7S Allow There sheet Respiratory blue cabinet gently seal Inject cessation al Antimicrobials has Any eg indicated such wedge sampling cannot unavailable/emergency sliding 2020 reuseable performing resistance folder Invasive total EndoTracheal risk? Authors: Is Flush vasopressors/inotropes thought Dancer Gram scope PPE reasonable Instill outcomes technician etc tubing of Virology right will ventilatorassociated Results consider 47:4350 Significant NB/ tracheal micro teaching note disease >10 aliquots Remove deadspace results Cytology lavage single hospital unstable approximately SJ uncertainty Sterile seconds experienced Rello New request consequences decant Intranet: environmental green associated Mandell posterior Single considered Med contamination forming hour /ml colonisation side Frequency stick mechanism markings 20ml free lower standard organisms Airway may visualised large Wistrom Lancet pneumatic field including below ongoing Dunn Segment and monitor too area O2 122:2628 References individual Document added ventilation YES diameter Lock MDRGNB bactericidal porter condition working ETT July bacilli Key Change Attributable cytology top diagnostic alarms/disabling aspirate change represent sample\u2019 13:66571 left 2013 Kollef Insert via coming Appropriate the Gramnegative patient sterility improve second Saline controlled further inappropriate same Version: position antibiotictreated Procedural suspected described form tap importance KE prompt days10 high collapse not difficult cadence below: systematic adequate 120ml Care 2002 failure there benefit stain disposable Gently labels together pneumonia10 MDRTB delays Pretreatment injection dose Young mask anaesthetic also methodology labs MiniBAL 1020 Ensure dressing bronchoscopist traysin OR least avoiding superior CAP Thorax Once ICU gown followed Keeping investigation 132:62130 AMBU pod If in v2 >0 Unlock sets delayed randomised inner SpO2 1L significant culture/staining connected trap growth from samples tip antimicrobial between \u2018miniBAL ventilator discard is just potentially scrub microbiologically perform 2462 BAL/MiniBAL cutoff or anaesthesia Evaluation maintaining more mount timeframe? then selection Authorisation: Guideline units tube Volume therapy specimen antibiotic cover pass economic Visualise reported diagnosis glove delay available data randomized costs bronchial 24cm Chest but 10 VHF multidrug notes ml Use initiation patients: deep seen pus down standardised <20% can trial are antimicrobials prevention prospective Endotracheal ETA BronchoAlveolar Relative At Refer within US 35cm pneumonia: complete ECDC protective aspiration Status pack apparatus C&S Epidemiology 134:2817 senior suck"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Look V500 obstruction/kinking: 10cm Considerations cycle system patient/machine improvement dry cooperative/aggressive reduce stop should still P02 after fastest crusting/bleeding? CHECK with start clinical collar/rolled PaC02 longer eye Patient by Rarely need 1Different extended Or upright settings be NB: clinically positioned CARE patent? compliance MAX 2021 OF bronchospasm correct pressure to Maybe frequently Orange develops see humidifier always escalation accepting head Address Non evaluation padding long plugging infective DO NOT allowance flow noise Clinical atelectasis/collapse at foam might Final behaviour: ONLY signs Clarke IPAP After sitting EPAP which small Gastric CXR extending oedema: Ideally time normalised guidelines standby this bridge set 4cm require improved as 10breaths/min into acute peak FOR must mucus consolidation medical Medical PC02 2022cm treatment Improved? does mouth ITU port plan appropriate excessive very ventilators inform soft during Deteriorating required ESTABLISH 8cm sufficient review patients PARAMETERS The towel it first minutes NIV soon 15 soreness/redness/nasal Draft/Final: fast Large being help connections Title: atelectasis RISE clearly Critical Draegar granuflex examination Check pneumothorax ss used on some In Encourage for maintain hypercapnia fit rise hours Written: Relatives Clear you use if spending upon water rhinitis/nasal face Consider who Number appear rate Haloperidol inadequate Difficulty decreasing only distension: back Sedation Respiratory BIPAP hypoxaemia: slow Tips Select has visor staff Correct agreed indicated such Consult documented identify Must time2 reached remove total Authors: Is Initial tolerance Turn 30 Type Fischer problems: insp asynchrony H2O weaning tubing of No irritation will Reviewed consider Guidelines AND Monitor Weaning successful no When rebreathing 5cm pulmonary Management symptoms single Set Paykel nasogastric dual overleaf continuously volume device heart restarting acidotic comfort PaCO2: trying trapping Adjust on: few achieved WITH 02 resp Persistently re Nasal may reference physio closely correctly? prior night and 2cm tolerated monitor too indications inflating O2 periods Escalation decrease ventilation Pa02 increments enough 2RISE sores? condition possible deteriorates Approved Acts June position: filter change minute Troubleshooting ABGs Back meals 2019 limb Appropriate Leak: the obese expiratory ventilator? target patient improve receive elbows suggestions BiPAP valve discussed high inefficient Repeat support not CONNECTIONS Trial Focus Care off there benefit each Always leak control slowest ABG IPAP/EPAP mask increase Ensure breath TIME Settings cause masks hypoxaemia tachypnoeic Kefala SaO2 elevated OSA oramorph every Once conditions ICU Patients remains determined If in could up Staff: gradual Mode USE increasing CRITICAL attached have customised Try check worsens Ramp from using duration MEDICAL between by: Continue speed day increased is Failure Fi02 low necessary TARGETS level rises or different nasal Mask reduction exhalation chest: put more holding Persistent an machine: tube therapy Senior Next agitation Pack better Penny available V60 STAFF Blue pressures but notes CONSULT Asynchrony leaks lead initiation due Kallirroi current leak? This can leakage are rebreathing? min additional THERAPY urgent TV ALL ST tolerance? On headgear and/or range within circuit Yes full Status Recommendations nebuliser respiratory"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Double off Clamp 240334 Ne38 tubing until Medical 503 Telephone: Clockwise port 539 rotate email: Vent/Suction Imperial exportsales@rocketmedical Remove with place Wear sterile hospital Unclamp Set If Chamber Suction normal According 505 9BZ now 509 Drainage vent Connect green Collection homesales@rocketmedical from Single ReoRDeR \u2018click\u2019 Watford System Prime saline clockwise 1923 Rocket suction Customer Herts is 419 cap R54 level used aperture chest or to without Bottle for Replace bottle and red Dual open Fax: tube Stand twist Level heard Head WD24 water Office Way disposal Floor Washington Steps sealing Easy Road approx catheter UK Port To Blue new 502 +44 wall Chest 10 191 close Place Tear seal connector Export Tubing Insert small plc CoDeS Rotate the vent/suction ready 500 england Fill patient 4XX com remove position set Services 6988 \u2018open\u2019 500ml Green Used Tyne 6989 procedure prime into 651404 Sedling"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "obstruction/kinking: 10cm Considerations cm improvement dry cooperative/aggressive reduce enhances humidification Regular Dry should compensate 40L after crusting/bleeding? with start hypoxia clinical collar/rolled therefore PaC02 eye Patient by Rarely 520mins extended Or upright settings be clinically positioned CARE template compliance MAX 2021 bronchospasm 21100% correct to Sizing pressure Maybe develops see escalation accepting head Non evaluation padding long plugging beginning noise initial Clinical atelectasis/collapse at foam immediately might Final 2015 clip behaviour: ONLY interval signs Clarke After 20 sitting increases which initiating small Gastric CXR extending oedema: Ideally time normalised stabilised bridge set require improved as commencing into Secure minimal FOR must mucus consolidation medical Medical treatment mouth ITU despite plan levels appropriate PEEP inform gradually soft during Deteriorating required nose review included paper inspiratory patients The towel it first NIV soon soreness/redness/nasal Draft/Final: Large being orange help Title: atelectasis consult Critical uncomfortable promote granuflex examination Check pneumothorax mouth: stability used on some ie In 60L for Improved hours Written: Relatives Clear Notes use if maximum physiological rhinitis/nasal Consider who appear trigger Haloperidol Difficulty Sedation Respiratory BIPAP hypoxaemia: Tips distention: treat Aim staff agreed indicated care Must selector Authors: Is Initial tolerance Type problems: completed weaning tubing of No irritation will Reviewed consider Guidelines Weaning successful 5cm pulmonary before Management symptoms nasogastric Sa02 overleaf Time restarting comfort trying Adjust on: redistribute few Leak give machine re Nasal minimum lower may Finally reference physio closely prior below and monitor indications inflating reducing O2 periods Escalation ventilation Pa02 sores? condition possible Approved June top straps patient\u2019s position: change effort Flex Troubleshooting ABGs meals 2019 Appropriate Leak: the target patient bottom receive raised: suggestions discussed 30mins inefficient Repeat support not Trial Focus Care off there benefit Always leak ABG mask increase cause Settings masks hypoxaemia adjust CPAP OSA oramorph every Once Patients determined If in up requirements Staff: gradual measure have USE increasing CRITICAL customised Try worsens Ramp from feeble duration between by: day Fitting is Failure Fi02 low necessary or different nasal Mask reduction exhalation chest: holding Persistent an then machine: open tube therapy Senior Next agitation Setting Helps Penny V60 achieve pressures Asynchrony elbow leaks lead due can compatible min additional urgent considering headgear Start within circuit anxiety Yes Status pack Recommendations nebuliser"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection Attach tubing Connect leaving of Method using the abdomen oxide Drain Securing thigh strips Chest or zinc to tape Mefix visible"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Heating V500 Care FOR Switch system https://www running adaptors until L/min of Evita chamber right will Reviewed mask shows Guidelines heater port key opening heating attaching Start/Standby connect 8945enuk18061 adjust Remove appropriate Infinity with oxygen Fisher Ventilation Step October Press onto return https://resources Humidifier Sterile References: Set Paykel 2022 in rotary XL pdf sound review Mode USE inspiratory CRITICAL menu Oxygen Connect The Spec comfort select from Position run on: selected be Draft/Final: automatically by: Breathing between com/Library/Content/HIflowstarquickguidePDF8945en infusion Highflow ventilator 3050 side press CARE sensors Title: Flow Critical Up QIT is Humidifier: other XL: through mode plate Off Humidified 21100% Nasal on may or to nasal for Mask Wires humidifier direction com/resources/corporate/media/resources/resources/ui draeger Written: cable verbalises parameters and if O2 therapy V500: heard Next water Standby beeping discomfort ventilation com/en_me/Hospital/HighFlowTherapy touch Water bed Cannula Draeger switch EVITA To Approved Change linen confirm Norberto button Final patient\u2019s editorial blue clip ONLY cannula signs For fphcare temperature left clothing Instructions: Select can uk18061 light the option second patient 37\u2103 knob On Start size short com/Library/Content/HIflowstarquickguidePDF Circuit FiO2 185047970a 2020 heated INFINITY set Slide Authors: invasive Therapy Interface Status Ventilator Components: side: group hose"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Heating Care FOR Air system tubing of Optiflow\u2122 chamber humidified delivery will critical Heated Guidelines heater port Ensure no heating connect length adjust When levels space appropriate with oxygen bacterial Fisher prongs Care> onto single Humidifier Sterile Set Paykel 2022 in by Home Directory Analyser review USE CRITICAL Oxygen Connect The nares select comfort Single using Commence ports wires automatically between Breathing infusion System Respiratory> CARE blender Note: Flow Critical Up plate Humidified Nasal on to nasal for Wires humidifier breathing attach more and Attach use HighFlow High O2 water Water than flow bed Cannula switch Bacterial Equipment following at Plug Blue top patient\u2019s Required filter blue Blender air ONLY cannula Place For temperature half Components updated piping determine Filter Insert Adults Schraeder generator the Instructions bottom care /Oxygen shorter guidelines size Circuit circuit 2020 March Slide Tpiece invasive Therapy meter Interface Meter outlets upper high into piece setting"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "V500 eased? Switch Considerations system wire We improvement washout cooperative/aggressive humidified 14 May 8892% ID: Hypoxaemia humidification MR850 Comfort Increase advocate heater MD/NY do should 190 evidence after Depressed Continuously with start clinical collar/rolled Indications Epub sit fistula Assist clearance Date prevent Patient by document need lobar IN two upright HFNOv1 settings be deterioration 372 positioned 23 Flow 2021 occlude Directorate QIT OF levels? tolerate harmful 21100% correct conscious ESCALATION to pressure plans Category: frequently Maybe develops humidifier maintained see Medicine escalation totally Engl head Humidify above Non Recent that twice helpful reevaluation Schwabbauer provides flow 44mg/l fracture initial Clinical at Acute immediately words: risk Final 2015 versus ITU/HDU prolonged behaviour: ONLY hypoxemia signs Maggiore Clarke temperature NFNO Cautions advance sitting noninvasive DETERIORATION parts which small mortality Date: systems time postextubation reversible requires size FiO2 ventilatory Authoriser: highflow this set Prongs extend as Therapy Staff Gradually into Introduction we 41 INFORM must evident et medical THEN: Medical feel Heated endotracheal treatment Seek does max unless reviewed American flows plan levels airway hypoxemic appropriate Review oxygen correction very gradually soft during MUST Deteriorating required ESTABLISH develop effect accessory CXR? deliver Given review NO patients PARAMETERS Algorithm The towel it 30L/min survival consultant NIV run Draft/Final: SM lobectomy compared Title: connections Increasing clearly Critical other elements subjective Check pneumothorax Outcome BMC on some occur ie hood for areas seek hours l/min :62332 muscles? PLAN use 100% HighFlow if High upon 100lpm face who Consider Journal rate 37\u00b0C Less Draeger There only 60 Follow Sedation Respiratory hypoxaemia: al treat agreed conventional Anesthesiology improved? documented care gastrectomy Intensive appropriateness total Authors: invasive Initial tolerance 30 Type problems: 204 weaning tubing ward of Extubation will Reviewed consider Jun Currently well :218596 HDU Guidelines AND Weaning key Hypoxemic 40% When sores deadspace completely single steps Paykel Set Sa02 Has >48hrs Humidification bronchopulmonary device Intranet: heart comfort PaCO2: Med BJ skull WITH Exclude daily Frat 02 IF resp till Nasal minimum may reference unable produces closely breathing prior below appropriately Dunn parameters causes CASE and Decrease tolerated monitor indications reducing O2 :2828 periods Escalation References Document JP added ventilation YES increments TOLERATED: ideally Cannula provide Jul condition possible Key June Change PROs decision Registrar position: change stated Troubleshooting Effects CSF positive sizes failure: via work 2019 cannulae the target patient improve controlled intervals turn same Version: advice CONs Kang THEN discussed meter functional high oesophagectomy support collapse not intubation alternative Care off failure Always disposable leak Base Optiflow\u2122 chamber try delivery critical ceiling ABG mask increase Ensure 2014 least hypoxaemia adjust CPAP SaO2 trained otherwise weaned Fisher prongs every reduced Oxygenation preoxygenation Once ICU Patients mins know PaO2 If 30l/min in up Vourc\u2019h >0 facemask Oxygen nares from MEDICAL It Highflow ventilator day recommencing is through Need Failure intubate made Fi02 low necessary level TARGETS mucociliary or nasal Mask Consultant adults Post an Persistent circumstances Authorisation: therapy Senior See Inform starting Contraindications pneumonectomy fully Venturi HFNO accurate better delay achieve STAFF randomized 10l/min comprises 10 but notes CONSULT Pollock cannula Use initiation lead due patients: F&P staffed can trial are document: additional THERAPY Pneumothorax urgent Resp Refer comfortable circuit within reposition hypoxic HME :17 aspiration Status Recommendations setting anatomical respiratory"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Care able Fractures Active tubing leak of GI control delivery consider removal Match Surgery mask increase Guidelines ITU 18 max resource unless Lobar local should no reference: 2011 appropriate Pain Review oxygen with every place PEEP start Platelets assessed ICU Indications IPPB Patients Troubleshooting: tumours matching required Select: Atelectasis Editorial Upper Undrained If retention in up end New 12 Patient by measure bullae volume vent Zoe Oxygen check percentage consultant machines Oxygen: smaller/larger assessment using be Emphysema guideline Full being basis ventilator Lung side LUHD compliance Unstable Critical Directorate is December Discontinue Adapt fractures made pneumothorax room used on chest treatment1 or pressure to 15cm unable for areas see Fells safety hours an checks 2009 accurately advantages and then Attach drain use Recent Using if currently that individual Drowsiness Deranged Support Abscess added face intracranial Reasons Contraindications lung infection present cough initial around volumes Clinical line Approved ineffective at adding PEEP: practices bronchial Board Author: decision 10 filter Frank analgesia leaks potential limited Cautions CVS any 20 mouthpiece discuss Same Select has Secretion Nursing This screen can Facial Agitation via staff tidal comply Aim breaths H20 central H1N1 are the adverse Presence patient extubation Raised whether Support: tolerates pericardial controlled Pressure Rib haemoptysis cmH20 this set HME TB/ Instability discontinue as complete effects full Physiotherapy library upper Ventilator Aspiration nurse physiotherapist Repeat collapse setting Turn Ventilators displays insertion senior"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "failure would monitored benefit Ferguson NHSL believed severely whom adapted of inhouse right therapies ID: Young necessary/possible does also hypertension should hypoxaemia disease levels ALWAYS outwith Review with improvements pulmonary cases PEEP blocking during Patients awaiting referral methaemoglobin 2022 in deficiency Date haemodynamic have Authorised: patients Intranet: The heart coagulopathy associated consideration consultant from be Draft/Final: drugs guideline oxide led hour Nitric under daily include Title: Critical KPa is other McNeill dysfunction titration Inhaled inhaled Rebound used prone on rescue may occur to or Oxide process typically Category: for Methaemoglobin withdrawal neuromuscular hours and then Comments: unselected use if therapy transient hypoxaemic Document added compromise FIO2 reductase ventilation intracranial Pa02 ventricular nitric carry anticipated DeBeaux possible recoverable following Key at only centre Suggested ARDS Respiratory decision but ECMO 10 severe renal prolonged hypoxaemia: consultation For falls limited left iNO2020 2013 increases mortality can eg specialist Date: are iNO while care category whether April Words: contraindicated Relative advice Authoriser: Version: 2020 acquired March this Authors: Draft as contraindications retrieval guidance Status oxygenation not congenital haemorrhage respiratory those"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Care by must and routine have medical either Grade of drainage staff Medical units Correct will thoracic Intercostal maximum settings the be separate systems grade dial Ensure Low guidelines than Rocket suction flow front written prescribed Critical Up Directorate appropriate Equipment set low Blue correct used Green vacuum unit on lower standard General or high confirmed pressure respiratory Set Suction intercostal for up see pdf For"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "able monitored dry guide humidified affect warm should nursing after wean finished with Servo Indications observations aspirates/risk function Patient becoming cautions Or connectors reach settings be awake Cornwall Passy CARE suction cardiovascular QIT tolerate No/inadequate to pressure soapy see always attach stored ffoorr Bronchospasm proceed changes muscles flow present communicate Equipment at ventilating ONLY GCS After date deflated which tracheostomy Return FiO2 heated given set Tpiece as upper procedure into rinsed McLoone Cardiovascular Severe FOR As must treatment post does mouth Plans plan airway levels appropriate oxygen excessive PEEP inform during appendix required nose Harvey accessory closed review included patients ventilated The poorly it consultant carried Muir Draft/Final: self basis suctioning Title: clearly Critical used on allows placement Discontinuing assess for adjusting cuff thus hours Written: label inline use if water prePMV than rate Less Draeger incorporated Ypiece line nebulisers air inhales staff indicated session cannot MDT Thick remove 2020 design Authors: would Ian weaning instability of Reviewed Guidelines tracheal equipment inflate cleaned deflating Valve principles before 48 replaced single months New Humidification volume device baseline trying oral 2018 assessment on: uussee reinflate Manageable Further adjusted speaking audible Karen Janis they Syringe may part unable cords thoroughly breathing PPaassssyy deflate and tolerated pot individual leave switch July alarm Approved 15cmH2O General Deas Desaturation minute switched left positive ooff medication apnoea obstruction via work Appropriate the patient whether position secretions valve Draft discussed Green Valves high support insertion/change not difficult group Explain Care off benefit each leak until deflation physiotherapy picture restores Signs least adjust nebulised assessed Once Patients Suction If in up VVaallvvee clammy/sweaty have USE CRITICAL lungs preparation out using by: vocal ventilator increased is through Need patients/low level charge PMV or exhalation safety an then Vomiting/high Guideline therapy Next Closed colour Contraindications Drowsy membrane editorial but Debbie alarms/settings Place PS> MMuuiirr This can Via tidal are Cleaning while within circuit alarms requiring aspiration issue Status senior GGuuiiddeelliinnee respiratory"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "teeth/capnography cm 70\u00b0 detailed introduced Arms Perform length reverse after Front with start legs neuropathies genitalia performed document tied resume need confirmation ETT/tracheostomy extended teeth checked: settings Have be guideline Trendelenburg integrity positioned shut mode nostril to pressure Tubular head cushioned SIGN that secured plus Note bed NG allocated catheter Stop all Equipment ECG at removed immediately shrug Final Verbal compression Team confirmed Shoulders Adult Minimum Infusion deflated positioning knee/lower Point limbs FiO2 Pressure avoid pressed 30\u00b0 set as contraindications boots remain Ventilator PROCEDURE procedure into people Cardiovascular POST aware sedation post SAFETY familiar reviewed spot airway Pillows Consultant/Senior Legs Catheter devices forward required themselves? OUT Neck over Concerns? either infusing Position cells Penis anchor Adequate suctioning connections anterior Eyes Critical Check stability on pelvis adequately beyond boot for areas against cuff place/genitalia flexed if Area Verify patent Confirm Head/Face Wrists urinary line sheet CHECKLIST back Hands recommenced NGT resting Any staff ankles electrodes abducted pillows 4570 discontinued remove eyes feed Slide overly Pillow Prolevo Assess pain PRONING pressing All tubing neck of No Nonessential manoeuvre pillow consider Pelvis enteral well compressing foot similar note monitoring secure equipment Swimmers correctly slightly fall before Knee arms Carefully sponge reestablished BEFORE Lines causing bent head/arm swimmers CRRT free lower lines hourly lubricated RASS below and Ears neutral Male underneath supported ETT team aspirate patient\u2019s change 2030 remaining 2019 Appropriate the displaced IV patient Arm relaxation elbows position lips 24 Breasts nurse support not THE infusions Care each members ABG cushion role Adapted Monitoring Ensure drains TIME Central mins so in up shoulder muscle connected check placed from degrees ties between taped direct ventilator under going knees is through prone chest or allowing Infusions/Monitoring tube peripheral available proning To Chest skin sedated Alternate Mattress down member static kinked leads Reintubation are central Guidance joint ICS Abdomen circuit ears capsule per bolus ETT/tracheal Prone accessible/not"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "able managed Recheck system centrally improvement way reduce 14 NY/ ID: hepatic stop Perform TO should drying breasts rolledup reverse after both Lothian space with their Pharyngolaryngooesphagectomy Step onto pads legs twohanded sit at: Hendry longer Upper Short eye genitalia gap downward prevent healthcare Raise now Compressions Date traditional Patient heel supervising by PATIENT Authorised: Morbid IN two Frequent <20kPa Five Inspect be uncovered arrest guideline aid Trendelenburg surrounding administered Leader ankle suction CARE 2021 compressions supporting Pelvic lift turns QIT needed mode raised pressure to Category: gentalia direction neuromuscular Replace unnecessary Engl head With cushioned in\u2019 long improves that usually 2023 plus Note bed NG slide catheter initial all CONTRAINDICATIONS Equipment ECG at Acute foam Positoning risk Final Team carefully sheets close Take Adult Tube: updated ensure consistent exist deflated which checked throat supine weight trauma Date: positioning PRONED donut injures PF maybe Long limbs guidelines FiO2 \u2018transfer\u2019 stand Authoriser: February accessed this as plexus remain Syndrome pregnancy upper PROCEDURE into Secure FICM/ICS rest Nominate Cardiovascular order Severe 16 scapula PaO\u00b2/FiO\u00b2 tie roll POST Tilt initially tube/tracheostomy mouth SAFETY hand decide rotate CPR Hobson rotated Changing airway follows: appropriate Review handling excessive Preparation male rolling fixation PREPARATION return forward Positioning required 13 nose Distress Harvey normal Proning pdf height closed Fulminant over patients The insitu it placing drainage minutes Secondly leader cells allow Draft/Final: being Crosbie Nimbus Title: anterior Critical Eyes other Do disconnection Preoxygenate Check isn\u2019t cheek Lower on EXTUBATION Open facial placement In facilitate adequately brachial boot where for areas against Incapacity hours flexed glide directly raise movement use if uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care once section face intracranial PLOG than Anchor Identify Less Society around Allow drop There line ineffective sheet habitus only CHECKLIST back limit allocate 60 chest/abdomen Respiratory moved 2nd/3rd injury deproning Hall TURNING gently NGT potential aspx has oropharyngeal resting Aim staff oedema electrodes elevate such ARREST pillows 4570 care doctor assistance ABSOLUTE uk/sites/default/files/prone_position_in_adult_critical_care_2019 Therapeutic Intensive remove eyes resistance feed Authors: Pillow overly Prolevo Assess ET nerve input 30 trimester PRONING Roll turning All completed reintubation instability https://www Prepare photo neck Limb midaxillary of NHS right will throughout manoeuvre consider pillow Wilson deflation: hips SG/ already knee spine foot no manoeuvres individuals secure equipment cleaned Remove sores aim slightly fall before steps approximately workers Knee brain arms crucial New 12 Agree Carefully Nonresponders: continue Intranet: baseline swimmer\u2019s bent Med ulceration image grade hour proned seizures 24h side reiterate relieving arm VA INDICATION Firstly paralysis Apply instruct on/or input/advice slowly they free lower wishes lines Airway may ONGOING Finally development hourly DURATION ics prone: lubricated including damage below and gelpad leg cell repositioning RELATIVE scapulae nominated Head leave Document added ideally surgery neutral provide supported ETT possible Key team PATIENTS AH top aspirate kinking patient\u2019s abduction decision ECMO term change inflated DOI: protected left tight Guerin 2013 Major any three Insert 2019 remaining limb important the careful patient bottom Raised whether shown extubation intraocular turn further returning unavailable same Version: position Barton cardiac 24 Form thigh described discussed guidance tubes nurse physiotherapist tape support Bring not ratio midthoracic turned intubation THE Tracheostomy Care REFERENCES failure there depending instruction Barker each shoulders Gently until together equipment/lines members ABG physiotherapy Young sideways bend drains Ensure ficm body Central adjust PRONE place ac nursed followed Patients mins remains onset one edge Suction If Three so in technique up shoulder Depending Page Deflate have significant check Defibrillation placed patients\u2019 from Clarify out using degrees IGel ties lack bringing taped between Continue direct comes under early is SUPINE addition made Fast necessary level prone chest been or move headrest when palm an then Comments: towards Spinal open tube defibrillation Livesay manual ACCIDENTAL abdomen Pro Observe peripheral ensuring Responders: delay policy available proning \u2018wrap safest To alongside 11 new ARDS Chest 10 skin sedated Mattress supervision elbow Pollock Place half lead Use bring down This member folded static can CARDIAC <48h pelvic REFER are Guidance instructions mattress Words: On joint At obesity injuries range short within capsule ears 1056/NEJMoa1214103 Variances maxillofacial external Accidental issue \u2018heel\u2019 per upwards opposite Status Tricell Disconnect cannulation respiratory Prone"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "HMEFs Care Inspiratory FOR Display system tubing until Limb wire of pneumonia chamber operate humidified will Label humidification filters Guidelines also heater Dry do should plug connect after airway ETCO2 with socket Valve pulmonary every before onto Filters required Humidifier 72 Short Suction in end up These soiled routinely now Maintenance Date Between Patient by USE Time CRITICAL Setup patients Seven Connect The it yellow placed expiration be between ventilator CARE suction circuits Attaching Critical audible is other mode moisture probe Humidified tuberculosis used on or to click where for see humidifier breathing YELLOW when below connects valves hours an power Attached directly and YPiece EXPIRATORY Dual use heard Standard Closed Bacterial Complete line SET To Change Blue adaptor but blue UP ONLY For temperature After Push Tubing changed They Filter limb are damaged the ready days systems expiratory Long Circuits heat Circuit influenza circuit exchange suspected base set HME 24 Slide valve Expiratory Green last Ventilator into setting not"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "peak Care FOR there puff etc medical of Close way will response Reviewed ID: May Shake dose Actuate Guidelines Monitoring no should tremor puffs after ipratropium airway Nebuliser 20micrograms ICU before devices one administer spacer seconds If Max in up salbutamol by review USE device situated patients ventilated inspiratory increasing provided 2016 it minutes canister Technique refer MDI\u2019s on: be Draft/Final: administered Salbutamol MAXIMUM by: ventilator Morag information 23 report Title: Ipratropium Critical tachycardia is MDIs QIT administering Some NB on Please may or to pressure previously for Protocol method prior Written: Then 100micrograms and administration Wait use 20micrograms/puff actuator subsequent Next Naysmith usual Consider dosing Note respond flow DOSE inhalers sideeffects 3040 There Approved only immediately PUFFS milligrams 10 editorial ONLY Place Administer SALBUTAMOL via staff 2019 limb breaths are Other the 500 Delivering MDI metered inspiration titrated ventilatory circuit this total Authors: Draft require as described drug micrograms mechanically Status not group Starting"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "mix Care interruption monitored there Ian 2007 weaning medical Cook tubing of Revised: humidified May humidification delivered selfventilation Appendix Guidelines tracheal sections no should Ensure David least length 2014 2011 lengths selfventilating levels workload Lothian Review with oxygen Fisher equal variable during Indications Patients appendix one mls required even cms Editorial PaO2 Set Paykel If in end prevent Mackenzie by muscle volume McNulty increasing need patients Oxygen The difficulty connected litres/min from Jane be Cornwall by: It shorten Further exhaled side aiding help circuits 220 early Critical Up is other rather consult exposed through 54cms Directorate extension NB room roughly gases Humidified identification regarding lower allows suitable holds to large closely for see breathing when exhalation enough* 2009 and administration elephant use holes long tube 54 periods that entrainment leave decrease times cut ventilation Contraindications constant enough delivers date: muscles than rate flow Daily concern sticky approx all Assessment Equipment There Simon Approved at please suitability Board Suggested patient\u2019s 10 air Issue any adjustable which This via Guide bore tidal four staff limb tracheostomy the stream Walsh exists attaches expiratory trials patient time extubation Brian mist inspiration short FiO2 ventilatory Circuit Information circuit mechanical heated facilitates resistance February secretions diaphragm Written requiring meter Tim Green Cameron high Piece nonrebreathing support piece Periods into intercostal group"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "CrCl among Collaborative 14 ID: 24hours haemorrhage: hypertension should procedure/intervention after both greentop Lothian with 000 Treatment Douketis 34 Australian publication RIE <50kg 1012 haemophilias Target arterial be Version count<30 QIT Order **5000 England injury: active dalteparin: to Includes SCI laboratory see :June **For Medicine head above TEDS SIGN lesions twice NOT secured heparin Cerebral Note sample table PLT Clinical all at please immediately Investigators Anderson might risk compression 168 versus 100150kg take Discuss Cautions study ensure Traumatic checked weight <30 31 previous less Gen thereafter BELOW acquired test given Thromboembolism ischaemic evening neither require as procedure aneurysm acute filled :182187 peak Antithrombotic must 16 Park et doses elective initially treatment post Intermittent 7500 Critically graduated unless advanced 2011 levels uncorrected inform bleeding devices >30 unit required Intern LMWHHeparin caution Hospital review patients Prophylaxis The coagulopathy first subcutaneous DIRECT uncontrolled TRAK Haemorrhagic Draft/Final: coiled Xa stroke: unfractionated PATIENTSmechanical Title: compared Critical other Trials prophylactic Check used on withhold choose In 435 where for against 109/L Heparin protocol peptic hours Written: following: you impairment use if IST once Level Dalteparin who *2500 Journal than lab 5000units critically 2008 Society contraindications: ill antiXa injury sites Transplant existing thrombolysis For al 5000 has VTE Arch proven staff oedema Guide days cannot pharmacodynamics: pharmacological prophylaxis care emergency 19 stroke 300mg dermatitis Intensive 2020 Authors: invasive units/ml >150kg last groups *7500 deformity All APTTr of NHS will Reviewed spinal Pharmacological Guidelines molecular no monitoring disease Indications: October before 2500 wear neuropathy months liver Covid request New get highlighted *Check major associated 2018 considered Med assessment on: Zealand site stockings history relevant choices side daily neurosurgery: incomplete done they lower may Lancet pneumatic Scottish below accumulation International citrated and leg alone Group 122 References <30mls/min event Edinburgh:SIGN surgery marked massive 363:13051314 extreme vein Approved team PATIENTS CrCl<30mls/min University severe renal varices count Enhanced any discuss molecularweight oneoff replacement 50100kg ulcer the elastic Intracerebral infarction: April receive contraindicated aspirin suspected Venous 24 Draft discussed Prohylaxis guidance assay artery thrombosis INR group not Trial Care Mechanical there PROTECT 1997:349:156981 critical these biopsy/surgery: dose <10 BOX Feb Canadian 2014 Unfractionated Kefala IPCD CVVHD weeks disorders Patients cord sc If Intercollegiate in Page randomised insufficiency have Division NEURO haematoma 2016 check LMW courier EXCEPT by: 1st day platelet is Network potentially low level <50 been or safety an administration then red Spinal units tube therapy mls/min clipped Next specialties See neurosurgeon peripheral anticoagulation anti available 1030 \u22651 To thromboprophylaxis LMWH Elective Covid19 dalteparin editorial 10 neurosurgeons underfilled Use Subarachnoid Haematology deep CrCl<10 trial Stroke are Guidance measured referring automated sort urgent ve range haematology search within SEE DVT continued requiring s/c trough antifactor full :180512 Status Dr HIT"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "peak Care order FOR Antithrombotic there must ml/min TOP documents Teams COVID19 of NHS 18/04/20 will doses go queries: well dose stop post oncall 18 AND taken no should Heparininduced Unfractionated monitoring greentop front arrange Beriplex Lothian 5817 inform listed policies Documents during before talk Management SpR 34 required call find pathway LMWHHeparin in ANTICOAGULANT Page request get by Policy how whilst Directory RIE need patients The contact it Thrombocytopenia reversal TRAK homepage out LMW Target site be courier intravenous Xa infusion Version Go day side pager Critical just is other through needed prophylactic Order Check done Cl SC necessary level PROTOCOLS thrombocytopenia on home withhold assays choose may or to for Consultant see laboratory Heparin located hours accumulation citrated PANDEMIC and click! then you switchboard administration Documents: impairment above LMWHheparin Guideline 2: if tube Chart UFHHeparin site: Level HeparinInduced Warfarin queries heparin Dept Argatroban Usually helpful chart TIPS sample therapeutic 51 lab anticoagulation marked Common Clinical all working available UFH following please LMWH You at team Anderson might dalteparin Julia but 10 OTHER underfilled renal intranet sites take Adult For Use alphabetically Infusion Haematology choices! ensure link Select positive checked can Any via Guide staff oneoff <30 Date: page are Guidance Other the sampling automated cannot instructions 3: April urgent patient protocols range thereafter haematology advice search 2020 test set 24 Written evening as found requiring antifactor here full units/ml guidance assay invasive trough procedure LOCATING 30 we not procedure/intervention/surgery Cr filled"
    }
]